Document:

EX-10.1

 Exhibit 10.1 

[EXECUTION VERSION] 
  

 
  

TERM LOAN AGREEMENT 
 dated as of
September 26, 2019, 
 among 

MPLX LP, 
 The LENDERS Party
Hereto 
 and 
 WELLS FARGO
BANK, NATIONAL ASSOCIATION, 
 as Administrative Agent 
  

 
 WELLS FARGO
SECURITIES, LLC, 
 BOFA SECURITIES, INC. 

and 
 MIZUHO BANK, LTD., 

Joint Lead Arrangers and Joint Bookrunners 

BANK OF AMERICA, N.A. 
 and 

MIZUHO BANK, LTD., 
 Syndication
Agents 
 BNP PARIBAS, 

CITIBANK, N.A., 
 JPMORGAN CHASE
BANK, N.A., 
 MUFG BANK, LTD., 

THE BANK OF NOVA SCOTIA, HOUSTON BRANCH, 

SUMITOMO MITSUI BANKING CORPORATION, 

SUNTRUST BANK, 
 THE
TORONTO-DOMINION BANK, NEW YORK BRANCH 
 and 

U.S. BANK NATIONAL ASSOCIATION, 

Documentation Agents 
  

 
  

[CS&M Ref. No. 11548-14] 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I Definitions	  	 	1	 
			
	 SECTION 1.01.
	 	 Defined Terms
	  	 	1	 
	 SECTION 1.02.
	 	 Classification of Loans and Borrowings
	  	 	26	 
	 SECTION 1.03.
	 	 Terms Generally
	  	 	26	 
	 SECTION 1.04.
	 	 Accounting Terms; GAAP
	  	 	26	 
	 SECTION 1.05.
	 	 Divisions
	  	 	27	 
		
	ARTICLE II The Credits	  	 	27	 
			
	 SECTION 2.01.
	 	 Commitments
	  	 	27	 
	 SECTION 2.02.
	 	 Loans and Borrowings
	  	 	27	 
	 SECTION 2.03.
	 	 Requests for Borrowings
	  	 	28	 
	 SECTION 2.04.
	 	 [Reserved]
	  	 	28	 
	 SECTION 2.05.
	 	 [Reserved]
	  	 	28	 
	 SECTION 2.06.
	 	 Funding of Borrowings
	  	 	28	 
	 SECTION 2.07.
	 	 Interest Elections
	  	 	29	 
	 SECTION 2.08.
	 	 Termination and Reduction of Commitments
	  	 	30	 
	 SECTION 2.09.
	 	 Repayment of Loans; Evidence of Debt
	  	 	31	 
	 SECTION 2.10.
	 	 Prepayment of Loans
	  	 	31	 
	 SECTION 2.11.
	 	 Fees
	  	 	32	 
	 SECTION 2.12.
	 	 Interest
	  	 	32	 
	 SECTION 2.13.
	 	 Alternate Rate of Interest
	  	 	33	 
	 SECTION 2.14.
	 	 Increased Costs
	  	 	36	 
	 SECTION 2.15.
	 	 Break Funding Payments
	  	 	37	 
	 SECTION 2.16.
	 	 Taxes
	  	 	38	 
	 SECTION 2.17.
	 	 Payments Generally; Pro Rata Treatment; Sharing of
Set-offs
	  	 	41	 
	 SECTION 2.18.
	 	 Mitigation Obligations; Replacement of Lenders
	  	 	42	 
	 SECTION 2.19.
	 	 Illegality
	  	 	43	 
	 SECTION 2.20.
	 	 Defaulting Lenders
	  	 	44	 
		
	ARTICLE III Representations and Warranties	  	 	45	 
			
	 SECTION 3.01.
	 	 Organization; Powers
	  	 	45	 
	 SECTION 3.02.
	 	 Authorization; Enforceability
	  	 	45	 
	 SECTION 3.03.
	 	 Governmental Approvals; No Conflicts
	  	 	45	 
	 SECTION 3.04.
	 	 Financial Condition; No Material Adverse Effect
	  	 	45	 
	 SECTION 3.05.
	 	 Properties
	  	 	46	 
	 SECTION 3.06.
	 	 Litigation and Environmental Matters
	  	 	46	 
	 SECTION 3.07.
	 	 Compliance with Laws; No Default
	  	 	46	 
	 SECTION 3.08.
	 	 Margin Regulations; Investment Company Status
	  	 	46	 
	 SECTION 3.09.
	 	 Taxes
	  	 	47	 
	 SECTION 3.10.
	 	 ERISA
	  	 	47	 
	 SECTION 3.11.
	 	 Disclosure
	  	 	47	 
	 SECTION 3.12.
	 	 Subsidiaries; Equity Investments
	  	 	47	 
	 SECTION 3.13.
	 	 Anti-Corruption Laws and Sanctions
	  	 	47	 
		
	ARTICLE IV Conditions	  	 	48	 
			
	 SECTION 4.01.
	 	 Closing Date
	  	 	48	 
	 SECTION 4.02.
	 	 Conditions to Each Funding Date
	  	 	49	 

  
 i 

							
		
	ARTICLE V Affirmative Covenants	  	 	49	 
			
	 SECTION 5.01.
	 	 Financial Statements; Ratings Change and Other Information
	  	 	50	 
	 SECTION 5.02.
	 	 Notices of Default
	  	 	51	 
	 SECTION 5.03.
	 	 Existence; Conduct of Business
	  	 	51	 
	 SECTION 5.04.
	 	 Payment of Taxes and other Obligations
	  	 	51	 
	 SECTION 5.05.
	 	 Maintenance of Properties; Insurance
	  	 	51	 
	 SECTION 5.06.
	 	 Books and Records; Inspection Rights
	  	 	52	 
	 SECTION 5.07.
	 	 Compliance with Laws
	  	 	52	 
	 SECTION 5.08.
	 	 Use of Proceeds
	  	 	52	 
	 SECTION 5.09.
	 	 Maintenance of Separateness
	  	 	52	 
	 SECTION 5.10.
	 	 Required Subsidiary Guarantors
	  	 	52	 
	 SECTION 5.11.
	 	 Anti-Corruption Laws and Sanctions
	  	 	53	 
	 SECTION 5.12.
	 	 Excluded Ventures
	  	 	53	 
		
	ARTICLE VI Negative Covenants; Financial Covenant	  	 	54	 
			
	 SECTION 6.01.
	 	 Indebtedness
	  	 	54	 
	 SECTION 6.02.
	 	 Liens and Sale and Leaseback Transactions
	  	 	55	 
	 SECTION 6.03.
	 	 Mergers, Fundamental Changes and Dispositions
	  	 	57	 
	 SECTION 6.04.
	 	 Transactions with Affiliates
	  	 	57	 
	 SECTION 6.05.
	 	 Fiscal Year; Accounting Principles
	  	 	58	 
	 SECTION 6.06.
	 	 Change in Nature of Business
	  	 	58	 
	 SECTION 6.07.
	 	 Restricted Payments
	  	 	58	 
	 SECTION 6.08.
	 	 Changes in Organization Documents
	  	 	58	 
	 SECTION 6.09.
	 	 Maximum Consolidated Leverage Ratio
	  	 	58	 
		
	ARTICLE VII Events of Default	  	 	59	 
		
	ARTICLE VIII The Administrative Agent	  	 	61	 
			
	 SECTION 8.01.
	 	 Appointment and Authority
	  	 	61	 
	 SECTION 8.02.
	 	 Rights as a Lender
	  	 	61	 
	 SECTION 8.03.
	 	 Exculpatory Provisions
	  	 	61	 
	 SECTION 8.04.
	 	 Reliance by Administrative Agent
	  	 	62	 
	 SECTION 8.05.
	 	 Delegation of Duties
	  	 	63	 
	 SECTION 8.06.
	 	 Resignation of Administrative Agent
	  	 	63	 
	 SECTION 8.07.
	 	 Non-Reliance on Administrative Agent and Other
Lenders
	  	 	64	 
	 SECTION 8.08.
	 	 No Other Duties, Etc.
	  	 	64	 
	 SECTION 8.09.
	 	 Administrative Agent May File Proofs of Claim
	  	 	64	 
	 SECTION 8.10.
	 	 Consent
	  	 	65	 
	 SECTION 8.11.
	 	 ERISA
	  	 	65	 
		
	ARTICLE IX Miscellaneous	  	 	66	 
			
	 SECTION 9.01.
	 	 Notices; Effectiveness; Communication
	  	 	66	 
	 SECTION 9.02.
	 	 Waivers; Amendments
	  	 	67	 
	 SECTION 9.03.
	 	 Expenses; Indemnity; Damage Waiver
	  	 	68	 
	 SECTION 9.04.
	 	 Successors and Assigns
	  	 	70	 
	 SECTION 9.05.
	 	 Survival
	  	 	73	 
	 SECTION 9.06.
	 	 Counterparts; Integration; Effectiveness; Electronic Execution
	  	 	74	 
	 SECTION 9.07.
	 	 Severability
	  	 	74	 
	 SECTION 9.08.
	 	 Right of Setoff
	  	 	75	 
	 SECTION 9.09.
	 	 Subsidiary Guarantees
	  	 	75	 
	 SECTION 9.10.
	 	 Governing Law; Jurisdiction; Consent to Service of Process
	  	 	75	 

  
 ii 

							
	 SECTION 9.11.
	 	 WAIVER OF JURY TRIAL
	  	 	76	 
	 SECTION 9.12.
	 	 Headings
	  	 	76	 
	 SECTION 9.13.
	 	 Confidentiality
	  	 	76	 
	 SECTION 9.14.
	 	 Interest Rate Limitation
	  	 	78	 
	 SECTION 9.15.
	 	 Certain Notices
	  	 	78	 
	 SECTION 9.16.
	 	 No Advisory or Fiduciary Responsibility
	  	 	78	 
	 SECTION 9.17.
	 	 Acknowledgment and Consent to Bail-In of EEA Financial
Institutions
	  	 	79	 

 SCHEDULES: 
  

			
	Schedule 2.01	  	Commitments
	Schedule 3.12	  	Subsidiaries; Other Equity Investments
	Schedule 6.01	  	Existing Indebtedness
	Schedule 6.02	  	Existing Liens
	Schedule 6.04	  	Transactions with Affiliates

 EXHIBITS: 
  

			
	Exhibit A	  	Form of Assignment and Assumption
	Exhibit B	  	Form of Borrowing Request
	Exhibit C	  	Form of Interest Election Request
	Exhibit D	  	Form of Note
	Exhibit E-1	  	Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)
	Exhibit E-2	  	Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Partnerships for U.S. Federal Income Tax Purposes)
	Exhibit E-3	  	Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Not Partnerships for U.S. Federal Income Tax Purposes)
	Exhibit E-4	  	Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Partnerships for U.S. Federal Income Tax Purposes)
	Exhibit F	  	Form of Subsidiary Guarantee

  
 iii 

 TERM LOAN AGREEMENT dated as of September 26, 2019, among MPLX LP, a Delaware limited
partnership, the LENDERS party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent. 
 The parties hereto agree as
follows: 
 ARTICLE I 

Definitions 

SECTION 1.01. Defined Terms. As used in this Agreement, the following terms have the meanings specified below: 

“ABR”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing,
are bearing interest at a rate determined by reference to the Alternate Base Rate. 
 “Acquisition Period” means the period
beginning with the quarter in which payment of the purchase price for a Specified Acquisition is made and ending on the earlier of (a) the last day of the second fiscal quarter following the fiscal quarter in which such payment is made and
(b) the date on which the Borrower notifies the Administrative Agent that it desires to end the Acquisition Period for such Specified Acquisition. 

“Adjusted LIBO Rate” means, with respect to any Eurodollar Borrowing for any Interest Period, an interest rate per annum
(rounded upwards, if necessary, to the next 1/100 of 1%) equal to (a) the LIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate. 

“Administrative Agent” means Wells Fargo Bank, National Association, in its capacity as administrative agent for the Lenders
hereunder and under the other Loan Documents, and any successor in such capacity as provided in Article VIII. 
 “Administrative
Questionnaire” means an Administrative Questionnaire in a form supplied by the Administrative Agent. 

“Affiliate” means, with respect to a specified Person, another Person that directly, or indirectly through one or more
intermediaries, Controls or is Controlled by or is under common Control with the Person specified. 
 “Agreement” means
this Term Loan Agreement, as it may from time to time be amended, restated, supplemented or otherwise modified. 
 “Alternate Base
Rate” means, for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the NYFRB Rate in effect on such day plus 1⁄2 of 1% per annum and (c) the Adjusted LIBO Rate on such day (or if such day is not a Business Day, the immediately preceding Business Day) for a deposit in dollars with a maturity of one month plus 1% per
annum. For purposes of clause (c) above, the Adjusted LIBO Rate for any day shall be based on the LIBO Screen Rate (or, in the event the LIBO Screen Rate is not available for such maturity of one month, the Interpolated Screen Rate) at
approximately 11:00 a.m., London time, on such day for deposits in dollars with a maturity of one month; provided that if such rate shall be less than zero, such rate shall be deemed to be zero. If the Alternate Base Rate is being used as an
alternate rate of interest pursuant to Section 2.13, then the Alternate Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above; provided that the Alternate Base
Rate shall not be less than 1% per annum. Any change in the Alternate Base Rate due to a change in the Prime Rate, the NYFRB Rate or the Adjusted LIBO Rate shall be effective from and including the effective date of such change in the Prime Rate,
the NYFRB Rate or the Adjusted LIBO Rate, respectively. 

 “Anti-Corruption Laws” means all laws, rules and regulations of any
jurisdiction applicable to the Borrower or any of its Subsidiaries from time to time concerning or relating to bribery or corruption. 

“Applicable Rate” means, for any day, with respect to any ABR Loan or Eurodollar Loan, as the case may be, the applicable
rate per annum set forth in the grid below under the caption “ABR Loan Spread” or “Eurodollar Loan Spread”, as the case may be, based upon the Applicable Ratings by S&P, Moody’s and Fitch, respectively, as of such date:

  

											
	Pricing
Level	  	 Applicable Ratings

(S&P/Moody’s/Fitch):
	  	Eurodollar Loan
Spread	 	 	ABR Loan
Spread	 
	1	  	 BBB+/Baa1/BBB+ or higher
	  	 	0.750	% 	 	 	0.00	% 
	2	  	 BBB/Baa2/BBB
	  	 	0.875	% 	 	 	0.00	% 
	3	  	 BBB-/Baa3/BBB-
or below
	  	 	1.00	% 	 	 	0.00	% 

 For purposes of the foregoing, (a) if at any time, only one Applicable Rating shall be in effect, the applicable Pricing
Level shall be determined by reference to the available Applicable Rating, (b) if no Applicable Rating shall be in effect (other than by reason of the circumstances referred to in the final paragraph of this definition), Pricing Level 3
shall apply, (c) if at any time there is more than one Applicable Rating in effect and such Applicable Ratings are in different Pricing Levels, then (i) if three Applicable Ratings are in effect, either (x) if two of the Applicable
Ratings are in the same Pricing Level, such Pricing Level will apply or (y) if all three Applicable Ratings are in different Pricing Levels, then the Pricing Level corresponding to the middle Applicable Rating will apply and (ii) if only
two Applicable Ratings are in effect, then the Pricing Level corresponding to the higher Applicable Rating will apply, unless there is more than one Pricing Level between such Applicable Ratings, in which case the Pricing Level one below that
applicable to the higher of the two such Applicable Ratings will apply, and (d) if the Applicable Ratings established by S&P, Moody’s or Fitch shall be changed (other than as a result of a change in the rating system of S&P,
Moody’s or Fitch), such change shall be effective as of the date on which it is first announced by the applicable rating agency, irrespective of when notice of such change shall have been furnished by the Borrower to the Administrative Agent
and the Lenders pursuant to Section 5.01 or otherwise. Each change in the Applicable Rate shall apply during the period commencing on the effective date of such change and ending on the date immediately preceding the effective date of the next
such change. 
 If the rating system of S&P, Moody’s or Fitch shall change, or if any of such rating agencies shall cease to be in the business of
rating corporate debt obligations, the Borrower and the Lenders shall negotiate in good faith to amend this definition to reflect such changed rating system or the unavailability of ratings from such rating agency and, pending the effectiveness of
any such amendment, the Applicable Rate shall be determined by reference to the rating most recently in effect prior to such change or cessation. 

“Applicable Rating” means, for each of S&P, Moody’s and Fitch, the rating assigned by such rating agency to the
Index Debt, provided that if such rating agency shall at any time fail to have in effect a rating for the Index Debt (other than by reason of the circumstances referred to in the final paragraph of the definition of “Applicable
Rate”), the Borrower may seek and obtain a rating of the 

  
 2 

 
Facility from such rating agency, and on and after the date on which such rating of the Facility is obtained until such time (if any) that a rating by such rating agency for the Index Debt
becomes effective again, the Applicable Rating for such rating agency shall mean the rating assigned by such rating agency to the Facility. 

“Approved Fund” means any Person (other than a natural person) that is engaged in making, purchasing, holding or otherwise
investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that
administers or manages a Lender. 
 “Arrangers” means Wells Fargo Securities, LLC, BofA Securities, Inc. and Mizuho Bank,
Ltd. 
 “Assignment and Assumption” means an assignment and assumption entered into by a Lender and an Eligible Assignee
(with the consent of any Person whose consent is required by Section 9.04), and accepted by the Administrative Agent, in the form of Exhibit A or any other form approved by the Administrative Agent in consultation with the Borrower. 

“Attributable Debt” means, as of any date of determination, the present value (discounted semiannually at an interest rate
implicit in the terms of the relevant lease) of the obligation of a lessee for rental payments pursuant to any Sale and Leaseback Transaction (reduced by the amount of the rental obligations of any sublessee of all or part of the same property)
during the remaining term of such Sale and Leaseback Transaction (including any period for which the lease relating thereto has been extended), such rental payments not to include amounts payable by the lessee for maintenance and repairs, insurance,
taxes, assessments and similar charges and for contingent rents (such as those based on sales). In the case of any Sale and Leaseback Transaction in which the lease is terminable by the lessee upon the payment of a penalty, such rental payments
shall be considered for purposes of this definition to be the lesser of (a) the rental payments to be paid under such Sale and Leaseback Transaction until the first date (after the date of such determination) upon which it may be so terminated
plus the then applicable penalty upon such termination and (b) the rental payments required to be paid during the remaining term of such Sale and Leaseback Transaction (assuming such termination provision is not exercised). 

“Bail-In Action” means, as to any EEA Financial Institution, the exercise of any
Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of such EEA Financial Institution. 

“Bail-In Legislation” means, with respect to any EEA Member Country implementing
Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time that is described in the EU Bail-In
Legislation Schedule. 
 “Bankruptcy Event” means, with respect to any Person, that such Person becomes the subject of a
bankruptcy, insolvency, reorganization, liquidation or similar proceeding, or has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation
of its business appointed for it (including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity), or, in the good faith determination of the Administrative Agent, has taken any
action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such proceeding or appointment; provided that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of
any ownership interest, in such Person by a Governmental Authority, so long as such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of
judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person. 

  
 3 

 “Beneficial Ownership Certification” means a certification regarding
beneficial ownership or control as required by the Beneficial Ownership Regulation. 
 “Beneficial Ownership Regulation”
means 31 C.F.R. § 1010.230. 
 “Benefit Plan” means (a) an “employee benefit plan” (as defined in
ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of
Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”. 

“Board” means the Board of Governors of the Federal Reserve System of the United States of America. 

“Borrower” means MPLX LP, a Delaware limited partnership. 

“Borrowing” means Loans of the same Type made, converted or continued on the same date and, in the case of Eurodollar Loans,
as to which a single Interest Period is in effect. 
 “Borrowing Request” means a request by the Borrower for a Borrowing
in accordance with Section 2.03, which shall be substantially in the form of Exhibit B. 
 “Business Day” means any
day that is not a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law to remain closed; provided that when used in connection with a Eurodollar Loan, the term “Business
Day” shall also exclude any day on which banks are not open for dealings in dollar deposits in the London interbank market. 

“Capital Lease Obligations” of any Person means, subject to Section 1.04, the obligations of such Person to pay rent or
other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such
Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP. For purposes of Section 6.02, a Capital Lease Obligation shall be deemed to be secured by a Lien on the property
being leased and such property shall be deemed to be owned by the lessee. 
 “Cash Equivalents” means: 

(a) direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of
America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America), in each case maturing within one year from the date of acquisition thereof; 

(b) investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the
highest credit rating obtainable from S&P or from Moody’s; 

  
 4 

 (c) investments in certificates of deposit, banker’s acceptances and demand or time
deposits, in each case, maturing within 180 days from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, any domestic office of any commercial bank organized under the laws
of the United States of America or any State thereof that has a combined capital and surplus and undivided profits of not less than $500,000,000; 

(d) fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (a) above and
entered into with a financial institution satisfying the criteria described in clause (c) above; 
 (e) deposits in money market funds
which invest 95% or more of their funds in investments described in any of clauses (a), (b) and (c) above; and 
 (f) in the case of any
Subsidiary organized or operating outside the United States, other short-term investments that are analogous to the foregoing, are of comparable credit quality and are customarily used by companies in the applicable foreign jurisdiction for cash
management purposes. 
 “Change in Control” means, as of any date, (a) failure of MPC to own, directly or indirectly,
at least 51% of the Equity Interests of the General Partner that are entitled to vote for the board of directors or equivalent governing body of the General Partner or (b) failure of the General Partner to be the sole general partner of, and to
Control, the Borrower. 
 “Change in Law” means the occurrence, after the date of this Agreement, of any of the following:
(a) the adoption or taking effect of any law, rule, regulation or treaty by any Governmental Authority, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof
by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) of any Governmental Authority; provided, however, that for purposes of this
Agreement (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated
by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to
be a “Change in Law”, regardless of the date enacted, adopted, promulgated or issued. 
 “Charges” has the
meaning assigned to such term in Section 9.14. 
 “Closing Date” means the date on which the conditions specified in
Section 4.01 are satisfied (or waived in accordance with Section 9.02). 
 “Code” means the Internal Revenue Code
of 1986, as amended from time to time. 
 “Commercial Operation Date” the date on which a Material Project is substantially
complete and commercially operable. 
 “Commitment” means, with respect to any Lender, the commitment of such Lender to
make Loans hereunder, expressed as an amount representing the maximum aggregate principal amount of the Loans to be made by such Lender hereunder, as such amount may be (a) reduced from time to time pursuant to Section 2.08 or
(b) reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04. The initial amount of each Lender’s Commitment is set forth on Schedule 2.01 or in the Assignment and Assumption
pursuant to which such Lender shall have assumed its Commitment, as applicable. The aggregate amount of the Commitments as of the date hereof is $1,000,000,000. 

  
 5 

 “Commodity Exchange Act” means the Commodity Exchange Act (7 U.S.C. 1, et
seq.), as amended from time to time, any successor statute, and any rule, regulation, or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof). 

“Communications” means, collectively, any notice, demand, communication, information, document or other material provided by
or on behalf of any Loan Party pursuant to any Loan Document or the transactions contemplated therein that is distributed to the Administrative Agent or any Lender by means of electronic communications pursuant to Section 9.01, including
through the Platform. 
 “Compliance Certificate” has the meaning assigned to such term in Section 5.01(c). 

“Compliance Certificate Delivery Date” with respect to a Quarter-End Date means the
earlier of (a) the date of delivery, pursuant to Section 5.01(c), of the Compliance Certificate with respect to the reporting period ending on such Quarter-End Date or (b) the date that such
Compliance Certificate is required to be delivered pursuant to Section 5.01(c). 
 “Connection Income Taxes” means
Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes. 

“Consolidated EBITDA” means, for any period, an amount equal to the sum of (a) Consolidated Net Income for such period
plus, (b) to the extent reducing Consolidated Net Income for such period, and without duplication: (i) net federal, state, local or foreign income or franchise tax expense; (ii) net interest expense (including amortization or write-off of debt issuance costs and commissions, discounts and other fees and charges associated with Indebtedness), amortization of capitalized interest and the net amount accrued (whether or not actually paid)
pursuant to any interest rate protection agreement during such period (or minus the net amount receivable (whether or not actually received) during such period); (iii) depreciation, depletion and amortization expense, including amortization of
intangibles; (iv) extraordinary expenses or loss and unusual or non-recurring non-cash expenses or losses (including, whether or not otherwise includable as a
separate item in the statement of such Consolidated Net Income for such period, (A) non-cash losses from dispositions not in the ordinary course of business and (B) goodwill or intangible asset
impairment); and (v) any other non-cash charges to income (including non-cash charges (I) relating to stock based compensation, (II) resulting from the
decline in the value of inventory due to the application of the lower of cost or market/net realizable value valuation method, (III) relating to Swap Agreements, and (IV) attributable to non-cash
write-downs of assets); minus, (c) to the extent included in the calculation of Consolidated Net Income for such period, without duplication, the sum of: (i) any extraordinary income or gains (including, whether or not otherwise
includable as a separate item in the statement of such Consolidated Net Income for such period, gains on dispositions not in the ordinary course of business); (ii) any cash expenditures during such period on account of any non-cash item which was added back to Consolidated EBITDA during any prior period with respect to which a calculation of Consolidated EBITDA was made under this Agreement (and provided that the cash
expenditure does not impact Consolidated Net Income in the period paid); (iii) any other unusual or non-recurring non-cash income or gains; and (iv) any non-cash gains attributable to non-cash write-ups of assets, all as determined for the Borrower and its Subsidiaries on a consolidated
basis. 
 For purposes of the foregoing clauses (a) and (b), without duplication, Consolidated Net Income and consolidated expenses
shall be adjusted with respect to net income and expenses of Non-Wholly Owned Subsidiaries, to the extent not already excluded from Consolidated Net Income, to reflect only the Borrower’s pro rata
ownership interest therein. 

  
 6 

 Consolidated EBITDA for the relevant period shall be calculated after giving effect, on a
pro forma basis, to acquisitions and dispositions consummated during such period of the following by the Borrower or its Subsidiaries, as if such acquisition or disposition occurred on the first day of such period: (w) more than 50% of the
Equity Interests in any other Person, (x) Equity Interests in any Person that is (or, in the case of an acquisition, that becomes after such acquisition) a Subsidiary of the Borrower, (y) Equity Interests in other Persons and
(z) other property or assets (other than acquisitions or dispositions of Equity Interests in a Person, capital expenditures and acquisitions of inventory or supplies in the ordinary course of business) of, or of an operating division or
business unit of, any other Person. In the case of any such acquisition, any such pro forma adjustment shall be at the Borrower’s option, and in the case of any such dispositions, the Borrower may elect to exclude the pro forma effect of
dispositions to the extent that the aggregate consideration received by the Borrower and its Subsidiaries in connection with such excluded dispositions does not exceed $50,000,000 during any period of four fiscal quarters. In the case of any such
acquisition of property or assets (either directly or indirectly through the acquisition of Equity Interests of any Person holding such property or assets) that were not in operation or otherwise did not constitute a “business” (as
described in Rule 11-01(d) of Regulation S-X promulgated under the Exchange Act) during the period of four fiscal quarters preceding the consummation of such
acquisition, the pro forma adjustment may be calculated on the basis of, at the Borrower’s option, either (i) annualizing the Consolidated EBITDA attributable to the operations of such property or assets for the portion of the relevant
period elapsed subsequent to the consummation of such acquisition or (ii) solely if less than a full fiscal quarter has elapsed subsequent to the consummation of such acquisition and subject to the approval by the Administrative Agent as set
forth below, the projected Consolidated EBITDA attributable to the operation of such property or assets for the 12-month period following the consummation of the acquisition (such projected Consolidated EBITDA
to be determined based on customer contracts relating to such property or assets, the creditworthiness of the other parties to such contracts, projected revenues from such contracts, capital costs and expenses and other reasonable factors) (such
calculation under this clause (ii), the “Projected Acquired Assets EBITDA Adjustments”). Any pro forma adjustments shall be calculated in good faith by the Borrower and shall be supported by reasonably detailed calculations
furnished together with the Compliance Certificate delivered pursuant to Section 5.01(c) for the applicable period; provided that in the case of any Projected Acquired Assets EBITDA Adjustments, (A) the Borrower shall have delivered
to the Administrative Agent a proposed determination of such Projected Acquired Assets EBITDA Adjustments setting forth pro forma adjustments of Consolidated EBITDA with respect to such property or assets, together with reasonably detailed
information with respect thereto, and (B) as soon as reasonably practicable after delivery by the Borrower of such proposed determination of Projected Acquired Assets EBITDA Adjustments, and in any event within 10 Business Days following the
Borrower’s delivery, the Administrative Agent shall either (1) approve such determination of Projected Acquired Assets EBITDA Adjustments (such approval not to be unreasonably withheld, conditioned or delayed), (2) object to such
determination of Projected Acquired Assets EBITDA Adjustments based on application of criteria set forth in clause (ii) above or (3) request additional information from the Borrower as is reasonably necessary to approve or object to the
Borrower’s proposed determination. If the Administrative Agent objects to the Borrower’s determination of Projected Acquired Assets EBITDA Adjustments or requests additional information, the Borrower and Administrative Agent shall
reasonably cooperate to agree upon the determination of Projected Acquired Assets EBITDA Adjustments as soon as is reasonably practicable. 

Further, in connection with any Material Project, Consolidated EBITDA, for purposes of calculating the ratio of Consolidated Total Debt to
Consolidated EBITDA and compliance with Section 6.09, may be modified so as to include Material Project EBITDA Adjustments, as provided in Section 6.09. 

“Consolidated Net Income” means, for any period, the sum of (a) net income (loss) of the Borrower and its Subsidiaries
on a consolidated basis for such period, determined in accordance with GAAP, provided that there shall be excluded from such net income (to the extent otherwise included therein) the income (or loss) of Excluded Ventures and any other Person
(other than a Subsidiary) in 

  
 7 

 
which the Borrower or any Subsidiary has an ownership interest, plus (b) cash dividends or similar cash distributions received by the Borrower and its Subsidiaries during such period from
Excluded Ventures and any other Person (other than a Subsidiary) in which the Borrower or any Subsidiary has an ownership interest. Further, when determining Consolidated Net Income for any fiscal quarter, Consolidated Net Income shall not include
any undistributed net income of a Subsidiary to the extent that the ability of such Subsidiary to make Restricted Payments to the Borrower or to a Subsidiary is, as of the date of determination of Consolidated Net Income, restricted by its
Organization Documents, any Contractual Obligation (other than pursuant to this Agreement) or any applicable law. 
 “Consolidated
Net Tangible Assets” means, at any date, (a) total assets of the Borrower and the Subsidiaries determined on a consolidated basis in accordance with GAAP minus (b) the sum of (i) current liabilities (excluding
short-term Indebtedness and the current portion of long-term Indebtedness) of the Borrower and the Subsidiaries and (ii) goodwill and other business combination related intangible assets of the Borrower and the Subsidiaries, in each case
determined on a consolidated basis in accordance with GAAP, all as reflected in the consolidated financial statements most recently delivered to the Administrative Agent and the Lenders pursuant to Section 5.01(a) or Section 5.01(b) (or,
prior to the first delivery of such financial statements, the most recent consolidated financial statements of the Borrower referred to in Section 3.04(b)); provided that the assets of Excluded Ventures and the liabilities of Excluded
Ventures shall be excluded from calculation of Consolidated Net Tangible Assets, provided that, in the case of any such liabilities, to the extent such liabilities are recourse to the Borrower or any Subsidiary, the full amount of such
liabilities that are so recourse shall be deducted for purposes of this definition. For purposes of this definition, the amount of assets and liabilities of any Non-Wholly Owned Subsidiary shall be included or
deducted, as the case may be, only to the extent of the proportional Equity Interests directly or indirectly owned by the Borrower in such Subsidiary, provided that, in the case of any such liabilities, to the extent such liabilities are
recourse to the Borrower or any other Subsidiary, the full amount of such liabilities that are so recourse shall be deducted for purposes of this definition. 

“Consolidated Total Debt” means, at any date, without duplication the aggregate amount of the Debt of the Borrower and its
Subsidiaries as of such date determined on a consolidated basis. For purposes of this definition, “Debt” means Indebtedness of the type specified in clause (a), (b), (c) or (g), clause (h) or (i) (so long as obligations
specified in such clause are not contingent) or clause (f) (if the Guarantees specified in such clause are of Indebtedness of the type referred to above) of the definition of “Indebtedness”. If (x) on or prior to a Quarter-End Date the Borrower or a Subsidiary has designated any Debt constituting Material Indebtedness (“Designated Material Debt”) to be repaid on or before the Compliance Certificate Delivery
Date with respect to such Quarter-End Date (whether such repayment is due to stated maturity, an irrevocable prepayment or redemption notice, a tender offer or otherwise), (y) on or prior to such Quarter-End Date the Borrower or a Subsidiary has issued new Debt that is included in the calculation of Consolidated Total Debt as of such Quarter-End Date (“New
Debt”) for the stated purpose of, among other things, repaying or redeeming the Designated Material Debt, and (z) on such Quarter-End Date an amount equal to the net cash proceeds of the New Debt
(or, if less, an amount sufficient to repay or redeem the Designated Material Debt) is held by the Borrower or such Subsidiary as unrestricted cash and cash equivalents (in both cases not subject to any Liens other than inchoate Liens arising by
operation of law or Liens in favor of the trustee or agent or holders of the Designated Material Debt) or deposited with the trustee or agent or holders of the Designated Material Debt (the amount so held or deposited is herein referred to as the
“Available Cash Amount”), then at the option of the Borrower, Designated Material Debt in an amount not to exceed the amount of the New Debt or the Available Cash Amount may be excluded from the calculation of Consolidated Total
Debt on such Quarter-End Date. 

  
 8 

 Notwithstanding the foregoing, Indebtedness of a
Non-Wholly Owned Subsidiary of a Person shall be included in Consolidated Total Debt only to the extent of the Borrower’s proportional interest therein, unless such Indebtedness is recourse to the
Borrower or any Subsidiary, in which case the full amount of such Indebtedness that is recourse to the Borrower or any Subsidiary shall be included in the calculation of Consolidated Total Debt. 

“Contractual Obligation” means, as to any Person, any provision of any security issued by such Person or of any agreement,
instrument or other undertaking to which such Person is a party or by which it or any of its property is bound. 

“Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative thereto. 

“Credit Contact” means, with respect to each Credit Party, such Person designated in the Administrative Questionnaire or
other notice provided to the Administrative Agent as the Credit Contact for such Credit Party. 
 “Credit Party” means the
Administrative Agent or any Lender. 
 “Default” means any event or condition which constitutes an Event of Default or
which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 
 “Defaulting Lender”
means any Lender that (a) has failed, within two Business Days of the date required to be funded or paid, (i) to fund any portion of its Loans, unless such Lender notifies the Administrative Agent in writing that such failure is the result
of such Lender’s good faith determination that a condition precedent to funding (specifically identified in such writing, including, if applicable, by reference to a specific Default) has not been satisfied or (ii) to pay to any Credit
Party any other amount required to be paid by it hereunder, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding
obligations under this Agreement (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and indicates that such position is based on such Lender’s good-faith determination that a condition
precedent to funding (which condition precedent, together with the applicable Default, shall be specifically identified in such writing or public statement) to funding a Loan cannot be satisfied) or generally under other agreements in which it
commits to extend credit, (c) has failed, within three Business Days after request by the Borrower or a Credit Party made in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with
its obligations to fund prospective Loans under this Agreement, provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon the Borrower’s or such Credit Party’s receipt of such
certification in form and substance satisfactory to the Borrower and the Administrative Agent, (d) has become the subject of a Bankruptcy Event or (e) has, or has a Lender Parent that has, become the subject of a Bail-In Action. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (e) above shall be conclusive and binding absent manifest error.

 “Delayed Draw Availability Period” means the period from and including the Closing Date to, and including, the Delayed
Draw Funding Deadline. 
 “Delayed Draw Funding Deadline” means the date that is 90 days after the Closing Date. 

  
 9 

 “Designated Material Debt” has the meaning set forth in the definition of
Consolidated Total Debt. 
 “Disposition” means any sale, transfer or other disposition. 

“dollars” or “$” refers to lawful money of the United States of America. 

“EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA Member Country
that is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country that is a parent of an institution described in clause (a) above or (c) any financial institution established in an
EEA Member Country that is a subsidiary of an institution described in clause (a) or (b) above and is subject to consolidated supervision with its parent. 

“EEA Member Country” means any member state of the European Union, Iceland, Liechtenstein and Norway. 

“EEA Resolution Authority” means any public administrative authority or any Person entrusted with public administrative
authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution. 

“Electronic Signature” means an electronic signature, sound, symbol or process attached to, or associated with, a contract or
other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record. 
 “Eligible
Assignee” means (a) a Lender, (b) a commercial bank, an insurance company, a commercial finance company or a company engaged in making commercial loans, in each case, which, together with its Affiliates, has a combined capital and
surplus in excess of $500,000,000, (c) any Affiliate of a Lender, (d) an Approved Fund or (e) any other Person that is an “accredited investor” (as defined in Regulation D under the Securities Act) and that extends credit or
makes or purchases loans in the ordinary course of its business, other than, in each case, (i) a Defaulting Lender or a Lender Parent thereof, (ii) the Borrower or any Subsidiary or other Affiliate of the Borrower or (iii) a natural
person (or a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of, a natural person). 

“Environmental Laws” means all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices
or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the management, release or threatened release of any Hazardous
Material or to health and safety matters. 
 “Environmental Liability” means any liability, contingent or otherwise
(including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), directly or indirectly resulting from or based upon (a) the violation of any Environmental Law, (b) any Environmental Law with
respect to the generation, use handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the release or threatened release of any Hazardous Materials into the
environment or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing. 

  
 10 

 “Equity Interests” means shares of capital stock, partnership interests,
membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any such equity
interest (other than any Indebtedness that is convertible at the option of the holder into Equity Interests, to the extent such holder has not so converted such Indebtedness). 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and the regulations
promulgated and rulings thereunder. 
 “ERISA Affiliate” means any trade or business (whether or not incorporated) that,
together with the Borrower or the General Partner, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single
employer under Section 414 of the Code. 
 “ERISA Event” means (a) any “reportable event”, as defined
in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30 day notice period is waived); (b) a failure by any Plan to satisfy the “minimum funding standards” (as defined
in Section 412 of the Code or Section 302 of ERISA) applicable to such Plan, in each instance, whether or not waived; (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a
waiver of the minimum funding standard with respect to any Plan; (d) the incurrence by the Borrower or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan; (e) the receipt by the
Borrower or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan; (f) the incurrence by the Borrower or any of its ERISA
Affiliates of any liability with respect to the withdrawal or partial withdrawal from any Plan or Multiemployer Plan; or (g) the receipt by the Borrower or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from the
Borrower or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent, within the meaning of Title IV of ERISA, or in endangered or critical
status, within the meaning of Section 305 of ERISA. 
 “EU Bail-In Legislation
Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time. 

“Eurodollar”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such
Borrowing, are bearing interest at a rate determined by reference to the Adjusted LIBO Rate. 
 “Events of Default” has the
meaning assigned to such term in Article VII. 
 “Exchange Act” means the United States Securities Exchange Act of 1934, as
amended. 
 “Excluded Taxes” means any of the following Taxes imposed on or with respect to a Recipient or required to be
withheld or deducted from a payment to a Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of such Recipient being organized
under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes,
(b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which
(i) such Lender acquires such interest in such Loan or Commitment (other than pursuant to an assignment 

  
 11 

 
request by the Borrower under Section 2.18(b)) or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.16, amounts with
respect to such Taxes were payable either to such Lender’s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Recipient’s
failure to comply with Section 2.16(f) and (d) any U.S. federal withholding Taxes imposed under FATCA. 
 “Excluded
Venture” means each subsidiary of the Borrower that has been designated by the Borrower as an Excluded Venture pursuant to Section 5.12(a) and, pursuant to Section 5.12(e), any subsidiary of such Excluded Venture. 

“Existing Credit Agreement” means that certain Amended and Restated Credit Agreement, dated as of July 26, 2019, among
the Borrower, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent. 
 “Facility”
means the term loan facility provided for herein. 
 “FATCA” means Sections 1471 through 1474 of the Code, as of the date
of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any intergovernmental agreements entered into and any fiscal or regulatory legislation, rules or practices
adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any current or future regulations or official interpretations
of the foregoing. 
 “Federal Funds Effective Rate” means, for any day, the rate calculated by the NYFRB based on such
day’s federal funds transactions by depositary institutions, as determined in such manner as the NYFRB shall set forth on its public website from time to time, and published on the next succeeding Business Day by the NYFRB as the federal funds
effective rate; provided that if such rate shall be less than zero, such rate shall be deemed to be zero. 
 “Fee
Letters” means, collectively, each fee letter executed by the Borrower and one or more of the Administrative Agent and the Arrangers in connection with the Facility or this Agreement. 

“Financial Officer” means, with respect to any Person, the chief financial officer, principal accounting officer, treasurer,
assistant treasurer, controller or vice president of finance of such Person; provided that, when such term is used in reference to any document executed by, or a certification of, a Financial Officer, the secretary or assistant secretary of
such Person shall have, theretofore (including on the Closing Date) or concurrently therewith, delivered an incumbency certificate to the Administrative Agent as to the authority of such individual. 

“Fitch” means Fitch Ratings, Inc., or any successor to the rating agency business thereof. 

“Foreign Lender” means a Lender that is not a U.S. Person. 

“Funding Date” means, with respect to any Loan or any Borrowing, each date on which such Loan, or the Loans comprising such
Borrowing, is or are made pursuant to Section 2.01. 
 “GAAP” means generally accepted accounting principles in the
United States of America as in effect, subject to Section 1.04, from time to time. 

  
 12 

 “General Partner” means (a) MPLX GP LLC, a Delaware limited liability
company, or (b) any successor to the Person referred to in clause (a) as the General Partner of the Borrower (as such term is defined in the Borrower’s partnership agreement). 

“Governmental Authority” means the government of the United States of America, any other nation or any political subdivision
thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining
to government (including any supra-national body exercising such powers or functions, such as the European Union or the European Central Bank). 

“Guarantee” of or by any Person (the “guarantor”) means any obligation, contingent or otherwise, of the
guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of the
guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the
payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity capital or any other
financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to
support such Indebtedness or other obligation; provided that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business. The amount, as of any date of determination, of any Guarantee shall
be the principal amount outstanding on such date of the Indebtedness or other obligation guaranteed thereby (or, in the case of (i) any Guarantee the terms of which limit the monetary exposure of the guarantor or (ii) any Guarantee of an
obligation that does not have a principal amount, the maximum monetary exposure as of such date of the guarantor under such Guarantee (as determined, in the case of clause (i), pursuant to such terms or, in the case of clause (ii), reasonably and in
good faith by a Financial Officer of the Borrower)). Notwithstanding the foregoing, to the extent that at any time on or after the Closing Date the Borrower or any of its Subsidiaries guarantees (x) the obligations of Crowley Blue Water
Partners LLC under the Amended and Restated Chapter 537 Reserve Fund and Financial Agreement, dated June 30, 2016, between Crowley Blue Water Partners LLC and the United States of America, Contract No.
MA-14402, (y) the obligations of Crowley Tankers II, LLC, Crowley Tanker Charters III, LLC, Crowley Tankers IV, LLC and/or Crowley Tankers V, LLC under that certain Amended and Restated Senior Secured Term
Loan Agreement, dated September 30, 2015, or (z) the obligations of Midwest Connector Capital Company, LLC under the Contingent Equity Contribution Undertaking (Senior Notes), dated March 11, 2019 (in each case, as amended, restated,
supplemented or otherwise modified from time to time, so long as the amount of the obligations of the Borrower and its Subsidiaries in respect of any such guarantee would not exceed the amount of the obligation of MPC in respect of its guarantee
thereof as in effect on the Closing Date), such guarantee shall not constitute a Guarantee hereunder if and for so long as the effectiveness of such obligations of the Borrower and its Subsidiaries is conditioned upon or subject to the occurrence of
certain events (other than the failure of the primary obligor to pay or perform), which events have not yet occurred. 
 “Hazardous
Materials” means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated
biphenyls, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any Environmental Law. 

  
 13 

 “Hydrocarbons” means crude oil, natural gas, casinghead gas, drip gasoline,
natural gasoline, condensate, distillate, liquid hydrocarbons, gaseous hydrocarbons and all constituents, elements or compounds thereof and products refined or processed therefrom. 

“Indebtedness” of any Person means, without duplication, (a) all obligations of such Person for borrowed money,
(b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person,
(d) all obligations of such Person in respect of the deferred purchase price of property or services (excluding (i) accounts payable and accrued liabilities incurred in the ordinary course of business and (ii) amounts which are being
contested in good faith and, if applicable, for which reserves in conformity with GAAP have been provided), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be
secured by) any Lien on property owned or acquired by such Person (other than, in the case of property owned or acquired by the Borrower or any Subsidiary, Liens on Equity Interests in Joint Ventures and Liens on Equity Interests in Excluded
Ventures, in each case to the extent permitted under Section 6.02(a)(ix)) whether or not the Indebtedness secured thereby has been assumed, but only to the extent of such property’s fair market value, (f) all Guarantees by such Person
of Indebtedness of others (other than, in the case of the Borrower or any Subsidiary, Guarantees solely in the form of Liens on Equity Interests in Joint Ventures and Liens on Equity Interests in Excluded Ventures, in each case to the extent
permitted under Section 6.02(a)(ix)), (g) all Capital Lease Obligations of such Person, (h) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty and
(i) all obligations, contingent or otherwise, of such Person in respect of bankers’ acceptances. The Indebtedness of any Person shall include the Indebtedness of any other Person (including any partnership in which such Person is a general
partner) to the extent such Person is legally liable therefor as a result of such Person’s ownership interest in or other relationship with such other Person, except to the extent the terms of such Indebtedness provide that such Person is not
liable therefor. The Indebtedness of any Person shall not include endorsements of checks, bills of exchange and other instruments for deposit or collection in the ordinary course of business. 

“Indemnified Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on
account of any obligation of any Loan Party under any Loan Document and (b) to the extent not otherwise described in clause (a) of this definition, Other Taxes. 

“Indemnitee” has the meaning assigned to such term in Section 9.03(b). 

“Index Debt” means senior, unsecured, long-term indebtedness for borrowed money of the Borrower that is not guaranteed by any
other Person or subject to any other credit enhancement. 
 “Information” has the meaning assigned to such term in
Section 3.11. 
 “Information Memorandum” means the Confidential Information Memorandum dated August 2019, relating to
the Borrower and the Facility. 
 “Interest Election Request” means a request by the Borrower to convert or continue a
Borrowing in accordance with Section 2.07, which shall be substantially in the form of Exhibit C. 
 “Interest Payment
Date” means (a) with respect to any ABR Loan, the first Business Day following the last day of each March, June, September and December of each year and (b) with respect to any Eurodollar Loan, the last day of the Interest Period
applicable to the Borrowing of which such Loan is a part and, in the case of a Eurodollar Borrowing with an Interest Period of more than three months’ duration, each day prior to the last day of such Interest Period that occurs at intervals of
three months’ duration after the first day of such Interest Period. 

  
 14 

 “Interest Period” means with respect to any Eurodollar Borrowing, the
period commencing on the date of such Borrowing and ending one week thereafter or on the numerically corresponding day in the calendar month that is one, two or three months thereafter or, with the consent of each Lender, any other period, in each
case, as the Borrower may elect; provided that (a) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless (other than in the case of a one
week Interest Period) such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, and (b) any Interest Period of one month or more that commences on
the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period. For
purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing. 

“Interpolated Screen Rate” means, with respect to any period, a rate per annum that results from interpolating on a linear
basis between (a) the applicable LIBO Screen Rate for the longest maturity for which a LIBO Screen Rate is available that is shorter than such period and (b) the applicable LIBO Screen Rate for the shortest maturity for which a LIBO Screen
Rate is available that is longer than such period, in each case, as of the time the Interpolated Screen Rate is required to be determined in accordance with the other provisions hereof. 

“IRS” means the United States Internal Revenue Service. 

“Joint Venture” means a joint venture entity the Equity Interests of which are owned by the Borrower or a Subsidiary with one
or more third parties so long as such joint venture entity does not constitute a Subsidiary or an Excluded Venture. 
 “Lender
Parent” means, with respect to any Lender, each Person in respect of which such Lender is, directly or indirectly, a subsidiary. 

“Lenders” means (a) the Persons listed on Schedule 2.01 and (b) any other Person that shall have become a party
hereto pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption. 

“LIBO Rate” means, with respect to any Eurodollar Borrowing for any Interest Period, the LIBO Screen Rate at approximately
11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period; provided that (a) if no LIBO Screen Rate shall be available at such time for such Interest Period but LIBO Screen Rates shall be available for
maturities both longer and shorter than such Interest Period, then the “LIBO Rate” for such Interest Period shall be Interpolated Screen Rate at such time and (b) if the LIBO Rate, determined as set forth above, shall be less than
zero, such rate shall be deemed to be zero. 
 “LIBO Screen Rate” means, for any date and time, with respect to any
Eurodollar Borrowing for any Interest Period, or with respect to any determination of the Alternate Base Rate pursuant to clause (c) of the definition thereof, the London interbank offered rate as administered by the ICE Benchmark
Administration (or any other Person that takes over the administration of such rate) for deposits in dollars (for delivery on the first day of such Interest Period) for a period equal in length to such Interest Period as displayed on the Reuters
screen page that displays such rate (currently page LIBOR01 or LIBOR02) or, in the event such rate does not appear on a page of the Reuters screen, on the appropriate page of such other information service that published such rate from time to time
as selected by the Administrative Agent from time to time in its reasonable discretion. 

  
 15 

 “Lien” means, with respect to any asset, (a) any mortgage, deed of
trust, lien, pledge, hypothecation, encumbrance, charge or security interest in, on or of such asset or (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing
lease having substantially the same economic effect as any of the foregoing) relating to such asset. 
 “Loan” means the
loans made by the Lenders to the Borrower pursuant to this Agreement. 
 “Loan Documents” means this Agreement, the
Subsidiary Guarantee, any other document executed by a Loan Party and the Administrative Agent that contains a provision stating that it is a “Loan Document” as herein defined and, other than for purposes of Section 9.02, each
promissory note executed and delivered by the Borrower under Section 2.09(e) (if any). 
 “Loan Parties” means the
Borrower and each Subsidiary Guarantor. 
 “Material Adverse Change” means any event, development or circumstance that has
had or could reasonably be expected to have a Material Adverse Effect. 
 “Material Adverse Effect” means (a) a
material adverse effect on the business, operations, property or financial condition of the Borrower and its Subsidiaries, taken as a whole, (b) a material impairment of the ability of the Loan Parties, taken as a whole, to perform their
obligations under the Loan Documents or (c) a material adverse effect on the legality, validity, binding effect or enforceability of or against any Loan Party of any Loan Document to which it is a party. 

“Material Agreement” means (a) a material contract between or among one or more of the Borrower and its Subsidiaries and
one or more MPC Companies necessary for the ongoing operation and business of the Borrower and its Subsidiaries and (b) any agreement to which any Loan Party is a party which, if terminated or cancelled, could reasonably be expected to have a
Material Adverse Effect. 
 “Material Indebtedness” means Indebtedness (other than the Loans), or obligations in respect of
one or more Swap Agreements, of any one or more of the Borrower and its Subsidiaries in an aggregate principal amount exceeding $100,000,000. For purposes of determining Material Indebtedness, the “principal amount” of the obligations of
the Borrower or any Subsidiary in respect of any Swap Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that the Borrower or such Subsidiary would be required to pay if such Swap Agreement were
terminated at such time. 
 “Material Project” means the construction or expansion of any capital asset of the Borrower,
any Subsidiary, any Excluded Venture or any Joint Venture, the aggregate actual or budgeted capital cost of which (in each case, including capital costs expended prior to the acquisition by the Borrower, such Subsidiary, such Excluded Venture or
such Joint Venture, as applicable, and including capital costs expended prior to the construction or expansion of such asset) exceeds $50,000,000. 

  
 16 

 “Material Project EBITDA Adjustments” means, with respect to each Material
Project: 
 (a) prior to the Commercial Operation Date of a Material Project (but including the fiscal quarter in which such Commercial
Operation Date occurs), a percentage (based on the then-current completion percentage of such Material Project) of an amount (such amount, the “Projected Consolidated EBITDA”) equal to the projected Consolidated EBITDA attributable
to such Material Project (including in the case of a Material Project of an Excluded Venture or Joint Venture, the Borrower’s pro-rata share of projected Consolidated EBITDA of such Excluded Venture or
Joint Venture (calculated in accordance with the definition of Consolidated EBITDA as if such Excluded Venture or Joint Venture were a Subsidiary of the Borrower) attributable to the equity interest of the Borrower in such Excluded Venture or Joint
Venture) for the first 12-month period following the scheduled Commercial Operation Date of such Material Project (such Projected Consolidated EBITDA to be determined based on customer contracts relating to
such Material Project, the creditworthiness of the other parties to such contracts, and projected revenues from such contracts, capital costs and expenses, scheduled Commercial Operation Date and other reasonable factors), which may, at the
Borrower’s option, be added to actual Consolidated EBITDA for the fiscal quarter in which construction of such Material Project commences and for each fiscal quarter thereafter until the Commercial Operation Date of such Material Project
(including the fiscal quarter in which such Commercial Operation Date occurs, but net of any actual Consolidated EBITDA attributable to such Material Project following such Commercial Operation Date (provided that, in the case of a Material
Project of an Excluded Venture or a Joint Venture, such actual Consolidated EBITDA shall be calculated in accordance with the definition of Consolidated EBITDA as if such Excluded Venture or Joint Venture were a Subsidiary of the Borrower));
provided that if the actual Commercial Operation Date does not occur by the scheduled Commercial Operation Date, then the Projected Consolidated EBITDA shall be reduced, in each of the four quarters ending after the scheduled Commercial
Operation Date to (but excluding) the first full quarter after its actual Commercial Operation Date, by the following percentage amounts depending on the period of delay (based on the period of actual delay or then-estimated delay, whichever is
longer): (i) 90 days or less, 0%, (ii) longer than 90 days, but not more than 180 days, 25%, (iii) longer than 180 days but not more than 270 days, 50%, (iv) longer than 270 days but not more than 365 days, 75% and (v) longer than 365 days,
100%; and 
 (b) thereafter, for the first full fiscal quarter following the Commercial Operation Date and the immediately two succeeding
fiscal quarters, the Projected Consolidated EBITDA (calculated in the manner set forth in clause (a) above) for the fiscal quarters constituting the balance of the four full fiscal quarter period following such Commercial Operation Date may, at
the Borrower’s option, be added to actual Consolidated EBITDA for such fiscal quarters (provided that in the event the actual Consolidated EBITDA attributable to such Material Project for any full fiscal quarter after the Commercial
Operation Date shall materially differ from the Projected Consolidated EBITDA for such fiscal quarter, the Projected Consolidated EBITDA attributable to such Material Project for any remaining fiscal quarters included in the foregoing calculation
shall be redetermined). 
 In the event that the Borrower intends to include Material Project EBITDA Adjustments with respect to any
Material Project, then: 
 (A) prior to the delivery of the first Compliance Certificate in which Material Project EBITDA
Adjustments are made with respect to such Material Project in the amount permitted pursuant to clause (a), the Borrower shall have delivered to the Administrative Agent a proposed determination of such Material Project EBITDA Adjustments setting
forth pro forma projections of Consolidated EBITDA with respect to such Material Project, together with reasonably detailed supporting information with respect thereto, and indicating the scheduled Commercial Operation Date; and 

  
 17 

 (B) as soon as reasonably practicable after delivery by the Borrower of such
proposed determination of Material Project EBITDA Adjustments pursuant to clause (A) above, and in any event within 10 Business Days following the Borrower’s delivery, the Administrative Agent shall either (1) approve such
determination of Material Project EBITDA Adjustments (such approval not to be unreasonably withheld, conditioned or delayed), (2) object to such determination of Material Project EBITDA Adjustments based on application of criteria set forth in
clause (a) of this definition, or (3) request additional information from the Borrower as is reasonably necessary to approve or object to the Borrower’s proposed determination. If the Administrative Agent objects to the
Borrower’s determination of Material Project EBITDA Adjustments or requests additional information, the Borrower and Administrative Agent shall reasonably cooperate to agree upon the determination of Material Project EBITDA as soon as is
reasonably practicable. 
 Material Project EBITDA Adjustments with respect to a Material Project shall not be allowed unless approved by
the Administrative Agent, prior to the delivery of the first Compliance Certificate in which Material Project EBITDA Adjustments are made with respect to such Material Project, as set forth in clause (B) above. 

Notwithstanding anything herein to the contrary, the aggregate amount of all Material Project EBITDA Adjustments during any period shall be
limited to 30% of the total actual Consolidated EBITDA for such period (which total actual Consolidated EBITDA shall be determined without including any Material Project EBITDA Adjustments or pro forma adjustments for acquisitions or dispositions).

 “Maturity Date” means September 26, 2021; provided, however, that if such date is not a Business Day,
then the Maturity Date shall be the next preceding Business Day. 
 “Maximum Rate” has the meaning assigned to such term in
Section 9.14. 
 “Midstream Business” means either (a) gathering, transportation, treating, processing, marketing
or otherwise handling Hydrocarbons, or activities or services reasonably related or ancillary thereto including, without limitation, entering into Swap Agreements to support such business, or (b) any other business that generates gross income
that constitutes “qualifying income” under Section 7704(d) of the Code. 
 “MNPI” means material information
concerning the Borrower, any Subsidiary, any Excluded Venture, any Joint Venture, their respective Affiliates or any securities of any of the foregoing that has not been disseminated in a manner making it available to investors generally, within the
meaning of Regulation FD under the Securities Act and the Exchange Act. For purposes of this definition, “material information” means information concerning the Borrower, any Subsidiary, any Excluded Venture, any Joint Venture, their
respective Affiliates or any securities of any of the foregoing that could reasonably be expected to be material for purposes of the United States federal and state securities laws. 

“Moody’s” means Moody’s Investors Service, Inc., or any successor to the rating agency business thereof. 

“MPC” means Marathon Petroleum Corporation, a Delaware corporation. 

“MPC Companies” means MPC and its Subsidiaries (other than the Borrower and its Subsidiaries). 

“Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA. 

  
 18 

 “Net Cash Proceeds” means, with respect to any Disposition of any asset of
the Borrower or any Subsidiary, the cash proceeds actually received by the Borrower or any Subsidiary in connection with such Disposition (including any such cash proceeds received by way of deferred payment of principal pursuant to, or by
monetization of, a note receivable or otherwise, but only as and when received), net of the sum, without duplication, of (a) the amount of all payments (including any premiums or penalties) required to be made by the Borrower or its
Subsidiaries as a result of such Disposition to repay Indebtedness (other than the Loans) secured by a Lien on such asset and subject to mandatory prepayment as a result of such Disposition (or that must be repaid in order to obtain a necessary
consent to such Disposition), (b) all attorneys’ fees, investment banking fees, accountants’ fees and other reasonable fees and expenses actually incurred or reasonably expected to be incurred by the Borrower or its Subsidiaries in
connection with such Disposition, (c) Taxes paid or reasonably estimated to be payable as a result of such Disposition, (d) all distributions and other payments required to be made to minority interest holders in Subsidiaries and Joint
Ventures as a result of such Disposition, or to any other Person owning a beneficial interest in the assets disposed of in such Disposition and (e) the amount of any reserves established by the Borrower or its Subsidiaries in accordance with
GAAP to fund purchase price adjustment, indemnities and other liabilities, contingent or otherwise, reasonably estimated to be payable by the Borrower or any Subsidiary in connection with such Disposition, provided that if a reserve
established with respect to any Disposition as described in this clause (e) shall be reduced, the amount of such reduction shall, except to the extent such reduction is made as a result of a payment having been made in respect of the contingent
liabilities with respect to which such reserve has been established, be deemed to be receipt, on the date of such reduction, of Net Cash Proceeds in respect of such Disposition; provided that if the Borrower shall, prior to the date of any
required prepayment of Loans as set forth herein, deliver to the Administrative Agent a written notice to the effect that the Borrower and its Subsidiaries intend to reinvest any such cash proceeds that would otherwise constitute Net Cash Proceeds
within 180 days of the actual receipt thereof in assets (other than inventory) to be used or useful in the business of the Borrower and/or its Subsidiaries (the amount of such cash proceeds so specified in such notice being referred to as a
“Reinvestment Amount”), then such Reinvestment Amount shall not constitute Net Cash Proceeds until, and except to the extent that, not so reinvested within 180 days following the date of the actual receipt of such cash proceeds (or,
if committed to be so reinvested within such 180-day period, within 270 days following the date of the actual receipt of such cash proceeds), at which time such cash proceeds shall then be deemed to have been
received at such time to such extent and shall constitute Net Cash Proceeds; provided, further, that until such time as the aggregate amount of any Net Cash Proceeds actually received by the Borrower and its Subsidiaries after the
Closing Date shall be at least $200,000,000, any cash proceeds that would otherwise constitute Net Cash Proceeds under this clause (c) shall be deemed permanently excluded from the definition of “Net Cash Proceeds”. 

“Non-Guarantor Subsidiary” means a Subsidiary of the Borrower that is not a
Subsidiary Guarantor. 
 “Non-Wholly Owned Subsidiary” means a Subsidiary that is
not a wholly owned Subsidiary. 
 “NYFRB” means the Federal Reserve Bank of New York. 

“NYFRB Rate” means, for any day, the greater of (a) the Federal Funds Effective Rate in effect on such day and
(b) the Overnight Bank Funding Rate in effect on such day (or for any day that is not a Business Day, on the immediately preceding Business Day); provided that if none of such rates are published for any day that is a Business Day, the
term “NYFRB Rate” means the rate for a federal funds transaction quoted at 11:00 a.m., New York City time, on such day received by the Administrative Agent from a federal funds broker of recognized standing selected by it; provided,
further, that if any of the aforesaid rates as so determined shall be less than zero, such rate shall be deemed to be zero. 

  
 19 

 “Obligations” means all advances to, and debts, liabilities, obligations,
covenants and duties of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan, in each case whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now
existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or any Affiliate thereof of any proceeding under any applicable bankruptcy, insolvency, reorganization, moratorium or other
laws affecting creditors’ rights generally naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding. 

“OFAC” means the United States Treasury Department Office of Foreign Assets Control. 

“Organization Documents” means, (a) with respect to any corporation, the certificate or articles of incorporation and
the bylaws; (b) with respect to any limited liability company, the certificate of formation and operating agreement; and (c) with respect to any partnership, joint venture, trust or other form of business entity, the partnership, joint
venture or other applicable agreement of formation and any agreement, instrument, filing or notice with respect thereto filed in connection with its formation with the secretary of state or other department in the state of its formation, in each
case as amended from time to time. 
 “Other Connection Taxes” means, with respect to any Recipient, Taxes imposed as a
result of a present or former connection between such Recipient and the jurisdiction imposing such Taxes (other than a connection arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received
payments under, received or perfected a security interest under, or engaged in any other transaction pursuant to, or enforced, any Loan Document, or sold or assigned an interest in any Loan or Loan Document). 

“Other Taxes” means all present or future stamp, court, documentary, intangible, recording, filing or similar Taxes that
arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, or from the registration, receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any
such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 2.18(b)). 

“Overnight Bank Funding Rate” means, for any day, the rate comprised of both overnight federal funds and overnight Eurodollar
borrowings by U.S.-managed banking offices of depository institutions, as such composite rate shall be determined by the NYFRB as set forth on its public website from time to time, and published on the next succeeding Business Day by the NYFRB as an
overnight bank funding rate. 
 “Participant” has the meaning assigned to such term in Section 9.04(d). 

“Participant Register” has the meaning assigned to such term in Section 9.04(d). 

“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing
similar functions. 
 “Permitted Encumbrances” means: 

(a) Liens imposed by law for Taxes that (i) are not yet due, (ii) are not more than 60 days past due and not subject to penalties for
non-payment or (iii) are being contested in compliance with Section 5.04; 

  
 20 

 (b) carriers’, warehousemen’s, mechanics’, materialmen’s,
repairmen’s, workmen’s, landlords’ and other like Liens arising in the ordinary course of business (or deposits to obtain the release of such Liens) and securing obligations that are not overdue for more than 60 days or, if so
overdue, that are being contested in compliance with Section 5.04; 
 (c) pledges and deposits made (i) in compliance with, or
deemed trusts arising in connection with, workers’ compensation, unemployment insurance and other social security laws or regulations (other than Liens imposed by ERISA) or (ii) in respect of letters of credit, bank guarantees, performance
bonds or similar instruments issued for the account of the Borrower or any Subsidiary in the ordinary course of business supporting obligations of the type set forth in clause (i) above; 

(d) Liens and deposits made (i) to secure the performance of bids, trade contracts (other than for payment of Indebtedness), government
contracts, leases (other than Capital Lease Obligations), statutory obligations (other than Liens imposed by ERISA), surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business
or (ii) in respect of letters of credit, bank guarantees or similar instruments issued for the account of the Borrower or any Subsidiary in the ordinary course of business supporting obligations of the type set forth in clause (i) above;

 (e) judgment or attachment liens in respect of judgments that do not constitute an Event of Default under clause (k) of Article VII;

 (f) easements, zoning restrictions, rights-of-way and
similar encumbrances on real property imposed by law or arising in the ordinary course of business that do not secure any monetary obligations and do not materially detract from the value of the affected property or materially interfere with the
ordinary conduct of business of the Borrower or any Subsidiary; 
 (g) any Lien in favor of the United States of America, any state or any
agency, department, political subdivision or other instrumentality of either, to secure partial, progress or advance payments to the Borrower or any Subsidiary pursuant to the provisions of any contract or any statute; 

(h) Liens created or evidenced by or resulting from precautionary financing statements filed by lessors of property (but only relating to the
leased property), other than in connection with capital leases and sale-leasebacks; 
 (i) Liens imposed by ERISA which are being contested
in good faith by appropriate proceedings and with respect to which adequate reserves have been set aside in accordance with GAAP, provided that the aggregate amount of the obligations secured by such Liens shall not at any time exceed
$75,000,000; 
 (j) Liens in favor of banks having a right of setoff, revocation, refund or chargeback with respect to money or instruments
of the Borrower or any of its Subsidiaries on deposit with or in the possession of such bank, in each case in the ordinary course of business; 

(k) Liens that are contractual rights of set-off; 

(l) Liens on cash and Cash Equivalents made to defease or to satisfy and discharge any debt securities; 

  
 21 

 (m) contractual Liens arising under operating agreements, joint venture agreements,
partnership agreements, oil and gas leases, farmout agreements, division orders, contracts for sale, transportation or exchange of oil and natural gas, unitization and pooling declarations and agreements, area of mutual interest agreements, terminal
and storage agreements and other agreements entered into in the ordinary course of the Borrower’s or any Subsidiary’s business that are customary in the Midstream Business, in each case granted to secure compliance with the applicable
agreement and limited to the property that is the subject of the applicable agreement, provided that any such Liens are for claims which are not delinquent or which are being contested in good faith and, if applicable, for which adequate
reserves have been maintained to the extent required by GAAP, and provided further that any such Lien does not materially impair the use of the property covered by such Lien for the purposes for which such property is held by the Borrower or
the applicable Subsidiary or materially impair the value of such property subject thereto; 
 (n) Liens on earnest money deposits made by the
Borrower or any Subsidiary in connection with any letter of intent or purchase agreement with respect to an acquisition or other investment permitted hereunder; 

(o) customary Liens arising under sale agreements related to any disposition permitted hereunder, provided that such Liens extend only
to the property to be disposed of; and 
 (p) pledges or deposits of cash and Cash Equivalents securing deductibles, self-insurance,
insurance premiums, co-payment, co-insurance, retentions and similar obligations (other than Indebtedness) to providers of insurance, provided that such Liens are
granted, and such obligations are incurred, in the ordinary course of business; 
 provided that the term “Permitted Encumbrances” shall not
include any Lien (other than any Lien referred to in clause (l) above) securing Indebtedness of the type included in Consolidated Total Debt. 

“Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company,
partnership, Governmental Authority or other entity. 
 “Plan” means any employee pension benefit plan (other than a
Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated, would under
Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA. 
 “Platform”
has the meaning assigned to such term in Section 9.01(d). 
 “Prepayment Event” means any Disposition of any assets by
the Borrower or any Subsidiary outside of the ordinary course of business (including any sale or issuance of Equity Interests in any Subsidiary to a Person other than the Borrower or its Subsidiaries) after the Closing Date, but excluding
(a) any Disposition to the Borrower or any Subsidiary, (b) the unwinding of any Swap Agreement, (c) any Disposition of accounts receivable and related assets and (d) any casualty or other insured damage to, or any taking under
power of eminent domain or by condemnation or similar proceeding of, any assets of the Borrower or any Subsidiary. 
 “Prime
Rate” means, at any time, the rate of interest per annum publicly announced from time to time by the Administrative Agent as its prime rate. Each change in the Prime Rate shall be effective as of the opening of business on the day such
change in such prime rate occurs. The parties hereto acknowledge that the rate announced publicly by the Administrative Agent as its prime rate is an index or base rate and shall not necessarily be its lowest or best rate charged to its customers or
other banks. 

  
 22 

 “PTE” means a prohibited transaction class exemption issued by the U.S.
Department of Labor, as any such exemption may be amended from time to time. 
 “Quarter-End
Date” means March 31, June 30, September 30 or December 31, as applicable. 
 “Recipient”
means, as applicable, the Administrative Agent or any Lender. 
 “Register” has the meaning assigned to such term in
Section 9.04(c). 
 “Reinvestment Amount” has the meaning assigned to such term in the definition of “Net Cash
Proceeds”. 
 “Related Parties” means, with respect to any specified Person, such Person’s Affiliates and the
respective directors, officers, partners, members, trustees, employees, agents and advisors of such Person and such Person’s Affiliates. 

“Removal Effective Date” has the meaning assigned to such term in Section 8.06(b). 

“Required Lenders” means, at any time, subject to Section 2.20, Lenders having Loans and Commitments representing more
than 50% of the aggregate principal amount of all the Loans outstanding and all the Commitments in effect at such time. 

“Responsible Officer” means, with respect to any Person, the president, the chief executive officer, the chief financial
officer, the vice president of finance or any Financial Officer of such Person or of the general partner of such Person; provided that, when such term is used in reference to any document executed by, or a certification of, a Responsible
Officer, the secretary or assistant secretary of such Person shall, at the request of the Administrative Agent, deliver an incumbency certificate to the Administrative Agent as to the authority of such individual. 

“Restricted Payment” by a Person means any dividend or other distribution (whether in cash, securities or other property)
with respect to any Equity Interest in such Person, or any payment (whether in cash, securities or other property), including any sinking fund or similar deposit on account of the purchase, redemption, retirement, acquisition, cancellation or
termination of any such Equity Interest or of any option, warrant or other right to acquire any such Equity Interest. 

“Reuters” means Thomson Reuters Corporation, a corporation incorporated under and governed by the Business Corporations Act
(Ontario), Canada, Refinitiv or, in each case, a successor thereto. 
 “S&P” means S&P Global Ratings, a division
of S&P Global Inc., or any successor to the rating agency business thereof. 
 “Sale and Leaseback Transaction” means
any arrangement with any Person providing for the leasing by the Borrower or any Subsidiary of any property (whether such property is now owned or hereafter acquired) that has been or is to be sold or transferred by the Borrower or any Subsidiary to
such Person or any of its Affiliates, other than (a) temporary leases for a term, including renewals at the option of the lessee, of not more than three years, and (b) leases between the Borrower and a Subsidiary or between Subsidiaries.
For the avoidance of doubt, the SMR Transaction (as defined in the Borrower’s Annual Report on Form 10-K for the year ended December 31, 2018) and the transactions contemplated thereby shall not be
considered a Sale and Leaseback Transaction. 

  
 23 

 “Sanctioned Country” means a country, territory or region that is itself
the subject or target of any Sanctions. 
 “Sanctioned Person” means (a) any Person listed in any Sanctions-related
list of designated Persons maintained by OFAC, the United States Department of State, the United Nations Security Council, the European Union, or Her Majesty’s Treasury of the United Kingdom, (b) any Person operating, organized or resident
in a Sanctioned Country or (c) any Person owned or controlled by any such Person or Persons described in clause (a) or (b) above. 

“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by
(a) the United States government, including those administered by the OFAC, or the United States Department of State, or (b) the United Nations Security Council, the European Union, or Her Majesty’s Treasury of the United Kingdom.

 “SEC” means the United States Securities and Exchange Commission, or any Governmental Authority succeeding to the
functions of said Commission. 
 “Securities Act” means the United States Securities Act of 1933, as amended. 

“Significant Subsidiary” means any Subsidiary that is a Significant Subsidiary as such term is defined in Regulation S-X promulgated under the Exchange Act. 
 “Specified Acquisition” means any one or more
transactions (a) consummated during a consecutive twelve-month period pursuant to which the Borrower or any Subsidiary acquires for an aggregate purchase price of not less than $50,000,000 (i) Equity Interests in an entity that is (or becomes,
after such acquisition) a Subsidiary of the Borrower or of MPC, (ii) Equity Interests in other entities or (iii) other property or assets (other than acquisitions of Equity Interests of a Person, capital expenditures and acquisitions of
inventory or supplies in the ordinary course of business) of, or of an operating division or business unit of, any other Person and (b) which is designated by the Borrower (by written notice to the Administrative Agent) as a “Specified
Acquisition”. 
 “Statutory Reserve Rate” means a fraction (expressed as a decimal), the numerator of which is the
number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves), expressed as a decimal, established by the Board to which the
Administrative Agent is subject for eurocurrency funding (currently referred to as “Eurocurrency Liabilities” in Regulation D of the Board). Such reserve percentage shall include those imposed pursuant to such Regulation D.
Eurodollar Loans shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under such
Regulation D or any comparable regulation. The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve percentage. 

“subsidiary” means, with respect to any Person (the “parent”) at any date, any corporation, limited
liability company, partnership, association or other entity of which Equity Interests representing more than 50% of the ordinary voting power or, in the case of a partnership, more than 50% of the general partnership interests are, as of such date,
directly or indirectly, owned, controlled or held by the parent. 
 “Subsidiary” means any subsidiary of the Borrower that
is not an Excluded Venture. 

  
 24 

 “Subsidiary Guarantor” means, at any time, each Subsidiary of the Borrower
that is party to the Subsidiary Guarantee as a guarantor. 
 “Subsidiary Guarantee” means a guarantee of the
Borrower’s obligations hereunder in substantially the form of Exhibit F or any other form approved by the Administrative Agent, together with all supplements thereto. 

“Swap Agreement” means (a) any agreement with respect to any swap, forward, future or derivative transaction, or any
option or similar agreement, involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or
value or any similar transaction or any combination of these transactions, (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement
published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master
Agreement”), including any such obligations or liabilities under any Master Agreement and (c) any other derivative agreement or other similar agreement or arrangement, in each case, including any agreement, contract or transaction that
constitutes a “swap” within the meaning of section 1a(47) of the Commodity Exchange Act; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors,
officers, employees or consultants of the Borrower or the Subsidiaries shall be a Swap Agreement. 
 “Taxes” means any
present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable
thereto. 
 “Transactions” means the execution, delivery and performance by each Loan Party of this Agreement and the other
Loan Documents to which such Loan Party is intended to be a party and the borrowing of Loans hereunder. 
 “Type”, when
used in reference to any Loan or Borrowing, refers to whether the rate of interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the Adjusted LIBO Rate or the Alternate Base Rate. 

“USA Patriot Act” has the meaning assigned to such term in Section 9.15. 

“U.S. Person” means a “United States person” within the meaning of Section 7701(a)(30) of the Code. 

“U.S. Tax Compliance Certificate” has the meaning assigned to such term in Section 2.16(f). 

“wholly owned” means, when used in reference to any subsidiary of any Person, that all of the Equity Interests in such
Subsidiary are directly or indirectly (through one or more other wholly owned subsidiaries of such Person) owned by such Person, excluding directors’ qualifying shares and other nominal amounts of Equity Interests that are required to be held
by other Persons under applicable law. 
 “Withdrawal Liability” means liability to a Multiemployer Plan as a result of a
complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA. 

  
 25 

 “Withholding Agent” means any Loan Party and the Administrative Agent. 

“Write-Down and Conversion Powers” means, with respect to any EEA Resolution Authority, the write-down and conversion powers
of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule. 
 SECTION 1.02. Classification of Loans and Borrowings. For
purposes of this Agreement, Loans and Borrowings may be classified and referred to by Type (e.g., a “Eurodollar Loan” or a “Eurodollar Borrowing”). 

SECTION 1.03. Terms Generally. The definitions of terms herein shall apply equally to the singular and plural forms of the terms
defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase
“without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The words “asset” and “property” shall be construed to have the same meaning and
effect and to refer to any and all tangible and intangible assets and properties, including intellectual property, cash, securities, accounts and contract rights. Except as otherwise provided herein and unless the context requires otherwise
(a) any definition of or reference to any agreement (including this Agreement), instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or
otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (b) any reference herein to any Person shall be construed to include such Person’s successors and assigns (subject to any
restrictions on assignment set forth herein) and, in the case of any Governmental Authority, any other Governmental Authority that shall have succeeded to any or all functions thereof, (c) the words “herein”, “hereof” and
“hereunder”, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all references herein to Articles, Sections, Exhibits and Schedules shall be
construed to refer to Articles and Sections of, and Exhibits and Schedules to, this Agreement, (e) with respect to the determination of any period of time, the word “from” means “from and including” and the word
“to” means “to but excluding” and (f) reference to any law, rule or regulation means such as amended, modified, codified or reenacted, in whole or in part, and in effect from time to time. 

SECTION 1.04. Accounting Terms; GAAP. Except as otherwise expressly provided herein, all terms of an accounting or financial
nature shall be construed in accordance with GAAP, as in effect from time to time; provided that if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any
change occurring after the Closing Date in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such
purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall
have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith (it being agreed, in the case of any such amendment that is solely in respect of an accounting change described in Financial
Accounting Standards Board Accounting Standards Codification 842 or 606 (or any other Accounting Standards Codifications having a similar result or effect) (and related interpretations), that no amendment fees shall be required to be paid by the
Borrower to the Lenders (but the Borrower shall be responsible for costs and expenses relating to such amendment in accordance with the terms of this Agreement)). Notwithstanding anything to the contrary in this Agreement or any other Loan Document,
all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (a) any election under Financial Accounting

  
 26 

 
Standards Board Accounting Standards Codification 825 (or any other Accounting Standards Codification having a similar result or effect) (and related interpretations) to value any Indebtedness of
the Borrower or any Subsidiary at “fair value”, as defined therein, (b) any treatment of Indebtedness in respect of convertible debt instruments under Financial Accounting Standards Board Accounting Standards Codification 470-20 (or any other Accounting Standards Codification having a similar result or effect) (and related interpretations) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such
Indebtedness shall at all times be valued at the full stated principal amount thereof, (c) any valuation of Indebtedness below its full stated principal amount as a result of application of Financial Accounting Standards Board Accounting
Standards Update No. 2015-03, it being agreed that Indebtedness shall at all times be valued at the full stated principal amount thereof, or (d) the Financial Accounting Standards Board Accounting
Standards Codification 842 (or any other Accounting Standards Codification having a similar result or effect) (and related interpretations) to the extent any lease (or similar arrangement conveying the right to use) would be required to be treated
as a capital lease thereunder where such lease (or similar arrangement) would have been treated as an operating lease under GAAP as in effect immediately prior to the effectiveness of the Financial Accounting Standards Board Accounting Standards
Codification 842. 
 SECTION 1.05. Divisions. For all purposes under this Agreement, in connection with any division or plan of
division under Delaware law (or any comparable event under a different jurisdiction’s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall
be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized and acquired on the first date of its existence by the
holders of its Equity Interests at such time. 
 ARTICLE II 

The Credits 

SECTION 2.01. Commitments. Subject to the terms and conditions set forth herein, each Lender agrees to make Loans denominated in
dollars to the Borrower from time to time during the Delayed Draw Availability Period, provided that (a) the principal amount of each Loan made by any Lender will not exceed such Lender’s Commitment as in effect immediately prior to
the making of such Loan and (b) the Loans shall be made on no more than four Funding Dates. Amounts borrowed under this Section 2.01 and repaid or prepaid may not be reborrowed. 

SECTION 2.02. Loans and Borrowings. 

(a) Each Loan shall be made as part of a Borrowing consisting of Loans made by the Lenders ratably in accordance with their respective
Commitments. The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder; provided that the Commitments of the Lenders are several and no Lender shall be responsible for
any other Lender’s failure to make Loans as required. 
 (b) Subject to Section 2.13, each Borrowing shall be comprised entirely of
ABR Loans or Eurodollar Loans as the Borrower may request in accordance herewith. Each Lender at its option may make any Eurodollar Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan; provided that
any exercise of such option shall not affect the obligation of the Borrower to repay such Loan in accordance with the terms of this Agreement. 

  
 27 

 (c) At the commencement of each Interest Period for any Eurodollar Borrowing, such Borrowing
shall be in an aggregate amount that is an integral multiple of $500,000 and not less than $5,000,000; provided that a Eurodollar Borrowing that results from a continuation of an outstanding Eurodollar Borrowing may be in an aggregate amount
that is equal to such outstanding Borrowing. At the time that each ABR Borrowing is made, such Borrowing shall be in an aggregate amount that is an integral multiple of $250,000 and not less than $1,000,000; provided that an ABR Borrowing may
be in an aggregate amount that is equal to the entire unused balance of the aggregate Commitments. Borrowings of more than one Type may be outstanding at the same time; provided that there shall not at any time be more than a total of 15
Eurodollar Borrowings outstanding. 
 (d) Notwithstanding any other provision of this Agreement, the Borrower shall not be entitled to
request, or to elect to convert to or continue, any Eurodollar Borrowing if the Interest Period requested with respect thereto would end after the Maturity Date. 

SECTION 2.03. Requests for Borrowings. To request a Borrowing, the Borrower shall submit to the Administrative Agent, by fax or
electronic mail (in .pdf or .tif format), a Borrowing Request, signed by a Responsible Officer of the Borrower (a) in the case of a Eurodollar Borrowing, not later than 1:00 p.m., New York City time, three Business Days before the requested
Funding Date or (b) in the case of an ABR Borrowing, not later than 1:00 p.m., New York City time, on the requested Funding Date. Each such Borrowing Request shall be irrevocable and shall specify the following information in compliance with
Section 2.02: 
 (i) the aggregate principal amount of the requested Borrowing; 

(ii) the date of such Borrowing, which shall be a Business Day; 

(iii) whether such Borrowing is to be an ABR Borrowing or a Eurodollar Borrowing; 

(iv) in the case of a Eurodollar Borrowing, the initial Interest Period to be applicable thereto, which shall be a period
contemplated by the definition of the term “Interest Period”; and 
 (v) the location and number of the
Borrower’s account to which funds are to be disbursed, which shall comply with the requirements of Section 2.06. 
 If no election as to the Type
of Borrowing is specified, then the requested Borrowing shall be an ABR Borrowing. If no Interest Period is specified with respect to any requested Eurodollar Borrowing, then the Borrower shall be deemed to have selected an Interest Period of one
month’s duration. Promptly following receipt of a Borrowing Request in accordance with this Section, the Administrative Agent shall advise each Lender of the details thereof and of the amount of such Lender’s Loan to be made as part of the
requested Borrowing. 
 SECTION 2.04. [Reserved]. 

SECTION 2.05. [Reserved]. 

SECTION 2.06. Funding of Borrowings. 

(a) Funding. Each Lender shall make each Loan to be made by it hereunder on each Funding Date by wire transfer of immediately available
funds by 3:00 p.m., New York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders. The Administrative Agent will make such Loans available to the Borrower by promptly
remitting the amounts so received, in like funds, to an account of the Borrower designated by the Borrower in the applicable Borrowing Request. 

  
 28 

 (b) Presumption by Administrative Agent. Unless the Administrative Agent shall have
received notice from a Lender prior to any Funding Date that such Lender will not make available to the Administrative Agent such Lender’s share of any Borrowing to be made on such Funding Date, the Administrative Agent may assume that such
Lender has made such share available on such date in accordance with paragraph (a) of this Section and may, in reliance upon such assumption, make available to the Borrower a corresponding amount. In such event, if a Lender has not in fact made
its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each
day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of payment to be made by such Lender, the greater of the NYFRB Rate and a rate
determined by the Administrative Agent in accordance with banking industry rules on interbank compensation or (ii) in the case of payment to be made by the Borrower, the interest rate applicable to the Loans comprising such Borrowing. If the
Borrower and such Lender shall both pay such interest to the Administrative Agent for the same or an overlapping period, the Administrative Agent shall promptly remit to the Borrower the amount of such interest paid by the Borrower for such period.
If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such Lender’s Loan included in such Borrowing. Any payment by the Borrower shall be without prejudice to any claim the Borrower may have against a
Lender that shall have failed to make such payment to the Administrative Agent. 
 SECTION 2.07. Interest Elections. 

(a) Each Borrowing initially shall be of the Type specified in the applicable Borrowing Request and, in the case of a Eurodollar Borrowing,
shall have an initial Interest Period as specified in such Borrowing Request or as otherwise provided in Section 2.03. Thereafter, the Borrower may, at any time and from time to time, elect to convert such Borrowing to a different Type or to
continue such Borrowing and, in the case of a Eurodollar Borrowing, may elect Interest Periods therefor, all as provided in this Section. The Borrower may elect different options with respect to different portions of the affected Borrowing, in which
case each such portion shall be allocated ratably among the Lenders holding the Loans comprising such Borrowing, and the Loans comprising each such portion shall be considered a separate Borrowing. 

(b) To make an election pursuant to this Section, the Borrower shall submit to the Administrative Agent, by fax or electronic mail (in .pdf or
..tif format), an Interest Election Request, signed by a Responsible Officer of the Borrower, by the time that a Borrowing Request would be required under Section 2.03 if the Borrower were requesting a Borrowing of the Type resulting from such
election to be made on the effective date of such election. Each Interest Election Request shall be irrevocable and shall specify the following information in compliance with Section 2.02: 

(i) the Borrowing to which such Interest Election Request applies and, if different options are being elected with respect to
different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to clauses (iii) and (iv) below shall be specified for each resulting Borrowing); 

(ii) the effective date of the election made pursuant to such Interest Election Request, which shall be a Business Day; 

(iii) whether the resulting Borrowing is to be an ABR Borrowing or a Eurodollar Borrowing; and 

  
 29 

 (iv) if the resulting Borrowing is a Eurodollar Borrowing, the Interest
Period to be applicable thereto after giving effect to such election, which shall be a period contemplated by the definition of the term “Interest Period”. 

If any such Interest Election Request requests a Eurodollar Borrowing but does not specify an Interest Period, then the Borrower shall be deemed to have
selected an Interest Period of one month’s duration. 
 (c) Promptly following receipt of an Interest Election Request in accordance
with this Section, the Administrative Agent shall advise each Lender of the details thereof and of such Lender’s portion of each resulting Borrowing. 

(d) If the Borrower fails to deliver a timely Interest Election Request with respect to a Eurodollar Borrowing prior to the end of the Interest
Period applicable thereto, then, unless such Borrowing is repaid as provided herein, at the end of such Interest Period such Borrowing shall be converted to an ABR Borrowing. Notwithstanding any contrary provision hereof, if an Event of Default
under clause (h) or (i) of Article VII has occurred and is continuing with respect to the Borrower, or if any other Event of Default has occurred and is continuing and the Administrative Agent, at the request of the Required Lenders, notifies
the Borrower of the election to give effect to this sentence on account of such other Event of Default, then, in each such case, so long as such Event of Default is continuing, (i) no outstanding Borrowing may be converted to or continued as a
Eurodollar Borrowing and (ii) unless repaid, each Eurodollar Borrowing shall be converted to an ABR Borrowing at the end of the Interest Period applicable thereto. 

SECTION 2.08. Termination and Reduction of Commitments. 

(a) Unless previously terminated pursuant to the terms of this Agreement, the Commitment of each Lender shall terminate at 5:00 p.m., New York
City time, on the Delayed Draw Funding Deadline. The Commitment of each Lender shall be reduced automatically and without further action upon the making by such Lender of any Loan by an amount equal to the principal amount of such Loan. 

(b) Prior to the Delayed Draw Funding Deadline, the Borrower may at any time terminate, or from time to time reduce, the Commitments;
provided that each partial reduction of the Commitments shall be in an amount that is an integral multiple of $5,000,000 and not less than $20,000,000. 

(c) The Borrower shall notify the Administrative Agent by telephone, fax or electronic mail (and, in the case of telephonic notice, promptly
confirmed by hand delivery, fax or electronic mail) of any election to terminate or reduce the Commitments under paragraph (b) of this Section at least three Business Days prior to the effective date of such termination or reduction, specifying
such election and the effective date thereof. Promptly following receipt of any such notice, the Administrative Agent shall advise the Lenders of the contents thereof. Each notice delivered by the Borrower pursuant to paragraph (b) of this
Section shall be irrevocable; provided that any such notice may state that such notice is conditioned upon the occurrence of one or more events specified therein, in which case such notice may be revoked by the Borrower (by notice to the
Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. Any termination or reduction of the Commitments shall be permanent. Each reduction of the Commitments shall be made ratably among the Lenders in
accordance with their respective Commitments. 

  
 30 

 SECTION 2.09. Repayment of Loans; Evidence of Debt. 

(a) The Borrower hereby unconditionally promises to pay, without premium or penalty (subject to Section 2.15), to the Administrative
Agent, for the account of each Lender, the then unpaid principal amount of each Loan of such Lender on the Maturity Date. 
 (b) Each Lender
shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to
such Lender from time to time hereunder. 
 (c) The Administrative Agent shall maintain accounts in which it shall record (i) the amount
of each Loan made hereunder, the Type thereof and, in the case of Eurodollar Loans, the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each
Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender’s share thereof. 

(d) The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section shall be prima facie
evidence of the existence and amounts of the obligations recorded therein; provided that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the
Borrower to repay the Loans in accordance with the terms of this Agreement. 
 (e) Any Lender may request that Loans made by it be evidenced
by a promissory note. In such event, the Borrower shall prepare, execute and deliver to such Lender a promissory note payable to such Lender substantially in the form of Exhibit D. Thereafter, the Loans evidenced by such promissory note and interest
thereon shall at all times (including after assignment pursuant to Section 9.04) be represented by one or more promissory notes in such form payable to the payee named therein. 

SECTION 2.10. Prepayment of Loans. 

(a) The Borrower shall have the right at any time and from time to time to prepay any Borrowing in whole or in part, without premium or penalty
(subject to Section 2.15), subject to prior notice in accordance with paragraph (c) of this Section. 
 (b) In the event and on
each occasion that, after the making of the Loans on a Funding Date, the Borrower or any Subsidiary actually receives any Net Cash Proceeds in respect of a Prepayment Event that occurs after the Closing Date, then the Borrower shall, on or prior to
the third Business Day after the actual receipt of such Net Cash Proceeds by the Borrower or any Subsidiary, prepay Borrowings in an amount equal to the lesser of (i) the aggregate principal amount of Loans then outstanding and (ii) 100% of
such Net Cash Proceeds. 
 (c) The Borrower shall notify the Administrative Agent by telephone, fax or electronic mail (and, in the case of
telephonic notice, promptly confirmed by hand delivery, fax or electronic mail) of any prepayment hereunder (i) in the case of prepayment of a Eurodollar Borrowing, not later than 1:00 p.m., New York City time, one Business Day before the date
of prepayment or (ii) in the case of prepayment of an ABR Borrowing, not later than 1:00 p.m., New York City time, on the same Business Day as the date of prepayment; provided, in each case, if such prepayment is pursuant to paragraph
(b) of this Section, then such notice or prepayment shall not be due until such later time on the required date of such prepayment as shall be practicable. Each such notice shall be irrevocable and shall specify the prepayment date and the
principal amount of each Borrowing or portion thereof to be prepaid; provided that a notice of prepayment of any Borrowing under paragraph (a) of this Section may state that such notice is conditioned upon the occurrence of one or more
events specified therein, in which case such 

  
 31 

 
notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified date of prepayment) if such condition is not satisfied. Promptly following receipt of any
such notice relating to a Borrowing, the Administrative Agent shall advise the Lenders of the contents thereof. Each partial prepayment of any Borrowing under paragraph (a) of this Section shall be in an amount that would be permitted in the
case of an advance of a Borrowing of the same Type as provided in Section 2.02. Each prepayment of a Borrowing shall be applied ratably to the Loans included in the prepaid Borrowing. Prepayments shall be accompanied by accrued interest on the
amount prepaid. 
 SECTION 2.11. Fees. The Borrower agrees to pay to the Administrative Agent, for its own account, fees payable in
the amounts and at the times separately agreed upon between the Borrower and the Administrative Agent. Such fees payable hereunder shall be paid on the dates due, in immediately available funds, to the Administrative Agent. Fees paid shall not be
refundable under any circumstances. 
 SECTION 2.12. Interest. 

(a) The Loans comprising each ABR Borrowing shall bear interest at the Alternate Base Rate plus the Applicable Rate. 

(b) The Loans comprising each Eurodollar Borrowing shall bear interest at the Adjusted LIBO Rate for the Interest Period in effect for such
Borrowing plus the Applicable Rate. 
 (c) Notwithstanding the foregoing, if any principal of or interest on any Loan or any fee or other
amount payable by the Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, such overdue amount shall bear interest, after as well as before judgment, at a rate per annum equal to (i) in the case
of overdue principal of any Loan, 2.000% per annum plus the rate otherwise applicable to such Loan as provided in the preceding paragraphs of this Section or (ii) in the case of any other amount, 2.000% per annum plus the rate applicable to ABR
Loans as provided in paragraph (a) of this Section. 
 (d) Accrued interest on each Loan shall be payable in arrears on each Interest
Payment Date for such Loan and on the Maturity Date; provided that (i) interest accrued pursuant to paragraph (c) of this Section shall be payable on demand, (ii) in the event of any repayment or prepayment of any Loan, accrued
interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii) in the event of any conversion of any Eurodollar Loan prior to the end of the current Interest Period therefor, accrued
interest on such Loan shall be payable on the effective date of such conversion. 
 (e) All interest hereunder shall be computed on the basis
of a year of 360 days, except that interest computed by reference to the Alternate Base Rate at times when the Alternate Base Rate is based on the Prime Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and in
each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day). The applicable Alternate Base Rate, Adjusted LIBO Rate or LIBO Rate shall be determined by the Administrative Agent in accordance
with the terms hereof, and such determination shall be conclusive absent manifest error. 

  
 32 

 SECTION 2.13. Alternate Rate of Interest. 

(a) If prior to the commencement of any Interest Period for a Eurodollar Borrowing: 

(i) the Administrative Agent reasonably determines (which determination shall be conclusive absent manifest error) that
adequate and reasonable means do not exist for ascertaining the Adjusted LIBO Rate for such Interest Period (including because the LIBO Screen Rate is not available or published on a current basis); or 

(ii) the Administrative Agent is advised by the Required Lenders that the Adjusted LIBO Rate for such Interest Period will not
adequately and fairly reflect the cost to such Lenders of making or maintaining their Loans included in such Borrowing for such Interest Period; 
 then the
Administrative Agent shall give written notice thereof (which may be by electronic mail) to the Borrower and the Lenders as promptly as practicable thereafter and, until the Administrative Agent notifies the Borrower and the Lenders that the
circumstances giving rise to such notice no longer exist, (i) any Interest Election Request that requests the conversion of any ABR Borrowing to, or continuation of any Eurodollar Borrowing as, a Eurodollar Borrowing shall be ineffective and
(ii) if any Borrowing Request requests a Eurodollar Borrowing, such Borrowing shall be made as an ABR Borrowing. 
 (b) (i)
Notwithstanding anything to the contrary herein or in any other Loan Document, upon the occurrence of a Benchmark Transition Event or an Early Opt-in Election, as applicable, the Administrative Agent and the
Borrower may amend this Agreement to replace the Adjusted LIBO Rate and the LIBO Rate with a Benchmark Replacement. Any such amendment with respect to a Benchmark Transition Event will become effective at 5:00 p.m., New York City time, on the fifth
Business Day after the Administrative Agent has posted such proposed amendment to all Lenders and the Borrower so long as the Administrative Agent has not received, by such time, written notice of objection to such amendment from Lenders comprising
the Required Lenders. Any such amendment with respect to an Early Opt-in Election will become effective on the date that Lenders comprising the Required Lenders have delivered to the Administrative Agent
written notice that such Required Lenders accept such amendment. No replacement of the Adjusted LIBO Rate and the LIBO Rate with a Benchmark Replacement pursuant to this Section 2.13(b) will occur prior to the applicable Benchmark Transition
Start Date. 
 (ii) In connection with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make
Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without
any further action or consent of any other party to this Agreement. 
 (iii) The Administrative Agent will promptly notify the Borrower and
the Lenders of (A) any occurrence of a Benchmark Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date and Benchmark Transition Start Date, (B) the
implementation of any Benchmark Replacement, (C) the effectiveness of any Benchmark Replacement Conforming Changes and (D) the commencement or conclusion of any Benchmark Unavailability Period. Any determination, decision or election that
may be made by the Administrative Agent or Lenders pursuant to this Section 2.13(b), including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an
event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in
each case, as expressly required pursuant to this Section 2.13(b). 

  
 33 

 (iv) Upon the Borrower’s receipt of notice of the commencement of a Benchmark
Unavailability Period, the Borrower may revoke any request for a Eurodollar Borrowing of, conversion to or continuation of Eurodollar Loans to be made, converted or continued during any Benchmark Unavailability Period and, failing that, the Borrower
will be deemed to have converted any such request into a request for a borrowing of or conversion to ABR Loans. During any Benchmark Unavailability Period, the component of Alternate Base Rate based upon the Adjusted LIBO Rate will not be used in
any determination of Alternate Base Rate. 
 (v) For purposes of this Section 2.13(b): 

“Benchmark Replacement” means the sum of: (a) the alternate benchmark rate (which may include Term SOFR) that has been
selected by the Administrative Agent and the Borrower giving due consideration to (i) any selection or recommendation of a replacement rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving
or then-prevailing market convention for determining a rate of interest as a replacement to the Adjusted LIBO Rate or the LIBO Rate for U.S. dollar-denominated syndicated credit facilities and (b) the Benchmark Replacement Adjustment;
provided that, if the Benchmark Replacement as so determined would be less than zero, the Benchmark Replacement will be deemed to be zero for the purposes of this Agreement. 

“Benchmark Replacement Adjustment” means, with respect to any replacement of the Adjusted LIBO Rate or the LIBO Rate with an
Unadjusted Benchmark Replacement for each applicable Interest Period, the spread adjustment (or method for calculating or determining such spread adjustment) (which may be a positive or negative value or zero) that has been selected by the
Administrative Agent and the Borrower giving due consideration to (i) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the Adjusted LIBO Rate or the
LIBO Rate with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread
adjustment, for the replacement of the Adjusted LIBO Rate or the LIBO Rate with the applicable Unadjusted Benchmark Replacement for U.S. dollar-denominated syndicated credit facilities at such time. 

“Benchmark Replacement Conforming Changes” means, with respect to any Benchmark Replacement, any technical, administrative or
operational changes (including changes to the definition of “Alternate Base Rate”, the definition of “Interest Period”, timing and frequency of determining rates and making payments of interest and other administrative matters)
that the Administrative Agent determines may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with
market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of the
Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement). 

“Benchmark Replacement Date” means the earlier to occur of the following events with respect to the LIBO Screen Rate: 

(1) in the case of clause (1) or (2) of the definition of “Benchmark Transition Event”, the later of
(a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of the LIBO Screen Rate permanently or indefinitely ceases to provide the LIBO Screen Rate; or 

(2) in the case of clause (3) of the definition of “Benchmark Transition Event”, the date of the public
statement or publication of information referenced therein. 

  
 34 

 “Benchmark Transition Event” means the occurrence of one or more of the
following events with respect to the LIBO Screen Rate: 
 (1) a public statement or publication of information by or on
behalf of the administrator of the LIBO Screen Rate announcing that such administrator has ceased or will cease to provide the LIBO Screen Rate, permanently or indefinitely, provided that, at the time of such statement or publication, there is no
successor administrator that will continue to provide the LIBO Screen Rate; 
 (2) a public statement or publication of
information by the regulatory supervisor for the administrator of the LIBO Screen Rate, the U.S. Federal Reserve System, an insolvency official with jurisdiction over the administrator for the LIBO Screen Rate, a resolution authority with
jurisdiction over the administrator for the LIBO Screen Rate or a court or an entity with similar insolvency or resolution authority over the administrator for the LIBO Screen Rate, which states that the administrator of the LIBO Screen Rate has
ceased or will cease to provide the LIBO Screen Rate permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the LIBO Screen Rate; or 

(3) a public statement or publication of information by the regulatory supervisor for the administrator of the LIBO Screen Rate
announcing that the LIBO Screen Rate is no longer representative. 
 “Benchmark Transition Start Date” means (a) in the
case of a Benchmark Transition Event, the earlier of (i) the applicable Benchmark Replacement Date and (ii) if such Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90th day prior
to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication) and
(b) in the case of an Early Opt-in Election, the date specified by the Administrative Agent or the Required Lenders, as applicable, by notice to the Borrower, the Administrative Agent (in the case of such
notice by the Required Lenders) and the Lenders. 
 “Benchmark Unavailability Period” means, if a Benchmark Transition Event
and its related Benchmark Replacement Date have occurred with respect to the LIBO Screen Rate and solely to the extent that the LIBO Screen Rate has not been replaced with a Benchmark Replacement, the period (x) beginning at the time that such
Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the LIBO Screen Rate for all purposes hereunder in accordance with this Section 2.13(b) and (y) ending at the time that a Benchmark Replacement
has replaced the LIBO Screen Rate for all purposes hereunder pursuant to this Section 2.13(b). 
 “Early Opt-in Election” means the occurrence of: 
 (1) (i) a determination by the
Administrative Agent or (ii) a notification by the Required Lenders to the Administrative Agent (with a copy to the Borrower) that the Required Lenders have determined that U.S. dollar-denominated syndicated credit facilities being executed at
such time, or that include language similar to that contained in this Section 2.13(b), are being executed or amended, as applicable, to incorporate or adopt a new benchmark interest rate to replace the Adjusted LIBO Rate and the LIBO Rate, and

 (2) (i) the election by the Administrative Agent or (ii) the election by the Required Lenders to declare that an
Early Opt-in Election has occurred and the provision, as applicable, by the Administrative Agent of written notice of such election to the Borrower and the Lenders or by the Required Lenders of written notice
of such election to the Administrative Agent. 

  
 35 

 “NYFRB’s Website” means the website of the NYFRB at
http://www.newyorkfed.org, or any successor source. 
 “Relevant Governmental Body” means the Board and/or the NYFRB, or a
committee officially endorsed or convened by the Board and/or the NYFRB or any successor thereto. 
 “SOFR” with respect to
any day means the secured overnight financing rate published for such day by the NYFRB, as the administrator of the benchmark (or a successor administrator) on the NYFRB’s Website. 

“Term SOFR” means the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant
Governmental Body. 
 “Unadjusted Benchmark Replacement” means the Benchmark Replacement excluding the Benchmark Replacement
Adjustment. 
 SECTION 2.14. Increased Costs. 

(a) Increased Costs Generally. If any Change in Law shall: 

(i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement
against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (except any such reserve requirement reflected in the Adjusted LIBO Rate); 

(ii) impose on any Lender or the London interbank market any other condition, cost or expense (other than Taxes) affecting this
Agreement or Loans made by such Lender; or 
 (iii) subject any Recipient to any Taxes (other than (A) Indemnified
Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, commitments or other obligations, or its deposits, reserves, other liabilities or
capital attributable thereto; 
 and the result of any of the foregoing shall be to increase the cost to such Lender or such other Recipient of making,
converting to, continuing or maintaining any Loan (or of maintaining its obligation to make any Loan) or to reduce the amount of any sum received or receivable by such Lender or such other Recipient hereunder (whether of principal, interest or any
other amount) then, subject to paragraphs (c) and (d) of this Section, upon request of such Lender or such other Recipient, the Borrower will pay to such Lender or such other Recipient, as the case may be, additional amount or amounts as will
compensate such Lender or such other Recipient, as the case may be, for such additional costs incurred or reduction suffered; provided that such Lender or such other Recipient is generally seeking, or intends generally to seek, compensation
from similarly situated borrowers under similar credit facilities (to the extent such Lender or such other Recipient has the right under such similar credit facilities to do so) with respect to such Change in Law regarding capital or liquidity
requirements. 

  
 36 

 (b) Capital Requirements. If any Lender determines in good faith that any Change in
Law affecting such Lender or any lending office of such Lender or such Lender’s holding company, if any, regarding capital or liquidity requirements has had or would have the effect of reducing the rate of return on such Lender’s capital
or on the capital of such Lender’s holding company, if any, as a consequence of this Agreement, the Commitment of or the Loans made by such Lender to a level below that which such Lender or such Lender’s holding company could have achieved
but for such Change in Law (taking into consideration such Lender’s policies and the policies of such Lender’s holding company with respect to capital adequacy and liquidity), then from time to time, subject to paragraphs (c) and (d)
of this Section, the Borrower will pay to such Lender such additional amount or amounts as will compensate such Lender or such Lender’s holding company for any such reduction suffered; provided that such Lender is generally seeking, or
intends generally to seek, compensation from similarly situated borrowers under similar credit facilities (to the extent such Lender has the right under such similar credit facilities to do so) with respect to such Change in Law regarding capital or
liquidity requirements. 
 (c) Certificates for Reimbursement. A certificate of a Lender or other Recipient setting forth the amount
or amounts necessary to compensate such Lender or other Recipient or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section, including a description of the basis for such claim for compensation and a
calculation of such amount or amounts, shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender or such other Recipient, as the case may be, the amount shown as due on any such certificate
within 30 days after receipt thereof. 
 (d) Delay in Requests. Failure or delay on the part of any Lender or other Recipient to
demand compensation pursuant to this Section shall not constitute a waiver of such Lender’s or such other Recipient’s right to demand such compensation; provided that the Borrower shall not be required to compensate a Lender or any
other Recipient pursuant to this Section for any increased costs incurred or reductions suffered more than 180 days prior to the date that such Lender or such other Recipient notifies the Borrower in writing of the Change in Law giving rise to such
increased costs or reductions and of such Lender’s or such other Recipient’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof). 

SECTION 2.15. Break Funding Payments. In the event of (a) the payment of any principal of any Eurodollar Loan other than on
the last day of an Interest Period applicable thereto (including as a result of an Event of Default), (b) the conversion of any Eurodollar Loan other than on the last day of the Interest Period applicable thereto, (c) the failure (other than as
a result of the failure of a Lender to fund a Loan required to be funded hereunder) to borrow, convert, continue or prepay any Eurodollar Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be
revoked under Section 2.10(c) and is revoked in accordance therewith) or (d) the assignment of any Eurodollar Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Borrower pursuant to
Section 2.18, then, in any such event, the Borrower shall compensate each Lender for the loss, cost and expense attributable to such event in accordance with the terms of this Section. In the case of a Eurodollar Loan, such loss, cost or
expense to any Lender shall be deemed to include an amount determined by such Lender to be the excess, if any, of (i) the amount of interest which would have accrued on the principal amount of such Loan had such event not occurred, at the
Adjusted LIBO Rate that would have been applicable to such Loan (but not including the Applicable Rate applicable thereto), for the period from the date of such event to the last day of the then current Interest Period therefor (or, in the case of a
failure to borrow, convert or continue, for the period that would have been the Interest Period for such Loan), over (ii) the amount of interest which would accrue on such principal amount for such period at the interest rate which such Lender
would bid were it to bid, at the commencement of such period, for dollar deposits of a comparable amount and period from other banks in the London interbank market. A certificate of any Lender setting forth any amount or amounts that such Lender is
entitled to receive pursuant to this Section, including in reasonable detail a description of the basis for such compensation and a calculation of such amount or amounts, shall be delivered to the Borrower and shall be conclusive absent manifest
error. The Borrower shall pay such Lender the amount shown as due on any such certificate within 30 days after receipt thereof. 

  
 37 

 SECTION 2.16. Taxes. 

(a) Withholding of Taxes; Gross-Up. Each payment by or on account of any obligation of any Loan
Party under any Loan Document shall be made without deduction or withholding for any Taxes, unless such deduction or withholding is required by any applicable law. If any Withholding Agent determines in good faith that it is required under
applicable law to deduct or withhold any Tax from any such payment, then such Withholding Agent shall be entitled to make such deduction or withholdings and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority
in accordance with applicable law, and, if such Tax is an Indemnified Tax, then the sum payable by such Loan Party shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings
applicable to additional sums payable under this Section), the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding been made. 

(b) Payment of Other Taxes by the Borrower and the other Loan Parties. The Borrower and the other Loan Parties shall timely pay to the
relevant Governmental Authority in accordance with applicable law or, at the option of the Administrative Agent, timely reimburse it for the payment of, any Other Taxes. 

(c) Evidence of Payments. As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to
this Section 2.16, such Loan Party shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other
evidence of such payment reasonably satisfactory to the Administrative Agent. 
 (d) Indemnification by the Loan Parties. The Loan
Parties shall jointly and severally indemnify each Recipient, within 20 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this
Section) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally
imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf
or on behalf of a Lender, shall be conclusive absent manifest error. 
 (e) Indemnification by the Lenders. Each Lender shall
severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for
such Indemnified Taxes and without limiting the obligation of the Loan Parties to do so), (ii) any Taxes attributable to such Lender’s failure to comply with the provisions of Section 9.04(d) relating to the maintenance of a Participant
Register and (iii) any Excluded Taxes attributable to such Lender, in each case, that are paid or payable by the Administrative Agent in connection with any Loan Document and any reasonable expenses arising therefrom or with respect thereto,
whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive
absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under this Agreement or any other Loan Document or otherwise payable by the Administrative Agent
to such Lender from any other source against any amount then due to the Administrative Agent under this paragraph. 

  
 38 

 (f) Status of Lenders. (i) Any Lender that is entitled to an exemption from, or
reduction of, any applicable withholding Tax with respect to any payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent,
such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if
reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the
Administrative Agent to determine whether or not such Lender is subject to any backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and
submission of such documentation (other than such documentation set forth in Section 2.16(f)(ii)(A), Section 2.16(f)(ii)(B) and Section 2.16(f)(ii)(D)) shall not be required if in the Lender’s judgment such completion, execution
or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender. Upon the reasonable request of the Borrower or the Administrative Agent, any Lender
shall update any form or certification previously delivered pursuant to this Section 2.16(f). If any form or certification previously delivered pursuant to this Section 2.16(f) expires or becomes obsolete or inaccurate in any respect with
respect to a Lender, such Lender shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legally inability to do so. 

(ii) Without limiting the generality of the foregoing, in the event that the Borrower is a U.S. Person, 

(A) any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on
which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed copies of IRS Form W-9 certifying
that such Lender is exempt from U.S. federal backup withholding Tax; 
 (B) any Foreign Lender shall, to the extent it is
legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from
time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable: 

(1) in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party
(x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN-E establishing an exemption from, or reduction of, U.S. federal
withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form
W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article
of such tax treaty; 
 (2) executed copies of IRS Form W-8ECI; 

  
 39 

 (3) in the case of a Foreign Lender claiming the benefits of the exemption
for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of Exhibit E-1 to the effect that such Foreign Lender is not a “bank” within the meaning
of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C)
of the Code (a “U.S. Tax Compliance Certificate”) and (y) executed copies of IRS Form W-8BEN-E; or 

(4) to the extent a Foreign Lender is not the beneficial owner, executed copies of IRS Form
W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN-E, a U.S. Tax Compliance
Certificate substantially in the form of Exhibit E-3 or Exhibit E-4, IRS Form W-9, and/or other certification documents from each
beneficial owner, as applicable; provided that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax
Compliance Certificate substantially in the form of Exhibit E-2 on behalf of each such direct and indirect partner; 

(C) any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative
Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the
Administrative Agent), executed copies of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be
prescribed by applicable law to permit the Borrower or the Administrative Agent to determine any withholding or deduction required to be made; and 

(D) if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if
such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent
at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code)
and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has
complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this paragraph (D), the term “FATCA” shall include any amendments made to FATCA after the
date of this Agreement. 
 (iii) Each Lender agrees that if any form or certification it previously delivered pursuant to
this Section 2.16 expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so. 

  
 40 

 (g) Treatment of Certain Refunds. If any party determines, in its sole discretion
exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 2.16 (including by the payment of additional amounts paid pursuant to this Section 2.16), it shall pay to the
indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section 2.16 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying
party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this Section 2.16(g) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the
event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph, in no event will any indemnified party be required to pay any amount to any indemnifying
party pursuant to this paragraph the payment of which would place such indemnified party in a less favorable net after-Tax position than such indemnified party would have been in if the Tax subject to
indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This Section 2.16(g) shall not be construed
to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes which it deems confidential) to the indemnifying party or any other Person. 

(h) Survival. Each party’s obligations under this Section 2.16 shall survive the resignation or replacement of the
Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all other Obligations. 

(i) Defined Terms. For purposes of this Section 2.16, the term “applicable law” includes FATCA. 

SECTION 2.17. Payments Generally; Pro Rata Treatment; Sharing of Set-offs. 

(a) The Borrower shall make each payment required to be made by it hereunder (whether of principal, interest or fees, or of amounts payable
under Section 2.14, Section 2.15 or Section 2.16, or otherwise) prior to 2:00 p.m., New York City time, on the date when due, in immediately available funds, without any defense, set off, recoupment or counterclaim. Any amounts
received after the time set forth above on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon. All such payments shall be made
to the Administrative Agent to such account of the Administrative Agent in the United States as the Administrative Agent may specify from time to time, except that payments pursuant to Section 2.14, Section 2.15, Section 2.16 and
Section 9.03 shall be made directly to the Persons entitled thereto. The Administrative Agent shall distribute any such payments received by it for the account of any other Person to the appropriate recipient promptly following receipt thereof.
If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the
period of such extension. All payments hereunder shall be made in dollars. 
 (b) If at any time insufficient funds are received by and
available to the Administrative Agent to pay fully all amounts of principal, interest and fees then due hereunder, such funds shall be applied (i) first, towards payment of interest and fees then due hereunder, ratably among the parties
entitled thereto in accordance with the amounts of interest and fees then due to such parties, and (ii) second, towards payment of principal then due hereunder, ratably among the parties entitled thereto in accordance with the amounts of
principal then due to such parties. 

  
 41 

 (c) If any Lender shall, by exercising any right of
set-off or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of its Loans resulting in such Lender receiving payment of a greater proportion of the aggregate amount of
its Loans and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall (a) notify the Administrative Agent of such fact, (b) purchase (for cash at face value)
participations in the Loans of the other Lenders, or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and
accrued interest on their respective Loans; provided that (i) if any such participations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations shall be rescinded and the purchase price
restored to the extent of such recovery, without interest, and (ii) the provisions of this paragraph shall not be construed to apply to any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement or
any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans to any Person that is an Eligible Assignee. The Borrower consents to the foregoing and agrees, to the extent it may effectively do
so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of set-off and counterclaim with respect to such participation
as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation. 
 (d) Unless the Administrative Agent
shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders hereunder that the Borrower will not make such payment, the Administrative Agent may assume that
the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders the amount due. In such event, if the Borrower has not in fact made such payment, then each of the Lenders
severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment
to the Administrative Agent, at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. 

(e) If any Lender shall fail to make any payment required to be made by it pursuant to Section 2.06(b), Section 2.16(e),
Section 2.17(d) or Section 9.03(c), then the Administrative Agent may, in its discretion and notwithstanding any contrary provision hereof, (i) apply any amounts thereafter received by the Administrative Agent for the account of such
Lender for the benefit of the Administrative Agent to satisfy such Lender’s obligations to the Administrative Agent under such Section until all such unsatisfied obligations are fully paid, and/or (ii) hold any such amounts in a segregated
account as cash collateral for, and application to, any future funding obligations of such Lender under any such Section, in the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its
discretion. 
 SECTION 2.18. Mitigation Obligations; Replacement of Lenders. 

(a) Designation of a Different Lending Office. If any Lender requests compensation under Section 2.14, or if the Borrower is
required to pay any Indemnified Taxes or additional amounts to any Lender or to any Governmental Authority for the account of any Lender pursuant to Section 2.16, then such Lender shall use reasonable efforts to designate a different lending
office for funding or booking its Loans hereunder or to assign and delegate its rights and obligations hereunder to another of its offices, branches or Affiliates, if, in the judgment of such Lender, such designation or assignment and

  
 42 

 
delegation (i) would eliminate or reduce amounts payable pursuant to Section 2.14 or Section 2.16, as the case may be, in the future and (ii) would not subject such Lender to
any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment and
delegation. 
 (b) Replacement of Lenders. If (i) any Lender requests compensation under Section 2.14, or if the Borrower is
required to pay any Indemnified Taxes or additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.16 and, in each case, such Lender has declined or is unable to designate a different
lending office, or to assign and delegate its rights and obligations, in accordance with Section 2.18(a), (ii) any Lender becomes a Defaulting Lender or (iii) any Lender refuses to consent to any proposed amendment, modification, waiver or
consent with respect to any provision hereof that requires the unanimous approval of all Lenders, or the approval of each of the Lenders affected thereby (in each case in accordance with Section 9.02), and the consent of the Required Lenders
shall have been obtained with respect to such amendment, modification, waiver or consent, then the Borrower may, at its sole expense and effort (including payment of any applicable processing and recordation fees), upon notice to such Lender and the
Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all of its interests, rights (other than its existing rights to payment pursuant
to Section 2.14 or Section 2.16) and obligations under this Agreement and the other Loan Documents to an Eligible Assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment);
provided that (A) the Borrower shall have (x) paid to the Administrative Agent the processing and recordation fee (if any) specified in Section 9.04, and (y) received the prior written consent of the Administrative Agent
(with respect to any assignee that is not already a Lender or an Affiliate of a Lender), which consent shall not unreasonably be withheld, conditioned or delayed, (B) such Lender shall have received payment of an amount equal to the outstanding
principal of its Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder (including any amounts under Section 2.15), from the assignee (to the extent of such outstanding principal and accrued interest and
fees) or the Borrower (in the case of all other amounts), (C) in the case of any such assignment and delegation resulting from a claim for compensation under Section 2.14 or payments required to be made pursuant to Section 2.16, such
assignment and delegation will result in a reduction in such compensation or payments, (D) in the case of any such assignment and delegation resulting from the failure to provide a consent as contemplated by clause (iii) above, the
assignee shall have given such consent and, as a result of such assignment and delegation and any contemporaneous assignments, delegations and consents, the applicable amendment, modification, waiver or consent can be effected and (E) such
assignment and delegation does not conflict with applicable law. A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the
Borrower to require such assignment and delegation cease to apply. Each party hereto agrees that an assignment and delegation required pursuant to this paragraph may be effected pursuant to an Assignment and Assumption executed by the Borrower, the
Administrative Agent and the assignee and that the Lender required to make such assignment and delegation need not be a party thereto (it being understood and agreed that such Lender shall not be deemed to make the representations and warranties in
such Assignment and Assumption if such Lender has not executed such Assignment and Assumption). 
 SECTION 2.19. Illegality.
If any Lender determines that any law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its lending office to make, maintain or fund Loans whose interest is determined by reference to the
LIBO Rate, or to determine or charge interest rates based upon the LIBO Rate, or any Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, dollars in the London
interbank market, then, on notice thereof by such Lender to the Borrower through 

  
 43 

 
the Administrative Agent, (a) any obligation of such Lender to make or continue Eurodollar Loans or to convert ABR Loans to Eurodollar Loans shall be suspended, and (b) if such notice
asserts the illegality of such Lender making or maintaining ABR Loans the interest rate on which is determined by reference to the LIBO Rate component of the Alternate Base Rate, the interest rate on which ABR Loans of such Lender shall, if
necessary to avoid such illegality, be determined by the Administrative Agent without reference to the LIBO Rate component of the Alternate Base Rate, in each case until such Lender notifies the Administrative Agent and the Borrower that the
circumstances giving rise to such determination no longer exist. Upon receipt of such notice, (x) the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all Eurodollar Loans
of such Lender to ABR Loans (the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the LIBO Rate component of the Alternate Base Rate), either
on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurodollar Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurodollar Loans and (y) if such
notice asserts the illegality of such Lender determining or charging interest rates based upon the LIBO Rate, the Administrative Agent shall during the period of such suspension compute the Alternate Base Rate applicable to such Lender without
reference to the LIBO Rate component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon the LIBO Rate. Upon any such prepayment or
conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted. 
 SECTION 2.20. Defaulting
Lenders. Notwithstanding any provision of any Loan Document to the contrary, if any Lender becomes a Defaulting Lender, then, for so long as such Lender is a Defaulting Lender, the Commitment and Loans of such Defaulting Lender shall not
be included in determining whether the Required Lenders or any other requisite Lenders have taken or may take any action hereunder or under any other Loan Document (including any consent to any amendment, waiver or other modification pursuant to
Section 9.02); provided that any amendment, waiver or other modification requiring the consent of all Lenders or all Lenders affected thereby shall, except as otherwise provided in Section 9.02, require the consent of such
Defaulting Lender in accordance with the terms hereof. 
 In the event that the Administrative Agent and the Borrower each agrees that a
Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then on such date such Lender shall take such actions as the Administrative Agent may determine to be appropriate in connection with such Lender
ceasing to be a Defaulting Lender, whereupon such Lender will cease to be a Defaulting Lender (it being understood that all amendments, waivers or modifications effected without its consent in accordance with the provisions of Section 9.02 and
this Section during such period shall be binding on it). 
 The rights and remedies against, and with respect to, a Defaulting Lender under
this Section 2.20 are in addition to, and cumulative and not in limitation of, all other rights and remedies that the Administrative Agent and each Lender, the Borrower or any other Loan Party may at any time have against, or with respect to,
such Defaulting Lender. 

  
 44 

 ARTICLE III 

Representations and Warranties 

The Borrower represents and warrants to the Lenders that on the Closing Date and on each Funding Date: 

SECTION 3.01. Organization; Powers. The General Partner is the sole general partner of the Borrower. Each of the Loan Parties,
their respective Significant Subsidiaries and the General Partner (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b) has all requisite power and authority to own its
properties and to carry on its business as now conducted and (c) except where the failure to be so qualified or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, is qualified
to do business in, and is in good standing in, every jurisdiction where such qualification is required. 
 SECTION 3.02. Authorization;
Enforceability. The Transactions to be entered into by each Loan Party are within such Loan Party’s limited liability company, partnership or corporate powers, as applicable, and have been duly authorized by all necessary limited
liability company, partnership or corporate action, as applicable. This Agreement has been, and each other Loan Document when delivered hereunder will have been, duly executed and delivered by each Loan Party that is a party thereto. This Agreement
constitutes, and each other Loan Document when so executed and delivered will constitute, a legal, valid and binding obligation of each Loan Party that is a party thereto, enforceable against such Loan Party in accordance with its terms, subject to
applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

SECTION 3.03. Governmental Approvals; No Conflicts. The Transactions (a) do not require any consent or approval of,
registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect and except for any reports required to be filed by the Borrower with the SEC pursuant to the
Exchange Act, (b) will not violate or result in any breach or contravention of any law, rule or regulation or any order, injunction, writ or decree of any Governmental Authority, in each case, applicable to or binding upon the Borrower or any
of its Subsidiaries or any of its property, except, in any such case, to the extent that a Material Adverse Effect would not reasonably be expected to result therefrom, (c) will not violate or result in a default under (i) the Existing
Credit Agreement or any indenture to which the Borrower or any of its Subsidiaries is then a party or (ii) any other Material Agreement, agreement or other instrument binding upon the Borrower or any of its Subsidiaries or by which any property
or asset of the Borrower or any of its Subsidiaries is bound, except, in each case under this clause (ii), to the extent that a Material Adverse Effect would not reasonably be expected to result therefrom, (d) will not result in the creation or
imposition of any Lien prohibited hereunder on any asset of the Borrower or any of its Subsidiaries and (e) will not violate the Organization Documents of the Borrower or any Subsidiary Guarantor. 

SECTION 3.04. Financial Condition; No Material Adverse Effect. 

(a) The audited consolidated balance sheet and related statements of income, equity and cash flows as of and for the fiscal year ended
December 31, 2018 of the Borrower and its consolidated Subsidiaries theretofore made available to Lenders present fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its
consolidated Subsidiaries as of such date or for such period on a consolidated basis in accordance with GAAP consistently applied. 
 (b) The
unaudited consolidated balance sheet and related statements of income, equity and cash flows as of and for the fiscal quarter ended June 30, 2019 of the Borrower and its consolidated Subsidiaries theretofore made available to Lenders present
fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP as of such date or for such period consistently
applied, subject to normal year-end audit adjustments and the absence of footnotes. 

  
 45 

 (c) Beginning with the initial delivery of the financial information required under
Section 5.01(a) and Section 5.01(b), the financial information delivered to the Lenders pursuant to such Sections fairly presents, in all material respects, in conformity with GAAP, the consolidated financial position of the Borrower and
its consolidated Subsidiaries as of the applicable date and their consolidated results of operations and cash flows for the applicable period (subject, in the case of interim statements, to normal year-end
adjustments and the absence of footnotes). 
 (d) There has been no Material Adverse Change since December 31, 2018. 

SECTION 3.05. Properties. 

(a) The Borrower and each of its Subsidiaries has good title to, or valid leasehold interests in, all its real and personal property necessary
or otherwise material to the business of the Borrower and its Subsidiaries, taken as a whole, except for Liens permitted hereby and except where the failure to have such title or leasehold interest would not reasonably be expected to result in a
Material Adverse Effect. 
 (b) The Borrower and each of its Subsidiaries owns, or is licensed to use, all trademarks, tradenames,
copyrights, patents and other intellectual property material to the business of the Borrower and its Subsidiaries, taken as a whole, except where the failure to own, or be licensed to use, such intellectual property would not reasonably be expected
to have a Material Adverse Effect, and the use thereof by the Borrower and its Subsidiaries does not infringe upon the rights of any other Person, except for any such infringements that, individually or in the aggregate, would not reasonably be
expected to result in a Material Adverse Effect. 
 SECTION 3.06. Litigation and Environmental Matters. 

(a) There are no actions, suits or proceedings by or before any arbitrator or Governmental Authority pending against or, to the knowledge of
the Borrower, threatened against or affecting the Borrower or any Subsidiary (i) as to which there is a reasonable possibility of an adverse determination and that, if adversely determined, would reasonably be expected, individually or in the
aggregate, to result in a Material Adverse Effect or (ii) that involve this Agreement. 
 (b) Except for matters that, individually or
in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, neither the Borrower nor any of its Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit,
license or other approval required under any Environmental Law or (ii) has become subject to any Environmental Liability. 
 SECTION
3.07. Compliance with Laws; No Default. The Borrower and each of its Subsidiaries are in compliance with all laws, regulations and orders of any Governmental Authority applicable to it or its property (including ERISA and Environmental
Laws), except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect. No Default has occurred and is continuing or will result from the execution and delivery of this
Agreement or any of the other Loan Documents, or the making of the Loans hereunder. 
 SECTION 3.08. Margin Regulations; Investment
Company Status. No Loan Party is engaged in the business of extending credit for the purpose of “purchasing” or “carrying” “margin stock” within the respective meanings of each of the quoted terms under
Regulation U of the Board. No proceeds of any Loan will be used by the Borrower or its Subsidiaries for “purchasing” or “carrying” “margin stock” as so defined in contravention of the provisions of Regulations T, U, or
X of the Board. No Loan Party is, or is required to be registered as, an “investment company” as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended. 

  
 46 

 SECTION 3.09. Taxes. The Borrower and each of its Subsidiaries has filed or
caused to be filed all Tax returns and reports required to have been filed by it and has paid or caused to be paid all Taxes required to have been paid by it, except (a) Taxes or the filing of Tax returns or reports that are being contested in
good faith by appropriate proceedings and for which the Borrower or such Subsidiary, as applicable, has set aside on its books adequate reserves or (b) to the extent that the failure to do so would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect. 
 SECTION 3.10. ERISA. No ERISA Event has occurred or is
reasonably expected to occur that, individually or in the aggregate, would reasonably be expected to result in a Material Adverse Effect. 

SECTION 3.11. Disclosure. Neither the Information Memorandum nor any of the other written reports, financial statements,
certificates or other written information (collectively, the “Information”), other than any general economic or industry data or other information that is cited as being derived from a third party source, furnished by or on behalf
of any Loan Party to the Administrative Agent or any Lender in connection with the negotiation of this Agreement or delivered hereunder (as modified or supplemented by other Information furnished prior to the Closing Date and taken as a whole) and
in conjunction with all other information that has been made publicly available by the Borrower in the two years prior to the Closing Date in its filings with the SEC or in investor-related materials publicly available on the Borrower’s website
(other than, in each case, any such information set forth under the caption “risk factors” or “forward-looking statements” and any other similarly cautionary, predictive or forward-looking information set forth in such filings or
materials) did not, as of the date such Information was furnished (or, if such Information expressly related to a specific date, as of such specific date, or with respect to the periods for which such information relates), or will not, when
furnished, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such statements are made;
provided that with respect to projected financial information, the Borrower represents only that such information was prepared in good faith based upon assumptions the Borrower considered reasonable at the time such projected financial
information is so furnished (it being understood that such projected financial information is subject to significant uncertainties and contingencies, many of which are beyond the Borrower’s control, and that actual results may vary materially
from the projected financial information). 
 SECTION 3.12. Subsidiaries; Equity Investments. As of the Closing Date, the
Borrower does not have (a) any Subsidiaries other than those specifically disclosed in part (a) of Schedule 3.12, and all of the outstanding Equity Interests in such Subsidiaries have been validly issued, are fully paid and non-assessable (to the extent applicable) and are owned by the Persons indicated on Schedule 3.12, or (b) any equity investment in any other corporation or other entity other than those specifically disclosed
in part (b) of Schedule 3.12. 
 SECTION 3.13. Anti-Corruption Laws and Sanctions. The Borrower has policies and procedures
designed and implemented to promote, in its reasonable business judgment, compliance by the Borrower, its wholly owned Subsidiaries and their respective directors, officers, employees and agents (acting in their capacity as agents for the Borrower
or its Subsidiaries, as applicable) with Anti-Corruption Laws and applicable Sanctions. The Borrower and its Subsidiaries and to the knowledge of the Borrower, their respective officers, employees, directors and agents, are in compliance with
Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower, any of their respective directors, officers or employees, or (b) to the knowledge of the
Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Borrowing, use of proceeds thereof or other transaction
contemplated by this Agreement will, to the knowledge of the Borrower, violate Anti-Corruption Laws or applicable Sanctions. 

  
 47 

 ARTICLE IV 

Conditions 
 SECTION
4.01. Closing Date. This Agreement shall become effective on the date on which each of the following conditions is satisfied (or waived in accordance with Section 9.02); provided that the obligations of the Lenders to make
Loans hereunder are subject to the satisfaction (or waiver in accordance with Section 9.02) of the conditions precedent set forth in Sections 4.02: 

(a) Loan Documents. The Administrative Agent shall have received (i) from each party hereto, either (A) a counterpart of this
Agreement signed on behalf of such party or (B) written evidence satisfactory to the Administrative Agent (which may include fax or electronic transmission of a signed signature page of this Agreement) that such party has signed a counterpart
of this Agreement and (ii) for the account of each Lender that has requested a promissory note, a duly executed promissory note conforming to the requirements of Section 2.09(e). 

(b) Subsidiary Guaranties. If required by Section 5.10, the Administrative Agent shall have received a counterpart of the
Subsidiary Guarantee executed by a duly authorized officer of each applicable Subsidiary. 
 (c) Legal Opinion. The Administrative
Agent shall have received a favorable written opinion (addressed to the Administrative Agent and the Lenders and dated the Closing Date) of Jones Day, counsel for the Loan Parties, reasonably satisfactory to the Administrative Agent, and covering
such matters relating to the Loan Parties, this Agreement and the other Loan Documents as the Arrangers shall reasonably request. The Borrower hereby requests such counsel to deliver such opinion. 

(d) Secretary’s Certificate(s). The Administrative Agent shall have received a certificate of a Secretary or an Assistant Secretary
of each Loan Party, dated as of the Closing Date, certifying (i) the resolutions of the board of directors or other governing body of such Loan Party (or its general partner) authorizing the execution, delivery and performance of each Loan
Document to which it is a party, (ii) the Organization Documents of such Loan Party and its general partner, if applicable, and (iii) the names and true signatures of the officers executing any Loan Document on behalf of the Loan Parties
on the Closing Date. 
 (e) Existence and Good Standing Certificates. The Administrative Agent shall have received a certificate of
existence and good standing with respect to each Loan Party, and its general partner, if applicable, dated as of a recent date prior to the Closing Date, from appropriate public officials in its jurisdiction of organization. 

(f) Closing Certificate. The Administrative Agent shall have received a certificate, dated the Closing Date and signed by a Responsible
Officer of the Borrower, certifying that, after giving effect to the Transactions that are to occur on the Closing Date, (i) no Default exists and (ii) the representations and warranties of the Loan Parties set forth in this Agreement and
the other Loan Documents are true and correct in all material respects, except to the extent any such representations and warranties are expressly limited to an earlier date, in which case such representations and warranties continue to be true and
correct in all material respects as of such specified earlier date (provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in
the text thereof), in form and substance reasonably satisfactory to the Administrative Agent. 

  
 48 

 (g) “Know Your Customer” Information. The Lenders shall have received, at
least three Business Days prior to the Closing Date, all documentation and other information that may be required by such Lenders in order to enable compliance with applicable “know your customer” and anti-money laundering rules and
regulations, including information required by the USA Patriot Act, information described in Section 9.15 and, if any Loan Party qualifies as a “legal entity customer” under the Beneficial Ownership Regulation, a Beneficial Ownership
Certification in relation to such Loan Party, to the extent requested by the Lenders in writing to the Borrower at least 10 Business Days prior to the Closing Date. 

(h) Fees and Expenses. The Administrative Agent, the Arrangers and the Lenders shall have received from the Borrower payment of all fees
required to be paid, and payment or reimbursement of all expenses required to be paid or reimbursed, by the Borrower pursuant to this Agreement or the Fee Letters on or prior to the Closing Date (and, in the case of expenses, which are invoiced at
least two Business Days prior to the Closing Date). 
 The Administrative Agent shall notify the Borrower and the Lenders of the Closing Date, and such
notice shall be conclusive and binding. 
 SECTION 4.02. Conditions to Each Funding Date. The obligation of each Lender to
make a Loan on the occasion of any Borrowing (other than any conversion or continuation of any Loan) is subject to the receipt of the request therefor in accordance herewith and to the satisfaction of the following conditions: 

(a) The representations and warranties of the Loan Parties set forth in this Agreement and the other Loan Documents shall be true and correct
in all material respects on and as of the date of such Borrowing, except to the extent any such representations and warranties are expressly limited to an earlier date, in which case, on and as of the date of such Borrowing, such representations and
warranties shall continue to be true and correct in all material respects as of such specified earlier date; provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties that already
are qualified or modified by materiality in the text thereof. 
 (b) At the time of and immediately after giving effect to such Borrowing,
no Default shall have occurred and be continuing. 
 Each Borrowing (other than any conversion or continuation of any Loan) shall be deemed to constitute a
representation and warranty by the Borrower on the date thereof that the conditions specified in paragraphs (a) and (b) of this Section have been satisfied. 

ARTICLE V 

Affirmative Covenants 

From and after the Closing Date and until the Commitments have expired or terminated and the principal of and interest on each Loan and all
fees and other Obligations have been paid in full (other than indemnities and other contingent obligations not then due and payable and as to which no claim has been made), the Borrower covenants and agrees with the Lenders that: 

  
 49 

 SECTION 5.01. Financial Statements; Ratings Change and Other Information. The
Borrower will furnish to the Administrative Agent for distribution to each Lender: 
 (a) within 90 days after the end of each fiscal year of
the Borrower (beginning with the fiscal year ended December 31, 2019) its audited consolidated balance sheet and related statements of income, equity and cash flows as of the end of and for such year, setting forth in each case in comparative
form the figures for the previous fiscal year, all reported on by PricewaterhouseCoopers LLP or other independent registered public accounting firm of recognized national standing (without a “going concern” or like qualification or
exception and without any qualification or exception as to the scope of such audit) to the effect that such consolidated financial statements present fairly, in all material respects, the financial position and results of operations and cash flows
of the Borrower and its consolidated subsidiaries on a consolidated basis in accordance with GAAP consistently applied; 
 (b) within 45 days
after the end of each of the first three fiscal quarters of each fiscal year of the Borrower (beginning with the fiscal quarter ending September 30, 2019), its consolidated balance sheet and related statements of income, equity and cash flows
as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end
of) the previous fiscal year, all certified by one of its Financial Officers as presenting fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its consolidated subsidiaries on a
consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes; 

(c) concurrently with any delivery of financial statements under clause (a) or (b) above, a certificate of a Financial Officer of the
Borrower (a “Compliance Certificate”) (i) certifying as to whether a Default has occurred and is continuing as of the date of such Compliance Certificate and, if such a Default has occurred and is continuing as of the date of such
Compliance Certificate, specifying the details thereof and any action taken or proposed to be taken with respect thereto, (ii) setting forth reasonably detailed calculations demonstrating compliance with Section 6.09, (iii) stating whether
any Designated Material Debt remains outstanding on the date that such Compliance Certificate is delivered, (iv) stating whether any change in GAAP or in the application thereof has occurred since the date of the most recent audited financial
statements provided under this Agreement that has had a significant effect on the calculation of the Consolidated Net Tangible Assets or the ratio referred to in Section 6.09 and, if any such change has occurred, specifying the nature of such
change and the effect of such change on such calculation, (v) if any Excluded Venture was a consolidated subsidiary of the Borrower during the period covered by such financial statements delivered pursuant to Section 5.01(a) or
Section 5.01(b), then, to the extent not already provided in connection with clause (ii) above, setting forth information reconciling Consolidated EBITDA for the period covered thereby to net income (loss) reported for such period and
indicating the amount of Debt (as defined in the definition of Consolidated Total Debt) of Excluded Ventures that is reflected in the financial statements but not included in the calculation of the ratio referred to in Section 6.09, (vi)
setting forth the names of all Subsidiaries that are Excluded Ventures as of the date of the financial statements being delivered and (vii) if, during the period covered by such financial statements, any Subsidiary was designated or deemed
designated as an Excluded Venture pursuant to Section 5.12(a) or Section 5.12(e) or any Excluded Venture was designated as a Subsidiary pursuant to Section 5.12(b), certifying that at the time of such designation or deemed
designation, the conditions described in Section 5.12(a) or Section 5.12(b), as applicable, were satisfied; 
 (d) promptly after
the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by the Borrower or any Subsidiary with the SEC, or with any national securities exchange, or distributed by the Borrower to its
shareholders generally, as the case may be; 
 (e) promptly after Moody’s, S&P or Fitch shall have announced a change in the rating
established or deemed to have been established for the Index Debt, written notice of such rating change; 

  
 50 

 (f) promptly following any request therefor, such other information regarding the
operations, business affairs and financial condition of the Borrower or any Subsidiary, or compliance with the terms of this Agreement, as the Administrative Agent or any Lender may reasonably request; and 

(g) promptly following the Administrative Agent’s request therefor, all documentation and other information that the Administrative Agent
reasonably requests on its behalf or on behalf of any Lender in order to comply with its ongoing obligations under (i) applicable “know your customer” and anti-money laundering rules and regulations, including the USA Patriot Act, and
(ii) the Beneficial Ownership Regulation. 
 Information required to be delivered pursuant to clause (a), (b) or (d) of this Section shall be
deemed to have been delivered if such information, or one or more reports containing such information, shall be publicly available on the website of the SEC at http://www.sec.gov. Information required to be delivered pursuant to this Section may
also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent. 
 SECTION 5.02. Notices of
Default. The Borrower will furnish, or cause to be furnished, to the Administrative Agent for distribution to each Lender prompt written notice of the occurrence of any Default of which any Responsible Officer of the Borrower or
the General Partner obtains knowledge. Each notice delivered under this Section shall be accompanied by a statement of a Responsible Officer or other executive officer of the Borrower setting forth the details of the event or development requiring
such notice and any action taken or proposed to be taken with respect thereto. 
 SECTION 5.03. Existence; Conduct of
Business. The Borrower will, and will cause each Significant Subsidiary to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect (a) its legal existence (in the case of the Borrower, in its
State of organization) and (b) the rights, licenses, permits, privileges and franchises material to the conduct of its business; provided that the foregoing shall not prohibit any merger, consolidation, liquidation or dissolution
permitted under Section 6.03; and provided further that this Section 5.03 shall not require the Borrower or any Significant Subsidiary to preserve or maintain any rights, licenses, permits, privileges or franchises or require any
Significant Subsidiary to maintain its legal existence, in each case, if the Borrower shall reasonably determine that the failure to maintain and preserve the same would not reasonably be expected, individually or in the aggregate, to result in a
Material Adverse Effect. 
 SECTION 5.04. Payment of Taxes and other Obligations. The Borrower will, and will cause each of
its Subsidiaries to, pay (a) its Tax liabilities and (b) its other governmental obligations which, if unpaid, would reasonably be expected to result in a Lien upon any property of the Borrower or such Subsidiary before the same shall
become delinquent or in default, except, in each case, to the extent that (i) the validity or amount thereof is being contested in good faith by appropriate proceedings and the Borrower or such Subsidiary has set aside on its books adequate
reserves with respect thereto in accordance with GAAP or (ii) the failure to make such payment would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. 

SECTION 5.05. Maintenance of Properties; Insurance. The Borrower will, and will cause each of its Subsidiaries to,
(a) maintain all property material to the conduct of the business of the Borrower and its Subsidiaries, taken as a whole, in good working order and condition, ordinary wear and tear excepted, and (b) maintain, with financially sound and
reputable insurance companies, insurance in such amounts and against such risks as are customarily maintained by companies engaged in the same or similar businesses operating in the same or similar locations (including by the maintenance of adequate
self-insurance reserves to the extent customary among such companies). 

  
 51 

 SECTION 5.06. Books and Records; Inspection Rights. The Borrower will, and
will cause each of its Subsidiaries to, keep proper books of record and account in which complete and accurate entries, in all material respects, are made of its financial and business transactions in conformity with GAAP and applicable law. The
Borrower will, and will cause each of its Subsidiaries to, permit any representatives designated by the Administrative Agent or any Lender, at the Administrative Agent’s or such Lender’s expense (unless an Event of Default has occurred and
is continuing, in which case it shall be at the Borrower’s sole expense), upon reasonable prior notice and subject to any applicable restrictions or limitations on access to any facility or information that is classified or restricted by
contract or by law, regulation or governmental guidelines, to visit and inspect its properties, to examine and make extracts from its books and records, and to discuss its affairs, finances and condition with its officers and independent
accountants, all at such reasonable times and as often as reasonably requested; provided that advance notice of any discussion with such independent accountants shall be given to the Borrower and, so long as no Event of Default shall have
occurred and be continuing, the Borrower shall have the opportunity to be present at any such discussion. The Administrative Agent and each Lender agree to keep all information obtained by them pursuant to this Section confidential in accordance
with Section 9.13. 
 SECTION 5.07. Compliance with Laws. The Borrower will, and will cause each of its Subsidiaries to,
comply with all laws, rules, regulations and orders of any Governmental Authority (including ERISA and Environmental Laws) applicable to it or its property, except where the failure to do so, individually or in the aggregate, would not reasonably be
expected to result in a Material Adverse Effect. 
 SECTION 5.08. Use of Proceeds. The proceeds of the Loans will be used only
for working capital and general partnership, corporate or company purposes, as applicable, of the Borrower and its Subsidiaries, including repayment of the existing Indebtedness of the Borrower. No part of the proceeds of any Loan will be used,
whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Board, including Regulations T, U and X. The Borrower will not request any Borrowing, and the Borrower shall not use, or permit its
Subsidiaries and its or their respective directors, officers, employees and agents to use, the proceeds of any Borrowing (a) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything
else of value, to any Person in violation of any Anti-Corruption Laws, in any material respect, (b) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any
Sanctioned Country or (c) in any other manner that would result in the material violation of any Sanctions applicable to any party to this Agreement. 

SECTION 5.09. Maintenance of Separateness. The Borrower will, and will cause each other Loan Party to, observe organizational
formalities and keep books and records separate from MPC and the other MPC Companies. 
 SECTION 5.10. Required Subsidiary
Guarantors. 
 (a) If on the Closing Date any Subsidiary guarantees (i) any Indebtedness under the Existing Credit Agreement
or (ii) any other Indebtedness of the Borrower in an aggregate principal amount of $20,000,000 or more, then, in each case, such Subsidiary shall execute the Subsidiary Guarantee and deliver it to the Administrative Agent on the Closing Date.
If, after the Closing Date, any Subsidiary that is not already a Subsidiary Guarantor guarantees (i) any Indebtedness under the Existing Credit Agreement (or any refinancing thereof) or (ii) any other Indebtedness of the Borrower in an
aggregate principal amount of $20,000,000 or more, then, in each case, such Subsidiary shall become a guarantor of the Obligations by executing the Subsidiary Guarantee and delivering it to the Administrative Agent within 10 Business Days of the
date on which it guaranteed such Indebtedness (or 

  
 52 

 
such later date as agreed to by the Administrative Agent), together with such other additional closing documents, certificates and legal opinions (which may be opinions of in-house counsel) as shall reasonably be requested by the Administrative Agent. In connection with the initial execution and delivery of the Subsidiary Guarantee, the Borrower shall execute and deliver a counterpart
thereof to the Administrative Agent. 
 (b) So long as no Default has occurred and is continuing (or would result from such release), (i) if
all of the Equity Interests of a Subsidiary Guarantor that are owned by the Borrower or any other Subsidiary are sold or otherwise disposed of in a transaction or transactions permitted by this Agreement and as a result of such disposition such
Person is no longer a Subsidiary or (ii) if (A) the conditions set forth in Section 5.10(a) requiring such Person to be a Subsidiary Guarantor no longer exist (other than as a result of a payment by such Subsidiary Guarantor upon its
guarantee) and (B) immediately after giving effect to the release of such Subsidiary Guarantor (and giving effect to any repayment of Indebtedness that occurs substantially concurrently with such release), all of the Indebtedness of the Non-Guarantor Subsidiaries is permitted under Section 6.01, then promptly following the Borrower’s request, the Administrative Agent shall execute a release of such Subsidiary Guarantor from its Subsidiary
Guarantee. A request by the Borrower for a release pursuant to this Section shall be accompanied by a certificate of a Responsible Officer of the Borrower certifying that the conditions to release set forth in this Section have been satisfied. Any
execution and delivery of any such release by the Administrative Agent shall be without recourse or warranty by the Administrative Agent. 

(c) The Borrower may, but shall not be required to, cause Subsidiaries (other than those required to become Subsidiary Guarantors pursuant to
Section 5.10(a)) to become Subsidiary Guarantors pursuant to Section 9.09. 
 SECTION 5.11. Anti-Corruption Laws and
Sanctions. The Borrower will maintain and implement policies and procedures designed, in its reasonable business judgment, to promote compliance by the Borrower, its wholly owned Subsidiaries and their respective directors, officers,
employees and agents (when acting in their capacity as agents for the Borrower or its Subsidiaries) with Anti-Corruption Laws and applicable Sanctions. 

SECTION 5.12. Excluded Ventures. 

(a) The Borrower may, on or after the Closing Date, designate any subsidiary to be an Excluded Venture; provided that at the time of
such designation and immediately after giving pro forma effect thereto (i) no Default shall exist, (ii) the representations and warranties of the Loan Parties set forth in this Agreement and the other Loan Documents will be true and
correct in all material respects as if remade at the time of such designation, except to the extent such representations and warranties specifically refer to an earlier date, in which case they were true and correct in all material respects as of
such earlier date (provided that such materiality qualifier shall not be applicable to any representation and warranty that already is qualified or modified by materiality in the text thereof) and (iii) such subsidiary does not, at the
time of designation and does not at any time thereafter while it is an Excluded Venture, Guarantee or otherwise become directly or indirectly liable with respect to, or grant any Liens on any of its property to secure, any Indebtedness of the
Borrower or any Subsidiary or any obligations of the Borrower or any Subsidiary in respect of any Sale and Leaseback Transaction. Designation by the Borrower pursuant to this Section shall be deemed to be a representation and warranty by the
Borrower as of such date as to the matters specified in this Section. 

  
 53 

 (b) The Borrower may designate any Excluded Venture to be a Subsidiary, provided that
at the time of such designation and after giving pro forma effect thereto, (i) such Excluded Venture shall not have outstanding Indebtedness, other than Indebtedness permitted under Section 6.01, or Liens on any of its property, other than
Liens permitted under Section 6.02 (in each case taking into account the other Indebtedness of Subsidiaries, and the Liens on property of the Borrower and its Subsidiaries, then existing), (ii) no Default shall exist and (iii) the
representations and warranties of the Loan Parties set forth in this Agreement and the other Loan Documents will be true and correct in all material respects as if remade at the time of such designation, except to the extent such representations and
warranties specifically refer to an earlier date, in which case they were true and correct in all material respects as of such earlier date (provided that such materiality qualifier shall not be applicable to any representation and warranty
that already is qualified or modified by materiality in the text thereof). The designation of any Excluded Venture as a Subsidiary shall constitute the incurrence by such Subsidiary, at the time of designation, of (x) all Indebtedness of such
Subsidiary and (y) all Liens on property of such Subsidiary existing at such time. 
 (c) The Borrower shall not, and shall not permit
any of its Subsidiaries to, Guarantee, or grant or otherwise permit a Lien on any of its or their property to secure, any Indebtedness of an Excluded Venture or any obligations of an Excluded Venture in respect of any Sale and Leaseback Transaction,
other than (i) Liens on Equity Interests of an Excluded Venture to secure Indebtedness of such Excluded Venture that is non-recourse to the Borrower and its Subsidiaries and (ii) Guarantees of
Indebtedness of Excluded Ventures in an aggregate amount not to exceed 5.0% of Consolidated Net Tangible Assets at the time of incurrence or assumption thereof. As used in this paragraph (c),
“non-recourse” means Indebtedness of an Excluded Venture for which recourse to the Borrower or any Subsidiary, whether contractual or as a matter of law, for
non-payment of such Indebtedness is limited to Equity Interests issued by such Excluded Venture. 

(d) If at any time an Excluded Venture fails to meet any requirement set forth in clause (iii) of paragraph (a) or in paragraph
(c) of this Section 5.12, it will thereafter automatically cease to be an Excluded Venture and shall constitute a Subsidiary for all purposes of this Agreement, and any Indebtedness and Liens of such Subsidiary will be deemed to be
incurred by such Subsidiary as of such date. 
 (e) Any subsidiary of an Excluded Venture shall automatically constitute an Excluded Venture.
At the time that a Person becomes a subsidiary of an Excluded Venture, the Borrower shall be deemed to have designated such subsidiary as an Excluded Venture pursuant to Section 5.12(a). 

(f) If at any time an entity that has been designated as an Excluded Venture ceases to be a subsidiary of the Borrower, then such entity shall
cease to be an Excluded Venture. 
 ARTICLE VI 

Negative Covenants; Financial Covenant 

From and after the Closing Date and until the Commitments have expired or terminated and the principal of and interest on each Loan and all
fees and other Obligations have been paid in full (other than indemnities and other contingent obligations not then due and payable and as to which no claim has been made), the Borrower covenants and agrees with the Lenders that: 

SECTION 6.01. Indebtedness. The Borrower will not permit any Non-Guarantor Subsidiary to
create, incur, assume or permit to exist any Indebtedness, except: 
 (a) Indebtedness owing to a Loan Party or a wholly
owned Subsidiary; 
 (b) Indebtedness existing on the Closing Date which is either (i) set forth on Schedule 6.01 or
(ii) in a principal amount which is less than (x) $25,000,000 individually and (y) $50,000,000 in the aggregate; 

  
 54 

 (c) Indebtedness incurred to finance the acquisition, construction, repair,
development or improvement of any fixed or capital assets, including Capital Lease Obligations, and any Indebtedness assumed in connection with the acquisition of any such assets or secured by a Lien on any such assets prior to the acquisition
thereof; provided that (i) such Indebtedness is incurred prior to or within 180 days after such acquisition or the completion of such construction, repair, development or improvement and (ii) if such Indebtedness is secured, the
Liens securing it are permitted by Section 6.02(a)(iii); 
 (d) Indebtedness of a Person that is not a subsidiary of the
Borrower and that becomes a Subsidiary after the Closing Date or is merged or consolidated with or into the Borrower or any Subsidiary after the Closing Date, in each case, if such Indebtedness is existing at the time such Person becomes a
Subsidiary or is so merged or consolidated and is not incurred in contemplation of such transaction; 
 (e) extensions,
refinancings, renewals or replacements of the Indebtedness permitted by clause (b), (c) or (d) above which, in the case of any such extension, refinancing, renewal or replacement, does not increase the amount of the Indebtedness being extended,
refinanced, renewed or replaced, other than amounts incurred to pay the costs of such extension, refinancing, renewal or replacement; 

(f) other Indebtedness of Non-Guarantor Subsidiaries; provided that the sum,
without duplication, of (i) the outstanding aggregate principal amount of all such Indebtedness of Non-Guarantor Subsidiaries, plus (ii) the outstanding aggregate amount of Attributable Debt
under all Sale and Leaseback Transactions permitted under Section 6.02(b), plus (iii) the outstanding aggregate principal amount of all Indebtedness or other obligations secured by Liens permitted under Section 6.02(a)(x) shall
not exceed 15% of Consolidated Net Tangible Assets at the time of creation, incurrence or assumption thereof; and 
 (g)
Indebtedness of any Non-Guarantor Subsidiary as an account party in respect of trade letters of credit or in respect of bid, performance or surety bonds, workers’ compensation claims or self-insurance
obligations, in each case incurred in the ordinary course of business, including reimbursement obligations of any Non-Guarantor Subsidiary incurred in the ordinary course of its business with respect to
letters of credit supporting such bid, performance or surety bonds, workers’ compensation claims and self-insurance obligations (in each case, other than Guarantees of and obligations for money borrowed). 

SECTION 6.02. Liens and Sale and Leaseback Transactions. 

(a) Liens. The Borrower will not, and will not permit any of its Subsidiaries to, create, incur, assume or permit to exist any Lien on
any property or asset (including accounts receivable, royalties and other revenues) now owned or hereafter acquired by it, or assign or sell any receivables in connection with any financing transaction or series of financing transactions (including
factoring arrangements), except: 
 (i) Permitted Encumbrances; 

(ii) any Lien on any property or asset of the Borrower or any Subsidiary existing on the Closing Date which is either
(A) set forth on Schedule 6.02 or (B) securing Indebtedness or other obligations in a principal amount which is less than (x) $25,000,000 individually and (y) $50,000,000 in the aggregate; 

  
 55 

 (iii) Liens on fixed or capital assets acquired, constructed, repaired,
developed or improved by the Borrower or any of its Subsidiaries; provided that (A) such Liens secure only Indebtedness, including Capital Lease Obligations, incurred to finance the acquisition, construction, repair, development or
improvement of such assets, (B) such Liens and the Indebtedness secured thereby are incurred prior to or within 180 days after such acquisition or the completion of such construction, repair, development or improvement, and (C) such Liens
shall not apply to any other property or assets (other than accessions and improvements thereto); 
 (iv) Liens under any
Sale and Leaseback Transaction permitted under Section 6.02(b); 
 (v) Liens securing Indebtedness or other obligations
of the Borrower or any of its Subsidiaries in favor of any Loan Party; 
 (vi) (A) Liens on property existing at
the time such property is acquired by the Borrower or any of its Subsidiaries after the Closing Date and not created in contemplation of such acquisition (or on repairs, improvements, additions or accessions thereto) and (B) Liens on the assets
of any Person that is not a subsidiary of the Borrower and that becomes a Subsidiary after the Closing Date or is merged or consolidated with or into the Borrower or any Subsidiary after the Closing Date, in each case, if such Liens exist at the
time such Person becomes a Subsidiary or is so merged or consolidated and not created in contemplation of such transaction (or on repairs, improvements, additions or accessions thereto), provided that, in the case of clauses (A) and (B),
such Liens do not extend to any other assets; 
 (vii) Liens on cash and cash equivalents securing obligations under any Swap
Agreement, provided that the aggregate amount of all such obligations secured by such Liens shall not at any time exceed $200,000,000; 

(viii) extensions, renewals and replacements of the Liens described in clause (ii), (iii) or (vi) above, so long as there
is no increase in the Indebtedness or other obligations secured thereby (other than amounts incurred to pay costs of the extension, renewal and replacement of the Indebtedness secured by such Liens) and no additional property (other than accessions
and improvements in respect of such property) is subject to such Lien; 
 (ix) Liens on Equity Interests in a Joint Venture
owned by the Borrower or any Subsidiary securing obligations of such Joint Venture and Liens on Equity Interests in an Excluded Venture owned by the Borrower or any Subsidiary securing obligations of such Excluded Venture; and 

(x) Liens not otherwise permitted by other clauses of this Section 6.02(a) securing Indebtedness or other obligations of
the Borrower or any of its Subsidiaries, provided that the sum, without duplication, of (A) the aggregate outstanding principal amount of all such Indebtedness and obligations plus (B) the aggregate outstanding amount of
Attributable Debt under all Sale and Leaseback Transactions permitted under Section 6.02(b) plus (C) the aggregate outstanding principal amount of Indebtedness of Non-Guarantor Subsidiaries
permitted pursuant to Section 6.01(f) shall not exceed 15% of Consolidated Net Tangible Assets at the time of creation, incurrence or assumption of such Lien. 

  
 56 

 (b) Sale and Leaseback Transactions. The Borrower will not, and will not permit any
Subsidiary to, enter into any Sale and Leaseback Transaction if, after giving effect to such Sale and Leaseback Transaction, the sum, without duplication, of (i) the aggregate amount of the Attributable Debt under all such Sale and Leaseback
Transactions, plus (ii) the outstanding aggregate principal amount of all Indebtedness of Non-Guarantor Subsidiaries permitted under Section 6.01(f), plus (iii) the outstanding
aggregate principal amount of all Indebtedness of the Borrower and its Subsidiaries secured by Liens permitted under Section 6.02(a)(x) shall exceed 15% of Consolidated Net Tangible Assets at the time of consummation of such Sale and Leaseback
Transaction. 
 SECTION 6.03. Mergers, Fundamental Changes and Dispositions. The Borrower will not, and will not permit
any other Loan Party to, merge into or consolidate with any other Person, or permit any other Person to merge into or consolidate with it, or sell, transfer, lease or otherwise dispose of (in one transaction or in a series of transactions) all or
substantially all of the assets of the Borrower and its Subsidiaries taken as a whole (in each case, whether now owned or hereafter acquired), or liquidate or dissolve, except that (a) if at the time thereof and immediately after giving effect
thereto, no Event of Default shall have occurred and be continuing, any Person may merge with or into the Borrower, provided that the Borrower shall be the surviving entity; (b) any Loan Party that is a Subsidiary may merge into or
consolidate with or sell, transfer, lease or otherwise dispose of its assets to the Borrower or another Subsidiary; (c) any Loan Party that is a Subsidiary may merge into, or consolidate with, any Person other than the Borrower or another
Subsidiary if (i) such Loan Party is the surviving entity or (ii) such other Person is the surviving entity and becomes a Subsidiary and a Subsidiary Guarantor contemporaneously with such merger or consolidation; and (d) any Loan
Party (other than the Borrower) may liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and is not materially disadvantageous to the Lenders. 

SECTION 6.04. Transactions with Affiliates. The Borrower will not, and will not permit any of its Subsidiaries to, enter into or
engage in any material transaction (including any sale, lease, transfer, purchase or acquisition of property or assets) with any of its Affiliates, except on terms and conditions, taken as a whole, that are substantially no less favorable to the
Borrower or such Subsidiary as could be obtained on an arm’s-length basis from unrelated third parties (or, if in the good faith judgment of the General Partner’s board of directors, no comparable
transaction is available with which to compare any such transaction, such transaction, taken as a whole, is otherwise fair to the Borrower or such Subsidiary); provided that the foregoing restriction shall not apply to (a) transactions
between or among the Loan Parties and wholly owned Subsidiaries and not involving any other Person; (b) transactions involving any employee benefit plans or related trusts of the Borrower or any of its Subsidiaries; (c) transactions
pursuant to any contract or agreement existing as of the Closing Date and listed on Schedule 6.04; (d) the payment of reasonable compensation, fees and expenses to, and indemnity provided on behalf of, directors and officers of the Borrower or any
of its Subsidiaries in the ordinary course of business; (e) transactions entered into with the MPC Companies on terms and conditions that are fair and reasonable to the Borrower and its Subsidiaries, taking into account the totality of the
relationship between the Borrower and the Subsidiaries, on the one hand, and the MPC Companies, on the other, including the contemplated transactions set forth on Schedule 6.04; (f) transactions pursuant to any contract or agreement, between the
Borrower or any of its Subsidiaries, on one hand, and MPC and its subsidiaries, on the other, that as of the Closing Date has been filed as an exhibit to any report or statement filed by the Borrower, MPC or Andeavor Logistics LP with the SEC, in
each case as such contract or agreement is in effect on the Closing Date or as amended, supplemented or otherwise modified, or as replaced, thereafter, so long as such amendments, supplements or other modifications, or

  
 57 

 
such replacement contract or agreement, individually or in the aggregate, are not materially adverse to the interests of the Lenders, (g) transactions approved by the Conflicts Committee of
the Board of Directors (or equivalent governing body) of the General Partner (or the equivalent successor body to such Conflicts Committee); (h) investments in Excluded Ventures (including Guarantees permitted by Section 5.12(c)) or in Joint
Ventures; and (i) any Restricted Payment permitted by Section 6.07. 
 SECTION 6.05. Fiscal Year; Accounting
Principles. The Borrower will not, and will not permit any Subsidiary to, change (a) its current fiscal year or (b) its current accounting principles used in the preparation of financial statements unless such change in
accounting principles is required or permitted by GAAP, in each case, other than changes with respect to a Subsidiary made in order to conform to the fiscal year or principles of the Borrower. 

SECTION 6.06. Change in Nature of Business. The Borrower will not, and will not permit any Subsidiary to, engage in any material
line of business substantially different from those lines of business conducted by the Borrower and its Subsidiaries on the Closing Date, any business substantially related or incidental thereto or logical extensions thereof or any other business
which generates “qualifying income” under the Code. 
 SECTION 6.07. Restricted Payments. The Borrower will not
declare or make, directly or indirectly, any Restricted Payment, or incur any obligation (contingent or otherwise) to do so, except that (a) the Borrower may declare and make dividend payments and other distributions payable solely in the
Equity Interests of the Borrower and (b) so long as no Event of Default exists or would be caused by the declaring or making of such Restricted Payment, the Borrower may declare and make Restricted Payments in accordance with its partnership
agreement; provided that the foregoing shall not operate to prohibit the payment of distributions of Available Cash (as defined in the Borrower’s partnership agreement) to limited partners of the Borrower or the payment by the Borrower
for the repurchase of limited partnership interests in the Borrower so long as (i) on the record date for such distribution, or on the date that the Borrower became legally bound to pay the repurchase price for such repurchase (herein also
referred to as a “record date”), as applicable, such distribution or such repurchase was permitted by the foregoing and (ii) such distribution or such repurchase price is paid within the earlier of 60 days after the record date
and any date under applicable law on which such dividend or repurchase must be consummated. 
 SECTION 6.08. Changes in Organization
Documents. The Borrower will not, and will not permit any other Loan Party to, make any changes to its Organization Documents that would reasonably be expected to have a Material Adverse Effect. 

SECTION 6.09. Maximum Consolidated Leverage Ratio. The Borrower shall not permit, as of each
Quarter-End Date (commencing with the first Quarter-End Date occurring on or after the Closing Date), a ratio of Consolidated Total Debt as of such date to Consolidated
EBITDA for the four fiscal quarter period ending on such date to be greater than (a) during an Acquisition Period, 5.5 to 1.0 and (b) at all other times, 5.0 to 1.0. In addition, in the event that any Designated Material Debt is excluded
from the calculation of Consolidated Total Debt as of any Quarter-End Date (such excluded Debt is referred to herein as the “Excluded Debt”) and any Excluded Debt remains outstanding on the
Compliance Certificate Delivery Date with respect to such Quarter-End Date, then the Borrower shall not permit, on such Compliance Certificate Delivery Date, the ratio of (x) Consolidated Total Debt as of
such Quarter-End Date plus the amount of Excluded Debt that remains outstanding on such Compliance Certificate Delivery Date to (y) Consolidated EBITDA for the four fiscal quarter period ended on such Quarter-End Date, to exceed the foregoing ratio. For purposes of calculating compliance with this Section 6.09, Consolidated EBITDA may include, at the Borrower’s option, any Material Project EBITDA
Adjustments as provided in the definition thereof. 

  
 58 

 ARTICLE VII 

Events of Default 

If any of the following events (“Events of Default”) shall occur: 

(a) the Borrower shall fail to pay any principal of any Loan when and as the same shall become due and payable, whether at the due date thereof
or at a date fixed for prepayment thereof or otherwise; 
 (b) any Loan Party shall fail to pay any interest on any Loan or any fee or any
other amount (other than an amount referred to in clause (a) of this Article) payable under this Agreement or any other Loan Document, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of
five Business Days; 
 (c) any representation, warranty or certification made or deemed made by or on behalf of the Borrower or any
Subsidiary in any Loan Document or any amendment or modification thereof or waiver thereunder, or in any report, certificate, financial statement or other document furnished pursuant to or in connection with any Loan Document or any amendment or
modification thereof or waiver thereunder, shall prove to have been incorrect in any material respect when made or deemed made; 
 (d) the
Borrower shall fail to observe or perform any covenant, condition or agreement contained in Section 5.02, Section 5.03 (with respect to the Borrower’s existence), Section 5.08, Section 5.10 or Article VI; 

(e) any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in this Agreement or any other Loan Document
(other than those specified in clause (a), (b) or (d) of this Article), and such failure shall continue unremedied for a period of 30 days after the earlier of (i) a Responsible Officer of a Loan Party becoming aware of such failure or
(ii) notice of such failure is given by the Administrative Agent to the Borrower; 
 (f) the General Partner or any Loan Party or any
Subsidiary shall fail to make any payment in excess of $1,000,000 in the aggregate (whether of principal, interest, fees or other amounts) in respect of Indebtedness under the Existing Credit Agreement (or any replacement or refinancing thereof) or
any other Material Indebtedness, when and as the same shall become due and payable, and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to such Indebtedness; 

(g) any event or condition occurs that results in Indebtedness under the Existing Credit Agreement (or any replacement or refinancing thereof)
or any other Material Indebtedness becoming due prior to its scheduled maturity; provided that this clause (g) shall not apply to (i) secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the
property or assets securing such Indebtedness or (ii) any Indebtedness that becomes due as a result of a voluntary prepayment, purchase or redemption thereof; 

(h) an involuntary proceeding shall be commenced, or an involuntary petition shall be filed, in any court of competent jurisdiction seeking
(i) liquidation, reorganization or other relief in respect of the General Partner, any Loan Party or any Significant Subsidiary or its debts, or of a substantial part of its assets, under any Federal, state or foreign bankruptcy, insolvency,
receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the General Partner, any Loan Party or any Significant Subsidiary or for a
substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered by such court; 

  
 59 

 (i) the General Partner, any Loan Party or any Significant Subsidiary shall
(i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect,
(ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (h) of this Article, (iii) apply for or consent to the appointment of a receiver, trustee,
custodian, sequestrator, conservator or similar official for the General Partner, any Loan Party or any Significant Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed
against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any corporate action for the purpose of effecting any of the foregoing; 

(j) the General Partner, any Loan Party or any Significant Subsidiary shall become unable, admit in writing its inability or fail generally to
pay its debts as they become due; 
 (k) one or more final judgments (whether or not appealable) for the payment of money in an aggregate
amount in excess of $100,000,000 (to the extent not covered by independent third-party insurance (other than normal deductibles) as to which the insurer has been notified of such judgment and has not issued a notice denying coverage thereof) shall
be rendered by a court of competent jurisdiction against the General Partner, a Loan Party or any Subsidiary or any combination thereof, and either (i) the same shall remain undischarged or unsatisfied for a period of 45 consecutive days (or 60
consecutive days in the case of judgments rendered in foreign jurisdictions outside of the United States of America, any State thereof and the District of Columbia) during which execution shall not be effectively stayed (it being understood that,
for the purposes of this clause (k), “independent third-party insurance” shall include industry mutual insurance companies in which the General Partner, any Loan Party or any Subsidiary has an ownership interest) or (ii) any action
shall be legally taken by a judgment creditor to attach or levy upon any assets of the General Partner, any Loan Party or any Subsidiary to enforce any such judgment; 

(l) an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, would reasonably be expected
to result in a Material Adverse Effect; 
 (m) other than as a result of (i) the termination of the obligations of any Subsidiary
Guarantor under the Subsidiary Guarantee pursuant to the terms thereof or pursuant to Section 5.10(b) or Section 9.09, (ii) the exchange or replacement of any promissory note hereunder (with respect to the previously existing promissory
note which was so exchanged or replaced), (iii) the agreement of the Required Lenders or all Lenders, as may be required hereunder, or (iv) in accordance with the other provisions of this Agreement, the expiration or termination of the
Commitments, the payment in full of the principal and interest on each Loan, all fees payable hereunder and all other Obligations, any Loan Document (or any material provision thereof), at any time after its execution and delivery, ceases to be in
full force and effect or is declared by a court of competent jurisdiction to be null and void, invalid or unenforceable; or any Loan Party denies in writing that it has any liability or obligation thereunder, or purports to revoke, terminate or
rescind any Loan Document (other than pursuant to the terms hereof or thereof); or 

  
 60 

 (n) a Change in Control shall occur; 

then, and in every such event (other than an event with respect to the Borrower described in clause (h) or (i) of this Article), and at any time
thereafter during the continuance of such event, the Administrative Agent shall at the request, or may with the consent, of the Required Lenders, by notice to the Borrower, take any or all of the following actions, at the same or different times:
(i) terminate the Commitments, and thereupon the Commitments shall terminate immediately and (ii) declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and
payable may thereafter (at any time during the continuance of such event) be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other
obligations of the Loan Parties accrued hereunder, shall become due and payable immediately without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Loan Party; and in case of any event with respect to
the Borrower described in clause (h) or (i) of this Article, the Commitments shall immediately and automatically terminate, the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other obligations
of the Loan Parties accrued hereunder, shall immediately and automatically become due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Loan Parties. 

ARTICLE VIII 
 The
Administrative Agent 
 SECTION 8.01. Appointment and Authority. Each of the Lenders hereby irrevocably appoints the
Person named as the Administrative Agent to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are
delegated to the Administrative Agent by the terms hereof and of the other Loan Documents, together with such actions and powers as are reasonably incidental thereto. The provisions of this Article are solely for the benefit of the Administrative
Agent and the Lenders, and, except for the approval rights of the Borrower set forth in Section 8.06, neither the Borrower nor any other Loan Party shall have rights as a third party beneficiary of any of such provisions. It is understood and
agreed that the use of the term “agent” herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising
under agency doctrine of any applicable law. Instead, such term is used as a matter of market custom and is intended to create or reflect only an administrative relationship between contracting parties. 

SECTION 8.02. Rights as a Lender. The Person serving as the Administrative Agent hereunder shall have the same rights and powers
in its capacity as a Lender as any other Lender, and may exercise the same as though it were not the Administrative Agent and the term “Lender” or “Lenders” shall, unless otherwise expressly indicated or unless the context
otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other
advisory capacity for and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.

 SECTION 8.03. Exculpatory Provisions. The Administrative Agent shall not have any duties or obligations except those
expressly set forth herein and in the other Loan Documents, and its duties hereunder shall be administrative in nature. Without limiting the generality of the foregoing, the Administrative Agent: 

(a) shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing; 

  
 61 

 (b) shall not have any duty to take any discretionary action or to exercise any
discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or
percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents), provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may
expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting creditors’ rights generally or otherwise or that may affect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting creditors’ rights generally or otherwise; and 
 (c) shall not, except as expressly
set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to a Loan Party or any of its Affiliates that is communicated to or obtained by the Person
serving as the Administrative Agent or any of its Affiliates in any capacity. 
 The Administrative Agent shall not be liable for any action
taken or not taken by it (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith to be necessary, under
the circumstances as provided in Section 9.02 and Article VII) or (ii) unless a court of competent jurisdiction shall have determined by a final, non-appealable judgment that the Administrative Agent
was grossly negligent or acted with willful misconduct in taking or not taking any such action. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until notice (stating that it is a “notice of
default”) describing such Default is given in writing to the Administrative Agent by a Loan Party or a Lender. 
 The Administrative
Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate,
report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the
occurrence of any Default, (iv) the sufficiency, validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set
forth in Article IV or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent. 

SECTION 8.04. Reliance by Administrative Agent. The Administrative Agent shall be entitled to rely upon, and shall not incur any
liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and
to have been signed, sent or otherwise authenticated by the proper Person (whether or not such Person in fact meets the requirements set forth in the Loan Documents for being the signatory, sender or authenticator thereof). The Administrative Agent
also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person (whether or not such Person in fact meets the requirements set forth in the Loan Documents for being the signatory, sender
or authenticator thereof), and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan that by its terms must be fulfilled to the satisfaction of a Lender, the Administrative
Agent may presume that such condition is satisfactory to such Lender unless the Administrative Agent shall have received notice to the contrary from such Lender sufficiently in advance prior to the making of such Loan.

  
 62 

 
The Administrative Agent may consult with legal counsel (who may be counsel for the Loan Parties), independent accountants and other experts selected by it, and shall not be liable for any action
taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. 
 SECTION 8.05. Delegation of
Duties. The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub agents appointed by the Administrative Agent. The
Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article
shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in
connection with the syndication of the Facility as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the negligence or misconduct of any sub-agents except to the
extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in the selection of such sub-agents. 
 SECTION 8.06. Resignation of Administrative Agent. 

(a) The Administrative Agent may at any time give notice of its resignation to the Lenders and the Borrower. Upon receipt of any such notice of
resignation, the Required Lenders shall have the right to appoint a successor (which shall be a bank with an office in the United States of America, or an Affiliate of any such bank with an office in the United States) approved by the Borrower (such
approval not to be unreasonably withheld, conditioned or delayed), provided that no approval of the Borrower shall be necessary if an Event of Default has occurred and is continuing. If no such successor shall have been so appointed by the
Required Lenders and shall have accepted such appointment within 30 days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders) (the “Resignation Closing
Date”), then the retiring Administrative Agent may (but shall not be obligated to), on behalf of the Lenders, appoint a successor Administrative Agent meeting the qualifications set forth above. Whether or not a successor has been
appointed, such resignation shall become effective in accordance with such notice on the Resignation Closing Date. 
 (b) If the Person
serving as Administrative Agent is a Defaulting Lender pursuant to clause (d) of the definition thereof, the Required Lenders may, to the extent permitted by applicable law, by notice in writing to the Borrower and such Person remove such
Person as Administrative Agent and appoint a successor (which shall be a bank with an office in the United States of America, or an Affiliate of any such bank with an office in the United States) approved by the Borrower (such approval not to be
unreasonably withheld, conditioned or delayed); provided that no approval of the Borrower shall be necessary if an Event of Default has occurred and is continuing. If no such successor shall have been so appointed by the Required Lenders and
shall have accepted such appointment within 30 days (or such earlier day as shall be agreed by the Required Lenders) (the “Removal Effective Date”), then such removal shall nonetheless become effective in accordance with such notice
on the Removal Effective Date. 
 (c) With effect from the Resignation Closing Date or the Removal Effective Date (as applicable) (i)
the retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and (ii) except for any indemnity payments or other amounts then owed to the retiring or removed
Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender directly, until such time, if any, as the Required Lenders appoint, with
the approval of the Borrower to the extent provided above, a successor Administrative Agent as provided for above. Upon the acceptance of a successor’s appointment as Administrative Agent hereunder, such successor

  
 63 

 
shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or removed) Administrative Agent (other than as provided in Section 2.16(h) and
other than any rights to indemnity payments or other amounts owed to the retiring or removed Administrative Agent as of the Resignation Closing Date or the Removal Effective Date, as applicable), and the retiring or removed Administrative Agent
shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent
shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the retiring or removed Administrative Agent’s resignation or removal hereunder and under the other Loan Documents, the
provisions of this Article and Section 9.03 shall continue in effect for the benefit of such retiring or removed Administrative Agent, its sub-agents and their respective Related Parties in respect of any
actions taken or omitted to be taken by any of them while the retiring or removed Administrative Agent was acting as Administrative Agent. 

SECTION 8.07. Non-Reliance on Administrative Agent and Other Lenders. Each Lender
acknowledges that it has, independently and without reliance upon the Administrative Agent, any Arranger or any other Lender, or any of their Related Parties, and based on such documents and information as it has deemed appropriate, made its own
credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Lender, or any of their Related Parties, and based on such documents
and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document, or any related agreement or any document furnished
hereunder or thereunder. 
 SECTION 8.08. No Other Duties, Etc. Anything herein to the contrary notwithstanding, none of the
Joint Bookrunners, the Joint Lead Arrangers, the Documentation Agents or the Syndication Agents listed on the cover page hereof shall have any duties or responsibilities under this Agreement or any of the other Loan Documents, except in its
capacity, as applicable, as the Administrative Agent or a Lender hereunder. 
 SECTION 8.09. Administrative Agent May File Proofs of
Claim. In case of the pendency of any proceeding under any applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally or otherwise or any other judicial proceeding relating to
any Loan Party, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any
demand on the Borrower or any other Loan Party) shall be entitled and empowered, by intervention in such proceeding or otherwise: 
 (a) to
file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have
the claims of the Lenders and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other
amounts due the Lenders and the Administrative Agent under Section 2.11 and Section 9.03) allowed in such judicial proceeding; and 

(b) to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; 

  
 64 

 and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any
such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the
Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under Section 2.11 and
Section 9.03. 
 Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or
adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such
proceeding. 
 SECTION 8.10. Consent. Each Lender, by delivering its signature page to this Agreement, or by delivering its signature
page to an Assignment and Assumption or any other Loan Document pursuant to which it shall become a Lender hereunder, shall be deemed to have acknowledged receipt of, and consented to and approved, each Loan Document and each other document required
to be delivered to, or be approved by or satisfactory to, the Administrative Agent or the Lenders on the Closing Date that has been made available by the Administrative Agent to the Lenders. 

SECTION 8.11. ERISA. Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, and
(y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and its Affiliates, and not, for the avoidance of doubt, to or for
the benefit of the Borrower or any other Loan Party, that at least one of the following is and will be true: (i) such Lender is not using “plan assets” (within the meaning of 29 CFR §
2510.3-101, as modified by Section 3(42) of ERISA) of one or more Benefit Plans with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the
Commitments or this Agreement, (ii) the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional
asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain
transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE
96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender’s entrance into, participation
in, administration of and performance of the Loans, the Commitments and this Agreement, (iii) (A) such Lender is an investment fund managed by a “Qualified Professional Asset Manager” (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Commitments and this Agreement,
(C) the entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE
84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender’s
entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement or (iv) such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent and such
Lender. 

  
 65 

 ARTICLE IX 

Miscellaneous 

SECTION 9.01. Notices; Effectiveness; Communication. 

(a) Notices Generally. Except in the case of notices and other communications expressly permitted to be given by telephone or electronic
mail (and subject to paragraph (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by fax as
follows: 
 (i) if to the Borrower or any other Loan Party, to it at MPLX LP, 200 East Hardin St., Findlay, Ohio 45840,
Attention of Pamela K.M. Beall, Executive Vice President and Chief Financial Officer (Telephone No. XXXXXXXX; Fax No. XXXXXXXX; Email: XXXXXXXX) and Suzanne Gagle, Vice President and General Counsel (Telephone: XXXXXXXX; Email: XXXXXXXX), with a
copy to Marathon Petroleum Corporation, 539 South Main Street, Findlay, Ohio 45840, Attention of Donald C. Templin, Executive Vice President and Chief Financial Officer (Telephone: XXXXXXXX; Email: XXXXXXXX) and Suzanne Gagle, General Counsel
(Telephone: XXXXXXXX; Email: XXXXXXXX) or such other address, telephone number, fax number or electronic mail address provided by the Borrower to the Administrative Agent for purposes of Section 9.10(d); 

(ii) if to the Administrative Agent, to Wells Fargo Bank, National Association, to it at Wells Fargo Bank, National
Association, 1525 W WT Harris Blvd, Charlotte, NC 28262, Mail Code: D1109-019, Attention: Syndication Agency Services (Telephone No. (704) 590-2706; Fax No. (704) 715-0017; Email: agencyservices.requests@wellsfargo.com), with a copy to Nathan Starr, Wells Fargo Energy Group, 1000 Louisiana Street, 10th Floor, Houston, TX
77002, Mail Code: MAC T0002-107 (Telephone No. XXXXXXXX; Fax No. XXXXXXXX; Email: XXXXXXXX); 

(iii) if to a Lender, to it at its address (or telephone number, fax number and email address, as applicable) set forth in its
Administrative Questionnaire. 
 Notices and other communications sent by hand or overnight courier service, or mailed by certified or registered mail,
shall be deemed to have been given when received; notices and other communications sent by fax shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given
at the opening of business on the next Business Day for the recipient). Notices and other communications delivered through electronic communications, to the extent provided in paragraph (b) below, shall be effective as provided in such
paragraph (b). 
 (b) Electronic Communications. Notices and other communications to the Lenders hereunder may be delivered or
furnished by electronic communications (including email and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices to any Lender pursuant to Article
II if such Lender has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication. The Administrative Agent or the Borrower (on behalf of itself and the other Loan Parties) may, in its
discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications.

 Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an
e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgement) and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient, at its e-mail address as described in the foregoing clause (i), of notification that such notice or communication is available and identifying the website address therefor; provided that, for both clauses
(i) and (ii) above, if such notice, email or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day
for the recipient. 

  
 66 

 (c) Change of Address, etc. Any party hereto may change its address, telephone
number, fax number or electronic mail address for notices and other communications hereunder by notice to the other parties hereto. 
 (d)
Platform. 
 (i) Each Loan Party agrees that the Administrative Agent may, but shall not be obligated to, make the
Communications available to the Lenders by posting the Communications on Debt Domain, Intralinks, Syndtrak or a substantially similar electronic transmission system (the “Platform”). 

(ii) The Platform is provided “as is” and “as available.” The Agent Parties (as defined below) do not
warrant the adequacy of the Platform and expressly disclaim liability for errors or omissions in the Communications. No warranty of any kind, express, implied or statutory, including any warranty of merchantability, fitness for a particular purpose,
non-infringement of third-party rights or freedom from viruses or other code defects, is made by any Agent Party in connection with the Communications or the Platform. In no event shall the Administrative
Agent or any of its Related Parties (collectively, the “Agent Parties”) have any liability to the Borrower or the other Loan Parties, any Lender or any other Person for damages of any kind, including direct or indirect, special,
incidental or consequential damages, losses or expenses (whether in tort, contract or otherwise) arising out of the Borrower’s, any other Loan Party’s or the Administrative Agent’s transmission of communications through the Platform.

 SECTION 9.02. Waivers; Amendments. 

(a) No failure or delay by the Administrative Agent or any Lender in exercising any right or power hereunder or under any other Loan Document
shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of
any other right or power. The rights and remedies of the Administrative Agent and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of
any provision of this Agreement or under any other Loan Document or consent to any departure by the Borrower or any other Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section,
and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the execution and delivery of any Loan Document and the making of any Loan shall
not be construed as a waiver of any Default, regardless of whether the Administrative Agent or any Lender, or any Related Party of any of the foregoing, may have had notice or knowledge of such Default at the time. 

(b) Subject to paragraph (c) of this Section, none of this Agreement, any other Loan Document or any provision hereof or thereof may be
waived, amended or modified except, in the case of this Agreement, pursuant to an agreement or agreements in writing entered into by the Borrower and the Required Lenders or by the Borrower and the Administrative Agent with the consent of the
Required Lenders and, in the case of any other Loan Document, pursuant to an agreement or agreements in writing entered into by the Administrative Agent and the Loan Party or Loan Parties that are parties thereto, in each case with the consent of
the Required Lenders; provided that no such agreement shall (i) increase the 

  
 67 

 
Commitment of any Lender without the written consent of such Lender, (ii) reduce the principal amount of any Loan or reduce the rate of interest thereon (other than as a result of any waiver
of any increase in the interest rate applicable to any Loan pursuant to Section 2.12(c)), or reduce any fees or other amounts (to the extent that such other amounts are then due and payable) payable hereunder, without the written consent of
each Lender affected thereby, (iii) postpone the scheduled date of payment of the principal amount of any Loan, or any interest thereon, or any fees payable hereunder, or reduce the amount of, waive or excuse any such payment (in each case,
other than as a result of any waiver of any increase in the interest rate applicable to any Loan pursuant to Section 2.12(c), and other than any mandatory prepayment), or postpone the scheduled date of expiration of any Commitment (including
any such postponement as a result of any modification to the definition of the term “Delayed Draw Funding Deadline”), without the written consent of each Lender affected thereby, (iv) change Section 2.17(b) or 2.17(c) in a manner
that would alter the pro rata sharing of payments required thereby, without the written consent of each Lender, (v) change any of the provisions of this Section or the percentage set forth in the definition of “Required Lenders” or
any other provision hereof specifying the number or percentage of Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Lender or
(vi) release any material Subsidiary Guarantor from its Subsidiary Guarantee, except as provided in Section 5.10 or Section 9.09, as applicable, without the written consent of each Lender; provided further that no such
agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent without the prior written consent of the Administrative Agent. Notwithstanding the foregoing, no consent with respect to any amendment, waiver or
other modification of this Agreement or any other Loan Document shall be required of any Defaulting Lender, except with respect to any amendment, waiver or other modification referred to in clause (i), (ii) or (iii) above and then only in the
event such Defaulting Lender shall be affected by such amendment, waiver or other modification. 
 (c) Notwithstanding anything to the
contrary in paragraph (a) or (b) of this Section: 
 (i) any provision of this Agreement or any other Loan Document may
be amended by an agreement in writing entered into by the Borrower and the Administrative Agent to cure any ambiguity, omission, defect or inconsistency, in each case, of a technical nature; and 

(ii) this Agreement may be amended in the manner provided in Section 2.13(b). 

(d) The Administrative Agent may, but shall have no obligation to, with the written concurrence of any Lender, execute amendments, waivers or
other modifications on behalf of such Lender. Any amendment, waiver or other modification effected in accordance with this Section 9.02 shall be binding upon each Person that is at the time thereof a Lender and each Person that subsequently
becomes a Lender. 
 SECTION 9.03. Expenses; Indemnity; Damage Waiver. 

(a) Costs and Expenses. The Borrower shall pay (i) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, the Arrangers and their respective Affiliates, including the reasonable and documented fees, charges and disbursements of one firm of outside
counsel for the Administrative Agent and the Arrangers (and, if necessary, one firm of local and regulatory counsel in each appropriate jurisdiction and regulatory field, as applicable, at any one time for the Administrative Agent, the Arrangers and
their respective Affiliates taken as a whole) in connection with the syndication of the Facility, the preparation and administration of this Agreement and the other Loan Documents and any amendments, modifications or waivers of the provisions hereof
or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated) and (ii) all out-of-pocket expenses incurred by the Administrative
Agent or any Lender, including the fees, charges and 

  
 68 

 
disbursements of any counsel for the Administrative Agent or any Lender, in connection with the enforcement or protection of its rights in connection with this Agreement and the other Loan
Documents, including its rights under this Section, or in connection with the Loans made hereunder, including all such out-of-pocket expenses incurred during any
workout, restructuring or negotiations in respect of any Loans. 
 (b) Indemnification by the Borrower. The Borrower shall indemnify
the Administrative Agent (and any sub-agent thereof), each Arranger and each Lender and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”)
against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses (and, without limiting the foregoing, shall reimburse each Indemnitee upon demand for any reasonable and documented out-of-pocket legal or other expenses incurred by such Indemnitee in connection with investigating or defending any of the foregoing), incurred by any Indemnitee or asserted
against any Indemnitee by any Person (including the Borrower or any of its Subsidiaries or other Affiliates) other than such Indemnitee and its Related Parties arising out of, in connection with, or as a result of (i) the execution or delivery
of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of any other transactions
contemplated hereby or thereby, (ii) any Loan or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by the Borrower or any of
its subsidiaries, or any Environmental Liability related in any way to the Borrower or any of its subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on
contract, tort or any other theory and regardless of whether any Indemnitee is a party thereto and regardless of whether brought by a third party or by the Borrower or any of its subsidiaries or any other Affiliates and regardless of any exclusive
or contributory negligence of any Indemnitee; provided that (i) the foregoing indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (x) are found by
a final, non-appealable judgment of a court of competent jurisdiction to arise out of or in connection with the willful misconduct, bad faith or gross negligence of such Indemnitee or the material breach by
such Indemnitee of the express terms of the Loan Documents or (y) arise out of, or in connection with, any claim, litigation, investigation or proceeding that does not involve an act or omission by the Borrower or any of its Affiliates and that
is brought by an Indemnitee against any other Indemnitee, provided that this clause (y) shall not limit the Borrower’s obligation to indemnify and hold harmless the Administrative Agent, each Arranger and any other titled person in
its capacity, or in fulfilling its role, as such; (ii) the Borrower shall not, in connection with any such proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate law firm (and,
if necessary, one firm of local and regulatory counsel in each appropriate jurisdiction and regulatory field, as applicable, at any one time for the Indemnitees as a whole); provided that in the case of a conflict of interest where the
Indemnitee affected by such conflict informs the Borrower of such conflict, the Borrower shall be responsible for the reasonable fees and expenses of one additional firm of counsel (and, if necessary, one additional firm of local and regulatory
counsel in each appropriate jurisdiction and regulatory field, as applicable, for each such affected Indemnitee (or the affected Indemnitees that are similarly situated); (iii) each Indemnitee shall consult with the Borrower from time to time at the
request of the Borrower regarding the conduct of the defense in any such proceeding (other than in respect of proceedings in which the Borrower or any of its Affiliates is a party adverse to such Indemnitee); and (iv) the Borrower shall not be
obligated to pay an amount of any settlement entered into without its consent (which shall not be unreasonably withheld, delayed or conditioned), except if such settlement shall have been entered into more than 90 days after receipt by the Borrower
of a request by an Indemnitee for reimbursement of its legal or other expenses incurred in connection with such proceeding and the Borrower shall not have either (x) reimbursed such Indemnitee therefor in accordance with, and to the extent
required by, this paragraph prior to the date of such settlement or (y) provided written notice to such Indemnitee that it disputes such Indemnitee’s claim for indemnification under this paragraph with respect to such proceeding. This
Section 9.03(b) shall not apply with respect to Taxes other than any Taxes that represent losses or damages arising from any non-Tax claim. 

  
 69 

 (c) Reimbursement by Lenders. To the extent that the Borrower for any reason fails to
pay any amount required to be paid by it to the Administrative Agent (or any sub-agent thereof) or any Related Party of the Administrative Agent under paragraph (a) or (b) of this Section (and without
limiting the Borrower’s obligation to do so), each Lender severally agrees to pay to the Administrative Agent (or any sub-agent thereof) or such Related Party, as the case may be, such Lender’s pro
rata share of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) in its capacity as such, or against any Related Party of the Administrative Agent acting for the Administrative Agent (or any such sub-agent) in connection with
such capacity. For purposes of this paragraph, a Lender’s “pro rata share” shall be determined based upon its share of the sum of the Commitments and outstanding Loans, in each case, at the time (or most recently in effect or
outstanding). 
 (d) Waiver of Consequential Damages, Etc. To the fullest extent permitted by applicable law and without limiting in
any way the Borrower’s or any other Loan Party’s reimbursement or indemnification obligations set forth in paragraph (a) or (b) of this Section or any other Loan Document, no party hereto nor any of their respective directors,
officers, employees and agents shall assert, and each party hereto hereby waives, any claim against each other such Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages)
arising out of, in connection with, or as a result of, this Agreement or any other Loan Document or any agreement or instrument contemplated hereby or thereby, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds
thereof. No Indemnitee shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through electronic, telecommunications or other information transmission systems in
connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby. 
 (e) Payments. All
amounts due under this Section shall be payable promptly after written demand therefor. 
 SECTION 9.04. Successors and Assigns. 

(a) Successors and Assigns Generally. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and assigns permitted hereby, except that (i) except as expressly provided in Section 6.03, neither the Borrower nor any other Loan Party may assign or otherwise transfer any of its rights or
obligations hereunder without the prior written consent of the Administrative Agent and each Lender (and any attempted assignment or transfer by the Borrower without such consent shall be null and void) and (ii) no Lender may assign or
otherwise transfer any of its rights or obligations hereunder except in accordance with this Section (and any other attempted assignment or transfer by any Lender shall be null and void). Nothing in this Agreement, expressed or implied, shall be
construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants (to the extent provided in paragraph (d) of this Section), the Arrangers and, to the extent expressly
contemplated hereby, the sub-agents of the Administrative Agent and the Related Parties of any of the Administrative Agent, the Arrangers and the Lenders) any legal or equitable right, remedy or claim under or
by reason of this Agreement. 

  
 70 

 (b) Assignment by Lenders. (i) Subject to the conditions set forth in paragraph
(b)(ii) below, any Lender may assign to one or more Eligible Assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it) with the prior written
consent (such consent not to be unreasonably withheld, conditioned or delayed) of: 
 (A) the Borrower; provided that
no consent of the Borrower shall be required for an assignment to (x) a Lender, an Affiliate of a Lender or an Approved Fund or (y) if an Event of Default has occurred and is continuing, any other assignee; provided further that the
Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within 10 Business Days after having received written notice thereof; and 

(B) the Administrative Agent; provided that no consent of the Administrative Agent shall be required for an assignment
to a Lender, an Affiliate of a Lender or an Approved Fund; 
 (ii) Assignments shall be subject to the following additional
conditions: 
 (A) except in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund or an
assignment of the entire remaining amount of the assigning Lender’s Commitment or Loans, the amount of the Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with
respect to such assignment is delivered to the Administrative Agent or, if “Trade Date” is specified in the Assignment and Assumption, as of the Trade Date) shall not be less than $5,000,000 unless each of the Borrower and the
Administrative Agent otherwise consent (not to be unreasonably withheld, conditioned or delayed); provided that no such consent of the Borrower shall be required if an Event of Default has occurred and is continuing; provided further
that the Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within 10 Business Days after having received written notice thereof; 

(B) each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights
and obligations under this Agreement with respect to the Loans or the Commitment assigned; provided that this clause (B) shall not be construed to prohibit the assignment of (x) a proportionate part of all the assigning
Lender’s rights and obligations in respect of its Commitment without assigning a proportionate part of the assigning Lender’s Loans or (y) a proportionate part of all the assigning Lender’s rights and obligations in respect of
its Loans without assigning a proportionate part of the assigning Lender’s Commitment; 
 (C) the parties to each
assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption (or an agreement incorporating by reference a form of Assignment and Assumption posted on the Platform), together with a processing and recordation fee of
$3,500; provided that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment; 

(D) the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire; 

(E) the assignee, if it shall not be a Lender, shall be required to execute and deliver the applicable forms to the extent
required under Section 2.16(f) for any Lender, and no assignment shall be effective in connection herewith unless and until such forms are so delivered; and 

  
 71 

 (F) the assignment shall be recorded in the Register as required under
Section 9.04(c), and no assignment shall be effective in connection herewith unless and until such assignment is so recorded. 

(iii) In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall
be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof
as appropriate (which may be outright payment or other compensating actions) to pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent and each other Lender hereunder (and interest accrued
thereon). Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the provisions of this paragraph, then the
assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs. 

(iv) Subject to acceptance and recording thereof by the Administrative Agent pursuant to paragraph (c) of this Section,
from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender
under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption
covering all of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Section 2.14, Section 2.15, Section 2.16 and
Section 9.03). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 9.04 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in
such rights and obligations in accordance with paragraph (c) of this Section. 
 (c) Register. The Administrative Agent, acting
solely for this purpose as a non-fiduciary agent of the Borrower, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names
and addresses of the Lenders, and the Commitment of, and principal amount (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be
conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement. The
Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice. 

(d) Participations. Any Lender may, at any time, without the consent of, or notice to, the Borrower or the Administrative Agent, sell
participations to one or more Eligible Assignees (each, a “Participant”) in all or a portion of such Lender’s rights and/or obligations under this Agreement (including all or a portion of its Commitment and/or the Loans owing
to it); provided that (i) such Lender’s obligations under this Agreement shall remain unchanged; (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations; and
(iii) the Borrower, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. For the avoidance of doubt, each Lender
shall be responsible for the indemnity under Section 9.03(c) with respect to any payments made by such Lender to its Participants. 

  
 72 

 Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such
Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement or any other Loan Document; provided that such agreement or instrument may provide that such
Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver described in the first proviso to Section 9.02(b) that affects such Participant. The Borrower agrees that each Participant shall be entitled
to the benefits of Section 2.14, Section 2.15 and Section 2.16 (subject to the requirements and limitations therein, including the requirements under Section 2.16(f) (it being understood that the documentation required under
Section 2.16(f) shall be delivered to the participating Lender)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section; provided that (A) such
Participant agrees to be subject to the provisions of Section 2.16 (including Section 2.16(f)), Section 2.17 and Section 2.18 as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of
this Section; (B) such Participant shall not be entitled to receive any greater payment under Section 2.14 or Section 2.16, with respect to any participation, than its participating Lender would have been entitled to receive, except
to the extent such entitlement to receive a greater payment results from a Change in Law that occurs after the Participant acquired the applicable participation; and (C) the Borrower shall be notified promptly by the applicable Lender of each
participation sold by such Lender to a Participant pursuant to this paragraph. Each Lender that sells a participation agrees, at the Borrower’s request and expense, to use reasonable efforts to cooperate with the Borrower to effectuate the
provisions of Section 2.18(b) with respect to any Participant. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it were a Lender, provided that such Participant agrees
to be subject to Section 2.17(c) as though it were a Lender. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on
which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under this Agreement and the other Loan Documents (the
“Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of any Participant or any information relating to a
Participant’s interest in any Commitments, Loans or its other obligations under any Loan Document) except to the Borrower as provided above and to the extent that such disclosure is necessary to establish that such Commitment, Loan or other
obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender
shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its
capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register. 
 (e) Pledge by Lender. Any
Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other
central bank having jurisdiction over such Lender, and this Section shall not apply to any such pledge or assignment of a security interest; provided that no such pledge or assignment of a security interest shall release a Lender from any of
its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. 
 SECTION 9.05.
Survival. All covenants, agreements, representations and warranties made by the Borrower and the other Loan Parties herein and in the other Loan Documents and in the certificates or other instruments delivered in connection with or
pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the other parties hereto and shall survive 

  
 73 

 
the execution and delivery of this Agreement and the other Loan Documents and the making of any Loans, regardless of any investigation made by any such other party or on its behalf and
notwithstanding that the Administrative Agent, any Arranger, any Lender or any Related Party of any of the foregoing may have had notice or knowledge of any Default or incorrect representation or warranty at the time this Agreement or any other Loan
Document is executed and delivered or any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement or any
other Loan Document is outstanding and unpaid and so long as the Commitments have not expired or terminated. The provisions of Section 2.14, Section 2.15, Section 2.16 and Section 9.03 and Article VIII shall survive and remain in
full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Commitments or the termination of this Agreement or any provision hereof. 

SECTION 9.06. Counterparts; Integration; Effectiveness; Electronic Execution. 

(a) This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute
an original, but all of which when taken together shall constitute a single contract. This Agreement, any other Loan Documents and any letter agreements with respect to fees payable to the Administrative Agent or the Arrangers (including on behalf
of the Lenders) constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof (but do not supersede any
provisions of any commitment letter entered into in connection with the Facility that by the terms of such commitment letter survive the effectiveness of this Agreement). Subject to Section 4.01, this Agreement shall become effective when it
shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon
and inure to the benefit of the parties hereto and their respective successors and assigns. Delivery of an executed counterpart of a signature page of this Agreement by fax or electronic transmission (in .pdf or .tif format) shall be effective for
all purposes as delivery of a manually executed counterpart of this Agreement. 
 (b) The words “execution”, “signed”,
“signature”, “delivery” and words of like import in or relating to any document to be signed in connection with this Agreement or any other Loan Document and the transactions contemplated hereby shall be deemed to include
Electronic Signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based
recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any
other similar state laws based on the Uniform Electronic Transactions Act; provided that nothing herein shall require the Administrative Agent or any Lender to accept electronic signatures in any form or format without its prior written
consent. 
 SECTION 9.07. Severability. Any provision of this Agreement held to be invalid, illegal or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof; and the invalidity of a
particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction. 

  
 74 

 SECTION 9.08. Right of Setoff. If an Event of Default shall have occurred and
be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable law, to set off and apply any and all deposits (general or special, time or demand,
provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by such Lender or any such Affiliate to or for the credit or the account of the Borrower or any other Loan Party against any
and all of the Obligations of the Borrower or such Loan Party now or hereafter existing under this Agreement or any other Loan Document to such Lender or its Affiliates which are then due and payable, irrespective of whether or not such Lender or
Affiliate shall have made any demand under this Agreement or any other Loan Document and although such obligations of the Borrower or such Loan Party are owed to a branch, office or Affiliate of such Lender different from the branch, office or
Affiliate holding such deposit or obligated on such indebtedness. The rights of each Lender and its Affiliates under this Section are in addition to other rights and remedies (including other rights of setoff) that such Lender or its Affiliates may
have. Each Lender agrees to promptly notify the Borrower and the Administrative Agent after any such setoff and application by such Lender, provided that the failure to give such notice shall not affect the validity of such setoff and
application. 
 SECTION 9.09. Subsidiary Guarantees. The Borrower may (but is not required to), at any time upon three
Business Days’ notice to the Administrative Agent, cause any of its Subsidiaries organized under the laws of the United States of America, any State thereof or the District of Columbia and not owned, directly or indirectly, by any
“controlled foreign corporation” (within the meaning of Section 957(a) of the Code) in its chain of ownership to become a Subsidiary Guarantor by such Subsidiary executing and delivering to the Administrative Agent the Subsidiary
Guarantee, together with such customary legal opinions (which may be opinions of in-house counsel), corporate documents, secretary’s certificates, good standing certificates and evidence of authority as
the Administrative Agent may reasonably request. So long as no Default has occurred and is continuing (or would result from such release), (a) if all of the Equity Interests of a Subsidiary Guarantor that are owned by the Borrower or any Subsidiary
are sold or otherwise disposed of in a transaction or transactions permitted by this Agreement and as a result of such disposition such Person is no longer a Subsidiary or (b) in the event that, immediately after giving effect to the release of
any Subsidiary Guarantor’s Subsidiary Guarantee, all of the Indebtedness of the Non-Guarantor Subsidiaries is permitted under Section 6.01, then, in each case, promptly following the Borrower’s
request, the Administrative Agent shall execute a release of such Subsidiary Guarantor from its Subsidiary Guarantee; provided, however that clause (b) of this Section 9.09 shall not authorize the release of a Subsidiary
Guarantor from its Subsidiary Guarantee if at the time of the requested release it is required to be a Subsidiary Guarantor pursuant to Section 5.10(a). A request by the Borrower for a release pursuant to this Section shall be accompanied by a
certificate of a Responsible Officer of the Borrower certifying that the conditions to release set forth in this Section have been satisfied. Any execution and delivery of any such release by the Administrative Agent shall be without recourse or
warranty by the Administrative Agent. 
 SECTION 9.10. Governing Law; Jurisdiction; Consent to Service of Process. 

(a) Governing Law. This Agreement and the other Loan Documents and any claims, controversy, dispute or cause of action (whether in
contract or tort or otherwise) based upon, arising out of or relating to this Agreement or any other Loan Document (except, as to any other Loan Document, as expressly set forth therein) and the transactions contemplated hereby and thereby shall be
governed by, and construed in accordance with, the laws of the State of New York. 
 (b) Jurisdiction. Each party hereto hereby
irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of New York State courts sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate
court from any thereof, in any action or proceeding arising out of or relating to this Agreement or any other Loan Document, or for recognition or enforcement of any judgment, and each party hereto hereby irrevocably and unconditionally agrees that
all claims in respect of any such action or proceeding may be 

  
 75 

 
heard and determined solely in such New York State court or, to the extent permitted by law, in such Federal court. Each party hereto agrees that a final judgment in any such action or proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. 
 (c)
Waiver of Venue. Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent permitted by applicable law, any objection that it may now or hereafter have to the laying of venue of any suit, action or proceeding
arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph (b) of this Section. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, the defense of an
inconvenient forum to the maintenance of such action or proceeding in any such court. 
 (d) Service of Process. Each party hereto
irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by applicable law. 

SECTION 9.11. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT
OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

SECTION 9.12. Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference
only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement. 

SECTION 9.13. Confidentiality. 

(a) Each of the Administrative Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that
Information may be disclosed (i) to its Affiliates and its and its Affiliates’ Related Parties, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed
of the confidential nature of such Information and instructed to keep such Information confidential or shall be subject to a professional obligation of confidentiality), (ii) upon the request or demand of any regulatory authority (including any
self-regulatory authority) having or purporting to have jurisdiction over the Administrative Agent or such Lender, as applicable, or its Affiliates (in which case such Person shall, except with respect to any audit or examination conducted by bank
accountants or any governmental bank regulatory authority exercising examination or regulatory authority (or any request by any governmental bank regulatory authority), (A) promptly notify the Borrower in advance of such disclosure, to the extent
permitted by law, and reasonably cooperate with the Borrower in any legal efforts to protect the confidentiality of such Information and (B) so furnish only that portion of such Information which the applicable Person is legally required to
disclose), (iii) to the extent required by any legal, judicial, administrative proceeding or other process or otherwise as required by applicable law or regulations (in 

  
 76 

 
which case the Administrative Agent or such Lender, as applicable, shall (A) promptly notify the Borrower in advance of such disclosure, to the extent permitted by law, and reasonably
cooperate with the Borrower in any legal efforts to protect the confidentiality of such Information and (B) so furnish only that portion of such Information which the applicable Person is legally required to disclose), (iv) to any other party
to this Agreement, (v) to any rating agency in connection with rating the Borrower or any Subsidiaries or this Agreement (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such
Information and instructed to keep such Information confidential), (vi) to the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers with respect to the Loans (it being understood that the Persons
to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (vii) in connection with the exercise of any remedies hereunder or any suit, action or proceeding
relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (viii) subject to an agreement containing provisions no less restrictive than those of this Section, (A) to any assignee of or
Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement and (B) any actual or prospective party (or its Related Parties), surety, reinsurer, guarantor or credit liquidity enhancer
(or their advisors) to or in connection with any swap, derivative or other similar transaction under which payments are to be made by reference to the Obligations or to the Borrower and its obligations or to this Agreement or payments hereunder,
(ix) to market data collectors, similar service providers, including league table providers, to the lending industry, in each case, information of the type routinely provided to such providers, (x) with the consent of the Borrower or
(xi) to the extent such Information (A) becomes publicly available other than as a result of a breach of this Section or (B) becomes available to the Administrative Agent or any Lender on a
non-confidential basis from a source other than the Borrower or any of its Affiliates; provided that (notwithstanding the foregoing) no such nonpublic information which contains projections or forecasts
with respect to the Borrower or any of its Affiliates shall be disclosed, disseminated or otherwise made available pursuant to clause (viii) above. For the purposes of this Section, “Information” means all information received
from MPC, the Borrower, or any of their respective Subsidiaries relating to MPC, the Borrower or any of their respective Affiliates, Excluded Ventures, Joint Ventures or their business, other than any such information that is available to the
Administrative Agent or any Lender on a non-confidential basis prior to disclosure by the Borrower or any of its Affiliates. Any Person required to maintain the confidentiality of Information as provided in
this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.

 (b) EACH LENDER ACKNOWLEDGES THAT ALL INFORMATION, INCLUDING REQUESTS FOR WAIVERS AND AMENDMENTS, FURNISHED BY A LOAN PARTY OR THE
ADMINISTRATIVE AGENT PURSUANT TO OR IN CONNECTION WITH, OR IN THE COURSE OF ADMINISTERING, THIS AGREEMENT WILL BE SYNDICATE-LEVEL INFORMATION, WHICH MAY CONTAIN MNPI. EACH LENDER REPRESENTS TO THE LOAN PARTIES AND THE ADMINISTRATIVE AGENT THAT
(I) IT HAS DEVELOPED COMPLIANCE PROCEDURES REGARDING THE USE OF MNPI AND THAT IT WILL HANDLE MNPI IN ACCORDANCE WITH SUCH PROCEDURES AND APPLICABLE LAW, INCLUDING FEDERAL, STATE AND FOREIGN SECURITIES LAWS, AND (II) IT HAS IDENTIFIED IN
ITS ADMINISTRATIVE QUESTIONNAIRE A CREDIT CONTACT WHO MAY RECEIVE INFORMATION THAT MAY CONTAIN MNPI IN ACCORDANCE WITH ITS COMPLIANCE PROCEDURES AND APPLICABLE LAW, INCLUDING FEDERAL, STATE AND FOREIGN SECURITIES LAWS. 

  
 77 

 SECTION 9.14. Interest Rate Limitation. Notwithstanding anything herein to the
contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively, the “Charges”), shall exceed the
maximum lawful rate (the “Maximum Rate”) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan
hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the
operation of this Section shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest
thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender. 
 SECTION 9.15. Certain
Notices. Each Lender that is subject to the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “USA Patriot Act”) and/or
the Beneficial Ownership Regulation hereby notifies the Borrower and the Subsidiary Guarantors that pursuant to the requirements of the USA Patriot Act and/or the Beneficial Ownership Regulation, it is required to obtain, verify and record
information that identifies the Borrower and the Subsidiary Guarantors, which information includes the name and address of the Borrower and each Subsidiary Guarantor and other information that will allow such Lender to identify the Borrower and the
Subsidiary Guarantors in accordance with the USA Patriot Act and the Beneficial Ownership Regulation. This notice is given in accordance with the requirements of the USA Patriot Act and is effective for the Administrative Agent and each Lender. 

SECTION 9.16. No Advisory or Fiduciary Responsibility. In connection with all aspects of each transaction contemplated hereby
(including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower and each other Loan Party acknowledges and agrees, and acknowledges its Affiliates’ understanding, that: (i) (A)
the arranging and other services regarding this Agreement provided by the Administrative Agent, the Arrangers and the Lenders are arm’s-length commercial transactions between the Borrower, each other Loan
Party and their respective Affiliates, on the one hand, and the Administrative Agent, the Arrangers and the Lenders, on the other hand, (B) each of the Borrower and the other Loan Parties has consulted its own legal, accounting, regulatory and
tax advisors to the extent it has deemed appropriate and (C) the Borrower and each other Loan Party is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other
Loan Documents; (ii) (A) each of the Administrative Agent, the Arrangers and each Lender is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be
acting as an advisor, agent or fiduciary for the Borrower, any other Loan Party or any of their respective Affiliates, or any other Person and (B) none of the Administrative Agent, the Arrangers or any Lender has any obligation to the Borrower,
any other Loan Party or any of their respective Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents; and (iii) the Administrative Agent, the
Arrangers and the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower, the other Loan Parties and their respective Affiliates, and none of the
Administrative Agent, the Arrangers or any Lender has any obligation to disclose any of such interests to the Borrower, any other Loan Party or any of their respective Affiliates. To the fullest extent permitted by law, each of the Borrower and each
other Loan Party hereby waives and releases any claims that it may have against the Administrative Agent, the Arrangers or any Lender with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any
transaction contemplated hereby. 

  
 78 

 SECTION 9.17. Acknowledgment and Consent to
Bail-In of EEA Financial Institutions. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among the parties hereto, each party hereto
acknowledges that any liability of any EEA Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of an EEA Resolution Authority and agrees and
consents to, and acknowledges to be bound by: 
 (a) the application of any Write-Down and Conversion Power by any EEA Resolution Authority
to any such liabilities arising hereunder that may be payable to it by any party hereto that is an EEA Financial Institution; and 
 (b) the
effects of any Bail-In Action on any such liability, including, if applicable, (i) a reduction in full or in part or cancelation of any such liability, (ii) a conversion of all, or a portion of, such
liability into shares or other instruments of ownership in such EEA Financial Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will
be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document or (iii) the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion
Powers of any EEA Resolution Authority. 
 [Remainder of Page Intentionally Blank; Signature Pages Follow] 

 

  
 79 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by
their respective authorized officers as of the date first above written. 
  

			
	MPLX LP
	By: MPLX GP LLC, its General Partner
		
	By:	 	 /s/ Peter Gilgen

		 	 Name: Peter Gilgen
 Title: Vice President and
Treasurer

 [Signature Page to MPLX Term Loan Agreement] 

 
			
	 WELLS FARGO BANK, NATIONAL

ASSOCIATION, individually and as Administrative Agent,

		
	By:	 	 /s/ Nathan Starr

		 	 Name: Nathan Starr
 Title:
Director

 [Signature Page to MPLX Term Loan Agreement] 

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	Name of Institution: BANK OF AMERICA, N.A.
		
	        by	 	 /s/ Alia Qaddumi

		 	Name: Alia Qaddumi
		 	Title: Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	Name of Institution: MIZUHO BANK, LTD.
		
	        by	 	 /s/ Edward Sacks

		 	Name: Edward Sacks
		 	Title: Authorized Signatory

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	Name of Institution: BNP Paribas
		
	        by	 	 /s/ Joseph Onischuk

		 	Name: Joseph Onischuk
		 	Title: Managing Director

  

			
	For any Lender requiring a second signature block:
		
	        by	 	 /s/ Claudia Zarate

		 	Name: Claudia Zarate
		 	Title: Managing Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	Citibank, N.A.:
		
	        by	 	 /s/ Peter Kardos

		 	Name: Peter Kardos
		 	Title: Vice President

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	JPMORGAN CHASE BANK, N.A.
		
	        by	 	 /s/ Jeffrey C. Miller

		 	Name: Jeffrey C. Miller
		 	Title: Executive Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

			
	MUFG Bank, Ltd., as a Lender
		
	        by	 	 /s/ Christopher Facenda

		 	Name: Christopher Facenda
		 	Title: Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	Name of Institution: The Bank of Nova Scotia, Houston Branch
			
	    	 	by	 	 /s/ Joe Lattanzi

		 		 	Name: Joe Lattanzi
		 		 	Title: Managing Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	SUMITOMO MITSUI BANKING CORPORATION
			
		 	by	 	 /s/ Michael Maguire

	    	 		 	Name: Michael Maguire
		 		 	Title: Executive Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	SUNTRUST BANK
			
	    	 	by	 	 /s/ Justin Lien

		 		 	Name: Justin Lien
		 		 	Title: Director

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	Name of Institution: THE TORONTO-DOMINION BANK, NEW YORK BRANCH
			
		 	by	 	 /s/ Peter Kuo

	    	 		 	Name: PETER KUO
		 		 	Title: AUTHORIZED SIGNATORY

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	U.S. Bank National Association:
			
		 	by	 	 /s/ John Prigge

	    	 		 	Name: John Prigge
		 		 	Title: Senior Vice President

 SIGNATURE PAGE TO 

TERM LOAN AGREEMENT 
 OF MPLX LP 

 

					
	Name of Institution: BRANCH BANKING & TRUST COMPANY;
			
		 	by	 	 /s/ Lincoln LaCour

	    	 		 	Name: Lincoln LaCour
		 		 	Title: Vice President

 EXHIBIT A 

[FORM OF] ASSIGNMENT AND ASSUMPTION 

This Assignment and Assumption (this “Assignment and Assumption”) is dated as of the Effective Date set forth below
and is entered into by and between the Assignor identified in Item 1 below (the “Assignor”) and the Assignee identified in Item 2 below (the “Assignee”). Capitalized terms used but not defined herein
shall have the meanings given to them in the Credit Agreement identified below (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), receipt of a copy of which is hereby acknowledged by
the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto (the “Standard Terms and Conditions”) are hereby agreed to and incorporated herein by reference and made a part of this Assignment and
Assumption as if set forth herein in full. 
 For an agreed consideration, the Assignor hereby irrevocably sells and assigns to the
Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date inserted by the Administrative Agent as
contemplated below, (a) all of the Assignor’s rights and obligations in its capacity as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to the amount and
percentage interest identified below of all of such outstanding rights and obligations of the Assignor under the credit facility provided for under the Credit Agreement (including any Guarantees made pursuant to such credit facility) and (b) to
the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any Person, whether known or unknown, arising under or in connection with the
Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including contract claims, tort claims, malpractice claims,
statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (a) above (the rights and obligations sold and assigned pursuant to clauses (a) and (b) above being
referred to herein collectively as the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except as expressly provided in this Assignment and Assumption, without representation or warranty
by the Assignor. 
  

					
	1.	  	Assignor:	  	                                      
                      
		
	        	  	[Assignor [is] [is not] a Defaulting Lender]1
			
	2.	  	Assignee:	  	                                      
                      
			
		  		  	[and is [a Lender][an Affiliate/Approved Fund of [Identify Lender]]]2
			
	3.	  	Borrower:	  	MPLX LP, a Delaware limited partnership
			
	4.	  	Administrative Agent:	  	Wells Fargo Bank, National Association, as the administrative agent under the Credit Agreement

  
  

	1 	 Select as applicable. 

	2	 Select as applicable. 

	5.	 Credit Agreement: Term Loan Agreement dated as of September [•], 2019, among MPLX LP, the Lenders
party thereto and Wells Fargo Bank, National Association, as Administrative Agent 

  

	6.	 Assigned Interest: 

  

									
	 Aggregate Amount of

Commitment/Loans for all Lenders3
	  	Amount of Commitment/Loans
Assigned4	 	  	Percentage Assigned of
Commitment/
Loans5	 
	 $
	  	$	 	 	  	 	%	 
	 $
	  	$	 	 	  	 	%	 
	 $
	  	$	 	 	  	 	%	 

  

	[7.	 Trade Date:
                                         
   ]6 

 Effective Date:
                    , 20     [TO BE INSERTED BY ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF
RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.] 
 The Assignee, if not already a Lender, agrees to deliver to the Administrative Agent a
completed Administrative Questionnaire in which the Assignee designates one or more Credit Contacts to whom all syndicate-level information (which may contain MNPI) will be made available and who may receive such information in accordance with the
Assignee’s compliance procedures and applicable laws, including Federal and state securities laws. 
  
  

 

	3 	 Amount to be adjusted by the counterparties to take into account any payments or prepayments made between the
Trade Date and the Effective Date. 

	4 	 Except in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund or an assignment
of the entire remaining amount of the assigning Lender’s Commitment or Loans, not to be less than $5,000,000 unless each of the Borrower and the Administrative Agent otherwise consent. 

	5 	 Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder.

	6 	 To be completed if the Assignor and the Assignee intend that the minimum assignment amount is to be determined
as of the Trade Date. 

	.	 

  
 2 

 The terms set forth in this Assignment and Assumption are hereby agreed to: 

 

			
	ASSIGNOR:
	
	 [NAME OF ASSIGNOR]

		
	 By:
	 	  

		 	 Name:

		 	 Title:

	
	ASSIGNEE:
	
	 [NAME OF ASSIGNEE]

		
	 By:
	 	  

		 	 Name:

		 	 Title:

  
 3 

 [Consented to and]1 Accepted: 

 

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Administrative Agent
		
	By:	 	  

		 	Name:
		 	Title:

  
  

	1 	 To be added only if the consent of the Administrative Agent is required under Section 9.04(b) of the
Credit Agreement. 

  
 4 

 [Consented to:] 2 
  

			
	MPLX LP, a Delaware limited partnership
	
	By: MPLX GP LLC, its General Partner
		
	    By:	 	  

		 	Name:
		 	Title:

  
  

	2 	 To be added only if the consent of the Borrower is required under Section 9.04(b) of the Credit Agreement.

  
 5 

 ANNEX 1 TO 

ASSIGNMENT AND ASSUMPTION 
 STANDARD
TERMS AND CONDITIONS FOR 
 ASSIGNMENT AND ASSUMPTION 

1. Representations and Warranties. 

1.1. Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned
Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Assumption and
to consummate the transactions contemplated hereby; and (b) makes no representation or warranty and assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with the Credit
Agreement or any other Loan Document, other than the representations and warranties made by it in this Assignment and Assumption, (ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement
or any other Loan Document or any collateral thereunder, if any, (iii) the financial condition of the Borrower, any of its Subsidiaries or other Affiliates or any other Person obligated in respect of any Loan Document or (iv) the
performance or observance by the Borrower, any of its Subsidiaries or other Affiliates or any other Person of any of their respective obligations under any Loan Document. 

1.2. Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action
necessary, to execute and deliver this Assignment and Assumption and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it is an Eligible Assignee and satisfies the other requirements, if
any, specified in the Credit Agreement that are required to be satisfied by it in order to acquire the Assigned Interest and become a Lender (subject to such consents, if any, as may be required thereunder), (iii) from and after the Effective
Date, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to the extent of the Assigned Interest, shall have the obligations of a Lender thereunder, (iv) it has received a copy of the Credit Agreement,
together with copies of the most recent financial statements delivered pursuant to Section 5.01 thereof, and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this
Assignment and Assumption and to purchase the Assigned Interest, on the basis of which it has made such analysis and decision independently and without reliance on the Administrative Agent, any Arranger, the Assignor or any other Lender, (v) if
it is a U.S. Person, attached hereto is an executed copy of IRS Form W-9 certifying that it is exempt from U.S. Federal backup withholding Tax, duly completed and executed by the Assignee and (vi) if it
is a Foreign Lender, attached hereto is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, duly completed and executed by the Assignee; and (b) agrees that (i) it will, independently and without
reliance on the Administrative Agent, any Arranger, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action
under the Credit Agreement and the other Loan Documents and (ii) it will perform in accordance with their terms all of the obligations which by the terms of the Credit Agreement and the other Loan Documents are required to be performed by it as
a Lender. 
 2. Payments. From and after the Effective Date, the Administrative Agent shall make all payments in respect of the
Assigned Interest (including payments of principal, interest, fees and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective
Date. 

  
 6 

 3. General Provisions. This Assignment and Assumption shall be binding upon, and
inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment and Assumption may be executed in any number of counterparts (and by different parties hereto on different counterparts), which together shall
constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment and Assumption by facsimile or other electronic image scan transmission shall be effective as delivery of a manually executed counterpart of this
Assignment and Assumption. This Assignment and Assumption shall be governed by, and construed in accordance with, the laws of the State of New York. 
  

  
 7 

 EXHIBIT B 

[FORM OF] BORROWING REQUEST 
 Wells Fargo
Bank, National Association 
 as Administrative Agent under the 

Credit Agreement referred to below 
 1525 W WT Harris Blvd 

Charlotte, NC 28262 
 Mail Code:
D1109-019 
 Attention: Syndication Agency Services 

______________, 20__ 
 Reference
is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the
“Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. Capitalized terms used herein and not otherwise defined herein are used herein as defined in the Credit Agreement.

 The Borrower hereby gives you notice, irrevocably, pursuant to Section 2.03 of the Credit Agreement that the Borrower hereby
requests a Borrowing and, in that connection, sets forth below the information relating to such Borrowing (the “Proposed Borrowing”) as required by Section 2.03 of the Credit Agreement: 

 

	 	(a)	 the aggregate principal amount of the Proposed Borrowing is $__________;1 

  

	 	(b)	 the date of the Proposed Borrowing is __________, 20__ (the “Funding Date”);2 

  

	 	(c)	 the Proposed Borrowing is [an ABR] [a Eurodollar] Borrowing; [and] 

 

	 	(d)	 [such Eurodollar Borrowing shall have an initial Interest Period of [one week] [[one] [two] [three] month[s]];]
[and] 

  

	 	(e)	 the funds of the Proposed Borrowing are to be disbursed to [Account Name and Number]. 

 
  

	1 	 For any Eurodollar Borrowing, such Proposed Borrowing shall be in an aggregate amount that is an integral
multiple of $500,000 and not less than $5,000,000. For an ABR Borrowing, such Proposed Borrowing shall be in an aggregate amount that is an integral multiple of $250,000 and not less than $1,000,000, except as permitted by Section 2.02(c) of the
Credit Agreement. 

	2 	 The Funding Date must be a Business Day. 

 
					
	MPLX LP, a Delaware limited partnership
		
	By:	 	MPLX GP LLC, its General Partner
			
		 	By:	 	  

		 		 	Name:
		 		 	Title:

  

  
 2 

 EXHIBIT C 

[FORM OF] INTEREST ELECTION REQUEST 

Wells Fargo Bank, National Association 
 as Administrative Agent
under the 
 Credit Agreement referred to below 
 1525 W WT
Harris Blvd 
 Charlotte, NC 28262 
 Mail Code: D1109-019 
 Attention: Syndication Agency Services 

______________, 20__ 
 Reference
is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the
“Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. Capitalized terms used herein and not otherwise defined herein are used herein as defined in the Credit Agreement.

 The Borrower hereby gives you notice, irrevocably, pursuant to Section 2.07 of the Credit Agreement that it elects to [continue the
Borrowing listed below, or a portion thereof as described below] [convert the Borrowing listed below, or a portion thereof as described below, to a different Type], and in that connection sets forth below the terms on which such [conversion]
[continuation] is to be made. 
  

							
				
	                	 	a.	  	The Borrowing to which this Interest	  	
		 		  	Election Request applies:1	  	
				
		 		  	(i) Principal Amount	  	                                    

				
		 		  	(ii) Type	  	                                    

				
		 		  	(iii) Interest Period2	  	                                    

				
		 	b.	  	The effective date of the election (which is a Business Day):	  	                                    

			
		 	c.	  	Type of Borrowing following [conversion] [continuation]: [ABR Borrowing] [Eurodollar Borrowing]

 
  

	1 	 If different options are being elected with respect to different portions of such Borrowing, specify the
portions thereof to be allocated to each resulting Borrowing and specify the information requested in clauses (b), (c) and (d) for each resulting Borrowing. 

	2 	 In the case of a Eurodollar Borrowing, specify the last day of the current Interest Period therefor.

							
			
	                	 	d.	  	Interest Period and the last day thereof:3 [one week] [[one] [two] [three] month[s]]

  

					
	MPLX LP, a Delaware limited partnership
		
	By:	 	MPLX GP LLC, its General Partner
			
		 	By:	 	  

		 		 	Name:
		 		 	Title:

  
  

	3 	 For Eurodollar Borrowings only. Shall be subject to the definition of “Interest Period” in the Credit
Agreement. 

  
 2 

 EXHIBIT D 

[FORM OF] NOTE 
  

			
	Lender: [NAME OF LENDER]	  	New York, New York
	Principal Amount: $ [________]	  	[__________], 20[__]

 FOR VALUE RECEIVED, the undersigned, MPLX LP, a Delaware limited partnership (the
“Borrower”), hereby promises to pay to the Lender set forth above (the “Lender”) the principal sum of [______________ dollars ($___________)] (the “Principal Amount”), or such
lesser amount as shall equal the aggregate unpaid principal amount of all Loans (as defined in the Credit Agreement referred to below) of the Lender to the Borrower, payable at such times, and in such amounts, as are specified in the Credit
Agreement. 
 The Borrower promises to pay interest on the unpaid principal amount of each Loan from the date such Loan is made until such
principal amount is paid in full, at such interest rates, and payable at such times, as are specified in the Credit Agreement. 
 Both
principal and interest payable to the Lender under this Note shall be payable in dollars (as defined in the Credit Agreement referred to below) to Wells Fargo Bank, National Association, as Administrative Agent, to such account as it may specify
from time to time pursuant to the Credit Agreement, in immediately available funds. 
 This Note is issued pursuant to, governed by and is
entitled to the benefits of, the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, the Lenders party
thereto and Wells Fargo Bank, National Association, as Administrative Agent. Capitalized terms used herein and not defined herein are used herein as defined in the Credit Agreement. 

The Credit Agreement, among other things, contains provisions for acceleration of the maturity of the unpaid principal amount of this
Note upon the happening of certain stated events and also for prepayments on account of the principal hereof prior to the maturity hereof upon the terms and conditions therein specified. 

Demand, diligence, presentment, protest and notice of non-payment and protest are hereby waived by the
Borrower. 
 THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

 

 IN WITNESS WHEREOF, the Borrower has caused this Note to be executed and delivered by its
duly authorized officer as of the day and year set forth above. 
  

					
	MPLX LP, a Delaware limited partnership
		
	By:	 	MPLX GP LLC, its General Partner
			
		 	By:	 	  

		 		 	Name:
		 		 	Title:

  

  
 2 

 EXHIBIT E-1 

[FORM OF] 
 U.S. TAX
COMPLIANCE CERTIFICATE 
 (For Foreign Lenders That Are Not Partnerships For U.S. Federal Income Tax Purposes) 

Reference is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to
time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the “Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. 

Pursuant to the provisions of Section 2.16 of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record
and beneficial owner of the Loan(s) (as well as any promissory note(s) evidencing such Loan(s)) in respect of which it is providing this certificate, (ii) it is not a bank within the meaning of Section 881(c)(3)(A) of the Code,
(iii) it is not a ten percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code and (iv) it is not a controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of
the Code. 
 The undersigned has furnished the Administrative Agent and the Borrower with a certificate of its non-U.S. Person status on IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable. By executing
this certificate, the undersigned agrees that (i) if the information provided on this certificate changes, the undersigned shall promptly so inform the Borrower and the Administrative Agent and (ii) the undersigned shall have at all times
furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the undersigned, or in either of the two calendar years preceding
such payments. 
 Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to
them in the Credit Agreement. 
 [NAME OF LENDER] 
  

			
	By:	 	  

		 	Name:
		 	Title:

 Date:    _______________, 20___ 

 

 EXHIBIT E-2 

[FORM OF] 
 U.S. TAX
COMPLIANCE CERTIFICATE 
 (For Foreign Lenders That Are Partnerships For U.S. Federal Income Tax Purposes) 

Reference is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to
time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the “Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. 

Pursuant to the provisions of Section 2.16 of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record
owner of the Loan(s) (as well as any promissory note(s) evidencing such Loan(s)) in respect of which it is providing this certificate, (ii) its direct or indirect partners/members are the sole beneficial owners of such Loan(s) (as well as any
promissory note(s) evidencing such Loan(s)), (iii) with respect to the extension of credit pursuant to the Credit Agreement or any other Loan Document, neither the undersigned nor any of its direct or indirect partners/members is a bank
extending credit pursuant to a loan agreement entered into in the ordinary course of its trade or business within the meaning of Section 881(c)(3)(A) of the Code, (iv) none of its direct or indirect partners/members is a ten percent
shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code and (v) none of its direct or indirect partners/members is a controlled foreign corporation related to the Borrower as described in
Section 881(c)(3)(C) of the Code. 
 The undersigned has furnished the Administrative Agent and the Borrower with IRS Form W-8IMY accompanied by one of the following forms from each of its partners/members that is claiming the portfolio interest exemption: (i) an IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, or (ii) an IRS Form W-8IMY accompanied by an IRS Form W-8BEN or
IRS Form W-8BEN-E, as applicable, from each of such partner’s/member’s beneficial owners that is claiming the portfolio interest exemption. By executing this
certificate, the undersigned agrees that (i) if the information provided on this certificate changes, the undersigned shall promptly so inform the Borrower and the Administrative Agent and (ii) the undersigned shall have at all times
furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the undersigned, or in either of the two calendar years preceding
such payments. 
 Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to
them in the Credit Agreement. 
  

			
	[NAME OF LENDER]
		
	By:	 	  

		 	Name:
		 	Title:
		
	Date:	 	                    , 20    

  

 EXHIBIT E-3 

[FORM OF] 
 U.S. TAX
COMPLIANCE CERTIFICATE 
 (For Foreign Participants That Are Not Partnerships For U.S. Federal Income Tax Purposes) 

Reference is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to
time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the “Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. 

Pursuant to the provisions of Section 2.16 of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record
and beneficial owner of the participation in respect of which it is providing this certificate, (ii) it is not a bank within the meaning of Section 881(c)(3)(A) of the Code, (iii) it is not a ten percent shareholder of the Borrower
within the meaning of Section 871(h)(3)(B) of the Code, and (iv) it is not a controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of the Code. 

The undersigned has furnished its participating Lender with a certificate of its non-U.S. Person
status on IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable. By executing this certificate, the undersigned agrees that
(i) if the information provided on this certificate changes, the undersigned shall promptly so inform such Lender in writing and (ii) the undersigned shall have at all times furnished such Lender with a properly completed and currently
effective certificate in either the calendar year in which each payment is to be made to the undersigned, or in either of the two calendar years preceding such payments. 

Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit
Agreement. 
  

			
	[NAME OF PARTICIPANT]
		
	By:	 	  

		 	Name:
		 	Title:
		
	Date:	 	                    , 20    

  

 EXHIBIT E-4 

[FORM OF] 
 U.S. TAX
COMPLIANCE CERTIFICATE 
 (For Foreign Participants That Are Partnerships For U.S. Federal Income Tax Purposes) 

Reference is made to the Term Loan Agreement dated as of September [•], 2019 (as amended, supplemented or otherwise modified from time to
time, the “Credit Agreement”), among MPLX LP, a Delaware limited partnership (the “Borrower”), the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent. 

Pursuant to the provisions of Section 2.16 of the Credit Agreement, the undersigned hereby certifies that (i) it is the sole record
owner of the participation in respect of which it is providing this certificate, (ii) its direct or indirect partners/members are the sole beneficial owners of such participation, (iii) with respect such participation, neither the
undersigned nor any of its direct or indirect partners/members is a bank extending credit pursuant to a loan agreement entered into in the ordinary course of its trade or business within the meaning of Section 881(c)(3)(A) of the Code,
(iv) none of its direct or indirect partners/members is a ten percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code and (v) none of its direct or indirect partners/members is a controlled foreign
corporation related to the Borrower as described in Section 881(c)(3)(C) of the Code. 
 The undersigned has furnished its
participating Lender with IRS Form W-8IMY accompanied by one of the following forms from each of its partners/members that is claiming the portfolio interest exemption: (i) an IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, or (ii) an IRS Form W-8IMY accompanied by an
IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, from each of such partner’s/member’s beneficial owners that is
claiming the portfolio interest exemption. By executing this certificate, the undersigned agrees that (i) if the information provided on this certificate changes, the undersigned shall promptly so inform such Lender and (ii) the
undersigned shall have at all times furnished such Lender with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the undersigned, or in either of the two calendar years
preceding such payments. 
 Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings
given to them in the Credit Agreement. 
  

			
	[NAME OF PARTICIPANT]
		
	By:	 	  

		 	Name:
		 	Title:
		
	Date:	 	                    , 20    

  

 EXHIBIT F 

[FORM OF] SUBSIDIARY GUARANTEE 

SUBSIDIARY GUARANTEE dated as of
                    ,          (this “Guarantee”), among MPLX LP, a
Delaware limited partnership (the “Borrower”), the Subsidiaries of the Borrower party hereto (collectively, the “Subsidiary Guarantors”) and Wells Fargo Bank, National Association, as Administrative
Agent. 
 WHEREAS, pursuant to the Term Loan Agreement dated as of September [•], 2019 (as the same may be amended, restated,
supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent (in such capacity, the
“Administrative Agent”), the Lenders have severally agreed to make extensions of credit to the Borrower upon the terms and subject to the conditions set forth therein; 

WHEREAS, each Subsidiary Guarantor is a direct or indirect Subsidiary of the Borrower; 

WHEREAS, each Subsidiary Guarantor will receive substantial direct and indirect benefits from the making of the Loans and the granting of the
other financial accommodations to the Borrower under the Credit Agreement; 
 WHEREAS, the Borrower and the Subsidiary Guarantors are
required or have elected, pursuant to Section 5.10 or 9.09 of the Credit Agreement, to have the Subsidiary Guarantors execute and deliver this Guarantee for the benefit of the Administrative Agent, each Lender and each other holder of an
Obligation (as such term is defined below) (collectively, the “Guarantied Parties”); and 
 WHEREAS, capitalized
terms used herein but not herein defined shall have the meaning set forth in the Credit Agreement. 
 NOW, THEREFORE, in consideration of
the premises set forth above, the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

ARTICLE I 
 Guarantee

 (a) Each Subsidiary Guarantor hereby absolutely, unconditionally and irrevocably guarantees, jointly with the other Subsidiary
Guarantors and severally, as primary obligor and not merely as surety, the full and punctual payment when due and in the currency due, whether at stated maturity or earlier, by reason of acceleration, mandatory prepayment or otherwise in accordance
herewith or any other Loan Document, of all the Obligations, whether or not from time to time reduced or extinguished or hereafter increased or incurred, whether or not recovery may be or hereafter may become barred by any statute of limitations,
whether or not enforceable as against the Borrower, whether now or hereafter existing, and whether due or to become due, including principal, interest (including interest accrued or accruing after the commencement of any proceeding under
Title 11 of the United States Code (the “Bankruptcy Code”) or any other bankruptcy, insolvency, receivership or other similar proceeding, and interest at the contract rate applicable upon default accrued or accruing
after the commencement of any such proceeding, in each case regardless of whether allowed or allowable in such proceeding), fees and costs of collection. This Guarantee constitutes a guarantee of payment when due (whether or not any proceeding under
the Bankruptcy Code shall have stayed the accrual or collection of any of the Obligations or operated as a discharge thereof) and not of collection. 

 (b) Each Subsidiary Guarantor further agrees that, if any payment made by the Borrower or
any other Person and applied to the Obligations is at any time annulled, avoided, set aside, rescinded, invalidated, declared to be fraudulent or preferential or otherwise required to be refunded or repaid, then, to the extent of such payment or
repayment, any such Subsidiary Guarantor’s liability hereunder shall be and remain in full force and effect, as fully as if such payment had never been made. If, prior to any of the foregoing, this Guarantee shall have been cancelled or
surrendered, this Guarantee shall be reinstated in full force and effect, and such prior cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect the obligations of any such Subsidiary Guarantor in respect of the
amount of such payment. 
 (c) In furtherance of the foregoing and not in limitation of any other right that any Guarantied Party has at law
or in equity against any Subsidiary Guarantor by virtue hereof, upon the failure of the Borrower to pay any Obligation when and as the same shall become due and payable, whether at stated maturity or earlier, by reason of acceleration, mandatory
prepayment or otherwise in accordance herewith or any other Loan Document, each Subsidiary Guarantor hereby promises to and will forthwith pay, or cause to be paid, to the Administrative Agent for distribution to the applicable Guarantied Parties in
cash the amount of such unpaid Obligations. Upon payment by any Subsidiary Guarantor of any sums to the Administrative Agent as provided in this paragraph, all rights of such Subsidiary Guarantor against the Borrower arising as a result thereof by
way of right of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subject to Article VIII hereof. 

(d) As used herein, the term “Obligations” means (i) the aggregate outstanding principal amount of, and all unpaid
interest (including interest accrued or accruing after the commencement of any proceeding under the Bankruptcy Code or any other bankruptcy, insolvency, receivership or other similar proceeding, and interest at the contract rate applicable upon
default accrued or accruing after the commencement of any such proceeding, in each case regardless of whether allowed or allowable in such proceeding) on, the Loans when and as due, whether at stated maturity or earlier, by reason of acceleration,
mandatory prepayment or otherwise in accordance herewith or any other Loan Document and (ii) all other outstanding liabilities, obligations and indebtedness owing by the Borrower to the Administrative Agent, any Lender or any other Indemnitee
arising under the Credit Agreement or any other Loan Document, of every type and description (whether by reason of an extension of credit, loan, guarantee, indemnification or otherwise), present or future, whether direct or indirect (including those
acquired by assignment), absolute or contingent, due or to become due, now existing or hereafter arising and however acquired and whether or not evidenced by any note, guarantee or other instrument for the payment of money (including any such
liabilities, obligations and indebtedness incurred after the commencement of any proceeding under the Bankruptcy Code or any other bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such
proceeding). 
 ARTICLE II 

Limitation of Guarantee 

Any term of this Guarantee to the contrary notwithstanding, the maximum aggregate amount of the Obligations for which any Subsidiary Guarantor
shall be liable shall not exceed the maximum amount for which such Subsidiary Guarantor can be liable without rendering this Guarantee, as it relates to such Subsidiary Guarantor, subject to avoidance under applicable law relating to fraudulent
conveyance or fraudulent transfer (including Section 548 of the Bankruptcy Code or any applicable provisions of comparable state law) (collectively, “Fraudulent Transfer Laws”), in each case after giving effect (a) to

  
 2 

 
all other liabilities of such Subsidiary Guarantor, contingent or otherwise, that are relevant under such Fraudulent Transfer Laws (specifically excluding, however, any liabilities of such
Subsidiary Guarantor in respect of intercompany Indebtedness to the Borrower to the extent that such Indebtedness would be discharged in an amount equal to the amount paid by such Subsidiary Guarantor hereunder) and (b) to the value as assets
of such Subsidiary Guarantor (as determined under the applicable provisions of such Fraudulent Transfer Laws) of any rights to subrogation, contribution, reimbursement, indemnity or similar rights held by such Subsidiary Guarantor pursuant to
(i) applicable federal, state, local and foreign laws, rules and regulations, orders, judgments, decrees and other determinations of any Governmental Authority or arbitrator and common law, (ii) Article III of this Guarantee or
(iii) any other obligation, agreement, undertaking or similar provisions of any security or any agreement, undertaking, contract, lease, indenture, mortgage, deed of trust or other instrument (excluding any Loan Document) providing for an
equitable allocation among such Subsidiary Guarantor and other Subsidiaries or Affiliates of the Borrower of obligations arising under this Guarantee or other guaranties of the Obligations by such parties. 

ARTICLE III 
 Indemnity
and Contribution 
 SECTION 3.01 Indemnity and Subrogation. In addition to all such rights of indemnity
and subrogation as the Subsidiary Guarantors may have under applicable law (but subject to Article VIII hereof), the Borrower agrees that in the event a payment in respect of any Obligation shall be made by any Subsidiary Guarantor under this
Guarantee, the Borrower shall indemnify such Subsidiary Guarantor for the full amount of such payment and such Subsidiary Guarantor shall be subrogated to the rights of the Person to whom such payment shall have been made to the extent of such
payment. 
 SECTION 3.02 Contribution. In the event that any Subsidiary Guarantor (the “Claiming
Party”) shall be required hereunder to make a payment in respect of any Obligation exceeding the greater of (a) the amount of the economic benefit actually received by such Subsidiary Guarantor from the Loans and the other
financial accommodations provided to the Borrower under the Loan Documents and (b) the amount such Subsidiary Guarantor would otherwise have paid if such Subsidiary Guarantor had paid the aggregate amount of the Obligations (excluding the
amount thereof repaid by the Borrower) in the same proportion as such Subsidiary Guarantor’s net worth on the date hereof (or, in the case of any Subsidiary Guarantor becoming a party hereto pursuant to Section 14.08, the date of the
Guarantee Supplement hereto executed and delivered by such Subsidiary Guarantor) bears to the aggregate net worth of all the Subsidiary Guarantors on the date hereof (or, in the case of any Subsidiary Guarantor becoming a party hereto pursuant to
Section 14.08, the date of the Guarantee Supplement hereto executed and delivered by such Subsidiary Guarantor), then (subject to Article VIII hereof) such Subsidiary Guarantor shall be reimbursed by such other Subsidiary Guarantors (each,
a “Contributing Party”) for the amount of such excess, pro rata, based on the respective net worth of such other Subsidiary Guarantors at the date enforcement hereunder is sought. Any Contributing Party making a payment to a
Claiming Party pursuant to this Section 3.02 shall be subrogated to the rights of such Claiming Party to the extent of such payment. 

ARTICLE IV 

Authorization; Other Agreements 

The Guarantied Parties are hereby authorized, without notice to, or demand upon, any Subsidiary Guarantor, which notice and demand
requirements each are expressly waived hereby, and without discharging or otherwise affecting the obligations of any Subsidiary Guarantor hereunder (which obligations shall remain absolute and unconditional notwithstanding any such action or
omission to act), from time to time, to do each of the following: 

  
 3 

 (a) supplement, renew, extend, accelerate or otherwise change the time for payment of, or
other terms relating to, the Obligations, or any part of them, or otherwise modify, amend or change the terms of any promissory note or other agreement, document or instrument (including the other Loan Documents) now or hereafter executed by the
Borrower and delivered to the Guarantied Parties or any of them, including any increase or decrease of principal or the rate of interest thereon; 

(b) waive or otherwise consent to noncompliance with any provision of any instrument evidencing the Obligations, or any part thereof, or any
other instrument or agreement in respect of the Obligations (including the other Loan Documents) now or hereafter executed by the Borrower and delivered to the Guarantied Parties or any of them; 

(c) accept partial payments on the Obligations; 

(d) receive, take and hold security or collateral for the payment of the Obligations or any part of them and exchange, enforce, waive,
substitute, liquidate, terminate, abandon, fail to perfect, subordinate, transfer, otherwise alter and release any such security or collateral; 

(e) settle, release, compromise, collect or otherwise liquidate the Obligations or accept, substitute, release, exchange or otherwise alter,
affect or impair any security or collateral for the Obligations or any part of them or any other guarantee therefor, in any manner; 
 (f)
add, release or substitute any one or more other guarantors, makers or endorsers of the Obligations or any part of them and otherwise deal with the Borrower or any other guarantor, maker or endorser; 

(g) apply to the Obligations any payment or recovery (i) from the Borrower, from any other guarantor, maker or endorser of the Obligations
or any part of them or (ii) from any Subsidiary Guarantor in such order as provided herein, in each case whether such Obligations are secured or unsecured or guaranteed or not guaranteed by others; 

(h) apply to the Obligations any payment or recovery from any Subsidiary Guarantor of the Obligations or any sum realized from security
furnished by such Subsidiary Guarantor upon its indebtedness or obligations to the Guarantied Parties or any of them, in each case whether or not such indebtedness or obligations relate to the Obligations; and 

(i) refund at any time any payment received by any Guarantied Party in respect of any Obligation, and payment to such Guarantied Party of the
amount so refunded shall be fully guaranteed hereby even though prior thereto this Guarantee shall have been cancelled or surrendered, and such prior cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect the
obligations of any Subsidiary Guarantor hereunder in respect of the amount so refunded; 
 in each case even if any right of reimbursement or subrogation or
other right or remedy of any Subsidiary Guarantor is extinguished, affected or impaired by any of the foregoing (including any election of remedies by reason of any judicial, nonjudicial or other proceeding in respect of the Obligations that impairs
any subrogation, reimbursement or other right of such Subsidiary Guarantor). 

  
 4 

 ARTICLE V 

Guarantee Absolute and Unconditional 

Each Subsidiary Guarantor hereby waives any defense of a surety or guarantor or any other obligor on any obligations arising in connection
with or in respect of any of the following and hereby agrees that its obligations under this Guarantee are absolute and unconditional and shall not be discharged, reduced, limited, impaired or terminated or otherwise affected as a result of any of
the following: 
 (a) the invalidity or unenforceability of, or any impossibility in the performance of, any of the Borrower’s
obligations under the Credit Agreement or any other Loan Document or any other agreement or instrument relating thereto, or any security for, or other guarantee of the Obligations or any part of them; 

(b) the absence of any attempt to collect on the Obligations or any part of them from the Borrower or other action to enforce the same; 

(c) any Guarantied Party’s election, in any proceeding instituted under chapter 11 of the Bankruptcy Code, of the application of
Section 1111(b)(2) of the Bankruptcy Code or any applicable provisions of comparable state or foreign law; 
 (d) any borrowing or grant
of a Lien by the Borrower, as debtor-in-possession, or extension of credit, under Section 364 of the Bankruptcy Code or any applicable provisions of comparable
state or foreign law; 
 (e) the disallowance, under Section 502 of the Bankruptcy Code, of all or any portion of any Guarantied
Party’s claim (or claims) for repayment of the Obligations ; 
 (f) any use of cash collateral under Section 363 of the Bankruptcy
Code; 
 (g) any agreement or stipulation as to the provision of adequate protection in any bankruptcy proceeding; 

(h) the avoidance of any Lien in favor of the Guarantied Parties or any of them for any reason; 

(i) any bankruptcy, insolvency, reorganization, arrangement, readjustment of debt, liquidation or dissolution proceeding commenced by or
against the Borrower, any Subsidiary Guarantor or any of the Borrower’s other Subsidiaries, including any discharge of, or bar or stay against collecting, any Obligation (or any part of them or interest thereon) in or as a result of any such
proceeding; 
 (j) failure by any Guarantied Party to file or enforce a claim against the Borrower or its estate in any bankruptcy or
insolvency case or proceeding or otherwise; 
 (k) any action taken by any Guarantied Party if such action is authorized hereby; 

(l) any change in the corporate existence or structure of the Borrower or any other Loan Party; 

  
 5 

 (m) any defense, set-off, counterclaim, recoupment
or termination (other than a defense of payment or performance) which may at any time be available to or be asserted by any Subsidiary Guarantor or any other Person against any Guarantied Party; 

(n) any applicable federal, state, local and foreign laws, rules and regulations, orders, judgments, decrees and other determinations of any
Governmental Authority or arbitrator and common law affecting any term of any Subsidiary Guarantor’s obligations under this Guarantee; 

(o) any rescission, waiver, amendment or modification of, or release from any of the terms or provisions of, any Loan Document or any other
agreement, including with respect to any other Subsidiary Guarantor under this Guarantee; or 
 (p) any other act, omission or circumstance
that might otherwise constitute a legal or equitable discharge or defense of a surety or guarantor or any other obligor on any obligations, other than the payment in full in cash of the Obligations (other than indemnities and other contingent
obligations not then due and payable and as to which no claim has been made as of the time of determination). 
 ARTICLE VI 

Waivers 
 Each Subsidiary
Guarantor hereby waives diligence, promptness, presentment, demand for payment or performance and protest and notice of protest, notice of acceptance and any other notice in respect of the Obligations or any part of them, and any defense arising by
reason of any disability or other defense of the Borrower or any of its Subsidiaries or the unenforceability of the Obligations or any part thereof from any cause or the cessation from any cause of the liability of the Borrower or any of its
Subsidiaries, other than any defense of payment in full in cash of the Obligations. In connection with the foregoing, each Subsidiary Guarantor covenants that its obligations hereunder shall not be discharged, except in accordance with
Article X hereof or Section 5.10 or 9.09 of the Credit Agreement. 
 ARTICLE VII 

Reliance 
 Each Subsidiary
Guarantor hereby assumes responsibility for keeping itself informed of the financial condition of the Borrower and any endorser and other guarantor of all or any part of the Obligations, and of all other circumstances bearing upon the risk of
nonpayment of the Obligations, or any part thereof, that diligent inquiry would reveal, and each Subsidiary Guarantor hereby agrees that no Guarantied Party shall have any duty to advise any Subsidiary Guarantor of information known to it regarding
such condition or any such circumstances. In the event any Guarantied Party, in its sole discretion, undertakes at any time or from time to time to provide any such information to any Subsidiary Guarantor, such Guarantied Party shall be under no
obligation (a) to undertake any investigation not a part of its regular business routine, (b) to disclose any information that such Guarantied Party, pursuant to accepted or reasonable commercial finance or banking practices, wishes to
maintain confidential or (c) to make any other or future disclosures of such information or any other information to any Subsidiary Guarantor. 

  
 6 

 ARTICLE VIII 

Waiver of Subrogation and Contribution Rights 

Until the Obligations have been paid in full in cash (other than indemnities and other contingent obligations not then due and payable and as
to which no claim has been made as of the time of determination) and the Commitments have expired or have been terminated, the Subsidiary Guarantors shall not enforce or otherwise exercise any right of subrogation to any of the rights of the
Guarantied Parties or any part of them against the Borrower or any right of reimbursement, indemnity or contribution or similar right against the Borrower by reason of this Guarantee or by any payment made by any Subsidiary Guarantor in respect of
the Obligations. No failure on the part of the Borrower or any other Subsidiary Guarantor to make the payments required by Article III hereof (or any other payments required under applicable law or otherwise) shall in any respect limit the
obligations and liabilities of any Subsidiary Guarantor with respect to its obligations hereunder, and each Subsidiary Guarantor shall remain liable for the full amount of the obligations of such Subsidiary Guarantor hereunder. 

ARTICLE IX 
 Default;
Remedies 
 The obligations of each Subsidiary Guarantor hereunder are independent of and separate from the Obligations. Upon any Event
of Default, the Administrative Agent may, at its sole election, proceed directly and at once, without notice, against any Subsidiary Guarantor to collect and recover the full amount or any portion of the Obligations then due, without first
proceeding against the Borrower or any other guarantor of the Obligations, or joining the Borrower or any other guarantor in any proceeding against any Subsidiary Guarantor. 

ARTICLE X 

Irrevocability; Termination 

Subject to any release pursuant to Section 5.10 or 9.09 of the Credit Agreement, this Guarantee shall be irrevocable as to the
Obligations (or any part thereof) until the Commitments have expired or have been terminated and the Obligations have been paid in full in cash (other than indemnities and other contingent obligations not then due and payable and as to which no
claim has been made as of the time of determination), at which time this Guarantee shall automatically be cancelled. Upon such cancellation and at the written request of any Subsidiary Guarantor or its successors or assigns, and at the cost and
expense of such Subsidiary Guarantor or its successors or assigns, the Administrative Agent shall execute in a timely manner a satisfaction of this Guarantee and such instruments, documents or agreements as are necessary or desirable to evidence the
termination of this Guarantee. Any execution and delivery of the instruments, documents and agreements by the Administrative Agent pursuant to this Article X (including any release pursuant to Section 5.10 or 9.09 of the Credit Agreement)
shall be without recourse or warranty by the Administrative Agent. 

  
 7 

 ARTICLE XI 

Setoff 
 If an Event of
Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable law, to set off and apply any and all deposits (general or
special, time or demand, provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by such Lender or any of its Affiliates to or for the credit or the account of the Borrower or any
other Loan Party against any and all of the Obligations of the Borrower or such Loan Party now or hereafter existing under this Agreement or any other Loan Document to such Lender or any of its Affiliates which are then due and payable, irrespective
of whether or not such Lender shall have made any demand under this Guarantee and although any such Obligations of the Borrower or such Loan Party are owed to a branch, office or Affiliate of such Lender different from the branch, office or
Affiliate holding such deposit or obligated on such indebtedness. The rights of each Lender and its Affiliates under this Article XI are in addition to other rights and remedies (including other rights of setoff) that such Lender or its Affiliates
may have. Each Lender agrees to promptly notify the Borrower and the Administrative Agent after any such setoff and application by such Lender, provided that the failure to give such notice shall not affect the validity of such setoff and
application. 
 ARTICLE XII 

No Marshalling 
 Each
Subsidiary Guarantor consents and agrees that no Guarantied Party or any Person acting for or on behalf of any Guarantied Party shall be under any obligation to marshal any assets in favor of any Subsidiary Guarantor or against or in payment of any
or all of the Obligations. 
 ARTICLE XIII 

Representations and Warranties 

Each Subsidiary Guarantor hereby represents and warrants that the representations and warranties as to it made by the Borrower in
Section 3.01, Section 3.02 and Section 3.03 of the Credit Agreement are true and correct in all material respects on and as of the date hereof, except to the extent any such representations and warranties are expressly limited to an
earlier date, in which case, such representations and warranties are true and correct in all material respects as of such specified earlier date; provided that, in each case, such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text thereof. 
 ARTICLE XIV 

Miscellaneous 
 SECTION
14.01. Successors and Assigns. This Guarantee shall be binding upon each Subsidiary Guarantor and upon the successors and assigns of such Subsidiary Guarantors and shall inure to the benefit of the Guarantied Parties and their respective
successors and assigns. The successors and assigns of the Subsidiary Guarantors and the Borrower shall include their respective receivers, trustees and
debtors-in-possession. 
 SECTION 14.02. Enforcement;
Waivers; Amendments 
 (a) No delay on the part of any Guarantied Party in the exercise of any right or remedy arising under this
Guarantee, the Credit Agreement, any other Loan Document or otherwise with respect to all or any part of the Obligations or any other guarantee of or security for all or any part of the Obligations shall operate as a waiver thereof, and no single or
partial exercise by any such Person of any such right or remedy, or any abandonment or discontinuance of steps to enforce such a right or remedy, shall preclude any other or further exercise thereof or the exercise of any other right or remedy. The

  
 8 

 
rights and remedies of the Guarantied Parties hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have. Failure by any Guarantied Party at any time
or times hereafter to require strict performance by the Borrower, any Subsidiary Guarantor, any other guarantor of all or any part of the Obligations or any other Person of any provision, warranty, term or condition contained in any Loan Document
now or at any time hereafter executed by any such Persons and delivered to any Guarantied Party shall not waive, affect or diminish any right of any Guarantied Party at any time or times hereafter to demand strict performance thereof and such right
shall not be deemed to have been waived by any act (except by a written instrument pursuant to Section 14.02(b)) or knowledge of any Guarantied Party, or its respective agents, officers or employees. No waiver of any provision of this Guarantee
or consent to any departure by any Subsidiary Guarantor therefrom shall in any event be effective unless the same shall be permitted by a written instrument pursuant to Section 14.02(b), and then such waiver or consent shall be effective only
in the specific instance and for the purpose for which given. No action by any Guarantied Party permitted hereunder shall in any way affect or impair any Guarantied Party’s rights and remedies or the obligations of any Subsidiary Guarantor
under this Guarantee. Any determination by a court of competent jurisdiction of the amount of any principal or interest owing by the Borrower to a Guarantied Party shall be conclusive and binding on each Subsidiary Guarantor irrespective of whether
such Subsidiary Guarantor was a party to the suit or action in which such determination was made. 
 (b) None of the terms or provisions of
this Guarantee may be waived, amended, supplemented or modified except pursuant to an agreement in writing entered into by the Subsidiary Guarantors and the Administrative Agent with the consent, if required pursuant to Section 9.02 of the
Credit Agreement, of the Required Lenders. 
 SECTION 14.03. Governing Law; Jurisdiction; Consent to Service of Process. 

(a) This Guarantee shall be construed in accordance with and governed by the law of the State of New York. 

(b) Each party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme
Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this
Guarantee, or for recognition or enforcement of any judgment, and each party hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined solely in such New York State
or, to the extent permitted by law, in such Federal court. Each party hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law. 
 (c) Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively
do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Guarantee in any court referred to in paragraph (b) of this Section. Each party hereto hereby
irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 

(d) Each party hereto hereby irrevocably consents to service of process in the manner provided for notices in Section 9.01 of the Credit
Agreement. Nothing in this Guarantee will affect the right of any party to this Guarantee to serve process in any other manner permitted by law. 

  
 9 

 SECTION 14.04. Certain Terms. The definitions of terms herein shall apply equally to
the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including”
shall be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The words “asset” and “property” shall
be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including intellectual property, cash, securities, accounts and contract rights. Except as otherwise provided herein and
unless the context requires otherwise (a) any definition of or reference to any agreement (including this Guarantee), instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from
time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth in the Credit Agreement), (b) any reference herein to any Person shall be construed to include such
Person’s successors and assigns (subject to any restrictions on assignment set forth in the Credit Agreement) and, in the case of any Governmental Authority, any other Governmental Authority that shall have succeeded to any or all functions
thereof, (c) the words “herein”, “hereof” and “hereunder”, and words of similar import, shall be construed to refer to this Guarantee in its entirety and not to any particular provision hereof, (d) all
references herein to Articles, Sections and Exhibits shall be construed to refer to Articles and Sections of, and Exhibits to, this Guarantee, (e) with respect to the determination of any period of time, the word “from” means
“from and including” and the word “to” means “to but excluding” and (f) reference to any law, rule or regulation means such as amended, modified, codified or reenacted, in whole or in part, and in effect from time
to time. 
 SECTION 14.05. Waiver of Jury Trial. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS GUARANTEE OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO
(A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT
IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS GUARANTEE BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

SECTION 14.06. Notices. Any notice or other communication herein required or permitted shall be given as provided in
Section 9.01 of the Credit Agreement and, in the case of any Subsidiary Guarantor, to such Subsidiary Guarantor in care of the Borrower. 

SECTION 14.07. Severability. Wherever possible, each provision of this Guarantee shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Guarantee shall be prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or invalidity without invalidating the remainder of such
provision or the remaining provisions of this Guarantee. 
 SECTION 14.08. Additional Subsidiary Guarantors. Each of the Subsidiary
Guarantors agrees that, if (a) pursuant to Section 5.10 of the Credit Agreement, any Subsidiary is required to become a Subsidiary Guarantor hereunder or (b) pursuant to Section 9.09 of the Credit Agreement, the Borrower
desires any Subsidiary to become a Subsidiary Guarantor hereunder, such Subsidiary shall execute and deliver to the Administrative Agent a Guarantee Supplement in substantially the form of Exhibit A (Guarantee Supplement) attached hereto and
shall thereafter become a Subsidiary Guarantor for all purposes and to the same extent as if originally a party hereto and shall be bound by and entitled to the rights, benefits and obligations of this Guarantee. The rights and obligations of each
Subsidiary Guarantor hereunder shall remain in full force and effect notwithstanding the addition of any new Subsidiary as a party to this Guarantee. 

  
 10 

 SECTION 14.09. Expenses; Indemnification. (a) Each Subsidiary Guarantor agrees
to pay or reimburse the Administrative Agent and each of the other Guarantied Parties upon demand for all out-of-pocket expenses incurred by the Administrative Agent or
any other Guarantied Party, including the fees, charges and disbursements of any counsel for the Administrative Agent or any other Guarantied Party, in connection with the enforcement of this Guarantee against such Subsidiary Guarantor or the
exercise or enforcement of any other right or remedy available in connection herewith or therewith. 
 (b) The Subsidiary Guarantors jointly
and severally agree to indemnify and hold harmless each Guarantied Party and the other Indemnitees as provided in Section 9.03(b) of the Credit Agreement as if each reference in such Section to “the Borrower” was a reference to
“the Subsidiary Guarantors” and with the same force and effect as if such Subsidiary Guarantors were parties to the Credit Agreement. 

(c) Any amounts payable as provided in paragraphs (a) and (b) of this Section shall be additional Obligations guaranteed hereby. All
amounts due under paragraph (a) or (b) of this Section shall be payable promptly after written demand therefor. 
 SECTION 14.10.
Waiver of Consequential Damages. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND WITHOUT LIMITING IN ANY WAY THE BORROWER’S AND THE SUBSIDIARY GUARANTORS’ OBLIGATIONS HEREUNDER (INCLUDING THE SUBSIDIARY GUARANTORS’ OBLIGATIONS
SET FORTH IN SECTIONS 14.09(a) AND 14.09(b)) OR IN ANY OTHER LOAN DOCUMENT, NO PARTY HERETO SHALL ASSERT, OR PERMIT ANY OF ITS AFFILIATES OR RELATED PARTIES TO ASSERT, AND EACH PARTY HERETO HEREBY WAIVES, ANY CLAIM AGAINST EACH OTHER SUCH PERSON
(AND, IN THE CASE OF THE BORROWER OR ANY SUBSIDIARY GUARANTOR, ANY GUARANTIED PARTY AND ANY OTHER INDEMNITEE), ON ANY THEORY OF LIABILITY, FOR SPECIAL, INDIRECT, CONSEQUENTIAL OR PUNITIVE DAMAGES (AS OPPOSED TO DIRECT OR ACTUAL DAMAGES) ARISING OUT
OF, IN CONNECTION WITH, OR AS A RESULT OF, THIS GUARANTEE OR ANY OTHER LOAN DOCUMENT OR ANY AGREEMENT OR INSTRUMENT CONTEMPLATED HEREBY OR THEREBY, THE TRANSACTIONS CONTEMPLATED HEREBY, ANY LOAN OR THE USE OF THE PROCEEDS THEREOF. 

SECTION 14.11. Entire Agreement. This Guarantee, taken together with all of the other Loan Documents executed and delivered by the
Subsidiary Guarantors, represents the entire agreement and understanding of the parties hereto and supersedes all prior understandings, written and oral, relating to the subject matter hereof. 

SECTION 14.12. Counterparts. This Guarantee may be executed in any number of separate counterparts and by different parties in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Signature pages may be detached from multiple counterparts and attached to a single
counterpart so that all signature pages are attached to the same document. Delivery of an executed counterpart by facsimile transmission or electronic mail shall be effective as delivery of a manually executed counterpart. 

SECTION 14.13 Headings. Article and Section headings used herein are for convenience of reference only, are not part of this Guarantee
and shall not affect the construction of, or be taken into consideration in interpreting, this Guarantee. 

  
 11 

 SECTION 14.14 Certain Acknowledgements and Agreements. Each Subsidiary Guarantor
hereby acknowledges the provisions of Section 2.16 of the Credit Agreement and agrees to be bound by such provisions with the same force and effect, and to the same extent, as if such Subsidiary Guarantor was a party to the Credit Agreement.

 [SIGNATURE PAGES FOLLOW] 

  
 12 

 IN WITNESS WHEREOF, this Guarantee has been duly executed by the parties hereto as of the
day and year first set forth above. 
  

			
	[NAME OF SUBSIDIARY GUARANTOR]
		
	By:	 	  

		 	Name:
		 	Title:

  
 13 

					
	MPLX LP, a Delaware limited partnership
	
	By: MPLX GP LLC, its General Partner
			
	        	 	By:	 	  

		 	 Name:
	 	
		 	 Title:
	 	
	
	 WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent

		
	By:	 	  

		 	 Name:
	 	
		 	 Title:
	 	

  
 14 

 EXHIBIT A TO 

SUBSIDIARY GUARANTEE 
 GUARANTEE
SUPPLEMENT 
 The undersigned hereby agrees to be bound as a Subsidiary Guarantor for purposes of the Guarantee, dated as of
[                    ,         ] (the “Subsidiary Guarantee”), among
MPLX LP, a Delaware limited partnership (the “Borrower”), the Subsidiaries of the Borrower party thereto and Wells Fargo Bank, National Association, as the Administrative Agent, and the undersigned hereby acknowledges receipt
of a copy of the Subsidiary Guarantee. Each reference to a “Subsidiary Guarantor” in the Subsidiary Guarantee shall be deemed to include the undersigned. 

The undersigned hereby represents and warrants that each of the representations and warranties contained in Article XIII of the Subsidiary
Guarantee applicable to it is true and correct on and as the date hereof as if made on and as of such date (or, to the extent such representations and warranties expressly relate to an earlier date, on and as of such earlier date). 

This Guarantee Supplement may be executed in any number of separate counterparts and by different parties in separate counterparts, each of
which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Signature pages may be detached from multiple counterparts and attached to a single counterpart so that all
signature pages are attached to the same document. Delivery of an executed counterpart by facsimile transmission or electronic mail shall be effective as delivery of a manually executed counterpart. 

This Guarantee Supplement shall be construed in accordance with and governed by the law of the State of New York. 

Capitalized terms used herein but not defined herein are used with the meanings given them in the Subsidiary Guarantee. 

IN WITNESS WHEREOF, the undersigned has caused this Guarantee Supplement to be duly executed and delivered as of
                    ,         . 

 

			
	 [NAME OF SUBSIDIARY GUARANTOR]

		
	By:	 	  

		 	 Name:

		 	 Title:

  

  
 15 

 ACKNOWLEDGED AND AGREED 

as of the date first above written: 
  

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent
		
	By:	 	  

		 	Name:
		 	Title:Exhibit 10.1

 

 

 

 

 

AMENDED
AND RESTATED CREDIT AGREEMENT

 

among

SOLSYS MEDICAL, LLC,

and

NEW MISONIX, INC.,

as Borrower,

 

SWK
FUNDING LLC,

 

as
Agent, Sole Lead Arranger and Sole Bookrunner,

 

and

 

the
financial institutions party hereto from time to time as Lenders

 

Dated
as of September 27, 2019

 

 

 

 

 

    [Solsys Medical] A&R Credit Agreement

     

    

 

Table
of Contents

 

	 	 	Page
	Section
    1	Definitions;
    Interpretation	1
	1.1	Definitions	1
	1.2	Interpretation	16
	 	 	 
	Section
    2	Credit
    Facility	16
	2.1	Term
    Loan Commitments	16
	2.2	[Reserved]	17
	2.3	Commitments
    Several	17
	2.4	Indebtedness
    Absolute; No Offset; Waiver	17
	2.5	Loan
    Accounting	18
	 	2.5.1	Recordkeeping	18
	 	2.5.2	Notes	18
	2.6	Payment
    of Interest	18
	 	2.6.1	Interest
    Rates	18
	 	2.6.2	Payments
    of Interest and Principal	19
	2.7	Fees	19
	2.8	Prepayment	19
	 	2.8.1	Mandatory
    Prepayment	19
	 	2.8.2	Voluntary
    Prepayment	19
	 	2.8.3	Change
    of Control	20
	2.9	Repayment
    of Term Loan	20
	 	2.9.1	Revenue-Based
    Payment	20
	 	2.9.2	Principal	22
	2.10	Payment	22
	 	2.10.1	Making
    of Payments	22
	 	2.10.2	Application
    of Payments and Proceeds	22
	 	2.10.3	Set-off	23
	 	2.10.4	Proration
    of Payments	23
	 	 	 	 
	Section
    3	Yield
    Protection	23
	3.1	Taxes	23
	3.2	Increased
    Cost	25
	3.3	Funding
    Losses	27
	3.4	Manner
    of Funding; Alternate Funding Offices	27
	3.5	Conclusiveness
    of Statements; Survival	27
	 	 	 
	Section
    4	Conditions
    Precedent	27
	4.1	Consummation
    of Merger	27
	4.2	Delivery
    of Loan Documents	28
	4.3	Fees	29
	4.4	Representations,
    Warranties, Defaults	29
	 	 	 
	Section
    5	Representations
    and Warranties	29
	5.1	Organization	29
	5.2	Authorization;
    No Conflict	29
	5.3	Validity;
    Binding Nature	29
	5.4	Financial
    Condition	30

 

    [Solsys Medical] A&R Credit Agreement
 
- i -

     

    

 

	5.5	No
    Material Adverse Change	30
	5.6	Litigation	30
	5.7	Ownership
    of Properties; Liens	30
	5.8	Capitalization	30
	5.9	Pension
    Plans	30
	5.10	Investment
    Company Act	30
	5.11	No
    Default	31
	5.12	Margin
    Stock	31
	5.13	Taxes	31
	5.14	Solvency	31
	5.15	Environmental
    Matters	31
	5.16	Insurance	31
	5.17	Information	32
	5.18	Intellectual
    Property; Products and Services	32
	5.19	Restrictive
    Provisions	33
	5.20	Labor
    Matters	33
	5.21	Material
    Contracts	33
	5.22	Compliance
    with Laws; Health Care Laws	33
	5.23	Existing
    Indebtedness; Investments, Guarantees and Certain Contracts	34
	5.24	Affiliated
    Agreements	34
	5.25	Names;
    Locations of Offices, Records and Collateral; Deposit Accounts	35
	5.26	Non-Subordination	35
	5.27	Broker’s
    or Finder’s Commissions	35
	5.28	Anti-Terrorism;
    OFAC	35
	5.29	Security
    Interest	36
	5.30	Survival	36
	 	 	 
	Section
    6	Affirmative
    Covenants	36
	6.1	Information	36
	 	6.1.1	Annual
    Report	36
	 	6.1.2	Interim
    Reports	37
	 	6.1.3	Revenue-Based
    Payment Reconciliation	37
	 	6.1.4	Compliance
    Certificate	37
	 	6.1.5	Reports
    to Governmental Authorities and Shareholders	37
	 	6.1.6	Notice
    of Default; Litigation	38
	 	6.1.7	Management
    Report	39
	 	6.1.8	Projections	39
	 	6.1.9	Updated
    Schedules to Guarantee and Collateral Agreement	39
	 	6.1.10	Other
    Information	39
	6.2	Books;
    Records; Inspections	39
	6.3	Conduct
    of Business; Maintenance of Property; Insurance	40
	6.4	Compliance
    with Laws; Payment of Taxes and Liabilities	41
	6.5	Maintenance
    of Existence	41
	6.6	Employee
    Benefit Plans	42
	6.7	Environmental
    Matters	42
	6.8	Further
    Assurances	42
	6.9	Compliance
    with Health Care Laws	42
	6.10	Cure
    of Violations	43
	6.11	Corporate
    Compliance Program	44
	6.12	Payment
    of Debt	44
	6.13	Collateral
    Access Agreements	44

 

    [Solsys Medical] A&R Credit Agreement
 
- ii -

     

    

 

	Section
    7	Negative
    Covenants	44
	7.1	Debt	44
	7.2	Liens	45
	7.3	Dividends;
    Redemption of Equity Interests	47
	7.4	Mergers;
    Consolidations; Asset Sales	47
	7.5	Modification
    of Organizational Documents	48
	7.6	Use
    of Proceeds	48
	7.7	Transactions
    with Affiliates	48
	7.8	Inconsistent
    Agreements	48
	7.9	Business
    Activities	49
	7.10	Investments	49
	7.11	Restriction
    of Amendments to Certain Documents	50
	7.12	Fiscal
    Year	50
	7.13	Financial
    Covenants	50
	 	7.13.1	Consolidated
    Unencumbered Liquid Assets	50
	 	7.13.2	Minimum
    Aggregate Revenue	51
	 	7.13.3	Minimum
    EBITDA	51
	7.14	Deposit
    Accounts	52
	7.15	Subsidiaries	52
	7.16	Regulatory
    Matters	52
	7.17	Name;
    Permits; Dissolution; Insurance Policies; Disposition of Collateral; Taxes; Trade Names	53
	7.18	Truth
    of Statements	53
	 	 	 
	Section
    8	Events
    of Default; Remedies	53
	8.1	Events
    of Default	53
	 	8.1.1	Non-Payment
    of Credit	53
	 	8.1.2	Default
    Under Other Debt	54
	 	8.1.3	Bankruptcy;
    Insolvency	54
	 	8.1.4	Non-Compliance
    with Loan Documents	54
	 	8.1.5	Representations;
    Warranties	54
	 	8.1.6	Pension
    Plans	55
	 	8.1.7	Judgments	55
	 	8.1.8	Invalidity
    of Loan Documents or Liens	55
	 	8.1.9	Invalidity
    of Subordination Provisions	55
	 	8.1.10	Change
    of Control	55
	 	8.1.11	Certificate
    Withdrawals, Adverse Test or Audit Results, and Other Matters	56
	8.2	Remedies	56
	 	 	 
	Section
    9	Agent	57
	9.1	Appointment;
    Authorization	57
	9.2	Delegation
    of Duties	57
	9.3	Limited
    Liability	57
	9.4	Reliance	58
	9.5	Notice
    of Default	58
	9.6	Credit
    Decision	58
	9.7	Indemnification	59
	9.8	Agent
    Individually	59
	9.9	Successor
    Agent	59
	9.10	Collateral
    and Guarantee Matters	60

 

    [Solsys Medical] A&R Credit Agreement
 
- iii -

     

    

 

	9.11	Intercreditor
    Agreement	61
	9.12	Actions
in Concert	61
	 	 	 
	Section
    10	Miscellaneous	61
	10.1	Waiver;
Amendments	61
	10.2	Notices	62
	10.3	Computations	62
	10.4	Costs;
Expenses	63
	10.5	Indemnification
by Borrower	63
	10.6	Marshaling;
Payments Set Aside	64
	10.7	Nonliability
of Lenders	64
	10.8	Assignments	64
	 	10.8.1	Assignments	64
	10.9	Participations	66
	10.10	Confidentiality	66
	10.11	Captions	67
	10.12	Nature
of Remedies	67
	10.13	Counterparts	67
	10.14	Severability	68
	10.15	Entire
Agreement	68
	10.16	Successors;
Assigns	68
	10.17	Governing
Law	68
	10.18	Forum
Selection; Consent to Jurisdiction	68
	10.19	Waiver
of Jury Trial	69
	10.20	Patriot
Act	69
	10.21	Amendment
and Restatement	69

 

    [Solsys Medical] A&R Credit Agreement
 
- iv -

     

    

 

Annexes

 

	Annex
    I	Commitments
    and Pro Rata Term Loan Shares
	Annex
    II	Addresses

 

Exhibits

 

	Exhibit
    A	Form
    of Assignment Agreement
	Exhibit
    B	Form
    of Compliance Certificate
	Exhibit
    C	Form
    of Note

 

 

 

    [Solsys Medical] A&R Credit Agreement
 
- v -

     

    

 

AMENDED
AND RESTATED CREDIT AGREEMENT

 

This
AMENDED AND RESTATED CREDIT AGREEMENT (as may be amended, restated, supplemented, or otherwise modified from time to time, this
“Agreement”) dated as of September 27, 2019 (the “Closing Date”), among SOLSYS MEDICAL,
LLC, a Delaware limited liability company (formerly known as Soluble Systems, LLC) (“Current Borrower”), New
Misonix, Inc., a Delaware Corporation (“Parent”, and together with Current Borrower, each individually and
collectively referred to herein as “Borrower” or “Borrowers” as the context so implies),
the financial institutions party hereto from time to time as lenders (each a “Lender” and collectively, the
“Lenders”) and SWK FUNDING LLC (in its individual capacity, “SWK”), as Agent for all Lenders.

 

WHEREAS,
Current Borrower, Agent and Lenders entered into that certain Credit Agreement, dated as of June 1, 2015 (as amended prior to
the date hereof, the “Original Credit Agreement”);

 

WHEREAS,
Current Borrower entered into that certain Agreement and Plan of Merger, dated as of May 2, 2019 (as the same may be amended,
modified or restated from time to time, the “Merger Agreement”), among Current Borrower, Parent, Misonix OpCo,
Inc. (formally Misonix, Inc.), and the other parties thereto; and

 

WHEREAS,
in connection with the consummation of the transactions contemplated in the Merger Agreement, Parent wishes to join the Loan Documents
as a Borrower; and

 

WHEREAS,
in consideration of the mutual agreements herein contained and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto desire to amend and restated the Original Credit Agreement as follows:

 

Section 1Definitions; Interpretation.

 

1.1
Definitions.

 

When
used herein the following terms shall have the following meanings:

 

Account
Control Agreement means, individually and collectively, any account control or similar agreement(s) entered into from time
to time at Agent’s request, among a Loan Party, Agent and any third party bank or financial institution at which such Loan
Party maintains a Deposit Account.

 

Acquisition
means any transaction or series of related transactions for the purpose of or resulting, directly or indirectly, in (a) the
acquisition of all or substantially all of the assets of a Person, or of all or substantially all of any business or division
of a Person, (b) the acquisition of in excess of fifty percent (50%) of the capital stock, partnership interests, membership interests
or equity of any Person, or otherwise causing any Person to become a Subsidiary, (c) the acquisition of a product license or a
product line (excluding, for purposes of Section 7.10 hereof, any pending Acquisitions as of the Closing Date as set forth
on Schedule 1.1 hereto), or (d) a merger or consolidation or any other combination (other than a merger, consolidation
or combination that effects a Disposition) with another Person (other than a Person that is already a Subsidiary).

 

Affiliate
of any Person means (a) any other Person which, directly or indirectly, controls or is controlled by or is under common control
with such Person, (b) any employee, manager, officer or director of such Person and (c) with respect to any Lender, any entity
administered or managed by such Lender or an Affiliate or investment advisor thereof which is engaged in making, purchasing, holding
or otherwise investing in commercial loans. For purposes of the definition of the term “Affiliate”, a Person shall
be deemed to be “controlled by” any other Person if such Person possesses, directly or indirectly, power to vote ten
percent (10%) or more of the securities (on a fully diluted basis) having ordinary voting power for the election of directors
or managers or power to direct or cause the direction of the management and policies of such Person whether by contract or otherwise.
Unless expressly stated otherwise herein, neither Agent nor any Lender shall be deemed an Affiliate of Borrower or of any Subsidiary.

 

    [Solsys Medical] A&R Credit Agreement
 
- 1 -

     

    

 

Agent means
SWK in its capacity as administrative agent for all Lenders hereunder and any successor thereto in such capacity.

 

Aggregate Revenue shall have the meaning
set forth in Section 2.9.1(a). 

 

Agreement has the meaning set forth in
the Preamble.

 

“Approved
AR Loan Facility means that certain revolving loan facility made by Silicon Valley Bank to certain Loan Parties pursuant to
that certain Loan and Security Agreement, dated as of January 22, 2019, as the same may be modified, amended or restated from time
to time in accordance with the Intercreditor Agreement; or any similar replacement revolving loan facility as approved by Agent
in its commercially reasonable discretion.

 

Approved Fund
means (a) any fund, trust or similar entity that invests in commercial loans in the ordinary course of business and is advised
or managed by (i) a Lender, (ii) an Affiliate of a Lender, (iii) the same investment advisor that manages a Lender or (iv) an Affiliate
of an investment advisor that manages a Lender or (b) any finance company, insurance company or other financial institution which
temporarily warehouses loans for any Lender or any Person described in clause (a) above.

 

Assignment Agreement means an agreement
substantially in the form of Exhibit A.

 

Authorization shall have the meaning set
forth in Section 5.22(b).

 

Borrower shall have the meaning set forth in
the Preamble.

 

Business Day
means any day on which commercial banks are open for commercial banking business in Dallas, Texas, and, in the case of a Business
Day which relates to the calculation of LIBOR, on which dealings are carried on in the London interbank Eurodollar market.

 

Capital Lease
means, with respect to any Person, any lease of (or other agreement conveying the right to use) any real or personal property by
such Person that, in conformity with GAAP, is accounted for as a capital lease on the balance sheet of such Person.

 

Cash Equivalent
Investment means, at any time, (a) any evidence of Debt, maturing not more than one year after such time, issued or guaranteed
by the United States Government or any agency thereof, (b) commercial paper, or corporate demand notes, in each case (unless issued
by a Lender or its holding company) rated at least “A-l” by Standard & Poor’s Ratings Group or “P-l”
by Moody’s Investors Service, Inc., (c) any certificate of deposit (or time deposit represented by a certificate of deposit)
or banker’s acceptance maturing not more than one year after such time, or any overnight Federal Funds transaction that is
issued or sold by any Lender (or by a commercial banking institution that is a member of the Federal Reserve System or is a U.S.
branch of a foreign banking institution and has a combined capital and surplus and undivided profits of not less than $500,000,000),
(d) any repurchase    agreement entered
into with any Lender (or commercial banking institution of the nature referred to in clause (c) above) which (i) is secured
by a fully perfected security interest in any obligation of the type described in any of clauses (a) through (c)
above and (ii) has a market value at the time such repurchase agreement is entered into of not less than one-hundred percent (100%)
of the repurchase obligation of such Lender (or other commercial banking institution) thereunder, (e) money market accounts or
mutual funds which invest exclusively or substantially in assets satisfying the foregoing requirements, (f) cash, and (g) other
short term liquid investments approved in writing by Agent.

 

    [Solsys Medical] A&R Credit Agreement
 
- 2 -

     

    

 

Change
of Control means the occurrence of any of the following, unless such action has been consented to in advance in writing by
Agent in its sole discretion:

 

(i)
any Person acquires the direct or indirect ownership of more than fifty-one percent (51%) of the issued and outstanding voting
Equity Interests of Borrower;

 

(ii) fifty
percent (50%) or more of the members of the Board of Directors (or other applicable governing body) of Borrower on any date shall
not have been (x) members of the Board of Directors (or other applicable governing body) of Borrower on the date twelve
(12) months prior to such date or (y) approved (by recommendation, nomination, election or otherwise) by Persons who constitute
at least a majority of the members of the Board of Directors (or other applicable governing body) of Borrower as constituted on
the date twelve (12) months prior to such date; or

 

(iii) any
“change in/of control” or “sale” or “disposition” or “merger” or similar event
as defined in any certificate of incorporation or formation or statement of designations or bylaws or operating agreement, as applicable,
of Borrower or in any document governing indebtedness of any Loan Party (other than any Loan Documents) in excess of $250,000,
individually or in the aggregate which gives the holder of such indebtedness the right to accelerate or otherwise require payment
of such indebtedness prior to the maturity date thereof.

 

CLIA
means (a) the Clinical Laboratory Improvement Act of 1967, as the same may be amended, modified or supplemented from time
to time, including without limitation the Clinical Laboratory Improvement Amendments, 42 U.S.C. § 263a et seq. (“CLIA
88”), and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder,
or (b) any equivalent state statute (and any and all rules or regulations promulgated from time to time thereunder) recognized
by the relevant Governmental Authority as (x) having an “Equivalency” (as defined by CLIA) to CLIA, and (y) offering
a compliance and regulatory framework that is applicable to a Person in such state in lieu of CLIA.

 

Closing
Date shall have the meaning set forth in the Preamble.

 

CMS
means the Center for Medicare and Medicaid Services of the United States of America.

 

Collateral has the meaning set
forth in the Guarantee and Collateral Agreement.

 

Collateral
Access Agreement means an agreement in form and substance reasonably satisfactory to Agent pursuant to which a mortgagee
or lessor of real property on which Collateral (or any books and records) is stored or otherwise located, or a warehouseman,
processor or other bailee of Inventory or other property owned by any Loan Party, acknowledges the Liens of Agent and waives
(or, if approved by Agent, subordinates) any Liens held by such Person on such property, and, in the case of any such
agreement with a mortgagee or lessor, permits Agent reasonable access to any Collateral stored or otherwise located
thereon.

 

    [Solsys Medical] A&R Credit Agreement
 
- 3 -

     

    

 

Collateral
Documents means, collectively, the Guarantee and Collateral Agreement, each IP Security Agreement, each Collateral Access
Agreement, any Mortgage delivered in connection with the Loan from time to time, each Account Control Agreement and each other
agreement or instrument pursuant to or in connection with which any Loan Party or any other Person grants a Lien in any Collateral
to Agent for the benefit of Lenders, each as amended, restated or otherwise modified from time to time.

 

Commitment
means, as to any Lender, such Lender’s Pro Rata Term Loan Share.

 

Compliance
Certificate means a certificate substantially in the form of Exhibit B.

 

Consolidated
Net Income means, with respect to any Person and its Subsidiaries, for any period, the consolidated net income (or loss) of
such Person and its respective Subsidiaries for such period, as determined under GAAP.

 

Consolidated
Unencumbered Liquid Assets means any Cash Equivalent Investment owned by Parent and its Subsidiaries on a consolidated basis
which are not the subject of any Lien or other arrangement with any creditor to have its claim satisfied out of the asset (or
proceeds thereof) prior to the general creditors of Parent and such Subsidiaries other than the Lien for the benefit of Agent
and Lenders.

 

Contingent
Obligation means any agreement, undertaking or arrangement by which any Person guarantees, endorses or otherwise becomes or
is contingently liable upon (by direct or indirect agreement, contingent or otherwise, to provide funds for payment, to supply
funds to or otherwise to invest in a debtor, or otherwise to assure a creditor against loss) any indebtedness, obligation or other
liability of any other Person (other than by endorsements of instruments in the course of collection), or guarantees the payment
of dividends or other distributions upon the shares of any other Person. The amount of any Person’s obligation in respect
of any Contingent Obligation shall be deemed to be the amount for which the Person obligated thereon is reasonably expected to
be liable or responsible.

 

Contract
Rate means a rate per annum equal to (x) the LIBOR Rate, plus (y)(1) as of any date of determination
where the EBITDA of Parent and its Subsidiaries was positive for the prior Fiscal Quarter, seven percent (7.00%) or (2) at all
other times, the applicable margin as identified in the table below:

 

	Condition	 	(y) Applicable Margin
	As of any date of determination where the Market Capitalization of Parent is less than $150,000,000.	 	ten and one quarter of one percent (10.25%)
	 	 	 
	As of any date of determination where the Market Capitalization of Parent is equal to or greater than $150,000,000, but less than $250,000,000	 	Nine percent (9.00%)
	 	 	 
	As of any date of determination where the Market Capitalization of Parent is equal to or greater than $250,000,000	 	Eight percent (8.00%)

 

    [Solsys Medical] A&R Credit Agreement
 
- 4 -

     

    

 

Controlled
Group means all members of a controlled group of corporations and all members of a controlled group of trades or businesses
(whether or not incorporated) under common control which, together with a Loan Party, are treated as a single employer under Section
414 of the IRC or Section 4001 of ERISA.

 

Controlled
Substances Act means the Drug Abuse Prevention and Control Act; Title 21 of the United States Code, 13 U.S.C, as amended from
time to time.

 

Copyrights shall mean
all of each Loan Party’s (or if referring to another Person, such other Person’s) now existing or hereafter acquired
right, title, and interest in and to: (i) copyrights, rights and interests in copyrights, works protectable by copyright, all
applications, registrations and recordings relating to the foregoing as may at any time be filed in the United States Copyright
Office or in any similar office or agency of the United States, any State thereof or any political subdivision thereof, or in
any other country, and all research and development relating to the foregoing; and (ii) all renewals of any of the foregoing.

 

Current Borrower has the meaning set forth
in the Preamble.

 

DEA means the Federal Drug Enforcement Administration
of the United States of America.

 

Debt of
any Person means, without duplication, (a) all indebtedness of such Person for borrowed money, (b) all indebtedness
evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person as lessee under Capital
Leases which have been or should be recorded as liabilities on a balance sheet of such Person in accordance with GAAP, (d)
all obligations of such Person to pay the deferred purchase price of property or services (excluding trade accounts payable
in the ordinary course of business), other than (i) payment obligations, earn-outs and similar obligations of such Person
arising in connection with an Acquisition or (ii) royalty payments or milestone payments made or to be made by such Person
from time to time in connection with an Acquisition, (e) all indebtedness secured by a Lien on the property of such Person,
whether or not such indebtedness shall have been assumed by such Person (with the amount thereof being measured as the lesser
of (x) the aggregate unpaid amount of such indebtedness and (y) the fair market value of such property), (f)
all reimbursement obligations, contingent or otherwise, with respect to letters of credit (whether or not drawn),
banker’s acceptances and surety bonds issued for the account of such Person, other than obligations that relate to
trade accounts payable in the ordinary course of business, (g) all Hedging Obligations of such Person, (h) all Contingent
Obligations of such Person in respect of Debt of others, (i) all indebtedness of any partnership of which such Person is a
general partner except to the extent such Person is not liable for such Debt, and (j) all obligations of such Person under
any synthetic lease transaction, where such obligations are considered borrowed money indebtedness for tax purposes but the
transaction is classified as an operating lease in accordance with GAAP.

 

    [Solsys Medical] A&R Credit Agreement
 
- 5 -

     

    

 

Debtor
Relief Law means, collectively: (a) Title 11 of the United States Code, 11 U.S.C. § 101 et. seq., as amended from time
to time, and (b) all other United States or foreign applicable liquidation, conservatorship, bankruptcy, moratorium, rearrangement,
receivership, insolvency, reorganization or similar debtor relief laws from time to time in effect affecting the rights of creditors
generally, in each case as amended from time to time.

 

Default
means any event that, if it continues uncured, will, with the lapse of time or the giving of notice or both, constitute an Event
of Default.

 

Default
Rate means a rate per annum equal to the lesser of (i) three percent (3%) over the Contract Rate, or (ii) the maximum rate
of interest permitted to be charged by applicable laws or regulation governing this Agreement until paid.

 

Deposit
Account means, individually and collectively, any bank or other depository accounts of a Loan Party.

 

Disposition
means, as to any asset or right of any Loan Party, (a) any sale, lease, assignment or other transfer (other than to any other Loan
Party), but specifically excluding any license or sublicense, (b) any loss, destruction or damage thereof or (c) any condemnation,
confiscation, requisition, seizure or taking thereof, in each case excluding (i) any Disposition (except as set forth in clauses
(ii) and (iii)  below) where the Net Cash Proceeds of any sale, lease, assignment, transfer, condemnation, confiscation,
requisition, seizure or taking do not in the aggregate exceed $250,000 in any Fiscal Year, (ii) the sale of Inventory or Product
in the ordinary course of business and (iii) any issuance of Equity Interests by Borrower.

 

Dollar
and $ mean lawful money of the United States of America.

 

Drug
Application means a new drug application, an abbreviated drug application, or a product license application for any Product,
as appropriate, as those terms are defined in the FDA Law and Regulation.

 

EBITDA
means, for any Person and its Subsidiaries for any period, Consolidated Net Income for such period plus, to the extent deducted
in determining such Consolidated Net Income for such period (and without duplication), (i) Interest Expense, (ii) income tax expense
(including tax accruals), (iii) depreciation and amortization, (iv) nonrecurring cash fees, costs and expenses incurred in connection
with the Acquisitions of product licenses and product lines from a third party, and milestone payments to any third party, in relation
to any material contract or any other Acquisition made prior to the date of this Agreement, (v) non-cash expenses relating to equity-based
compensation or purchase accounting, and (vi) other non-recurring and/or non-cash expenses or charges approved by the Agent.

 

Environmental
Claims means all claims, however asserted, by any Governmental Authority or other Person alleging potential liability or responsibility
for violation of any Environmental Law, or for release or injury to the environment or any Person or property.

 

    [Solsys Medical] A&R Credit Agreement
 
- 6 -

     

    

 

 Environmental Laws means all present or future foreign, federal, state or local laws, statutes, common
law duties, rules, regulations, ordinances and codes, together with all administrative orders, directed duties, requests, licenses,
authorizations and permits of, and agreements with, any Governmental Authority, in each case relating to any matter arising out
of or relating to the effect of the environment on health and safety, or pollution or protection of the environment or workplace,
including any of the foregoing relating to the presence, use, production, generation, handling, transport, treatment, storage,
disposal, distribution, discharge, release, control or cleanup of any Hazardous Substance.

 

Equity
Interests means, with respect to any Person, its equity ownership interests, its common stock and any other capital stock or
other equity ownership units of such Person authorized from time to time, and any other shares, options, interests, participations
or other equivalents (however designated) of or in such Person, whether voting or nonvoting, including, without limitation, common
stock, options, warrants, preferred stock, phantom stock, membership units (common or preferred), stock appreciation rights, membership
unit appreciation rights, convertible notes or debentures, stock purchase rights, membership unit purchase rights and all securities
convertible, exercisable or exchangeable, in whole or in part, into any one or more of the foregoing.

 

Event of Default means any of the events
described in Section 8.1. 

 

Excluded Taxes has the meaning set forth
in Section 3.1(a).

 

Exempt
Accounts means any Deposit Accounts, securities accounts or other similar accounts (i) into which there are deposited no funds
other than those intended solely to cover compensation to employees of the Loan Parties (and related contributions to be made on
behalf of such employees to health and benefit plans) plus balances for outstanding checks for compensation and such contributions
from prior periods; or (ii) constituting employee withholding accounts and contain only funds deducted from pay otherwise due to
employees for services rendered to be applied toward the tax obligations of such Person or its employees.

 

Exit Fee shall have the meaning set forth
in Section 2.7(b).

 

Fair
Valuation shall mean the determination of the value of the consolidated assets of a Person on the basis of the amount which
may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going
concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm’s length transaction.

 

FATCA
means Sections 1471 through 1474 of the IRC and any current or future regulations thereunder or official interpretations thereof.

 

FD&C
Act means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301 et seq., as amended.

 

FDA means the Food and Drug Administration
of the United States of America.

 

FDA Law
and Regulation means the provisions of the FD&C Act and all applicable regulations promulgated by the FDA.

 

FDA Products
means any finished products sold by Borrower or any of the other Loan Parties for itself or for a third party that are subject
to applicable Health Care Laws.

 

    [Solsys Medical] A&R Credit Agreement
 
- 7 -

     

    

 

Fiscal Quarter means a calendar quarter of a Fiscal Year.

 

Fiscal Year
means the fiscal year of Borrower and its Subsidiaries, which period shall be the 12-month period ending on December 31 of each
year.

 

Foreign Lender
means any Lender that is not a “United States person” within the meaning of Section 7701(a)(30) of the IRC.

 

FRB means the Board of Governors of the Federal
Reserve System or any successor thereto.

 

GAAP means generally
accepted accounting principles in effect in the United States of America set forth from time to time in the opinions and pronouncements
of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements
of the Financial Accounting Standards Board (or agencies with similar functions of comparable stature and authority within the
U.S. accounting profession), which are applicable to the circumstances as of the date of determination.

 

Governmental Authority
means any nation or government, any state or other political subdivision thereof, and any agency, branch of government, department
or Person exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government and
any corporation or other Person owned or controlled (through stock or capital ownership or otherwise) by any of the foregoing,
whether domestic or foreign. Governmental Authority shall include any agency, branch or other governmental body charged with the
responsibility and/or vested with the authority to administer and/or enforce any Health Care Laws.

 

Guarantee and Collateral
Agreement means the A&R Guarantee and Collateral Agreement dated as of the Closing Date by each Loan Party signatory thereto
from time to time in favor of Agent and Lenders.

 

Hazardous Substances
means hazardous waste, pollutant, contaminant, toxic substance, oil, hazardous material, chemical or other substance regulated
by any Environmental Law.

 

Health Care Laws
mean all foreign, federal and state fraud and abuse laws relating to the regulation of healthcare products, pharmaceutical
products, laboratory facilities and services, healthcare providers, healthcare professionals, healthcare facilities, clinical
research facilities or healthcare payors, including but not limited to (i) the federal Anti-Kickback Statute (42 U.S.C.
(§1320a-7b(b)), the Stark Law (42 U.S.C. §1395nn and §1395(q)), the civil False Claims Act (31 U.S.C.
§3729 et seq.), TRICARE (10 U.S.C. Section 1071 et seq.), Section 1320a-7 and 1320a-7a of Title 42 of the United States
Code and the regulations promulgated pursuant to such statues; (ii) the Health Insurance Portability and Accountability Act
of 1996 (Pub. L. No. 104-191), as amended by the Health Information, Technology for Economic and Clinical Health Act of 2009
(collectively, “HIPPA”), and the regulations promulgated thereunder, (iii) Medicare (Title XVIII of the Social
Security Act) and the regulations promulgated thereunder; (iv) Medicaid (Title XIX of the Social Security Act) and the
regulations promulgated thereunder; (v) the FD&C Act and all applicable requirements, regulations and guidances issued
thereunder by the FDA (including FDA Law and Regulation); (vi) the Controlled Substances Act, as amended, and all applicable
requirements, regulations and guidances issued thereunder by the DEA; (vii) CLIA, as amended, and all applicable
requirements, regulations, and guidance issued thereunder by the applicable Governmental Authority; (viii) quality, safety
and accreditation standards and requirements of all applicable foreign and domestic federal, provincial or state laws or
regulatory bodies; (ix) all applicable licensure laws and regulations; (x) all applicable professional standards
regulating healthcare providers, healthcare professionals, healthcare facilities, clinical research facilities or healthcare
payors; and (xi) any and all other applicable health care laws (whether foreign or domestic), regulations, manual provisions,
policies and administrative guidance, including those related to the corporate practice of medicine, fee-splitting, state
anti-kickback or self-referral prohibitions, each of clauses (i) through (xi) as may be amended from time to
time.

 

    [Solsys Medical] A&R Credit Agreement
 
- 8 -

     

    

 

Hedging
Obligation means, with respect to any Person, any liability of such Person under any interest rate, currency or commodity swap
agreement, cap agreement or collar agreement, and any other agreement or arrangement designed to protect a Person against fluctuations
in interest rates, currency exchange rates or commodity prices. The amount of any Person’s obligation in respect of any Hedging
Obligation shall be deemed to be the incremental obligation that would be reflected in the financial statements of such Person
in accordance with GAAP.

 

Intellectual
Property shall mean all present and future: trade secrets, know-how and other proprietary information; Trademarks and Trademark
Licenses (as defined in the Guarantee and Collateral Agreement), internet domain names, service marks, trade dress, trade names,
business names, designs, logos, slogans (and all translations, adaptations, derivations and combinations of the foregoing) indicia
and other source and/or business identifiers, and the goodwill of the business relating thereto and all registrations or applications
for registrations which have heretofore been or may hereafter be issued thereon throughout the world; Copyrights (including Copyrights
for computer programs, but excluding commercially available off-the-shelf software and any Intellectual Property rights relating
thereto) and Copyright Licenses (as defined in the Guarantee and Collateral Agreement) and all tangible and intangible property
embodying the Copyrights, unpatented inventions (whether or not patentable); Patents and Patent Licenses (as defined in the Guarantee
and Collateral Agreement); industrial design applications and registered industrial designs; license agreements related to any
of the foregoing and income therefrom, books, records, writings, computer tapes or disks, flow diagrams, specification sheets,
computer software, source codes, object codes, executable code, data, databases and other physical manifestations, embodiments
or incorporations of any of the foregoing; customer lists and customer information, the right to sue for all past, present and
future infringements of any of the foregoing; all other intellectual property; and all common law and other rights throughout the
world in and to all of the foregoing.

 

Indemnified Taxes has the meaning set
forth in Section 3.1(a).

 

Intercreditor
Agreement means that certain Intercreditor Agreement between Agent and Silicon Valley Bank, dated as of January 22, 2019, or
any similar intercreditor agreement entered into between Agent and any subsequent lender under an Approved AR Loan Facility, as
each may be modified, amended or restated from time to time.

 

Interest
Expense means for any Person and its Subsidiaries for any period the consolidated interest expense of such Person and its Subsidiaries
for such period (including all imputed interest on Capital Leases).

 

Internal
Rate of Return means, with respect to the Term Loan, as of any date of determination, a return on the principal amount of the
Term Loan calculated using the XIRR function of Microsoft Excel, excluding from such return, for the avoidance of doubt, any payments
in respect of any interest due and owing at the Default Rate and any costs, indemnifications and reimbursements under the Loan
Documents; provided, however, that if Microsoft Excel is no longer available or if the Microsoft Excel spreadsheet formulas
have changed, then the Internal Rate of Return will be calculated to arrive at an equivalent result.

 

    [Solsys Medical] A&R Credit Agreement
 
- 9 -

     

    

 

Inventory has the meaning set forth in the Guarantee and Collateral Agreement.

 

Investment
means, with respect to any Person, (a) the purchase of any debt or equity security of any other Person, (b) the making of any loan
or advance to any other Person, (c) becoming obligated with respect to a Contingent Obligation in respect of obligations of any
other Person (other than travel and similar advances to employees in the ordinary course of business) or (d) the making of an Acquisition.

 

IP Security
Agreement means, individually and collectively, (i) the Intellectual Property Security Agreement dated on or about the Original
Closing Date by Current Borrower in favor of Agent and Lenders and (ii) any additional Intellectual Property Security Agreements
to be delivered by any Loan Party in favor of Agent and Lenders as required by Agent from time to time.

 

IRC means the Internal Revenue Code of
1986, as amended.

 

IRS means the United States Internal Revenue
Service.

 

Legal
Costs means, with respect to any Person, all reasonable, duly documented, out-of-pocket fees and charges of any counsel, accountants,
auditors, appraisers, consultants and other professionals to such Person, and all court costs and similar legal expenses.

 

Lenders has the meaning set forth in the
Preamble.

 

LIBOR
Rate means a fluctuating rate per annum equal to the rate which appears on the Bloomberg Page BBAM1 (or on such other substitute
Bloomberg page that displays rates at which U.S. Dollar deposits are offered by leading banks in the London interbank deposit market),
as the offered rate for loans in Dollars for a three (3) month period, rounded upwards, if necessary, to the nearest 1/8 of 1%.
The rate is set by the ICE Benchmark Administration as of 11:00 a.m. (London time) as determined two (2) Business Days prior to
each Payment Date, and effective on the Payment Date immediately following such determination date. If Bloomberg Professional Service
(or another nationally-recognized rate reporting source acceptable to Agent) no longer reports the LIBOR Rate or Agent determines
in good faith that the rate so reported no longer accurately reflects the rate available to Agent in the London Interbank Market
or if such index no longer exists or if page USD-LIBOR-BBA (ICE) no longer exists or accurately reflects the rate available to
Agent in the London Interbank Market, Agent may select a replacement index that approximates as near as possible such prior index.
Notwithstanding the foregoing, in no event shall the “LIBOR Rate” ever be less than two percent (2.0%) or greater than
three percent (3.0%) per annum at any time.

 

Lien
means, with respect to any Person, any interest granted by such Person in any real or personal property, asset or other right owned
or being purchased or acquired by such Person which secures payment or performance of any obligation and shall include any mortgage,
lien, encumbrance, charge or other security interest of any kind, whether arising by contract, as a matter of law, by judicial
process or otherwise.

 

LifeNet means Skin Wound and Allograft
Institute, LLC, a Virginia limited liability company.

 

Loan
or Loans means, individually and collectively the Term Loans and any other advances made by Agent and Lenders in accordance
with the Loan Documents.

 

Loan
Documents means this Agreement, the Notes, the Collateral Documents, the Subordination Agreement, and all documents, instruments
and agreements delivered in connection with the foregoing.

 

    [Solsys Medical] A&R Credit Agreement
 
- 10 -

     

    

 

Loan Party means Parent and each of its Subsidiaries.

 

Manufacturing
Agreement means that certain Second Amended and Restated Distribution and Supply Agreement dated as of October 13, 2017, between
LifeNet and Current Borrower, as the same may be modified, amended or restated from time to time.

 

Margin Stock means any “margin stock”
as defined in Regulation T, U or X of the FRB.

 

Market
Capitalization means, with respect to Parent, the volume weighted average closing price per share of ParentCo’s publicly
traded common stock as of the end of the five trading days immediately prior to such date of determination (as quoted by Bloomberg
L.P. or, if such quote is not available, such other customary inter-dealer quotation system reasonably acceptable to Agent) multiplied
by (b) the number of outstanding shares of ParentCo’s publicly traded common stock publicly disclosed in its most recent
SEC filing as outstanding as of such date of determination.

 

Material
Adverse Effect means (a) a material adverse change in, or a material and adverse effect upon, the financial condition, operations,
assets, business or properties of the Loan Parties taken as a whole, (b) a material impairment of the ability of any Loan Party
to perform any of its payment Obligations under any Loan Document or (c) a material and adverse effect upon any material portion
of the Collateral under the Collateral Documents or upon the legality, validity, binding effect or enforceability against any Loan
Party of any material Loan Document. For the avoidance of doubt, the investigation, inspection, examination, audit or view of the
operations of any Loan Party in the ordinary course of business by any Governmental Authority shall not, in itself, be deemed to
be a Material Adverse Effect or be deemed to be an event that could or would reasonably be expected to result in or have a Material
Adverse Effect.

 

Material
Contract means the agreements and contracts disclosed by Parent pursuant to Item 601(a)(10) of Regulation S-K under the Securities
Act of 1933, as amended.

 

Merger Agreement shall have the meaning
set forth in the Recitals hereto.

 

Mortgage
means a mortgage, deed of trust, leasehold mortgage or similar instrument granting Agent a Lien on a real property interest of
any Loan Party, each as amended, restated or otherwise modified from time to time.

 

Multiemployer
Pension Plan means a multiemployer plan, as defined in Section 4001(a)(3) of ERISA, to which any Borrower or any member of
the Controlled Group may have any liability.

 

Net
Cash Proceeds means, with respect to any Disposition, the aggregate cash proceeds (including cash proceeds received
pursuant to policies of insurance and by way of deferred payment of principal pursuant to a note, installment receivable or
otherwise, but only as and when received) received by any Loan Party pursuant to such Disposition net of (i) the reasonable
direct costs relating to such Disposition (including sales commissions and legal, accounting and investment banking fees,
commissions and expenses), (ii) any portion of such proceeds deposited in an escrow account pursuant to the documentation
relating to such Disposition (provided that such amounts shall be treated as Net Cash Proceeds upon their release from
such escrow account to and receipt by the applicable Loan Party), (iii) taxes and other governmental costs and expenses paid
or reasonably estimated by a Loan Party to be payable as a result thereof (after taking into account any available tax
credits or deductions and any tax sharing arrangements), (iv) amounts required to be applied to the repayment of any Debt
(together with any interest thereon, premium or penalty and any other amount payable with respect thereto) secured by a Lien
that has priority over the Lien, if any, of Agent on the asset subject to such Disposition, (v) reserves for purchase price
adjustments and retained liabilities reasonably expected to be payable by the Loan Parties in connection therewith
established in accordance with GAAP (provided that upon the final determination of the amount paid in respect of such
purchase price adjustments and retained liabilities, the actual amount of purchase price adjustments and retained liabilities
paid is less than such reserves, the difference shall, at such time, constitute Net Cash Proceeds) and (vi)(A) with respect
to any Disposition described in clauses (a), (b) or (c) of the definition thereof, all money actually applied
within one-hundred eighty (180) days to replace such assets to be used in the business of Borrower and the Subsidiaries, and
(B) with respect to any Disposition, all money actually applied within one-hundred eighty (180) days to replace the assets in
question or to repair or reconstruct damaged property or property affected by loss, destruction, damage, condemnation,
confiscation, requisition, seizure or taking.

 

    [Solsys Medical] A&R Credit Agreement
 
- 11 -

     

    

 

Net Sales means
the gross amount billed or invoiced by Parent and its Subsidiaries for Services and for the sale of Products and (including products
and services ancillary thereto) to independent customers, less deductions for (a) quantity, trade, cash or other discounts, allowances,
credits or rebates (including customer rebates) actually allowed or taken, (b) amounts deducted, repaid or credited by reason of
rejections or returns of goods and government mandated rebates, or because of chargebacks or retroactive price reductions, (c)
charges for freight, handling, postage, transportation, insurance and other shipping charges and (d) taxes, tariffs, duties or
other governmental charges or assessments (including any sales, value added or similar taxes other than an income tax) levied,
absorbed or otherwise imposed on or with respect to the production, sale, transportation, delivery or use of pharmaceutical products.
A Product or Service shall be considered sold and/or provided when billed out or invoiced. To the extent applicable, components
of Net Sales shall be determined in the ordinary course of business in accordance with historical practice and using the accrual
method of accounting in accordance with GAAP. For the purposes of calculating Net Sales, Lenders and Agent understand and agree
that (i) Affiliates of a Borrower shall not be regarded as independent customers and (ii) Net Sales shall not include Products
distributed for product development purposes, including for use in pre-clinical trials.

 

Note means a promissory note substantially
in the form of Exhibit C.

 

Obligations
means all liabilities, indebtedness and obligations (monetary (including post-petition interest, allowed or not) or otherwise)
of any Loan Party under this Agreement, any other Loan Document or any other document or instrument executed in connection herewith
or therewith which are owed to any Lender or Affiliate of a Lender, in each case howsoever created, arising or evidenced, whether
direct or indirect, absolute or contingent, now or hereafter existing, or due or to become due.

 

OFAC mean the U.S.
Department of Treasury’s Office of Foreign Asset Control.

 

Original Closing Date
means June 1, 2015.

 

Original Credit Agreement
shall have the meaning set forth in the Recitals hereto.

 

Paid in Full, Pay
in Full or Payment in Full means, with respect to any Obligations, the payment in full in cash of all such Obligations
(other than contingent indemnification obligations, yield protection and expense reimbursement to the extent no claim giving rise
thereto has been asserted in respect of contingent indemnification obligations, and to the extent no amounts therefor have been
asserted, in the case of yield protection and expense reimbursement obligations).

 

Parent has the meaning set forth in the Preamble.

 

    [Solsys Medical] A&R Credit Agreement
 
- 12 -

     

    

 

Patents mean all of each Loan Party’s (or if referring to another Person, such other Person’s)
now existing or hereafter acquired right, title and interest in and to: (i) all patents, patent applications, inventions, invention
disclosures and improvements, and all applications, registrations and recordings relating to the foregoing as may at any time be
filed in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state thereof
or any political subdivision thereof, or in any other country, and all research and development relating to the foregoing; and
(ii) the reissues, divisions, continuations, renewals, re-examinations, extensions and continuations-in-part of any of the foregoing.

 

Payment
Date means the forty-fifth (45th) day following the last calendar day of each Fiscal Quarter (or the next succeeding
Business Day to the extent such 45th day is not a Business Day), commencing with August 14, 2015.

 

PBGC
means the Pension Benefit Guaranty Corporation and any entity succeeding to any or all of its material functions under ERISA.

 

Pension
Plan means a “pension plan”, as such term is defined in Section 3(2) of ERISA, which is subject to Title IV of
ERISA (other than a Multiemployer Pension Plan), and to which Borrower or any member of the Controlled Group may have any liability,
including any liability by reason of having been a substantial employer within the meaning of Section 4063 of ERISA at any time
during the preceding five years, or by reason of being deemed to be a contributing sponsor under Section 4069 of ERISA.

 

Permit
means collectively all licenses, leases, powers, permits, franchises, certificates, authorizations and approvals.

 

Permitted Licenses has the meaning assigned
in Section 7.4(c) hereof.

 

Permitted Liens means Liens permitted
by Section 7.2.

 

Person
means any natural person, corporation, partnership, trust, limited liability company, association, Governmental Authority or unit,
or any other entity, whether acting in an individual, fiduciary or other capacity.

 

Pro Rata
Term Loan Share means, with respect to any Lender, the applicable percentage (as adjusted from time to time in accordance with
the terms hereof) specified opposite such Lender’s name on Annex I which percentage represents the aggregate percentage
of the Term Loan Commitment held by such Lender, which percentage shall be with respect to the outstanding balance of the Term
Loan as of any date of determination after the Term Loan Commitment has terminated.

 

Product
means any products manufactured, sold, developed, tested or marketed by Parent or any of its Subsidiaries, including without limitation,
those products set forth on Schedule 5.18(b) (as updated from time to time in accordance with Section 6.1.2); provided,
however, that if Borrower shall fail to comply with the obligations under Section 6.1.2 to give notice to Agent and
update Schedule 5.18(b) prior to manufacturing, selling, developing, testing or marketing any new Product, any such improperly
undisclosed Product shall be deemed to be included in this definition; and provided, further, that products manufactured
by Borrower for unaffiliated third parties shall not be deemed “Products” hereunder.

 

Registered
Intellectual Property means all applications, registrations and recordings for or of Patents, Trademarks or Copyrights filed
by a Loan Party with any Governmental Authority, all internet domain name registrations owned by a Loan Party, and all proprietary
software owned by a Loan Party.

  

    [Solsys Medical] A&R Credit Agreement
 
- 13 -

     

    

 

Required Lenders means Lenders having an aggregate Pro Rata Term Loan Share in excess of fifty percent
(50%), collectively; provided that if there are only two Lenders, then Required Lenders means both such Lenders (Lenders
that are Affiliates of one another being considered as one Lender for purposes of this proviso).

 

Required
Permit means a Permit (a) issued or required under applicable law to the business of LifeNet, Parent or any of their respective
Subsidiaries or necessary in the manufacturing, importing, exporting, possession, ownership, warehousing, marketing, promoting,
sale, labeling, furnishing, distribution or delivery of goods or services under any laws applicable to the business of LifeNet,
Borrower or any of their respective Subsidiaries (including, without limitation, any Health Care Laws) or any Drug Application
(including without limitation, at any point in time, all licenses, approvals and permits issued by the FDA, CMS, or any other applicable
Governmental Authority necessary for the testing, manufacture, marketing or sale of any Product by any of LifeNet, Parent or their
respective Subsidiary as such activities are being conducted by LifeNet, Borrower or such Subsidiary with respect to such Product
at such time), and (b) issued by any Person from which LifeNet, Parent or any of their respective Subsidiaries have received an
accreditation.

 

Responsible
Officer shall mean the president, vice president, manager or secretary of a Person, or any other officer having substantially
the same authority and responsibility; or, with respect to compliance with financial covenants or delivery of financial information,
the chief financial officer, the treasurer, manager or the controller of a Person, or any other officer having substantially the
same authority and responsibility, and in all cases such person shall be listed on an incumbency certificate delivered to Agent,
in form and substance acceptable to Agent in its sole discretion.

 

Revenue-Based Payment has the meaning
set forth in Section 2.9.1(a).

 

Royalties
means the amount of any and all royalties, license fees and any other payments or income of any type recognized as revenue in accordance
with GAAP by Parent and its Subsidiaries with respect to the sale of Products or the provision of services by independent licensees
of Parent and/or its Subsidiaries, including any such payments characterized as a share of net profits, any up-front or lump sum
payments, any milestone payments, commissions, fees or any other similar amounts, less deductions for amounts deducted, repaid
or credited by reason of adjustments to the sales upon which royalty amounts are based, regardless of the reason for such adjustment
to such sales. For the purposes of calculating Royalties, Lenders and Agent understand and agree that Affiliates of Borrowers shall
not be regarded as independent licensees.

 

Services
means services provided by Borrowers or any Affiliate of Borrowers to un-Affiliated Persons, including without limitation any sales,
laboratory analysis, testing, consulting, marketing, commercialization and any other healthcare-related services.

 

Solvent
means, as to any Person at any time, that (a) the fair value of the property of such Person is greater than the amount of such
Person’s liabilities (including disputed, contingent, unmatured and unliquidated liabilities); (b) the present fair saleable
value of the property of such Person is not less than the amount that will be required to pay the probable liability of such Person
on its debts as they become absolute and matured; (c) such Person is able to pay its debts and other liabilities (including subordinated,
disputed, contingent, unmatured and unliquidated liabilities) as they mature in the normal course of business; (d) such Person
does not intend to, and does not believe that it will, incur debts or liabilities beyond such Person’s ability to pay as
such debts and liabilities mature; and (e) such Person is not engaged in business or a transaction, and is not about to engage
in business or a transaction, for which such Person’s property would constitute unreasonably small capital.

 

    [Solsys Medical] A&R Credit Agreement
 
- 14 -

     

    

 

Subsidiary means, with respect to any Person, a corporation, partnership, limited liability company or
other entity of which such Person owns, directly or indirectly, such number of outstanding shares or other equity interests as
to have more than fifty percent (50%) of the ordinary voting power for the election of directors or other managers of such corporation,
partnership, limited liability company or other entity. Unless the context otherwise requires, each reference to Subsidiaries herein
shall be a reference to direct and indirect Subsidiaries of Borrower.

 

SWK has the meaning set forth in the Preamble.

 

Taxes has the meaning set forth in Section
3.1(a).

 

Term Loan Commitment means the aggregate amount
set forth on Annex I for all Lenders.

 

Term Loan Maturity
Date means June 30, 2023, or such earlier date on which the Commitments terminate pursuant to Section 8.

 

Term Loan has the meaning set forth in Section
2.1.

 

Trademarks shall
mean all of each Loan Party’s (or if referring to another Person, such other Person’s) now existing or hereafter acquired
right, title, and interest in and to: (i) all of such Loan Party’s (or if referring to another Person, such other Person’s)
trademarks, trade names, corporate names, company names, business names, fictitious business names, trade styles, service marks,
logos, other business identifiers, all applications, registrations and recordings relating to the foregoing as may at any time
be filed in the United States Patent and Trademark Office or in any similar office or agency of the United States, or in any other
country, and all research and development and the goodwill of the business relating to the foregoing; (ii) all renewals thereof;
and (iii) all designs and general intangibles of a like nature.

 

Uniform Commercial
Code means the Uniform Commercial Code as in effect in the State of New York; provided that if perfection or the effect
of perfection or non-perfection or the priority of any security interest in any Collateral is governed by the Uniform Commercial
Code as in effect in a jurisdiction other than the State of New York, “Uniform Commercial Code” means the Uniform
Commercial Code as in effect from time to time in such other jurisdiction for purposes of the provisions hereof relating to such
perfection, effect of perfection or non-perfection or priority.

 

U.S. Lender
means any Lender that is a “United States person” within the meaning of Section 7701(a)(30) of the IRC.

 

Wholly-Owned Subsidiary
means, as to any Person, another Person all of the equity interests of which (except directors’ qualifying shares) are at
the time directly or indirectly owned by such Person and/or another Wholly-Owned Subsidiary of such Person.

 

    [Solsys Medical] A&R Credit Agreement
 
- 15 -

     

    

 

1.2 Interpretation.

 

(a)
In the case of this Agreement and each other Loan Document, (a) the meanings of defined terms are equally applicable to the singular
and plural forms of the defined terms; (b) Annex, Exhibit, Schedule and Section references are to such Loan Document unless otherwise
specified; (c) the term “including” is not limiting and means “including but not limited to”; (d) in the
computation of periods of time from a specified date to a later specified date, the word “from” means “from
and including”; the words “to” and “until” each mean “to but excluding”, and the word
“through” means “to and including”; (e) unless otherwise expressly provided in such Loan Document, (i)
references to agreements and other contractual instruments shall be deemed to include all subsequent amendments, restatements
and other modifications thereto, but only to the extent such amendments, restatements and other modifications are not prohibited
by the terms of any Loan Document, and (ii) references to any statute or regulation shall be construed as including all statutory
and regulatory provisions amending, replacing, supplementing or interpreting such statute or regulation; (f) this Agreement and
the other Loan Documents may use several different limitations, tests or measurements to regulate the same or similar matters,
all of which are cumulative and each shall be performed in accordance with its terms and (g) this Agreement and the other Loan
Documents are the result of negotiations among and have been reviewed by counsel to Agent, Borrower, Lenders and the other parties
hereto and thereto and are the products of all parties; accordingly, they shall not be construed against Borrower, Agent or Lenders
merely because of Borrower’s, Agent’s or Lenders’ involvement in their preparation. Except where otherwise expressly
provided in the Loan Documents, in any instance where the approval, consent or the exercise of Agent’s judgment is required,
the granting or denial of such approval or consent and the exercise of such judgment shall be (x) within the sole and absolute
discretion of Agent and/or Lenders; and (y) deemed to have been given only by a specific writing intended for such purpose
executed by Agent.

 

(b)
For purposes of converting any amount reported or otherwise denominated in any currency other than Dollars to Dollars under or
in connection with the Loan Documents, Agent shall calculate such currency conversion via the applicable exchange rate identified
and normally published by Bloomberg Professional Service as the applicable exchange rate as of the close of currency trading on
each trading date during the applicable period of measurement, or, if such currency conversion deals exclusively with a particular
date of determination, as of the close of currency trading on such date of determination (or the following trading date to the
extent no currency trading took place on such date of determination). If Bloomberg Professional Service no longer reports such
currency exchange rate, Agent shall select another nationally-recognized currency exchange rate reporting service selected by
Agent in good faith.

 

Section
2Credit Facility.

 

2.1
Term Loan Commitments.

 

(a)
Borrower, Agent and Lenders hereby agree and acknowledge that, as of the Closing Date (but prior to the advances described in
Section 2.1(b)), the outstanding principal balance of the Term Loan is $20,095,761 (which amount includes, for the avoidance
of doubt, (i) accrued interest that was capitalized into the Loan in relation to the accrued interest that was otherwise due and
payable on the Payment Dates in May 2016, February 2017, May 2017 and August 2017, (ii) the capitalization of all unpaid interest
accrued from the Payment Date in August 2017 through October 26, 2017, (iii) the additional term loan advance of $2,500,000 made
to Borrower on May 2, 2019 and (iv) the additional term loan advance of $2,500,000 made to Borrower on or about September 25,
2019).

 

(b)
In addition to the foregoing, on the Closing Date, Lenders shall make one (1) additional term loan advance in the amount of $5,000,000
to Borrower resulting in an outstanding principal balance of the Term Loan of $25,095,761. Upon the funding of such additional
term loan amount under this Section 2.1(b) Borrower shall pay to Agent, for its own account, an origination fee in the
amount of $50,000, which origination fee shall be deemed fully earned and non-refundable as of the Closing Date.

 

    [Solsys Medical] A&R Credit Agreement
 
- 16 -

     

    

 

(c)
All such term loan advances described in this Section 2.1 shall be deemed a single term Loan (each such loan,
individually and collectively, the “Term Loan”) which shall be in an aggregate principal amount equal to
the Term Loan Commitment plus any additional amounts capitalized into the Term Loan as described in Section 2.1(a).
The Loan is not a revolving credit facility, and therefore, any amount thereof that is repaid or prepaid by Borrower, in
whole or in part, may not be re-borrowed.

 

2.2[Reserved].

 

2.3Commitments
Several.

 

The
failure of any Lender to fund its Pro Rata Term Loan Share of the Term Loan shall not relieve any other Lender of its obligation
hereunder, but no Lender shall be responsible for the failure of any other Lender to fund such other Lender’s Pro Rata Term
Loan Share.

 

2.4Indebtedness
Absolute; No Offset; Waiver.

 

The
payment obligations of Borrower hereunder are absolute and unconditional, without any right of rescission, setoff,
counterclaim or defense for any reason against Agent and Lenders. As of the Closing Date, the Loan has not been compromised,
adjusted, extended, satisfied, rescinded, set-off or modified, and the Loan Documents are not subject to any litigation,
dispute, refund, claims of rescission, setoff, netting, counterclaim or defense whatsoever, including but not limited to,
claims by or against any Loan Party or any other Person. Payment of the Obligations by Borrower, shall be made only by wire
transfer, in Dollars, and in immediately available funds when due and payable pursuant to the terms of this Agreement and the
other Loan Documents, is not subject to compromise, adjustment, extension, satisfaction, rescission, set-off, counterclaim,
defense, abatement, suspension, deferment, deductible, reduction, termination or modification, whether arising out of
transactions concerning the Loan, or otherwise. Without limitation to the forgoing, to the fullest extent permitted under
applicable law and notwithstanding any other term or provision contained in this Agreement or any other Loan Document,
Borrower hereby waives (and shall cause each Loan Party to waive) (a) presentment, protest and demand, notice of default
(except as expressly required in the Loan Documents), notice of intent to accelerate, notice of acceleration, notice of
protest, notice of demand and of dishonor and non-payment of the Obligations, (b) any requirement of diligence or promptness
on Agent’s part in the enforcement of its rights under the provisions of this Agreement and any other Loan Document,
(c) any rights, legal or equitable, to require any marshalling of assets or to require foreclosure sales in a particular
order, (d) all notices of every kind and description which may be required to be given by any statute or rule of law except
as specifically required hereunder, (e) the benefit of all laws now existing or that may hereafter be enacted providing for
any appraisement before sale or any portion of the Collateral, (f) all rights of homestead, exemption, redemption,
valuation, appraisement, stay of execution, notice of election to mature or declare due the whole of the Obligations in the
event of foreclosure of the Liens created by the Loan Documents, (g) the pleading of any statute of limitations as a defense
to any demand under any Loan Document and (h) any defense to the obligation to make any payments required under the Loan
Documents, including the obligation to pay taxes based on any damage to, defects in or destruction of the Collateral or any
other event, including obsolescence of any of the Collateral, it being agreed and acknowledged that such payment obligations
are unconditional and irrevocable. Each Borrower further acknowledges and agrees (i) to any substitution, subordination,
exchange or release of any security or the release of any party primarily or secondarily liable for the payment of the Loan;
(ii) that Agent shall not be required to first institute suit or exhaust its remedies hereon against others liable for
repayment of all or any part of the Loan, whether primarily or secondarily (collectively, the “Obligors”),
or to perfect or enforce its rights against any Obligor or any security for the Loan; and (iii) that its liability for
payment of the Loan shall not be affected or impaired by any determination that any security interest or lien taken by Agent
for the benefit of Lenders to secure the Loan is invalid or unperfected. Each Borrower acknowledges, warrants and represents
in connection with each waiver of any right or remedy of such Borrower contained in any Loan Document, that it has been fully
informed with respect to, and represented by counsel of its choice in connection with, such rights and remedies, and all such
waivers, and after such advice and consultation, has presently and actually intended, with full knowledge of its rights and
remedies otherwise available at law or in equity, to waive or relinquish such rights and remedies to the full extent
specified in each such waiver.

 

    [Solsys Medical] A&R Credit Agreement
 
- 17 -

     

    

 

2.5Loan
Accounting.

 

2.5.1
Recordkeeping.

 

Agent,
on behalf of each Lender, shall record in its records the date and amount of the Loan made by each Lender, each prepayment and
repayment thereof. The aggregate unpaid principal amount so recorded shall be final, binding and conclusive absent manifest error.
The failure to so record any such amount or any error in so recording any such amount shall not, however, limit or otherwise affect
the Obligations of Borrower hereunder or under any Note to repay the principal amount of the Loans hereunder, together with all
interest accruing thereon.

 

2.5.2
Notes.

 

At the request of
any Lender, the Loan of such Lender shall be evidenced by a Note, with appropriate insertions, payable to the order of such Lender
in a face principal amount equal to such Lender’s Pro Rata Term Loan Share and payable in such amounts and on such dates
as are set forth herein.

 

2.6Payment
of Interest.

 

2.6.1
Interest Rates.

 

(a) The outstanding principal balance under the
Loan shall bear interest at a per annum rate of interest equal to the Contract Rate (as may be adjusted from time to time in accordance
with this Section 2.6.1). Whenever, subsequent to the date hereof, the LIBOR Rate is increased or decreased (as determined
on the date that is two (2) Business Days prior to each Payment Date), the Contract Rate, as set forth herein, shall be similarly
changed effective as of such subsequent Payment Date, without notice or demand of any kind by an amount equal to the amount of
such change in the LIBOR Rate on the date that is two (2) Business Days prior to each Payment Date. The interest due on the principal
balance of the Loan outstanding as of any Payment Date shall be computed for the actual number of days elapsed during the period
in question on the basis of a year consisting of three hundred sixty (360) days and shall be calculated by determining the average
daily principal balance outstanding for each day of such period in question. The daily rate shall be equal to 1/360th times the
Contract Rate. If any statement furnished by Agent for the amount of a payment due exceeded the actual amount that should have
been paid because the LIBOR Rate decreased and such decrease was not reflected in such statement, Borrower shall make the payment
specified in such statement from Agent and Borrower shall receive a credit for the overpayment, which credit shall be applied
towards the next subsequent payment due hereunder. If any statement furnished by Agent for the amount of a payment due was less
than the actual amount that should have been paid because the LIBOR Rate increased and such increase was not reflected in such
statement, Borrower shall make the payment specified in such statement from Agent and Borrower shall be required to pay any resulting
underpayment with the next subsequent payment due hereunder.

 

    [Solsys Medical] A&R Credit Agreement
 
- 18 -

     

    

 

(b)Each Borrower recognizes and
acknowledges that any default on any payment, or portion thereof, due hereunder or to be made under any of the other Loan
Documents, will result in losses and additional expenses to Agent in servicing the Loan, and in losses due to Lenders’
loss of the use of funds not timely received. Each Borrower further acknowledges and agrees that in the event of any such
Default, Lenders would be entitled to damages for the detriment proximately caused thereby, but that it would be extremely
difficult and impracticable to ascertain the extent of or compute such damages. Therefore, upon the Term Loan Maturity Date
and upon the occurrence and during the existence of an Event of Default (or upon any acceleration), interest shall
automatically accrue hereunder, without notice to Borrower, at the Default Rate. The Default Rate shall be calculated and due
from the date that the Event of Default occurred and shall be payable upon demand.

 

2.6.2 Payments of Interest and Principal.

 

Borrower
shall pay to Lenders all accrued interest on the Loan in arrears on each Payment Date, upon a prepayment of such Loan in accordance
with Section 2.8 and at maturity in cash. For the avoidance of doubt, no interest that accrues on or after October 27, 2017
may be capitalized into the Loan. Any partial prepayment of the Loan shall be applied in inverse order of maturity and so shall
not reduce the amount of any quarterly principal amortization payment required pursuant to Section 2.9.1 (but this shall
not be construed as permitting any partial prepayment other than as may be expressly permitted elsewhere in this Agreement).

 

2.7
Fees.

 

(a) [Reserved]

 

(b) Exit
Fee. Subject to Section 2.8.3 hereof, upon the earlier to occur of (i) the Term Loan Maturity Date, or (ii) full repayment
of the Loan and all other Obligations, whether as a result of the contractual acceleration of the Loan hereunder, an acceleration
of the Loan by Agent in accordance with this Agreement or otherwise, Borrower shall pay an exit fee to Agent, for the benefit of
Lenders, in an amount equal to one percent (1.0%) multiplied by the aggregate principal amount of all Term Loans advanced hereunder
and any accrued interest that was capitalized into the principal balance of the Term Loans prior to such date of determination.

 

2.8
Prepayment.

 

2.8.1
Mandatory Prepayment. Borrower shall prepay the Term Loans until paid in full within two (2) Business Days after the receipt
by a Loan Party of any Net Cash Proceeds from any Disposition, in an amount equal to such Net Cash Proceeds.

 

2.8.2
Voluntary Prepayment.

 

(a)
Subject to clause (b) below and Section 2.8.3 hereof, Borrower may, on or after the first anniversary of the
Closing Date and from time to time thereafter, on at least five (5) Business Day’s written notice or telephonic notice
(followed on the same Business Day by written confirmation thereof) to Agent (which shall promptly advise each Lender
thereof) not later than 12:00 noon Dallas time on such day, prepay the Term Loan and all related Obligations in whole or in
part. Such notice to Agent shall specify the amount and proposed date of such prepayment, and the application of such amounts
to be prepaid shall be applied in accordance with Section 2.9.1(b) or 2.10.2 (as applicable). Any such partial
prepayment shall be in an amount equal to $500,000 or a higher integral multiple of $100,000. For avoidance of doubt,
permitted payments under this Section 2.8.2 are independent of and in addition to Revenue-Based Payments that are
credited toward the principal of the Loans under Section 2.9.1(b).

 

    [Solsys Medical] A&R Credit Agreement
 
- 19 -

     

    

 

(b) If
Borrower makes any prepayment of the Term Loan under clause (a), it shall pay to Agent, for the benefit of Lenders, the
following amounts (in addition to any such prepayment of the Term Loan and related Obligations) on the date of such prepayment:
(i) if such prepayment is made on or after the first anniversary of the Closing Date but prior to the second anniversary of the
Closing Date, (A) four percent (4%) of the aggregate amount of the Term Loan so prepaid to the extent that the additional advance
of the Term Loan pursuant to Section 2.1(b) above has not been funded as of such date of determination or (B) three and
two-tenths of one percent (3.2%) to the extent that such additional advance of the Term Loan was made hereunder; (ii) if such prepayment
is made on or after the second anniversary of the Closing Date but prior to the third anniversary of the Closing Date, one percent
(1%) of the aggregate amount of the Term Loan so prepaid; and (iii) if such prepayment is made on or after the third anniversary
of the Closing Date, zero percent (0%) of the aggregate amount of the Term Loan so prepaid.

 

(c)
Notwithstanding anything set forth herein or in any other Loan Documents to the contrary, any prepayment of the Loans other than
via the application of Revenue-Based Payments made pursuant to Section 2.9.1 or Section 2.10.2, as applicable, or
prepayments in accordance with Section 2.8.3, shall be limited and governed by this Section 2.8.2.

 

2.8.3
Change of Control. Upon a Change of Control, Borrower shall immediately prepay the outstanding principal balance of the
Term Loan in full and all other outstanding Obligations (subject to the limitations set forth in this Section 2.8.3), plus,
the prepayment fee that would otherwise be due and payable upon a prepayment made pursuant to Section 2.8.2(b) on such
date of determination.

 

2.9
Repayment of Term Loan.

 

2.9.1
Revenue-Based Payment.

 

(a)
During the period commencing on the date hereof until the Obligations are Paid in Full, Borrower promises to pay to Agent, for
the account of each Lender according to its Pro Rata Term Loan Share, an amount based on a percentage of the aggregate of Net
Sales, Royalties and any other income or revenue recognized by Parent and/or its Subsidiaries, on a consolidated basis, in accordance
with GAAP (collectively, the “Aggregate Revenue”) in each Fiscal Quarter (the “Revenue-Based Payment”),
which will be applied to the Obligations as provided in clause (b) below. The Revenue-Based Payment with respect to each
Fiscal Quarter shall be payable on the Payment Date next following the end of such Fiscal Quarter. Commencing with the Fiscal
Quarter in which the Closing Date occurs, the Revenue-Based Payment with respect to each Fiscal Quarter shall be equal to the
difference between (i) the aggregate Revenue-Based Payments payable from January 1 of the Fiscal Year of which such Fiscal Quarter
is part through the end of such Fiscal Quarter, calculated as the sum of:

 

(A) Fifteen
percent (15%) of Aggregate Revenue up to and including $15,000,000.00 in such Fiscal Year; plus

 

(B) Twelve
and one-half percent (12.5%) of Aggregate Revenue greater than $15,000,000 in such Fiscal Year; and

 

 (ii) the amount of Revenue-Based Payments, if any, made with respect to prior Fiscal Quarters in such Fiscal
Year; provided that the Revenue-Based Payment is payable solely upon Aggregate Revenue in a given Fiscal Year, and will
not be calculated on a cumulative, year-over-year basis.

 

    [Solsys Medical] A&R Credit Agreement
 
- 20 -

     

    

 

(b)
So long as no Event of Default has occurred and is continuing and until the Obligations have been Paid in Full, each
Revenue-Based Payment on each Payment Date will be applied in the following priority:

 

(i)
FIRST, to the payment of all fees, costs, expenses and indemnities due and owing to Agent pursuant to Sections
2.7, 3.1, 3.2, 6.3(d), 10.4 and/or 10.5 under
this Agreement or otherwise pursuant to the Collateral Documents, and any other Obligations owing to Agent in respect of sums
advanced by Agent to preserve or protect the Collateral or to preserve or protect its security interest in the Collateral;

 

(ii) SECOND,
to the payment of all fees, costs, expenses and indemnities due and owing to Lenders in respect of the Loans and Commitments pursuant
to Sections 2.7, 3.1, 3.2, 6.3(d), 10.4 and/or 10.5
under this Agreement or otherwise pursuant to the Collateral Documents, pro rata based on each Lender’s Pro Rata Term Loan
Share, until Paid in Full;

 

(iii) THIRD,
to the payment of all accrued but unpaid interest in respect of the Loans as of such Payment Date, pro rata based on each Lender’s
Pro Rata Term Loan Share, until Paid in Full;

 

(iv) FOURTH,
as it relates to each Payment Date on or after the Payment Date occurring in February 2021, to the payment of all principal of
the Loans, pro rata based on each Lender’s Pro Rata Term Loan Share, up to an aggregate amount of $1,250,000 on any such
Payment Date;

 

(v) FIFTH,
all remaining amounts to the Borrower.

 

In the event that the amounts distributed
under Section 2.9.1(b) on any Payment Date are insufficient for payment of the amounts
set forth in Section 2.9.1(b)(i) through (iii)
for such Payment Date, Borrower shall pay an amount equal to the extent of such insufficiency within five (5) Business Days of
request by Agent. For the avoidance of doubt, at all times after the Closing Date and prior to the Payment Date in February 2021,
Borrower shall only be required to pay Revenue-Based Payments to the extent of amounts owing under clauses
(i), (ii), and (iii) above on each such Payment Date prior to February
2021.

 

(c) In
the event that Parent makes any adjustment to Aggregate Revenue after it has been reported to Agent, and such adjustment results
in an adjustment to the Revenue-Based Payment due to the Lenders pursuant to this Section 2.9.1,
Borrower shall so notify Agent and such adjustment shall be captured, reported and reconciled with the next scheduled report and
payment of Revenue-Based Payment hereunder. Notwithstanding the foregoing, Agent and Borrower shall discuss and agree on the amount
of any such adjustment prior to it being given effect with respect to future Revenue-Based Payments.

  

    [Solsys Medical] A&R Credit Agreement
 
- 21 -

     

    

 

2.9.2
Principal.

 

Notwithstanding
the foregoing, the outstanding principal balance of the Term Loans and all other Obligations then due and owing shall be Paid in
Full on the Term Loan Maturity Date.

 

2.10
Payment.

 

2.10.1
Making of Payments.

 

Except
as set forth in the last sentence of this Section 2.10.1, all payments of principal, interest, fees and other amounts,
shall be made in immediately-available funds, via wire transfer as directed by Agent and each Lender in writing, not later than
1:00 p.m. Dallas time on the date due, and funds received after that hour shall be deemed to have been received by Agent and/or
such Lenders on the following Business Day. Not later than two (2) Business Days prior to each Payment Date, Agent shall provide
to Borrower and each Lender a quarterly statement with the amounts payable by Borrower to Agent and each Lender on such Payment
Date in accordance with Section 2.9.1(b) hereof, which shall include, for additional clarity, Agent’s calculation
of the Revenue-Based Payment for the prior Fiscal Quarter, which statement shall be binding on Borrower absent manifest error,
and Borrower shall be entitled to rely on such quarterly statement in relation to its payment obligations on such Payment Date.
Except as otherwise specified herein or as otherwise directed by Agent in writing, all payments under this Agreement shall be
made by Borrower directly to each Lender entitled thereto.

 

2.10.2
Application of Payments and Proceeds Following an Event of Default.

 

Following
the occurrence and during the continuance of an Event of Default, or if the Obligations have otherwise become or have been declared
to become immediately due and payable in accordance with this Agreement, then notwithstanding anything herein or in any other Loan
Document to the contrary, Agent shall apply all or any part of payments in respect of the Obligations and proceeds of Collateral,
in each case as received by Agent, to the payment of the Obligations in the following order:

 

(i) FIRST,
to the payment of all fees, costs, expenses and indemnities due and owing to Agent under this Agreement or any other Loan Document,
and any other Obligations owing to Agent in respect of sums advanced by Agent to preserve or protect the Collateral or to preserve
or protect its security interest in the Collateral;

 

(ii) SECOND,
to the payment of all fees, costs, expenses and indemnities due and owing to Lenders in respect of the Loans, pro rata based on
each Lender’s Pro Rata Term Loan Share, until Paid in Full;

 

(iii) THIRD,
to the payment of all accrued and unpaid interest due and owing to Lenders in respect of the Loans, pro rata based on each Lender’s
Pro Rata Term Loan Share, until Paid in Full;

 

(iv) FOURTH,
to the payment of all principal of the Loans due and owing, pro rata based on each Lender’s Pro Rata Term Loan Share, until
Paid in Full;

 

(v) FIFTH,
to the payment of all other Obligations owing to each Lender, pro rata based on each Lender’s Pro Rata Term Loan Share,
until Paid in Full; and

 

    [Solsys Medical] A&R Credit Agreement
 
- 22 -

     

    

 

(vi)
SIXTH, to Borrower or whomsoever may be entitled to such amount by applicable law. 

 

2.10.3
Set-off.

 

Borrower
agrees that Agent and each Lender and its Affiliates have all rights of set-off and bankers’ lien provided by applicable
law, and in addition thereto, Borrower agrees that at any time an Event of Default exists, Agent and each Lender may, to the fullest
extent permitted by applicable law, apply to the payment of any Obligations of Borrower hereunder then due, any and all balances,
credits, deposits, accounts or moneys of Borrower then or thereafter with Agent or such Lender. Notwithstanding the foregoing,
no Lender shall exercise any rights described in the preceding sentence without the prior written consent of Agent.

 

2.10.4
Proration of Payments.

 

If any Lender
shall obtain any payment or other recovery (whether voluntary, involuntary, by application of set-off or otherwise, on account
of principal of or interest on any Loan, but excluding any payment pursuant to Section 3.1, 3.2, 10.5 or 10.8) in
excess of its applicable Pro Rata Term Loan Share of payments and other recoveries obtained by all Lenders on account of principal
of and interest on such Term Loan then held by them, then such Lender shall purchase from the other Lenders such participations
in the Loans held by them as shall be necessary to cause such purchasing Lender to share the excess payment or other recovery ratably
with each of them; provided that if all or any portion of the excess payment or other recovery is thereafter recovered from
such purchasing Lender, the purchase shall be rescinded and the purchase price restored to the extent of such recovery.

 

Section 3Yield Protection.

 

3.1
Taxes.

 

(a)
All payments of principal and interest on the Loans and all other amounts payable hereunder by or on behalf of Borrower to or
for the account of Agent or any Lender shall be made free and clear of and without deduction for any present or future income,
excise, stamp, documentary, property or franchise taxes and other taxes, fees, duties, levies, withholdings or other similar charges
imposed by any Governmental Authority that is a taxing authority (“Taxes”), excluding (i) taxes imposed on or measured
by Agent’s or any Lender’s net income (however denominated) or gross profits, and franchise taxes, imposed by any
jurisdiction (or subdivision thereof) under the laws of which Agent or such Lender is organized or in which Agent or such Lender
conducts business or, in the case of any Lender, in which its applicable lending office is located, (ii) any branch profit taxes
imposed by the United States of America or any similar tax imposed by any other jurisdiction in which Agent or a Lender is located
or conducts business; (iii) in the case of any Foreign Lender, any withholding tax that is imposed on amounts payable to such
Foreign Lender at the time such Foreign Lender becomes a party to this Agreement or designates a new lending office; (iv) in the
case of any U.S. Lender, any United States federal backup withholding tax; and (v) taxes imposed under FATCA (items in clauses
(i) through (v), “Excluded Taxes”, and all Taxes other than Excluded Taxes, “Indemnified
Taxes”). If any withholding or deduction from any payment to be made by Borrower hereunder is required in respect of
any Taxes pursuant to any applicable law, rule or regulation, then Borrower shall: (w) make such withholding or deduction;
(x) pay directly to the relevant Governmental Authority the full amount required to be so withheld or deducted; (y)
as promptly as practicable forward to Agent the original or a certified copy of an official receipt or other documentation reasonably
satisfactory to Agent evidencing such payment to such Governmental Authority; and (z) if the withholding or deduction is
with respect to Indemnified Taxes, pay to Agent for the account of Lenders such additional amount or amounts as is necessary to
ensure that the net amount actually received by each Lender will equal the full amount such Lender would have received had no
such withholding or deduction of Indemnified Taxes been required. To the extent that any amounts shall ever be paid by Borrower
in respect of Indemnified Taxes, such amounts shall, for greater certainty, be considered to have accrued and to have been paid
by Borrower as interest on the Loans.

 

    [Solsys Medical] A&R Credit Agreement
 
- 23 -

     

    

 

(b) Borrower
shall indemnify Agent and each Lender for any Indemnified Taxes paid by Agent or such Lender, as applicable, on or with respect
to any payment by or on account of any obligation of Borrower hereunder, and any additions to Tax, penalties and interest paid
by Agent or such Lender with respect to such Indemnified Taxes; provided that Borrower shall not have any obligation to
indemnify any party hereunder for any Indemnified Taxes or additions to Tax, penalties or interest with respect thereto that result
from or are attributable to such party’s own gross negligence or willful misconduct. Payment under this Section 3.1(b)
shall be made within thirty (30) days after the date Agent or the Lender, as applicable, makes written demand therefor; provided,
however, that if such written demand is made more than one-hundred eighty (180) days after the earlier of (i) the date on
which Agent or the Lender, as applicable, pays such Indemnified Taxes or additions to Tax, penalties or interest with respect thereto
and (ii) the date on which the applicable Governmental Authority makes written demand on Agent or such Lender, as applicable, for
payment of such Indemnified Taxes or additions to Tax, penalties or interest with respect thereto, then Borrower shall not be obligated
to indemnify Agent or such Lender for such Indemnified Taxes or additions to Tax, penalties or interest with respect thereto.

 

(c) Each
Foreign Lender that is a party hereto on the Closing Date or becomes an assignee of an interest under this Agreement under Section
10.8.1 after the Closing Date (unless such Lender was already a Lender hereunder immediately prior to such assignment) shall
deliver to Borrower and Agent on or prior to the date on which such Foreign Lender becomes a party to this Agreement:

 

(i) Two
duly completed and executed originals of IRS Form W-8BEN (or IRS Form W-8BENE) claiming exemption from withholding of Taxes under
an income tax treaty to which the United States of America is a party;

 

(ii) two
duly completed and executed originals of IRS Form W-8ECI;

 

(iii) a
certificate in form and substance reasonably satisfactory to Agent and Borrower claiming entitlement to the portfolio interest
exemption under Section 881(c) of the IRC and certifying that such Foreign Lender is not (x) a “bank” within
the meaning of Section 881(c)(3)(A) of the IRC, (y) a “10 percent shareholder” of Borrower within the meaning
of Section 881(c)(3)(B) of the IRC, or (z) a “controlled foreign corporation” described in Section 881(c)(3)(C)
of the IRC, together with two duly completed and executed originals of IRS Form W-8BEN (or IRS Form W-8BENE); or

 

(iv) if
the Foreign Lender is not the beneficial owner of amounts paid to it hereunder, two duly completed and executed originals of IRS
Form W-8IMY, each accompanied by a duly completed and executed IRS Form W-8ECI, IRS Form W-8BEN (or IRS Form W-8BENE), IRS Form
W-9 or a portfolio interest certificate described in clause (iii) above from each beneficial owner of such amounts claiming
entitlement to exemption from withholding or backup withholding of Taxes.

 

    [Solsys Medical] A&R Credit Agreement
 
- 24 -

     

    

 

Each
Foreign Lender shall (to the extent legally entitled to do so) provide updated forms to Borrower and Agent on or prior to
the date any prior form previously provided under this clause (c) becomes obsolete or expires, after the occurrence of
an event requiring a change in the most recent form or certification previously delivered by it pursuant to this clause
(c) or from time to time if requested by Borrower or Agent. Each U.S. Lender shall deliver to Agent and Borrower on or
prior to the date on which such Lender becomes a party to this Agreement (and from time to time thereafter upon the request
of Borrower or Agent) properly completed and executed originals of IRS Form W-9 certifying that such Lender is exempt from
backup withholding. Notwithstanding anything to the contrary contained in this Agreement, Borrower shall not be required to
pay additional amounts to or indemnify any Lender pursuant to this Section 3.1 with respect to any Taxes required to
be deducted or withheld (or any additions to Tax, penalties or interest with respect thereto) (A) on the basis of the
information, certificates or statements of exemption provided by a Lender pursuant to this clause (c), or (B) if such
Lender shall fail to comply with the certification requirements of this clause (c).

 

(d) Without
limiting the foregoing, each Lender shall timely comply with any certification, documentation, information or other reporting necessary
to establish an exemption from withholding under FATCA and shall provide any documentation reasonably requested by Borrower or
Agent sufficient for Borrower and Agent to comply with their obligations under FATCA and to determine that such Lender has complied
with such applicable reporting requirements.

 

(e) If
Agent or a Lender determines that it is entitled to or has received a refund of any Taxes for which it has been indemnified by
Borrower (or another Loan Party) or with respect to which Borrower (or another Loan Party) shall have paid additional amounts pursuant
to this Section 3.1, it shall promptly notify Borrower of such refund, and promptly make an appropriate claim to the relevant
Governmental Authority for such refund (if it has not previously done so). If Agent or a Lender receives a refund (whether or not
pursuant to such claim) of such Taxes, it shall promptly pay over such refund to Borrower (but only to the extent of indemnity
payments made, or additional amounts paid, by Loan Parties under this Section 3.1 with respect to the Taxes giving rise
to such refund), net of all out-of-pocket expenses of the Agent or such Lender and without interest (other than any interest paid
by the relevant Governmental Authority with respect to such refund); provided that Borrower, upon the request of Agent or
such Lender, agrees to repay to Agent or such Lender the amount paid over to Borrower in the event Agent or such Lender is required
to repay such refund to such Governmental Authority. This Section 3.1(e) shall not be construed to require Agent or any
Lender to make available its Tax returns (or any other information relating to its Taxes which it deems confidential) to Borrower
or any other Person or to alter its internal practices or procedures with respect to the administration of Taxes.

 

(f) Each
Lender shall severally indemnify Borrower for any Excluded Taxes attributable to such Lender and any additions to Tax, penalties
and interest with respect to such Excluded Taxes that are paid by Borrower with respect to a payment hereunder.

 

3.2 Increased
Cost.

 

(a)
If, after the Closing Date, the adoption of, or any change in, any applicable law, rule or regulation, or any change in the interpretation
or administration of any applicable law, rule or regulation by any Governmental Authority, central bank or comparable agency charged
with the interpretation or administration thereof (provided that notwithstanding anything herein to the contrary, the Dodd-Frank
Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection
therewith shall be considered a change in applicable law, regardless of the date enacted, adopted or issued), or compliance by
any Lender with any request or directive (whether or not having the force of law) issued after the Closing Date of any such authority,
central bank or comparable agency: (i) shall impose, modify or deem applicable any reserve (including any reserve imposed by the
FRB), special deposit or similar requirement against assets of, deposits with or for the account of, or credit extended by any
Lender; or (ii) shall impose on any Lender any other condition affecting its ability to make loans based on the LIBOR Rate or
its obligation to make loans based on the LIBOR Rate; and the result of anything described in clauses (i) and (ii)
above is to increase the cost to (or to impose a cost on) such Lender of making or maintaining any loan based on the LIBOR Rate,
or to reduce the amount of any sum received or receivable by such Lender under this Agreement or under its Note with respect thereto,
then upon demand by such Lender (which demand shall be accompanied by a statement setting forth the basis for such demand and
a calculation of the amount thereof in reasonable detail, a copy of which shall be furnished to Agent), and without duplication
of other payment obligations of Borrower hereunder (including pursuant to Section 3.1), Borrower shall pay directly to
such Lender such additional amount as will compensate such Lender for such increased cost or such reduction, so long as such amounts
have accrued on or after the day which is one-hundred eighty (180) days prior to the date on which such Lender first made demand
therefor; provided that if the event giving rise to such costs or reductions has retroactive effect, such one-hundred eighty
(180) day period shall be extended to include the period of retroactive effect. For the avoidance of doubt, this clause (a) will
not apply to any such increased costs or reductions resulting from Taxes, as to which Section 3.1 shall govern.

 

    [Solsys Medical] A&R Credit Agreement
 
- 25 -

     

    

 

(b) If
any Lender shall reasonably determine that any change after the Closing Date in, or the adoption or phase-in after the Closing
Date of, any applicable law, rule or regulation regarding capital adequacy, or any change after the Closing Date in the interpretation
or administration thereof by any Governmental Authority, central bank or comparable agency charged with the interpretation or administration
thereof, or the compliance by any Lender or any Person controlling such Lender with any request or directive issued after the Closing
Date regarding capital adequacy (whether or not having the force of law) of any such authority, central bank or comparable agency,
has or would have the effect of reducing the rate of return on such Lender’s or such controlling Person’s capital as
a consequence of such Lender’s obligations hereunder to a level below that which such Lender or such controlling Person could
have achieved but for such change, adoption, phase-in or compliance (taking into consideration such Lender’s or such controlling
Person’s policies with respect to capital adequacy) by an amount deemed by such Lender or such controlling Person to be material,
then from time to time, within five (5) Business Days of demand by such Lender (which demand shall be accompanied by a statement
setting forth the basis for such demand and a calculation of the amount thereof in reasonable detail, a copy of which shall be
furnished to Agent), Borrower shall pay to such Lender such additional amount as will compensate such Lender or such controlling
Person for such reduction, so long as such amounts have accrued on or after the day which is one-hundred eighty (180) days prior
to the date on which such Lender first made demand therefor; provided that if the event giving rise to such costs or reductions
has retroactive effect, such one-hundred eighty (180) day period shall be extended to include the period of retroactive effect.

 

(c)
Each Lender agrees that, as promptly as practicable after the officer of such Lender responsible for administering its Loans,
becomes aware of the occurrence of an event or the existence of a condition that would entitle such Lender to receive payments
under this Section 3.2, it will, to the extent not inconsistent with the internal policies of such Lender and any applicable
legal or regulatory restrictions, use reasonable efforts to (i) make, issue, fund or maintain its Loans through another office
of such Lender, or (ii) take such other measures as such Lender may deem reasonable, if as a result thereof the additional amounts
which would otherwise be required to be paid to such Lender pursuant to this Section 3.2 would be materially reduced and
if, as determined by such Lender in its sole discretion, the making, issuing, funding or maintaining of such Loans through such
other office or in accordance with such other measures, as the case may be, would not otherwise adversely affect such Loans or
the interests of such Lender; provided that such Lender will not be obligated to utilize such other office pursuant to
this clause (c) unless Borrower agrees to pay all incremental expenses incurred by such Lender as a result of utilizing
such other office as described above. A certificate as to the amount of any such expenses payable by Borrower pursuant to this
clause (c) (setting forth in reasonable detail the basis for requesting such amount) submitted by such Lender to Borrower
(with a copy to Agent) shall be conclusive absent manifest error.

 

    [Solsys Medical] A&R Credit Agreement
 
- 26 -

     

    

 

3.3 Funding
Losses.

 

Borrower
hereby agrees that upon demand by any Lender (which demand shall be accompanied by a statement setting forth the basis for the
amount being claimed, a copy of which shall be furnished to Agent), Borrower will indemnify such Lender against any net loss or
expense which such Lender may sustain or incur (including any net loss or expense incurred by reason of the liquidation or reemployment
of deposits or other funds acquired by such Lender to fund or maintain the Term Loans subject to the LIBOR Rate, as reasonably
determined by such Lender, as a result of (a) any payment or prepayment of any Term Loan of such Lender on a date other than the
Term Loan Maturity Date or (b) any failure of Borrower to borrow any Loan on a date specified therefor in a notice of borrowing
pursuant to this Agreement. For the purposes of this Section 3.3, all determinations shall be made as if such Lender had
actually funded and maintained each Term Loan through the purchase of deposits having a maturity corresponding to the Loan and
bearing an interest rate equal to the LIBOR Rate during such period of time being measured.

 

3.4
Manner of Funding; Alternate Funding Offices.

 

Notwithstanding
any provision of this Agreement to the contrary, each Lender shall be entitled to fund and maintain its funding of all or any part
of its Loans in any manner it may determine at its sole discretion. Each Lender may, if it so elects, fulfill its commitment to
make any Term Loan by causing any branch or Affiliate of such Lender to make such Loan; provided that in such event for
the purposes of this Agreement (other than Section 3.1) such Loan shall be deemed to have been made by such Lender and the
obligation of Borrower to repay such Loan shall nevertheless be to such Lender and shall be deemed held by it, to the extent of
such Loan, for the account of such branch or Affiliate.

 

3.5 Conclusiveness
of Statements; Survival.

 

Determinations
and statements of any Lender pursuant to Section 3.1, 3.2, 3.3 or 3.4 shall be conclusive absent demonstrable
error. Lenders may use reasonable averaging and attribution methods in determining compensation under Sections 3.1 or 3.2, and
the provisions of such Sections shall survive repayment of the Loans, cancellation of the Notes and termination of this Agreement.

 

Section 4 Conditions
Precedent. 

 

The
effectiveness of this Agreement and the obligation of each Lender to make the additional advances of the Term Loan described herein
are subject to the following conditions precedent, each of which shall be reasonably satisfactory in all respects to Agent.

 

4.1 Consummation
of Merger.

 

(a)
No material provision of the Merger Agreement or the schedules or exhibits thereto shall have been amended, waived or
otherwise modified or supplemented (including any amendment, waiver or modification of the term Surge Material Adverse Effect
or Motor Material Adverse Effect (each as defined in the Merger Agreement) to the extent deemed (by Agent in its commercially
reasonable discretion) material and adverse to the interests of Lenders or Agent) in a manner that is materially adverse to
the interests of the Lenders or Agent (in their capacity as such) without the prior written consent of Agent (which approval
shall not be unreasonably withheld, delayed or conditioned); provided, that neither a reduction in the purchase price by less
than ten percent (10%) under the Merger Agreement nor any amendment or waiver to the terms of the Merger Agreement that has
the effect of increasing the consideration required to be paid thereunder on the Closing Date by less than ten percent (10%)
will be deemed to be materially adverse to the Lenders or Agent.

 

    [Solsys Medical] A&R Credit Agreement
 
- 27 -

     

    

 

(b) All
“Transactions” as defined in the Merger Agreement have closed or will close simultaneously with the effectiveness
of this Agreement.

 

4.2 Delivery
of Loan Documents.

 

Borrower
shall have delivered the following documents (and, as applicable, duly executed and dated the Closing Date or an earlier date satisfactory
to Agent):

 

(a)
Loan Documents. (1) this Agreement, duly executed by each Borrower together with updated schedules and exhibits to this
Agreement in form and substance reasonably acceptable to Agent; (2) a Joinder to the Guarantee and Collateral Agreement (in the
form of Annex I to such agreement) executed by Parent and each Subsidiary of Parent not already a party thereto together with
the schedules to be provided therewith, (3) an IP Security Agreement (in the form delivered by Current Borrower on the Original
Closing Date) executed by Parent and any other Loan Party that holds any Intellectual Property as of the Closing Date in favor
of Agent, (4) an amendment to the Intercreditor Agreement in form and substance reasonably satisfactory to Agent that allows for
the additional Term Loan that may be advanced under Section 2.1(b) hereof as well as any increase in the revolving loan
facility available under the Approved AR Loan Facility on or about the Closing Date; and (5) any other Loan Documents as reasonably
required by Agent in substantially the same forms as provided by Current Borrower on the Original Closing Date.

 

(b)
Lien Searches. Copies of Uniform Commercial Code, foreign, state and county search reports listing all effective financing
statements filed and other Liens of record against any Loan Party to be added to the Loan Documents on or about the Closing Date,
with copies of any financing statements and applicable searches of the records of the U.S. Patent and Trademark Office performed
with respect to each Loan Party, all in each jurisdiction reasonably determined by Agent.

 

(c)
[Reserved].

 

(d)
Authorization Documents. For each Loan Party, such Person’s (i) charter (or similar formation document), certified
by the appropriate Governmental Authority, (ii) good standing certificates in its jurisdiction of incorporation (or formation)
and in each other jurisdiction reasonably requested by Agent, (iii) bylaws (or similar governing document), (iv) resolutions of
its board of directors (or similar governing body) approving and authorizing such Person’s execution, delivery and performance
of the Loan Documents to which it is party and the transactions contemplated thereby, and (v) signature and incumbency certificates
of its officers executing any of the Loan Documents, all certified by its secretary or an assistant secretary (or similar officer)
as being in full force and effect without modification, in form and substance reasonably satisfactory to Agent.

 

(e)
Opinions of Counsel. Customary opinions of counsel for each Loan Party in substantially the form delivered on the Original
Closing Date, or such other form as reasonably approved by Agent, in relation to the Loan Documents to be delivered on the Closing
Date.

 

(f)
[Reserved].

 

    [Solsys Medical] A&R Credit Agreement
 
- 28 -

     

    

 

(g)
Financials. The financial statements, projections and pro forma balance sheet described in Section 5.4.

 

4.3 Fees.
The Lenders and Agent shall have received all fees required to be paid, and all expenses for which invoices have
been presented (including the reasonable fees and expenses of legal counsel), required to be paid under the Loan Documents on
or before the Closing Date.

 

4.4 Representations,
Warranties, Defaults. As of the Closing Date, after giving effect to the “Transactions” as defined in the
Merger Agreement, (a) all representations and warranties of Loan Parties set forth in any Loan Document shall be true and
correct in all material respects as if made on and as of the Closing Date (except for representations and warranties that
specifically refer to an earlier date, which shall be true and correct in all material respects as of such earlier date), (b)
no Default, Event of Default or Material Adverse Effect shall exist and (c) since the date of the Merger Agreement, there has
not occurred a Surge Material Adverse Effect or a Motor Material Adverse Effect (each as defined in the Merger
Agreement).

 

Section 5 Representations
and Warranties.

 

To
induce Agent and Lenders to enter into this Agreement and to induce Lenders to make Loans hereunder, Borrower represents and warrants
to Agent and Lenders, as of the Closing Date that:

 

5.1 Organization.

 

Each
Loan Party is validly existing and in good standing under the laws of its state or country of jurisdiction as set forth on Schedule
5.1, and is duly qualified to do business in each additional jurisdiction in which the failure to so qualify could reasonably
be likely to have or result in a Material Adverse Effect.

 

5.2 Authorization;
No Conflict.

 

Each
Loan Party is duly authorized to execute and deliver each Loan Document to which it is a party, to borrow or guaranty monies hereunder,
as applicable, and to perform its Obligations under each Loan Document to which it is a party. The execution, delivery and performance
by Loan Parties of this Agreement and the other Loan Document to which it is a party, as applicable, and the transactions contemplated
therein, do not and will not (a) require any consent or approval of any Governmental Authority (other than any consent or approval
which has been obtained and is in full force and effect), (b) conflict with (i) any provision of applicable law (including any
Health Care Law), (ii) the charter, bylaws or other organizational documents of such Loan Party or (iii) any Material Contract,
or any judgment, order or decree, which is binding upon any Loan Party or any of its properties or (c) require, or result in, the
creation or imposition of any Lien on any asset of any Loan Party (other than Liens in favor of Agent created pursuant to the Collateral
Documents).

 

5.3 Validity;
Binding Nature.

 

Each
of this Agreement and each other Loan Document to which any Loan Party is a party, as applicable, is the legal, valid and binding
obligation of such Loan Party, enforceable against such Loan Party in accordance with its terms, subject to bankruptcy, insolvency
and similar laws affecting the enforceability of creditors’ rights generally and to general principles of equity and concepts
of reasonableness.

 

    [Solsys Medical] A&R Credit Agreement
 
- 29 -

     

    

 

5.4 Financial
Condition.

 

(a) [Reserved].

 

(b) The
consolidated financial projections (including an operating budget and a cash flow budget) of Borrower delivered to Agent and Lenders
on or prior to the Closing Date (i) were prepared by Borrower in good faith and (ii) were prepared in accordance with assumptions
for which Borrower believes it has a reasonable basis, and the accompanying consolidated and consolidating pro forma unaudited
balance sheet of Borrower as at the Closing Date, adjusted to give effect to the financings contemplated hereby as if such transactions
had occurred on such date, is consistent in all material respects with such projections (it being understood that the projections
are not a guaranty of future performance and that actual results during the period covered by the projections may materially differ
from the projected results therein).

 

5.5 No
Material Adverse Change.

 

Since
the date of the Merger Agreement, there has not occurred a Surge Material Adverse Effect or a Motor Material Adverse Effect (each
as defined in the Merger Agreement.

 

5.6 Litigation.

 

No
litigation (including derivative actions), arbitration proceeding or governmental investigation or proceeding is pending or, to
Borrower’s knowledge, threatened against any Loan Party that would reasonably be expected to have, either individually or
in the aggregate, a Material Adverse Effect.

 

5.7 Ownership
of Properties; Liens.

 

Borrower
and each other Loan Party owns all of its material properties and assets, tangible and intangible, of any nature whatsoever that
it purports to own (including Intellectual Property), free and clear of all Liens and charges and claims (including infringement
claims with respect to Intellectual Property), except Permitted Liens and as set forth on Schedule 5.7.

 

5.8 Capitalization.

 

All
issued and outstanding Equity Interests of Loan Parties are duly authorized, validly issued, fully paid, non-assessable, and such
securities were issued in compliance in all material respects with all applicable state and federal laws concerning the issuance
of securities.

 

5.9 Pension
Plans.

 

No Loan Party has,
nor to Borrower’s knowledge has any Loan Party ever had, a Pension Plan.

 

5.10 Investment
Company Act.

 

No
Loan Party is an “investment company” or a company “controlled” by an “investment company”
or a “subsidiary” of an “investment company”, within the meaning of the Investment Company Act of 1940.

 

    [Solsys Medical] A&R Credit Agreement
 
- 30 -

     

    

 

5.11 No
Default.

 

No
Event of Default or Default exists or would result from the incurrence by Borrower of any Debt hereunder or under any other Loan
Document or as a result of any Loan Party entering into the Loan Documents to which it is a party.

 

5.12 Margin Stock.

 

No
Loan Party is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of
purchasing or carrying Margin Stock. As of the Closing Date, no portion of the Obligations is secured directly or indirectly by
Margin Stock.

 

5.13 Taxes.

 

Each
Loan Party has filed, or caused to be filed, all federal, state, foreign and other tax returns and reports required by law to have
been filed by it and has paid all federal, state, foreign and other taxes and governmental charges thereby shown to be owing, except
any such taxes or charges (a) that are not delinquent or (b) that are being diligently contested in good faith by appropriate proceedings
and for which adequate reserves in accordance with GAAP have been set aside on its books.

 

5.14 Solvency.

 

On
the Closing Date, and immediately prior to and after giving effect to the borrowing hereunder and the use of the proceeds thereof,
Borrower is, and will be, Solvent.

 

5.15 Environmental
Matters.

 

The
on-going operations of Loan Parties comply in all respects with all applicable Environmental Laws, except for non-compliance which
could not (if enforced in accordance with applicable law) reasonably be expected to result in a Material Adverse Effect. Each Loan
Party has obtained, and maintained in good standing, all licenses, permits, authorizations and registrations required under any
Environmental Law and necessary for its respective ordinary course operations, and each Loan Party is in compliance with all material
terms and conditions thereof, except where the failure to do so would not reasonably be expected to result in a Material Adverse
Effect. Neither Borrower, any of its Subsidiaries nor any of their respective properties or operations is subject to any outstanding
written order from or agreement with any federal, state, or local Governmental Authority, nor subject to any judicial or docketed
administrative proceeding, respecting any Environmental Law, Environmental Claim or Hazardous Substance. There are no Hazardous
Substances or other conditions or circumstances existing with respect to any property, or arising from operations prior to the
Closing Date, of any Loan Party that would reasonably be expected to result in a Material Adverse Effect. No Loan Party has underground
storage tanks.

 

5.16 Insurance.

 

Loan
Parties and their respective properties are insured with financially sound and reputable insurance companies which are not Affiliates
of any Loan Party, in such amounts, with such deductibles and covering such risks as are customarily carried by companies engaged
in similar businesses and owning similar properties in localities where such Loan Parties operate, as applicable. A true and complete
listing of such insurance as of the Closing Date, including issuers, coverages and deductibles, is set forth on Schedule 5.16.

 

    [Solsys Medical] A&R Credit Agreement
 
- 31 -

     

    

 

5.17 Information.

 

All
written information heretofore or contemporaneously herewith furnished in writing by Borrower to Agent or any Lender for purposes
of or in connection with this Agreement and the transactions contemplated hereby, taken as a whole, is, and all written information
hereafter furnished by or on behalf of Borrower to Agent or any Lender pursuant hereto or in connection herewith, taken as a whole,
will be true and accurate in every material respect on the date as of which such information, taken as a whole, is dated or certified,
and none of such information is or will be incomplete by omitting to state any material fact necessary to make such information
not misleading in any material respect in light of the circumstances under which made (it being recognized by Agent and Lenders
that any projections and forecasts provided by Borrower are based on good faith estimates and assumptions believed by Borrower
to be reasonable as of the date of the applicable projections or assumptions and that actual results during the period or periods
covered by any such projections and forecasts may differ from projected or forecasted results).

 

5.18 Intellectual
Property; Products and Services.

 

(a)
Schedule 5.18(a) (as updated from time to time in accordance with Section 6.1.2 hereof) accurately and completely lists
all of Loan Parties’ Registered Intellectual Property. Each Loan Party owns and possesses or has a license or other right
to use all Intellectual Property as is necessary for the conduct of the business of such Loan Party, without any infringement
upon the intellectual property rights of others, except as otherwise set forth on Schedule 5.18(a) hereto.

 

(b)
Schedule 5.18(b) (as updated from time to time in accordance with Section 6.1.2 hereof) accurately and completely lists
all Products, Services, and all Required Permits in relation thereto, and Borrower has delivered to Agent a copy of all Required
Permits as of the date hereof.

 

(i) With
respect to any Product or Service being tested, manufactured, marketed, sold, and/or delivered by LifeNet and/or Loan Parties,
LifeNet and/or the applicable Loan Party has received (or the applicable, authorized third parties have received), and such Product
or Service is the subject of, all Required Permits needed in connection with the testing, manufacture, marketing, sale, and/or
delivery of such Product or Service by or on behalf of LifeNet and/or Loan Parties as currently conducted. No Loan Party has received,
and to Borrower’s knowledge, LifeNet has not received, any notice from any applicable Governmental Authority, specifically
including the FDA and/or CMS, that such Governmental Authority is conducting an investigation or review (other than a normal routine
scheduled inspection) of LifeNet and/or any Loan Party’s (x) manufacturing facilities, laboratory facilities, the
processes for such Product, or any related sales or marketing activities and/or the Required Permits related to such Product, and
(y) laboratory facilities, the processes for such Services, or any related sales or marketing activities and/or the Required
Permits related to such Services. There are no material deficiencies or violations of applicable laws in relation to the manufacturing,
processes, sales, marketing, or delivery of such Product or Services and/or the Required Permits related to such Product or Services,
no Required Permit has been revoked or withdrawn, nor, to the best of Borrower’s knowledge, has any such Governmental Authority
issued any order or recommendation stating that the development, testing, manufacturing, sales and/or marketing of such Product
or Services by or on behalf of LifeNet and/or Loan Parties should cease or be withdrawn from the marketplace, as applicable.

 

(ii)
Except as set forth on Schedule 5.18(b), (A) there have been no adverse clinical test results in respect of any
Product since the date on which LifeNet and/or the applicable Loan Party acquired rights to such Product, and (B) there have
been no product recalls or voluntary product withdrawals from any market in respect of any Product since the date on which
LifeNet and/or the applicable Loan Party acquired rights to such Product.

 

    [Solsys Medical] A&R Credit Agreement
 
- 32 -

     

    

 

(iii) Neither
LifeNet or any Loan Party has experienced any significant failures in its manufacturing of any Product which caused any reduction
in Products sold.

 

5.19 Restrictive
Provisions.

 

No
Loan Party is a party to any agreement or contract or subject to any restriction contained in its operative documents which would
reasonably be expected to have a Material Adverse Effect.

 

5.20 Labor Matters.

 

No
Loan Party is subject to any labor or collective bargaining agreement. There are no existing or threatened strikes, lockouts or
other labor disputes involving any Loan Party that singly or in the aggregate would reasonably be expected to have a Material Adverse
Effect. Hours worked by and payment made to employees of each Loan Party are not in violation in any material respect of the Fair
Labor Standards Act or any other applicable law, rule or regulation dealing with such matters. Each Loan Party has fully and timely
made any and all social benefits and pension contributions and payments required to be made by such Loan Party according to any
applicable law or agreement.

 

5.21 Material
Contracts.

 

Schedule
5.21 sets forth, with respect to each real estate lease agreement to which any Loan Party is a party as of the Closing Date,
the address of the subject property. The consummation of the transactions contemplated by the Loan Documents will not give rise
to a right of termination in favor of any party to any Material Contract (other than a Loan Party) which would reasonably be expected
to have, either individually or in the aggregate, a Material Adverse Effect.

 

5.22 Compliance
with Laws; Health Care Laws.

 

(a)
Laws Generally. Each Loan Party is in compliance with, and is conducting and has conducted its business and operations
in material compliance with the requirements of all applicable laws, rules, regulations, decrees, orders, judgments, licenses
and permits except where the failure to be in compliance would not reasonably be expected to have a Material Adverse Effect.

 

(b)
Health Care Laws. Without limiting the generality of clause (a) above:

 

(i) No
Loan Party is in violation of any of the Health Care Laws, except for any such violation which would not reasonably be expected
(either individually and taken as a whole with any other violations) to have a Material Adverse Effect.

 

    [Solsys Medical] A&R Credit Agreement
 
- 33 -

     

    

 

(ii)
Each Loan Party(either directly or through one or more authorized third parties) has (i) all licenses, consents, certificates,
permits, authorizations, approvals, franchises, registrations, qualifications and other rights from, and has made all declarations
and filings with, all applicable Governmental Authorities and self-regulatory authorities (each, an “Authorization”)
necessary to engage in the business conducted by it, except for such Authorizations with respect to which the failure to obtain
would not reasonably be expected to have a Material Adverse Effect, and (ii) no knowledge that any Governmental Authority is considering
limiting, suspending or revoking any such Authorization, except where the limitation, suspension or revocation of such Authorization
would not reasonably be expected to have a Material Adverse Effect. All such Authorizations are valid and in full force and effect
and such Loan Party is in material compliance with the terms and conditions of all such Authorizations and with the rules and
regulations of the regulatory authorities having jurisdiction with respect to such Authorizations, except where failure to be
in such compliance or for an Authorization to be valid and in full force and effect could not reasonably be expected to have a
Material Adverse Effect.

 

(iii) Each
Loan Party has received and maintains accreditation in good standing and without limitation or impairment by all applicable accrediting
organizations, to the extent required by applicable law or regulation (including any foreign law or equivalent regulation), except
where the failure to be so accredited and in good standing without limitation would not reasonably be expected to have a Material
Adverse Effect.

 

(iv) Except
where any of the following would not reasonably be expected to have a Material Adverse Effect, no Loan Party has been, and has
been threatened to be, (i) excluded from U.S. health care programs pursuant to 42 U.S.C. §1320(a)7 or any related regulations,
(ii) “suspended” or “debarred” from selling products to the U.S. government or its agencies pursuant to
the Federal Acquisition Regulation, relating to debarment and suspension applicable to federal government agencies generally (48
C.F.R. Subpart 9.4), or other applicable laws or regulations, or (iii) made a party to any other action by any Governmental Authority
that may prohibit it from selling products to any governmental or other purchaser pursuant to any federal, state or local laws
or regulations.

 

(v) No
Loan Party has received any written notice from the FDA, CMS, or any other Governmental Authority with respect to, nor to Borrower’s
best knowledge is there, any actual or threatened investigation, inquiry, or administrative or judicial action, hearing, or enforcement
proceeding by the FDA, CMS, or any other Governmental Authority against any Loan Party regarding any violation of applicable law,
except for such investigations, inquiries, or administrative or judicial actions, hearings, or enforcement proceedings which, individually
and in the aggregate, could not reasonably be expected to result in a Material Adverse Effect.

 

5.23 Existing
Indebtedness; Investments, Guarantees and Certain Contracts.

 

Except
as permitted by Section 7.1 and Section 7.10, Loan Parties do not (a) have any outstanding Debt, or (b) own or hold
any equity or long-term debt investments in, or have any outstanding advances to or any outstanding guarantees for the obligations
of, or any outstanding borrowings from, any other Person.

 

5.24 Affiliated
Agreements.

 

Except
as set forth on Schedule 7.7 and employment agreements entered into with employees, managers, officers and directors
from time to time in the ordinary course of business, (i) there are no existing or proposed agreements, arrangements,
understandings or transactions between any Loan Party, on the one hand, and such Loan Party’s members, managers,
managing members, investors, officers, directors, stockholders, other equity holders, employees, or Affiliates or any members
of their respective families, on the other hand, and (ii) to Borrower’s knowledge, none of the foregoing Persons are
directly or indirectly, indebted to or have any direct or indirect ownership or voting interest in, any Affiliate of any Loan
Party or any Person with which any Loan Party has a business relationship or which competes with any Loan Party (except that
any such Persons may own equity interests in (but not exceeding two percent (2%) of the outstanding equity interests of) any
publicly traded company that may compete with Loan Parties).

 

    [Solsys Medical] A&R Credit Agreement
 
- 34 -

     

    

 

5.25 Names; Locations
of Offices, Records and Collateral; Deposit Accounts.

 

No
Loan Party has conducted business under or used any name (whether corporate, partnership or assumed) other than such names set
forth on Schedule 5.25A. Each Loan Party is the sole owner(s) of all of its respective names listed on Schedule 5.25A,
and any and all business done and invoices issued in such names are such Loan Party’s sales, business and invoices. Each
Loan Party maintains, and since its formation has maintained, respective places of business only at the locations set forth on
Schedule 5.25B, and all books and records of Loan Parties relating to or evidencing the Collateral are located in and at
such locations (other than (i) Deposit Accounts, and (ii) Collateral in the possession of Agent, for the benefit of Lenders). Schedule
7.14 lists all of Loan Parties’ Deposit Accounts as of the Closing Date. All of the tangible Collateral is located exclusively
within the United States.

 

5.26 Non-Subordination.

 

The
payment and performance of the Obligations by Loan Parties are not subordinated in any way to any other obligations of such Loan
Parties or to the rights of any other Person, other than pursuant to any Intercreditor Agreement.

 

5.27 Broker’s
or Finder’s Commissions.

 

Except
as set forth in Schedule 5.27, no broker’s, finder’s or placement fee or commission will be payable to any broker
or agent engaged by any Loan Party or any of its officers, directors or agents with respect to the Loan or the transactions contemplated
by this Agreement except for fees payable to Agent and Lenders. Borrower agrees to indemnify Agent and each Lender and hold each
harmless from and against any claim, demand or liability for broker’s, finder’s or placement fees or similar commissions,
whether or not payable by Borrower, alleged to have been incurred in connection with such transactions, other than any broker’s
or finder’s fees payable to Persons engaged by Agent and/or Lenders.

 

5.28 Anti-Terrorism;
OFAC.

 

(a) No
Loan Party nor any Person controlling or controlled by a Loan Party, nor, to Borrower’s knowledge, any Person having a beneficial
interest in a Loan Party, nor any Person for whom a Loan Party is acting as agent or nominee in connection with this transaction
(1) is a Person whose property or interest in property is blocked or subject to blocking pursuant to Section 1 of Executive Order
13224 of September 23, 2001, Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support
Terrorism (66 Fed. Reg. 49079 (2001)), (2) engages in any dealings or transactions prohibited by Section 2 of such executive order,
or is otherwise associated with any such Person in any manner violative of Section 2 of such executive order, or (3) is a Person
on the list of Specially Designated Nationals and Blocked Persons or is in violation of the limitations or prohibitions under any
other OFAC regulation or executive order.

 

(b)
No part of the proceeds of the Loans will be used, directly or indirectly, for any payments to any governmental official or
employee, political party, official of a political party, candidate for political office, or anyone else acting in an
official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United
States Foreign Corrupt Practices Act of 1977, as amended.

 

    [Solsys Medical] A&R Credit Agreement
 
- 35 -

     

    

 

5.29 Security
Interest.

 

Each
Loan Party has full right and power to grant to Agent, for the benefit of itself and the other Lenders, a perfected, second priority
(subject to currently existing Permitted Liens and the terms of any Intercreditor Agreement) security interest and Lien on the
Collateral pursuant to this Agreement and the other Loan Documents, as applicable, subject to the following sentence. Upon the
execution and delivery of this Agreement and the other Loan Documents, and upon the filing of the necessary financing statements
and/or appropriate filings and/or delivery of the necessary certificates evidencing an equity interest, control and/or possession,
as applicable, without any further action, Agent will have a good, valid and first priority (subject to Permitted Liens and the
terms of any Intercreditor Agreement) perfected Lien and security interest in the Collateral, for the benefit of Lenders. Borrower
is not party to any agreement, document or instrument that conflicts with this Section 5.29.

 

5.30 Survival.

 

Borrower
hereby makes the representations and warranties contained herein with the knowledge and intention that Agent and Lenders are relying
and will rely thereon. All such representations and warranties will survive the execution and delivery of this Agreement, the Closing
and the making of the Loan.

 

Section 6 Affirmative
Covenants.

 

Until
all Obligations have been Paid in Full, Borrower agrees that, unless at any time Required Lenders shall otherwise expressly consent
in writing, it will:

 

6.1 Information.

 

Furnish to Agent (which
shall furnish to each Lender):

 

6.1.1 Annual Report.

 

Promptly
when available and in any event within ninety (90) days after the close of each Fiscal Year (unless Parent files a Notice of Late
Filing (12b-25 Notice) in which case such report shall be due within one hundred five (105) days of the end of the relevant Fiscal
Year): (a) a copy of the annual audited report of Parent and its Subsidiaries for such Fiscal Year, including therein a consolidated
balance sheet and statement of earnings and cash flows of Parent and its Subsidiaries as at the end of and for such Fiscal Year,
certified without qualification (except for qualifications relating to changes in accounting principles or practices reflecting
changes in GAAP and required or approved by Parent’s independent certified public accountants) by independent auditors of
recognized standing selected by Parent and reasonably acceptable to Agent, and (ii) a comparison with the previous Fiscal Year;
and (b) upon Agent’s reasonable request, a consolidated balance sheet of Parent and its Subsidiaries as of the end of such
Fiscal Year and consolidated statements of earnings and cash flows for Parent and its Subsidiaries for such Fiscal Year, together
with a comparison of actual results for such Fiscal Year with the budget for such Fiscal Year, each certified by the chief financial
officer or another executive officer of Parent.

 

    [Solsys Medical] A&R Credit Agreement
 
- 36 -

     

    

 

6.1.2 Interim Reports.

 

(a) Promptly
when available and in any event within forty-five (45) days after the end of each Fiscal Quarter (unless Parent files a Notice
of Late Filing (12b-25 Notice) in which case such report shall be due within fifty (50) days of the end of the relevant Fiscal
Quarter), unaudited consolidated balance sheets of Parent and its Subsidiaries as of the end of such Fiscal Quarter, together with
consolidated statements of earnings and cash flows for such Fiscal Quarter and for the period beginning with the first day of such
Fiscal Year and ending on the last day of such Fiscal Quarter, together with a comparison with the corresponding period of the
previous Fiscal Year and a comparison with the budget for such period of the current Fiscal Year (which may be in preliminary form),
certified by the chief financial officer or other executive officer of Parent.

 

(b) Together
with each such quarterly report to be delivered pursuant to Section 6.1.2(a) above, Borrower shall provide to Agent (i)
a written statement of Borrower’s management in a mutually agreed format setting forth a summary discussion of Borrower’s
financial condition, changes in financial condition and results of operations, and (ii) updated Schedules 5.18(a) and (b)
setting forth any changes to the disclosures set forth in such schedules as most recently provided to Agent or, as applicable,
a written statement of Borrower’s management stating that there have been no changes to such disclosures as most recently
provided to Agent.

 

6.1.3 Revenue-Based
Payment Reconciliation.

 

Upon
Agent’s request Borrower shall furnish to Agent, a report, in form acceptable to Agent, reconciling the Royalties, Net Sales
and all other revenue reported by Parent to Agent during any reporting period to the Aggregate Revenue reported by Parent hereunder
for such period and the amount of Revenue-Based Payment(s) made by Borrower in connection with such period(s).

 

6.1.4 Compliance
Certificate.

 

Contemporaneously
with the furnishing of a copy of each annual audit report pursuant to Section 6.1.1 and each set of quarterly statements
pursuant to Section 6.1.2, a duly completed Compliance Certificate, with appropriate insertions, dated the date of delivery
and corresponding to such annual report or such quarterly statements, and signed by the chief financial officer (or other executive
officer) of Parent, containing a computation showing compliance with Section 7.13 and a statement to the effect that such
officer has not become aware of any Event of Default or Default that exists or, if there is any such event, describing it and the
steps, if any, being taken to cure it.

 

6.1.5 Reports to
Governmental Authorities and Shareholders.

 

Promptly
upon the filing or sending thereof, copies of (a) all regular, periodic or special reports of each Loan Party filed with any Governmental
Authority, (b) all registration statements (or such equivalent documents) of each Loan Party filed with any Governmental Authority
and (c) all proxy statements or other communications made to the holders of Parent’s Equity Interests generally.

  

    [Solsys Medical] A&R Credit Agreement
 
- 37 -

     

    

 

6.1.6 Notice of
Default; Litigation.

 

Promptly
upon becoming aware of any of the following, written notice describing the same and the steps being taken by Borrower or the applicable
Loan Party affected thereby with respect thereto:

 

(a) the
occurrence of an Event of Default;

 

(b) any
litigation, arbitration or governmental investigation or proceeding not previously disclosed by Borrower to Lenders which has been
instituted or, to the knowledge of Borrower, is threatened in writing against Borrower or any other Loan Party or to which any
of the properties of any thereof is subject, which in any case would reasonably be expected to have a Material Adverse Effect;

 

(c) the
institution of any steps by any member of the Controlled Group or any other Person to terminate any Pension Plan, or the failure
of any member of the Controlled Group to make a required contribution to any Pension Plan (if such failure is sufficient to give
rise to a Lien under Section 302(f) of ERISA) or to any Multiemployer Pension Plan, or the taking of any action with respect to
a Pension Plan which could result in the requirement that Borrower or any other Loan Party furnish a bond or other security to
the PBGC or such Pension Plan, or the occurrence of any event with respect to any Pension Plan or Multiemployer Pension Plan which
could result in the incurrence by any member of the Controlled Group of any material liability, fine or penalty (including any
claim or demand for withdrawal liability or partial withdrawal from any Multiemployer Pension Plan), or any material increase in
the contingent liability of Borrower or any other Loan Party with respect to any post-retirement welfare plan benefit, or any notice
that any Multiemployer Pension Plan is in reorganization, that increased contributions may be required to avoid a reduction in
plan benefits or the imposition of an excise tax, that any such plan is or has been funded at a rate less than that required under
Section 412 of the IRC, that any such plan is or may be terminated, or that any such plan is or may become insolvent, in each;

 

(d) any
cancellation or material adverse change in any insurance maintained by Borrower or any other Loan Party;

 

(e) any
other event (including (i) any violation of any law, including any Environmental Law, or the assertion of any Environmental Claim
or (ii) the enactment or effectiveness of any law, rule or regulation) which could reasonably be expected to have a Material Adverse
Effect; or

 

(f) to
the extent that it would reasonably be expected to result in a Material Adverse Effect (i) any suspension, revocation, cancellation
or withdrawal of an Authorization required for Borrower or any other Loan Party, is threatened or there is any basis for believing
that such Authorization will not be renewable upon expiration or will be suspended, revoked, cancelled or withdrawn, (ii) Borrower
or any other Loan Party enters into any consent decree or order pursuant to any Health Care Law and Regulation, or becomes a party
to any judgment, decree or judicial or administrative order pursuant to any Health Care Law, (iii) receipt of any written notice
or other written communication from the FDA, CMS, or any other applicable Governmental Authority alleging non-compliance with CLIA
or any other applicable Health Care Law, (iv) the occurrence of any violation of any Health Care Law by Borrower or any of the
other Loan Parties in the development or provision of Services, and record keeping and reporting to the FDA or CMS that could reasonably
be expected to require or lead to an investigation, corrective action or enforcement, regulatory or administrative action, (v)
the occurrence of any civil or criminal proceedings relating to Borrower or any of the other Loan Parties or any of their respective
employees, which involve a matter within or related to the FDA’s or CMS’ jurisdiction, (vi) any officer, employee or
agent of Borrower or any of the other Loan Parties is convicted of any crime or has engaged in any conduct for which debarment
is mandated or permitted by 21 U.S.C. § 335a, or (vii) any officer, employee or agent of Borrower or any of the other Loan
Parties has been convicted of any crime or engaged in any conduct for which such Person could be excluded from participating in
any federal, provincial, state or local health care programs under Section 1128 of the Social Security Act or any similar law or
regulation.

 

    [Solsys Medical] A&R Credit Agreement
 
- 38 -

     

    

 

6.1.7 Management
Report.

 

Promptly
upon receipt thereof, copies of all detailed financial and management reports submitted to Parent or any other Loan Party by independent
auditors in connection with each annual or interim audit made by such auditors of the books of Parent or any other Loan Party.

 

6.1.8 Projections.

 

Within
thirty (30) days of the written request therefor by Agent, financial projections on a monthly basis of revenues and EBITDA for
Parent and the Subsidiaries for the Fiscal Year specified by Agent prepared in a manner consistent with the projections delivered
by Parent and/or Current Borrower to Agent prior to the Closing Date or otherwise in a manner reasonably satisfactory to Agent,
accompanied by a certificate of a chief financial officer (or other executive officer) of Borrower on behalf of Borrower to the
effect that (a) such projections were prepared by them in good faith, (b) Borrower believes that it has a reasonable basis for
the assumptions contained in such projections and

(c) such
projections have been prepared in accordance with such assumptions.

 

6.1.9 Updated Schedules
to Guarantee and Collateral Agreement.

 

Contemporaneously
with the furnishing of each annual audit report pursuant to Section 6.1.1, updated versions of the Schedules to the Guarantee
and Collateral Agreement showing information as of the date of such audit report (it being agreed and understood that this requirement
shall be in addition to the notice and delivery requirements set forth in the Guarantee and Collateral Agreement).

 

6.1.10 Other Information.

 

(a) Unless
Parent is not subject to, or is not in compliance with, Item 601(a)(10) of Regulation S-K under the Securities Act of 1933, as
amended, promptly, upon the reasonable written request of Agent, copies of any reports, statements or written materials (other
than routine communications (electronic or otherwise) between Borrower or its Affiliates and such entities that are not material
in nature) in relation to any Material Contract (or any replacements thereof) set forth on Schedule 7.11 hereto (as such
schedule may be updated by Agent from time to time to include any Material Contracts that are entered into by a Loan Party from
time to time after the Closing Date) shall be delivered to Agent.

 

(b) Promptly
from time to time, such other information concerning Borrower and any other Loan Party as Agent may reasonably request.

 

6.2 Books;
Records; Inspections.

 

Keep,
and cause each other Loan Party to keep, its books and records in accordance with sound business practices sufficient to
allow the preparation of financial statements in accordance with GAAP; permit, and cause each other Loan Party to permit (at
any reasonable time and with reasonable notice), Agent or any representative thereof to inspect the properties and operations
of Borrower or any other Loan Party; and permit, and cause each other Loan Party to permit, at any reasonable time and with
reasonable notice (or at any time without notice if an Event of Default exists), Agent (accompanied by any Lender) or any
representative thereof to visit any or all of its offices, to discuss its financial matters with its officers and its
independent auditors (and Borrower hereby authorizes such independent auditors to discuss such financial matters with any
Lender or Agent or any representative thereof), and to examine (and, at the expense of Borrower or the applicable Loan Party,
photocopy extracts from) any of its books or other records; and permit, and cause each other Loan Party to permit, (at any
reasonable time and with reasonable notice) Agent and its representatives to inspect the Collateral and other tangible assets
of Borrower or Loan Party, to perform appraisals of the equipment of Borrower or Loan Party, and to inspect, audit, check and
make copies of and extracts from the books, records, computer data, computer programs, journals, orders, receipts,
correspondence and other data relating to any Collateral; provided, however, that unless a Default or Event of Default is
continuing, such inspections, audits and appraisals shall not be conducted more than once per calendar year.

 

    [Solsys Medical] A&R Credit Agreement
 
- 39 -

     

    

 

6.3 Conduct
of Business; Maintenance of Property; Insurance.

 

(a) Borrower
shall, and shall cause each other Loan Party to, (i) conduct its business in accordance with its current business practices, (ii)
engage principally in the same or similar lines of business substantially as heretofore conducted, (iii) collect the Royalties
in the ordinary course of business, (iv) maintain all of its Collateral used or useful in its business in good repair, working
order and condition (normal wear and tear excepted and except as may be disposed of in the ordinary course of business and in accordance
with the terms of the Loan Documents), (v) from time to time to make all necessary repairs, renewals and replacements to the Collateral;
(vi) maintain and keep in full force and effect all material Permits and qualifications to do business and good standing in its
jurisdiction of formation and each other jurisdiction in which the ownership or lease of property or the nature of its business
makes such Permits or qualification necessary and in which failure to maintain such Permits or qualification could reasonably be
expected to be, have or result in a Material Adverse Effect; (vii) remain in good standing and maintain operations in all jurisdictions
in which it is currently located, except where the failure to remain in good standing or maintain operations would not reasonably
be expected to be, have or result in a Material Adverse Effect, and (viii) maintain, comply with and keep in full force and effect
all Intellectual Property and Permits necessary to conduct its business, except in each case where the failure to maintain, comply
with or keep in full force and effect could not reasonably be expected to be, have or result in a Material Adverse Effect.

 

(b) Borrower
shall keep, and cause each other Loan Party to keep, all property necessary in the business of Borrower or each other Loan Party
in good working order and condition, ordinary wear and tear excepted.

 

(c)
Borrower shall maintain, and cause each other Loan Party to maintain, with responsible insurance companies, such insurance
coverage as shall be required by all laws, governmental regulations and court decrees and orders applicable to it and such
other insurance, to such extent and against such hazards and liabilities, as is (i) customarily maintained by Persons
operating in the same geographical region as Borrower that are (A) subject to CLIA and other applicable Health Care Laws, or
(B) otherwise delivering to customers products or services similar to the Services (in each case, as determined by Agent in
its reasonable discretion), and (ii) otherwise in form, substance, and amounts acceptable to Agent in its reasonable
discretion; provided that in any event, such insurance shall, unless the Agent otherwise agrees, insure against all
risks and liabilities of the type insured against as of the Closing Date and shall have insured amounts no less than, and
deductibles no higher than, those amounts provided for as of the Closing Date. Upon request of Agent or any Lender, Borrower
shall furnish to Agent or such Lender a certificate setting forth in reasonable detail the nature and extent of all insurance
maintained by Borrower and each other Loan Party. Borrower shall cause each issuer of an insurance policy to provide Agent
with an endorsement (x) showing Agent as a loss payee with respect to each policy of property or casualty insurance
and naming Agent as an additional insured with respect to each policy of liability insurance promptly upon request by Agent,
(y) providing that the insurance carrier will endeavor to give at least twenty (20) days’ prior written notice
to Borrower and Agent (or ten (10) days’ prior written notice for cancellation due to nonpayment of premiums or if the
Agent consents to such shorter notice) before the termination or cancellation of the policy prior to the expiration thereof
and (z) reasonably acceptable in all other respects to Agent. Borrower shall execute and deliver, and cause each other
applicable Loan Party to execute and deliver, to Agent a collateral assignment, in form and substance reasonably
satisfactory to Agent, of each business interruption insurance policy maintained by the Loan Parties.

 

    [Solsys Medical] A&R Credit Agreement
 
- 40 -

     

    

 

(d) Unless
Borrower provides Agent with evidence of the continuing insurance coverage required by this Agreement, Agent (upon reasonable
advance notice to Borrower) may purchase insurance at Borrower’s expense to protect Agent’s and Lenders’
interests in the Collateral. This insurance shall protect Borrower’s and each other Loan Party’s interests. The
coverage that Agent purchases shall pay any claim that is made against Borrower or any other Loan Party in connection with
the Collateral. Borrower may later cancel any insurance purchased by Agent, but only after providing Agent with evidence that
Borrower has obtained the insurance coverage required by this Agreement. If Agent purchases insurance for the Collateral, as
set forth above, Borrower will be responsible for the reasonable costs of that insurance, including interest and any other
charges that may be imposed with the placement of the insurance, until the effective date of the cancellation or expiration
of the insurance, and such costs of the insurance may be added to the principal amount of the Loans owing
hereunder.

 

6.4 Compliance
with Laws; Payment of Taxes and Liabilities.

 

(a)
Comply, and cause each other Loan Party to comply, in all material respects with all applicable laws, rules, regulations, decrees,
orders, judgments, licenses and permits, except where failure to comply would not reasonably be expected to have a Material Adverse
Effect; (b) without limiting clause (a) above, ensure, and cause each other Loan Party to ensure, that no person who Controls
a Loan Party is (i) listed on the Specially Designated Nationals and Blocked Person List maintained by OFAC, and/or any other
similar lists maintained by OFAC pursuant to any authorizing statute, Executive Order or regulation or (ii) a Person designated
under Section 1(b), (c) or (d) or Executive Order No. 13224 (September 23, 2001), any related enabling legislation
or any other similar Executive Orders; (c) without limiting clause (a) above, comply and cause each other Loan Party to
comply, with all applicable Bank Secrecy Act and anti-money laundering laws and regulations, (d) file, or cause to be filed, all
federal, state, foreign and other tax returns and reports required by law to be filed by any Loan Party, and (e) pay, and cause
each other Loan Party to pay, prior to delinquency, all foreign, federal, state and other taxes and other material governmental
charges against it or any of its property, as well as material claims of any kind which, if unpaid, could become a Lien (other
than a Permitted Lien) on any of its property; provided that the foregoing shall not require Borrower or any other Loan
Party to pay any such tax, charge or claim so long as it shall contest the validity thereof in good faith by appropriate proceedings
and shall set aside on its books adequate reserves with respect thereto in accordance with GAAP. For purposes of this Section
6.4, “Control” shall mean, when used with respect to any Person, (x) the direct or indirect beneficial
ownership of fifty-one percent (51%) or more of the outstanding Equity Interests of such Person or (y) the power to direct
or cause the direction of the management and policies of such Person whether by contract or otherwise.

 

6.5 Maintenance
of Existence.

 

Maintain
and preserve, and (subject to Section 7.4) cause each other Loan Party to maintain and preserve, (a) its existence and good
standing in the jurisdiction of its organization and (b) its qualification to do business and good standing in each jurisdiction
where the nature of its business makes such qualification necessary, other than any such jurisdiction where the failure to be qualified
or in good standing would not reasonably be expected to have a Material Adverse Effect.

 

    [Solsys Medical] A&R Credit Agreement
 
- 41 -

     

    

 

6.6 Employee
Benefit Plans.

 

Except
to the extent that failure to do so would not be reasonably expected to result in (a) a Material Adverse Effect or (b) liability
in excess of $100,000 of any Loan Party, maintain, and cause each other Loan Party to maintain, each Pension Plan (if any) in substantial
compliance with all applicable requirements of law and regulations.

 

6.7 Environmental
Matters.

 

Except
to the extent the failure to do so would not be reasonably expected to result in a Material Adverse Effect, if any release or disposal
of Hazardous Substances shall occur or shall have occurred on any real property or any other assets of Borrower or any other Loan
Party, cause, or direct the applicable Loan Party to cause, the prompt containment and removal of such Hazardous Substances and
the remediation of such real property or other assets as is necessary to comply in all material respects with all Environmental
Laws and to preserve the value of such real property or other assets. Without limiting the generality of the foregoing, except
to the extent the failure to do so would not be reasonably expected to result in a Material Adverse Effect, Borrower shall, and
shall cause each other Loan Party to, comply with each valid Federal or state judicial or administrative order requiring the performance
at any real property by Borrower or any other Loan Party of activities in response to the release or threatened release of a Hazardous
Substance.

 

6.8 Further
Assurances.

 

Take,
and cause each other Loan Party to take, such actions as are necessary or as Agent or the Required Lenders may reasonably request
from time to time to ensure that the Obligations of Borrower and each other Loan Party under the Loan Documents are secured by
a perfected Lien in favor of Agent (subject only to the Permitted Liens) on substantially all of the assets of Borrower and each
Subsidiary of Borrower (as well as all equity interests of each Subsidiary of Borrower) and guaranteed by all of the Subsidiaries
of Borrower (including, promptly upon the acquisition or creation thereof, any Subsidiary of Borrower acquired or created after
the Closing Date), in each case including (a) the execution and delivery of guaranties, security agreements, pledge agreements,
mortgages, deeds of trust, financing statements and other documents, and the filing or recording of any of the foregoing and (b)
the delivery of certificated securities (if any) and other Collateral with respect to which perfection is obtained by possession
but excluding (a) the requirement for the Loan Parties to execute and deliver leasehold mortgages, and (b) any other Excluded Collateral
as defined in the Guarantee and Collateral Agreement.

 

6.9 Compliance
with Health Care Laws.

 

(a) Without
limiting or qualifying Section 6.4 or any other provision of this Agreement, Borrower will comply, and will cause each other
Loan Party and each Subsidiary of Borrower to comply, in all material respects with all applicable Health Care Laws relating to
the operation of such Person’s business, except where failure to comply would not reasonably be expected to have a Material
Adverse Effect.

 

(b) Borrower
will, and will cause each other Loan Party and each Subsidiary to:

 

(i)
Keep in full force and effect all Authorizations required to operate such Person’s business under applicable Health
Care Laws and maintain any other qualifications necessary to conduct, arrange for, administer, provide services in connection
with or receive payment for all applicable Services, except to the extent such failure to keep in full force and effect or
maintain would not reasonably be expected to have a Material Adverse Effect.

 

    [Solsys Medical] A&R Credit Agreement
 
- 42 -

     

    

 

(ii) Promptly
furnish or cause to be furnished to the Agent, with respect to matters that could reasonably be expected to have a Material Adverse
Effect, (i) copies of all material reports of investigational/inspectional observations issued to and received by the Loan Parties
or any of their Subsidiaries, and issued by any Governmental Authority relating to such Person’s business, (ii) copies of
all material establishment investigation/inspection reports (including, but not limited to, FDA Form 483’s) issued to and
received by Loan Parties or any of their Subsidiaries and issued by any Governmental Authority, and (iii) copies of all material
warnings and material untitled letters as well as other material documents received by Loan Parties or any of their Subsidiaries
from the FDA, CMS, DEA, or any other Governmental Authority relating to or arising out of the conduct applicable to the business
of the Loan Parties or any of their Subsidiaries that asserts past or ongoing lack of compliance with any Health Care Law or any
other applicable foreign, federal, state or local law or regulation of similar import and (iv) notice of any material investigation
or material audit or similar proceeding by the FDA, DEA, CMS, or any other Governmental Authority.

 

(iii) Promptly
furnish or cause to be furnished to the Agent, with respect to matters that would reasonably be expected to have a Material Adverse
Effect, (in such form as may be reasonably required by Agent) copies of all non-privileged, reports, correspondence, pleadings
and other communications relating to any matter that could lead to the loss, revocation or suspension (or threatened loss, revocation
or suspension) of any material Authorization or of any material qualification of any Loan Party or Subsidiary; provided that
any internal reports to a Person’s compliance “hot line” which are promptly investigated and determined to be
without merit need not be reported.

 

(iv) Promptly
furnish or cause to be furnished to the Agent notice of all material fines or penalties imposed by any Governmental Authority under
any Health Care Law against any Loan Party or any of its Subsidiaries.

 

(v) Promptly
furnish or cause to be furnished to the Agent notice of all material allegations by any Governmental Authority (or any agent thereof)
of fraudulent activities of any Loan Party or any of its Subsidiaries in relation to the provision of clinical research or related
services.

 

Notwithstanding
anything to the contrary in any Loan Document, no Loan Party or any of its Subsidiaries shall be required to furnish to Agent or
any Lender patient-related or other information, the disclosure of which to Agent or such Lender is prohibited by any applicable
law.

 

6.10 Cure
of Violations.

 

If
there shall occur any breach of Section 6.9, Borrower shall take such commercially reasonable action as is necessary to
validly challenge or otherwise appropriately respond to such fact, event or circumstance within any timeframe required by applicable
Health Care Laws, and shall thereafter diligently pursue the same.

 

    [Solsys Medical] A&R Credit Agreement
 
- 43 -

     

    

 

6.11 Corporate
Compliance Program.

 

Maintain,
and will cause each other Loan Party to maintain on its behalf, a corporate compliance program reasonably acceptable to Agent.
Until the Obligations have been Paid in Full, Borrower will modify such corporate compliance program from time to time (and cause
the other Loan Parties and Subsidiaries to modify their respective corporate compliance programs) as may be reasonable to attempt
to ensure continuing compliance in all material respects with all material applicable laws, ordinances, rules, regulations and
requirements (including, in all applicable material respects, any material Health Care Laws). Borrower will permit Agent and/or
any of its outside consultants to review such corporate compliance programs from time to time upon reasonable notice and during
normal business hours of Borrower.

 

6.12 Payment
of Debt.

 

Except
as otherwise prescribed in the Loan Documents, Borrower shall pay, discharge or otherwise satisfy when due and payable (subject
to applicable grace periods and, in the case of trade payables, to ordinary course of payment practices) all of its material obligations
and liabilities, except when the amount or validity thereof is being contested in good faith by appropriate proceedings and appropriate
reserves shall have been made in accordance with GAAP consistently applied.

 

6.13 Collateral
Access Agreements.

 

Borrower
shall use commercially reasonable efforts to provide to Agent fully executed (except by Agent and the Lenders) Collateral Access
Agreements reasonably requested by Agent with respect to the Collateral that are not otherwise subject to a Collateral Access Agreement
as of the Closing Date; provided, that Borrower shall not be required to provide Collateral Access Agreements for freezers maintained
on consignment with third parties in the ordinary course of business.

 

6.14 Post-Closing
Requirements.

 

As
soon as possible following the Closing Date (and, in any event, no later than November 30, 2019), Borrower shall deliver to Agent
certificates or other evidence of insurance in relation to Parent and its Subsidiaries in effect as required by Section 6.3(c)
and (d), with endorsements naming Agent as lenders’ loss payee and/or additional insured, as applicable, all in form
and substance reasonably acceptable to Agent.

 

Section 7 Negative Covenants.

 

Until
all Obligations have been Paid in Full, Borrower agrees that, unless at any time Agent shall otherwise expressly consent in writing,
in its sole discretion, it will:

 

7.1 Debt.

 

Not, and not permit
any other Loan Party to, create, incur, assume or suffer to exist any Debt, except:

 

(a) Obligations
under this Agreement and the other Loan Documents;

 

(b) Debt
under any Approved AR Loan Facility;

 

    [Solsys Medical] A&R Credit Agreement
 
- 44 -

     

    

 

(c)
Debt secured by Liens permitted by Section 7.2(b), Section 7.2(d), Section 7.2(e) or Section 7.2(o)
and extensions, renewals and re-financings thereof; provided that the aggregate amount of all such Debt permitted under
Section 7.2(d) at any time outstanding shall not exceed $500,000;

 

(d) Debt
with respect to any Hedging Obligations incurred for bona fide hedging purposes and not for speculation;

 

(e) Debt
(i) arising from customary agreements for indemnification related to sales of goods, licensing of intellectual property or adjustment
of purchase price or similar obligations in any case incurred in connection with the acquisition or disposition of any business,
assets or Subsidiary of Borrower otherwise permitted hereunder, (ii) representing deferred compensation to employees of any Loan
Party incurred in the ordinary course of business, and (iii) representing customer deposits and advance payments received in the
ordinary course of business from customers for goods purchased in the ordinary course of business;

 

(f) Debt
with respect to cash management obligations and other Debt in respect of automatic clearing house arrangements, netting services,
overdraft protection and similar arrangements, in each case incurred in the ordinary course of business;

 

(g)
Debt incurred in connection with surety bonds, performance bonds or letters of credit for worker’s compensation, unemployment
compensation and other types of social security and otherwise in the ordinary course of business or referred to in Section
7.2(e);

 

(h) [Reserved]

 

(i) Debt
incurred in connection with Borrower’s corporate credit card program in place as of such date of determination; provided
that the aggregate amount of all such Debt at any time outstanding shall not exceed $500,000; and

 

(j) unsecured
Debt (which for further clarity shall exclude accounts payable and other current liabilities incurred by Loan Parties in the ordinary
course of business), in addition to the Debt listed above, in an aggregate outstanding amount not at any time exceeding $500,000.

 

7.2 Liens.

 

Not,
and not permit any other Loan Party to, create or permit to exist any Lien on any of its real or personal properties, assets or
rights of whatsoever nature (whether now owned or hereafter acquired), except:

 

(a) Liens
for taxes or other governmental charges not at the time delinquent or thereafter payable without penalty or being diligently contested
in good faith by appropriate proceedings and, in each case, for which it maintains adequate reserves in accordance with GAAP and
with respect to which no execution or other enforcement has occurred;

 

(b)
Liens arising in the ordinary course of business (including without limitation (i) Liens of carriers, warehousemen,
mechanics, landlords and materialmen and other similar Liens imposed by law and (ii) Liens incurred in connection with
worker’s compensation, unemployment compensation and other types of social security (excluding Liens arising under
ERISA that secure an amount in excess of $250,000) or in connection with surety bonds, bids, tenders, performance bonds,
trade contracts not for borrowed money, licenses, statutory obligations and similar obligations) for sums not overdue or
being diligently contested in good faith by appropriate proceedings and not involving any deposits or advances or borrowed
money or the deferred purchase price of property or services and, in each case, for which it maintains adequate reserves in
accordance with GAAP and with respect to which no execution or other enforcement of which is effectively stayed;

 

    [Solsys Medical] A&R Credit Agreement
 
- 45 -

     

    

 

(c) Liens
described on Schedule 7.2 as of the Closing Date (other than Liens being released at the closing under this Agreement) and
the replacement, extension or renewal of any Lien permitted by this clause (c) upon or in the same property subject thereto
arising out of the extension, renewal or replacement of the Debt secured thereby (without increase in the amount thereof);

 

(d) subject
to the limitation set forth in Section 7.1(c), (i) Liens arising in connection with Capital Leases (and attaching only to
the property being leased), (ii) Liens on any property securing debt incurred for the purpose of financing all or any part of the
cost of acquiring or improving such property; provided that any such Lien attaches to such property within ninety (90) days
of the acquisition or improvement thereof and attaches solely to the property so acquired or improved, and (iii) the replacement,
extension or renewal of a Lien permitted by one of the foregoing clauses (i) or (ii) in the same property subject
thereto arising out of the extension, renewal or replacement of the Debt secured thereby (without increase in the amount thereof);

 

(e) Liens
relating to litigation bonds and attachments, appeal bonds, judgments and other similar Liens arising in connection with any judgment
or award that is not an Event of Default hereunder;

 

(f) easements,
rights of way, restrictions, minor defects or irregularities in title and other similar Liens not interfering in any material respect
with the ordinary conduct of the business of Borrower or any Subsidiary;

 

(g) Liens
arising under the Loan Documents;

 

(h) the
replacement, extension or renewal of any Lien permitted by clause (c) above upon or in the same property subject thereto
arising out of the extension, renewal or replacement of the Debt secured thereby (without increase in the amount thereof);

 

(i) any
interest or title of a licensor, sublicensor, lessor or sublessor under any license, lease, sublicense or sublease agreement to
the extent limited to the item licensed or leased;

 

(j) (i) Liens
of a collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection and (ii) customary
set off rights of deposit banks with respect to deposit accounts maintained at such deposit banks or which are contained in standard
agreements for the opening of an account with a bank;

 

(k) Liens
arising from precautionary filings of financing statements under the Uniform Commercial Code or similar legislation of any applicable
jurisdiction in respect of operating leases permitted hereunder and entered into by a Loan Party in the ordinary course of business;

 

(l)
Liens attaching to cash earnest money deposits in connection with any letter of intent or purchase agreement permitted hereunder
or indemnification other post-closing escrows or holdbacks;

 

    [Solsys Medical] A&R Credit Agreement
 
- 46 -

     

    

 

(m) Liens incurred with respect to Hedging
Obligations incurred for bona fide hedging purposes and not for speculation;

 

(n) Liens
to secure obligations of a Loan Party to another Loan Party;

 

(o) Liens
arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods in the ordinary course
of business; and

 

(p) Liens
securing an Approved AR Loan Facility.

 

7.3 Dividends;
Redemption of Equity Interests.

 

Not
(a) declare, pay or make any dividend or distribution on any Equity Interests or other securities or ownership interests, (b) apply
any of its funds, property or assets to the acquisition, redemption or other retirement of any Equity Interests or other securities
or interests or of any options to purchase or acquire any of the foregoing, (c) otherwise make any payments, dividends or distributions
to any member, manager, managing member, stockholder, director or other equity owner in such Person’s capacity as such other
than in compliance with Section 7.7 hereof, or (d) make any payment of any management, service or related or similar fee
to any Affiliate or holder of Equity Interests of Borrower other than in compliance with Section 7.7 hereof; provided,
that (i) so long as no Default or Event of Default has occurred or is continuing, or would be caused by such distribution, Borrower
shall be permitted to pay dividends or make distributions to the holder of Equity Interests of Borrower in an amount necessary
for such Persons to pay taxes existing from such Person’s ownership of such Equity Interests in Borrower.

 

7.4 Mergers;
Consolidations; Asset Sales.

 

(a) Not
be a party to any amalgamation or any other form of merger or consolidation, unless agreed to by Agent in its sole discretion,
nor permit any other Loan Party to be a party to any amalgamation or any other form of merger or consolidation, unless agreed to
by Agent in its reasonable discretion.

 

(b)
Not, and not permit any other Loan Party to, sell, transfer, dispose of, convey or lease any of its assets or Equity
Interests, or sell or assign with or without recourse any receivables, except for (i) sales of inventory in the ordinary
course of business for at least fair market value, (ii) transfers, destruction or other disposition of inventory or obsolete
or worn-out assets in the ordinary course of business and any other sales and dispositions of assets (excluding (A) any
equity interests of Borrower or any Subsidiary or (B) sales of inventory described in clause (i) above) for at least
fair market value (as determined by the Board of Directors of Borrower) so long as the net book value of all assets sold or
otherwise disposed of in any Fiscal Year does not exceed $250,000 with respect to sales and dispositions made pursuant to
this clause (ii), (iii) sales and dispositions to Loan Parties, (iv) leases, licenses, subleases and sublicenses
entered into in the ordinary course of business, (v) sales and exchanges of Cash Equivalent Investments to the extent
otherwise permitted hereunder, (vi) Liens expressly permitted under Section 7.2 and transactions expressly permitted
by Section 7.4(a) or 7.10, (vii) sales or issuances of Equity Interests by Borrower, (viii) issuances of Equity
Interests by any Loan Party to any other Loan Party, (ix) dispositions in the ordinary course of business consisting of the
abandonment of intellectual property rights which, in the reasonable good faith determination of Borrower, are not material
to the conduct of the business of the Loan Parties, (x) a cancellation of any intercompany Debt among the Loan Parties, (xi)
a disposition which constitutes an insured event or pursuant to a condemnation, “eminent domain” or similar
proceeding, (xii) sales and dispositions among Subsidiaries of Borrower, and (xiii) exchanges of existing equipment for new
equipment that is substantially similar to the equipment being exchanged and that has a value equal to or greater than the
equipment being exchanged.

 

    [Solsys Medical] A&R Credit Agreement
 
- 47 -

     

    

 

(c)
Notwithstanding any provision in this Agreement or any other Loan Documents to the contrary, the prior consent of Agent shall
not be required in connection with the licensing or sublicensing of Intellectual Property pursuant to collaborations, licenses
or other strategic transactions with third parties executed (i) in the normal course of a Loan Party’s business, (ii) on
an arms-length basis and (iii) prior to an Event of Default (“Permitted Licenses”).

 

7.5 Modification
of Organizational Documents.

 

Not
permit the charter, by-laws or other organizational documents of Borrower or any other Loan Party to be amended or modified in
any way which could reasonably be expected to materially and adversely affect the interests of Agent or any Lender. An amendment
to Borrower’s certificate of incorporation to increase Borrower’s authorized capital stock shall not be deemed to adversely
affect the interests of Agent or any Lender.

 

7.6 Use
of Proceeds.

 

Use
the proceeds of the Loans solely for payment of the consideration for the transactions described in Section 4.10 above,
working capital, for fees and expenses related to the negotiation, execution, delivery and closing of this Agreement and the other
Loan Documents and the transactions contemplated hereby and thereby and for other general business purposes of Borrower and its
Subsidiaries, and not use any proceeds of any Loan or permit any proceeds of any Loan to be used, either directly or indirectly,
for the purpose, whether immediate, incidental or ultimate, of “purchasing or carrying” any Margin Stock.

 

7.7 Transactions
with Affiliates.

 

Not,
and not permit any other Loan Party to, enter into, or cause, suffer or permit to exist any transaction, arrangement or contract
with any of its other Affiliates, which is on terms which are less favorable than are obtainable from any Person which is not one
of its Affiliates, other than (i) reasonable compensation and indemnities to, benefits for, reimbursement of expenses of, and employment
arrangements with, officers, employees and directors in the ordinary course of business, (ii) transactions among Loan Parties and
(iii) transactions pursuant to agreements in existence on the Closing Date and set forth on Schedule 7.7.

 

7.8 Inconsistent
Agreements.

 

Not,
and not permit any other Loan Party to, enter into any agreement containing any provision which would (a) be violated or
breached by any borrowing by Borrower hereunder or by the performance by Borrower or any other Loan Party of any of its
Obligations hereunder or under any other Loan Document, (b) prohibit Borrower or any other Loan Party from granting to Agent
and Lenders a Lien on any of its assets or (c) create or permit to exist or become effective any encumbrance or restriction
on the ability of any other Loan Party to (i) pay dividends or make other distributions to Borrower or any other Subsidiary,
or pay any Debt owed to Borrower or any other Subsidiary, (ii) make loans or advances to Borrower or any other Loan Party or
(iii) transfer any of its assets or properties to Borrower or any other Loan Party, other than, in the cases of clauses
(b) and (c), (A) restrictions or conditions imposed by any agreement relating to purchase money Debt, Capital
Leases and other secured Debt or to leases and licenses permitted by this Agreement if such restrictions or conditions apply
only to the property or assets securing such Debt or the property leased or licensed, (B) customary provisions in leases and
other contracts restricting the assignment thereof, (C) restrictions and conditions imposed by law, (D) those arising under
any Loan Document or any loan documents governing an Approved AR Loan Facility and (E) customary provisions in contracts for
the disposition of any assets; provided that the restrictions in any such contract shall apply only to the assets or
Subsidiary that is to be disposed of and such disposition is permitted hereunder.

 

    [Solsys Medical] A&R Credit Agreement
 
- 48 -

     

    

 

7.9 Business
Activities.

 

Not,
and not permit any other Loan Party to, engage in any line of business other than the businesses engaged in on the Closing Date
and businesses reasonably related thereto. Not, and not permit any other Loan Party to, issue any Equity Interest other than (a)
Equity Interests of Borrower that do not require any cash dividends or other cash distributions to be made prior to the Obligations
being Paid in Full, (b) any issuance by a Subsidiary to Borrower or another Subsidiary in accordance with Section 7.4 or
Section 7.10, or (c) any issuance of directors’ qualifying shares as required by applicable law.

 

7.10 Investments.

 

Not,
and not permit any other Loan Party to, make or permit to exist any Investment in any other Person, except the following:

 

(a) The
creation of any Wholly-Owned Subsidiary and contributions by Borrower to the capital of any Wholly-Owned Subsidiary of Borrower,
so long as the recipient of any such contribution has guaranteed the Obligations and such guaranty is secured by a pledge of all
of its equity interests and substantially all of its real and personal property, in each case in accordance with Section 6.8;

 

(b) Cash
Equivalent Investments;

 

(c) bank
deposits in the ordinary course of business;

 

(d) Investments
listed on Schedule 7.10 as of the Closing Date, together with any roll-over or reinvestment of such Investment(s);

 

(e) any
purchase or other acquisition by Borrower or any Wholly-Owned Subsidiary of Borrower of the assets or equity interests of any Subsidiary
of Borrower;

 

(f) transactions
among Loan Parties permitted by Section 7.4;

 

(g) Hedging
Obligations permitted under Section 7.1(c);

 

(h) (i)
advances given to employees and directors in the ordinary course of business and (ii) other emergency or special circumstance advances
given to employees not to exceed in the case of clauses (i) and (ii) taken together $100,000 in the aggregate outstanding
at any time;

 

(i) lease,
utility and other similar deposits made in the ordinary course of business and trade credit extended in the ordinary course of
business;

 

    [Solsys Medical] A&R Credit Agreement
 
- 49 -

     

    

 

(j) Investments consisting of the non-cash portion of the
consideration received in respect of Dispositions permitted hereunder;

 

(k) Investments
resulting from or otherwise constituting Acquisitions not to exceed $500,000 in the aggregate during any calendar year of the term
of this Loan; provided that for purposes of calculating such aggregate annual Investments during any calendar year, such
calculation shall exclude (i) any payments made by or on behalf of Borrower based solely on actual sales, revenues or other income-related
metrics, (ii) any payments to be made in relation to such Investment after the Term Loan Maturity Date and (iii) any payments made
during such calendar year in relation to Products in existence as of the Closing Date and/or Investments made by Borrower prior
to the Closing Date;

 

(l) Investments
permitted by Borrower or any Loan Party as a result of the receipt of insurance and/or condemnation proceeds in accordance with
the Loan Documents; and

 

(m) Investments
(i) received as a result of the bankruptcy or reorganization of any Person or taken in settlement of or other resolution of claims
or disputes or (ii) in securities of customers and suppliers received in connection with the bankruptcy or reorganization of, or
settlement of delinquent accounts and bona fide disputes with, customers and suppliers, and, in each case, extensions, modifications
and renewals thereof.

 

7.11 Restriction
of Amendments to Certain Documents.

 

Not,
nor permit any Loan Party to, amend or otherwise modify in any material manner, or waive any rights under, any provisions of (i)
any loan documents governing an Approved AR Loan Facility (except that the terms of any Approved AR Loan Facility may be amended,
modified or otherwise waived to the extent permitted under the applicable Intercreditor Agreement), or (ii) any of the Material
Contracts (or any replacements thereof) set forth on Schedule 7.11 hereto (as such schedule may be updated by Agent from
time to time to include any Material Contracts that are entered into by a Loan Party from time to time after the Closing Date).

 

7.12 Fiscal
Year.

 

Not change its Fiscal
Year.

 

7.13 Financial
Covenants

 

7.13.1 Consolidated
Unencumbered Liquid Assets.

 

Not
permit the Consolidated Unencumbered Liquid Assets as measured on the last day of any Fiscal Quarter to be less than (a) as of
any date of determination where the Market Capitalization of Parent is of greater than or equal to $150,000,000, $1,000,000 or
(b), as of any date of determination where the aggregate Market Capitalization of Parent is less than $150,000,000, the greater
of (i) $1,000,000 or (ii) an amount equal to two hundred percent (200%) of the Operational Burn for the prior Fiscal Quarter.
For purposes of this Section 7.13, “Operational Burn” for any period being measured shall mean (A) the
aggregate cash flow from operations of Parent and its Subsidiaries less (B) capital expenditures and changes in net working
capital (normalized for any non-recurring items; in the case of clauses (A) and (B) for the period being measured and as determined
in accordance with GAAP.

 

    [Solsys Medical] A&R Credit Agreement
 
- 50 -

     

    

 

7.13.2 Minimum
Aggregate Revenue.

 

Not
permit the Aggregate Revenue for the twelve (12) consecutive month period ending on the last Business Day of any Fiscal Quarter
(commencing with the Fiscal Quarter in which the Closing Date occurs) to be less than $50,000,000. For purposes of clarification,
if Aggregate Revenue is calculated for a period that includes any period prior the consummation of the Merger, Aggregate Revenue
will include, without duplication, the combined aggregate of Net Sales, Royalties and any other income or revenue recognized by
Parent and/or its Subsidiaries, on one hand, and by Current Borrower and/or its Subsidiaries, on the other hand, for such period.
Notwithstanding the foregoing, any failure of Borrower to satisfy the requirements set forth in this Section 7.13.2 shall
not otherwise constitute an Event of Default so long as Borrower maintains Consolidated Unencumbered Liquid Assets of at least
the greater of (i) $7,500,000 or (ii) an amount equal to four hundred percent (400%) of the Operational Burn for the prior Fiscal
Quarter at all times until the Borrower is otherwise in compliance with this Section 7.13.2.

 

7.13.3 Minimum
EBITDA.

 

Not
either (a) fail to maintain an aggregate Market Capitalization of Parent greater than or equal to $150,000,000 or (b) to the extent
the aggregate Market Capitalization of Parent is less than $150,000,000 as of any date of determination, permit the EBITDA of Parent
and its Subsidiaries for the consecutive month period ending on the last Business Day of any Fiscal Quarter ending immediately
prior to such date of determination (designated by “Q” in the table below) to be less than the applicable amount set
forth in the table below for such period of measure set forth in the table below.

 

Minimum LTM EBITDA
as of the end of:

 

	
        Six
(6) month period ending Q4 2019
	 	 	-($6,000,000)	 
	Nine (9) month period ending Q1 2020	 	 	-($6,500,000)	 
	Twelve (12) month period ending Q2 2020	 	 	-($6,500,000)	 
	Twelve (12) month period ending Q3 2020	 	 	-($4,000,000)	 
	Twelve (12) month period ending Q4 2020	 	 	-($2,000,000)	 
	Twelve (12) month period ending Q1 2021	 	 	-($1,000,000)	 
	Twelve (12) month period ending Q2 2021 and each Fiscal Quarter thereafter	 	$	0	 

 

    [Solsys Medical] A&R Credit Agreement
 
- 51 -

     

    

 

Notwithstanding
the foregoing, any failure of Borrower to satisfy the requirements set forth in this Section 7.13.3 shall not otherwise
constitute an Event of Default so long as Borrower maintains Consolidated Unencumbered Liquid Assets of at least the greater of
(i) $7,500,000 or (ii) an amount equal to four hundred percent (400%) of the Operational Burn for the prior Fiscal Quarter at all
times until the Borrower is otherwise in compliance with this Section 7.13.3.

 

7.14 Deposit
Accounts.

 

Not,
and not permit any other Loan Party, to maintain or establish any new Deposit Accounts other than (a) Exempt Accounts and (b) the
Deposit Accounts set forth on Schedule 7.14 (which Deposit Accounts constitute all of the Deposit Accounts, securities accounts
or other similar accounts maintained by the Loan Parties as of the Closing Date) without prior written notice to Agent. To the
extent such Deposit Account is not an Exempt Account or otherwise subject to the control of the lender(s) in relation to an Approved
AR Loan Facility, Borrower or such other applicable Loan Party and the bank or other financial institution at which the account
is to be opened after the Closing Date shall promptly enter into an Account Control Agreement in relation to such new account,
in form and substance reasonably acceptable to Agent.

 

7.15 Subsidiaries.

 

Not,
and not permit any other Loan Party to, in each case without the prior written consent of Agent in its sole discretion, establish
or acquire any Subsidiary unless (i) no Default or Event of Default has occurred and is continuing or would result therefrom, (ii)
such Subsidiary shall have assumed and joined each Loan Document as a Loan Party pursuant to documentation acceptable to Agent
in its sole discretion and (iii) all other Loan Parties shall have reaffirmed all Obligations as well as all representations and
warranties under the Loan Documents (except to the extent such representations and warranties specifically relate to a prior date
only).

 

7.16 Regulatory
Matters.

 

To
the extent that any of the following would reasonably be expected to result in a Material Adverse Effect, not, and not
permit any other Loan Party to, (i) make, and use commercially reasonable efforts to not permit any officer, employee or
agent of any Loan Party to make, any untrue statement of material fact or fraudulent statement to any Governmental Authority;
fail to disclose a material fact required to be disclosed to any Governmental Authority; or commit a material act, make a
material statement, or fail to make a statement in breach of CLIA or that could otherwise reasonably be expected to provide
the basis for CMS or any Governmental Authority to undertake action against such Loan Party, (ii) conduct any clinical
studies in the United States or sponsor the conduct of any clinical research in the United States, (iii) introduce into
commercial distribution any FDA Products which are, upon their shipment, adulterated or misbranded in violation of 21 U.S.C.
§ 331, (iv) make, and use commercially reasonable efforts to not permit any officer, employee or agent of any Loan Party
to make, any untrue statement of material fact or fraudulent statement to the FDA or any other Governmental Authority; fail
to disclose a material fact required to be disclosed to the FDA or any other Governmental Authority; or commit a material
act, make a material statement, or fail to make a statement in breach of the FD&C Act or that could otherwise reasonably
be expected to provide the basis for the FDA or any other Governmental Authority to invoke its policy respecting
“Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,” as set forth in 56 Fed. Reg. 46191
(September 10, 1991), or (v) otherwise incur any material liability (whether actual or contingent) for failure to comply with
Health Care Laws.

 

    [Solsys Medical] A&R Credit Agreement
 
- 52 -

     

    

 

7.17
Name; Permits; Dissolution; Insurance Policies; Disposition of Collateral; Taxes; Trade Names.

 

Borrower
shall not, nor shall it permit any Loan Party to, (a) change its jurisdiction of organization or change its corporate name without
thirty (30) calendar days prior written notice to Agent; provided, that, Agent hereby authorizes Parent to change
its corporate name to Misonix, Inc. so long as such name change takes place within five (5) Business Days of the date hereof and
Borrower gives Agent copies of all documents filed with the applicable Governmental Authority effectuating such change, (b) amend,
alter, suspend, terminate or make provisional in any material way, any Permit, the suspension, amendment, alteration or termination
of which could reasonably be expected to be, have or result in a Material Adverse Effect without the prior written consent of
Agent, which consent shall not be unreasonably withheld, (c) wind up, liquidate or dissolve (voluntarily or involuntarily) or
commence or suffer any proceedings seeking or that would result in any of the foregoing, (d) amend, modify, restate or change
any insurance policy in a manner adverse to Agent or Lenders, (e) engage, directly or indirectly, in any business other than as
set forth herein, (f) change its federal tax employer identification number or similar tax identification number under the relevant
jurisdiction or establish new or additional trade names without providing not less than thirty (30) days advance written notice
to Agent, or (g) revoke, alter or amend any Tax Information Authorization (on IRS Form 8821 or otherwise) or other similar authorization
mandated by the relevant Government Authority given to any Lender.

 

7.18 Truth
of Statements.

 

Borrower
shall not knowingly furnish to Agent or any Lender any certificate or other document that contains any untrue statement of a material
fact or that omits to state a material fact necessary to make it not misleading in light of the circumstances under which it was
furnished.

 

Section 8 Events of
Default; Remedies.

 

8.1 Events
of Default.

 

Each of the following
shall constitute an Event of Default under this Agreement:

 

8.1.1 Non-Payment of Credit.

 

(a)
Default in the payment when due of the principal of any Loan; (b) default in the payment of any Revenue-Based Payment on or before
the applicable Payment Date or, if there is any good faith dispute as to the amount of any Revenue-Based Payment required to be
paid with respect to any Fiscal Quarter, failure by Borrower, upon final resolution of such dispute (by agreement or non-appealable
judgment of a New York Court) to pay within fifteen (15) days after such final resolution the amount of any such Revenue-Based
Payment determined to be payable by it and not previously paid or (c) without duplication of clause (b) hereof, default, and continuance
thereof for five (5) Business Days, in the payment when due of any interest, fee, or other amount payable by any Loan Party hereunder
or under any other Loan Document.

 

    [Solsys Medical] A&R Credit Agreement
 
- 53 -

     

    

 

8.1.2 Default Under
Other Debt.

 

Any
default shall occur under the terms applicable to any Debt of any Loan Party (excluding the Obligations) in an aggregate principal
amount (for all such Debt so affected and including undrawn committed or available amounts and amounts owing to all creditors under
any combined or syndicated credit arrangement) exceeding $250,000 and such default shall (a) consist of the failure to pay such
Debt when due (after giving effect to applicable grace periods), whether by acceleration or otherwise, or (b) accelerate the maturity
of such Debt or permit the holder or holders thereof, or any trustee or agent for such holder or holders, to cause such Debt to
become due and payable (or require Borrower or any other Loan Party to purchase or redeem such Debt or post cash collateral in
respect thereof) prior to its expressed maturity.

 

8.1.3 Bankruptcy;
Insolvency.

 

(a) Any
Loan Party shall (i) be unable to pay its debts generally as they become due, (ii) have filed against it a petition under any insolvency
statute, (iii) make a general assignment for the benefit of its creditors, (iv) commence a proceeding for the appointment of a
receiver, trustee, liquidator or conservator of itself or of the whole or any substantial part of its property or shall otherwise
be dissolved or liquidated, or (v) make an application or commence a proceeding seeking reorganization or liquidation or similar
relief under any Debtor Relief Law or any other applicable law; or

 

(b) (i)
a court of competent jurisdiction shall (A) enter an order, judgment or decree appointing a custodian, receiver, trustee, liquidator
or conservator of any Loan Party or the whole or any substantial part of any of Loan Party’s properties, which shall continue
unstayed and in effect for a period of sixty (60) calendar days, (B) approve a petition or claim filed against any Loan Party seeking
reorganization, liquidation, appointment of a receiver, interim receiver, liquidator, conservator, trustee or special manager or
similar relief under the any Debtor Relief Law or any other applicable law, which is not dismissed within sixty (60) calendar days
or, (C) under the provisions of any Debtor Relief Law or other applicable law or statute, assume custody or control of any Loan
Party or of the whole or any substantial part of any of Loan Party’s properties, which is not irrevocably relinquished within
sixty (60) calendar days, or (ii) there is commenced against any Loan Party any proceeding or petition seeking reorganization,
liquidation or similar relief under any Debtor Relief Law or any other applicable law or statute, which (A) is not unconditionally
dismissed within sixty (60) calendar days after the date of commencement, or (B) is with respect to which Borrower takes any action
to indicate its approval of or consent.

 

8.1.4 Non-Compliance
with Loan Documents.

 

(a)
Failure by Borrower to comply with or to perform any covenant set forth in Section 7; or (b) failure by any Loan Party
to comply with or to perform any other provision of this Agreement or any other Loan Document applicable to it (and not constituting
an Event of Default under any other provision of this Section 8) and continuance of such failure described in this clause
(b) for thirty (30) days after the earlier of any Loan Party becoming aware of such failure or notice thereof to Borrower
from Agent or any Lender.

 

8.1.5 Representations;
Warranties.

 

Any
representation or warranty made by any Loan Party herein or any other Loan Document is false or misleading in any material
respect when made, or any schedule, certificate, financial statement, report, notice or other writing furnished by any Loan
Party to Agent or any Lender in connection herewith is false or misleading in any material respect on the date as of which
the facts therein set forth are stated or certified.

  

    [Solsys Medical] A&R Credit Agreement
 
- 54 -

     

    

 

8.1.6 Pension Plans.

 

(a) Institution of
any steps by any Person to terminate a Pension Plan if as a result of such termination any Loan Party or any member of the Controlled
Group could be required to make a contribution to such Pension Plan, or could incur a liability or obligation to such Pension Plan,
in excess of $250,000; (b) a contribution failure occurs with respect to any Pension Plan sufficient to give rise to a Lien under
Section 302(f) of ERISA securing obligations in excess of $250,000; or (c) there shall occur any withdrawal or partial withdrawal
from a Multiemployer Pension Plan and the withdrawal liability (without un-accrued interest) to Multiemployer Pension Plans as
a result of such withdrawal (including any outstanding withdrawal liability that Borrower or any other Loan Party or any member
of the Controlled Group have incurred on the date of such withdrawal) exceeds $250,000.

 

8.1.7 Judgments.

 

Final judgments which
exceed an aggregate of $250,000 (to the extent not adequately covered by insurance as to which the insurance company has not disclaimed
liability (provided that customary “reservation of rights” letters shall not be deemed to be disclaimers of liability))
shall be rendered against any Loan Party and shall not have been paid, discharged or vacated or had execution thereof stayed pending
appeal within sixty (60) calendar days after entry or filing of such judgments.

 

8.1.8 Invalidity of Loan Documents or Liens.

 

(a) Any
Loan Document shall cease to be in full force and effect otherwise in accordance with its express terms that results in a
material diminution of the rights and remedies afforded to Agent and/or Lenders or any other secured parties thereunder; (b)
any Loan Party (or any Person by, through or on behalf of any Loan Party) shall contest in any manner the validity, binding
nature or enforceability of any Loan Document; or (c) any Lien created pursuant to any Loan Document ceases to constitute a
valid first priority perfected Lien (subject to Permitted Liens and the terms of any Intercreditor Agreement) on any material
portion of the Collateral in accordance with the terms thereof, or Agent ceases to have a valid perfected first priority
security interest (subject to Permitted Liens and the terms of any Intercreditor Agreement) in any material portion of the
Collateral pledged to Agent, for the benefit of Lenders, pursuant to the Collateral Documents.

 

8.1.9 Invalidity of Subordination Provisions.

 

Any subordination provision
in any document or instrument governing any Approved AR Loan Facility or any subordination provision in the Intercreditor Agreement
shall cease to be in full force and effect, or any Loan Party shall contest in any manner the validity, binding nature or enforceability
of any such provision.

 

8.1.10 Change of Control.

 

A Change of Control
not otherwise permitted pursuant to Section 7.4 above shall occur that does not result in the payment in full of all Obligations
hereunder in accordance with Section 2.8.3.

  

    [Solsys Medical] A&R Credit Agreement
 
- 55 -

     

    

 

8.1.11 Certificate Withdrawals, Adverse Test or
Audit Results, and Other Matters.

 

(a) The institution
of any proceeding by FDA, CMS, or any other Governmental Authority to order the withdrawal of any Product or Product category or
Service or Service category from the market or to enjoin LifeNet, Borrower or any of their respective Subsidiaries from manufacturing,
marketing, selling, distributing, or otherwise providing any Product or Product category or Service or Service category that could
reasonably be expected to have a Material Adverse Effect, (b) the institution of any action or proceeding by DEA, FDA, CMS, or
any other Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Required Permit held by LifeNet,
Borrower or their respective Subsidiary or any of their representatives, which, in each case, could reasonably be expected to have
a Material Adverse Effect, (c) the commencement of any enforcement action against LifeNet, Borrower or their respective Subsidiary
by DEA, FDA, CMS, or any other Governmental Authority that could reasonably be expected to have a Material Adverse Effect, (d)
the recall of any Products or Service from the market, the voluntary withdrawal of any Products or Service from the market, or
actions to discontinue the sale of any Products or Service that could reasonably be expected to have a Material Adverse Effect,
(e) the occurrence of adverse test, audit, or inspection results in connection with a Product or Service which could reasonably
be expected to have a Material Adverse Effect, (f) the occurrence of any event described in clauses (a) through (e)
above that would otherwise cause LifeNet or Borrower to be excluded from participating in any federal, provincial, state or local
health care programs under Section 1128 of the Social Security Act or any similar law or regulation; or (g) any termination of
the Manufacturing Agreement without Agent’s consent in its commercially reasonable discretion.

 

8.2 Remedies.

 

(a) If
any Event of Default described in Section 8.1.3 shall occur, the Loans and all other Obligations shall become immediately
due and payable without presentment, demand, protest or notice of any kind; and, if any other Event of Default shall occur and
be continuing, Agent may, and upon the written request of Required Lenders shall, declare all or any part of the Loans and other
Obligations to be due and payable, whereupon the Loans and other Obligations shall become immediately due and payable (in whole
or in part, as applicable), all without presentment, demand, protest or notice of any kind. Agent shall use commercially reasonable
efforts to promptly advise Borrower of any such declaration, but failure to do so shall not impair the effect of such declaration.

 

(b) In addition to
the acceleration provisions set forth in Section 8.2(a) above, upon the occurrence and continuation of an Event of Default,
Agent may (or shall at the request of Required Lenders) exercise any and all rights, options and remedies provided for in any
Loan Document, under the Uniform Commercial Code, any other applicable foreign or domestic laws or otherwise at law or in equity,
including, without limitation, the right to (i) apply any property of Borrower held by Agent to reduce the Obligations, (ii) foreclose
the Liens created under the Loan Documents, (iii) realize upon, take possession of and/or sell any Collateral or securities pledged,
with or without judicial process, (iv) exercise all rights and powers with respect to the Collateral as Borrower might exercise,
(v) collect and send notices regarding the Collateral, with or without judicial process, (vi) by its own means or with judicial
assistance, enter any premises at which Collateral and/or pledged securities are located, or render any of the foregoing unusable
or dispose of the Collateral and/or pledged securities on such premises without any liability for rent, storage, utilities, or
other sums, and Borrower shall not resist or interfere with such action, (vii) at Borrower’s expense, require that all or
any part of the Collateral be assembled and made available to Agent, for the benefit of Lenders, or Required Lenders at any place
reasonably designated by Required Lenders in their sole discretion and/or relinquish or abandon any Collateral or securities pledged
or any Lien thereon. Notwithstanding the foregoing, Agent agrees that the rights of any licensees under any Permitted Licenses
shall not be terminated, limited or otherwise adversely affected in connection with any foreclosure so long as such licensees
are not otherwise in default under such Permitted Licenses in a way that would permit the licensor to terminate such Permitted
License.

 

    [Solsys Medical] A&R Credit Agreement
 
- 56 -

     

    

  

(c) The
enumeration of any rights and remedies in any Loan Document is not intended to be exhaustive, and all rights and remedies of Agent
and Lenders described in any Loan Document are cumulative and are not alternative to or exclusive of any other rights or remedies
which Agent and Lenders otherwise may have. The partial or complete exercise of any right or remedy shall not preclude any other
further exercise of such or any other right or remedy.

 

(d) Notwithstanding
any provision of any Loan Document, Agent, in its sole discretion shall have the right, but not any obligation, at any time that
Loan Parties fail to do so, subject to any applicable cure periods permitted by or otherwise set forth in the Loan Documents, and
from time to time, without prior notice, to: (i) discharge (at Borrower’s expense) taxes or Liens affecting any of the Collateral
that have not been paid in violation of any Loan Document or that jeopardize Agent’s Lien priority in the Collateral; or
(ii) make any other payment (at Borrower’s expense) for the administration, servicing, maintenance, preservation or protection
of the Collateral (each such advance or payment set forth in clauses (i) and (ii) herein, a “Protective Advance”).
Agent shall be reimbursed for all Protective Advances pursuant to Section 2.9.1(b) and/or Section 2.10, as applicable,
and any Protective Advances shall bear interest at the Default Rate from the date such Protective Advance is paid by Agent until
it is repaid. No Protective Advance by Agent shall be construed as a waiver by Agent, or any Lender of any Default, Event of Default
or any of the rights or remedies of Agent or any Lender under any Loan Document.

 

Section 9 Agent.

 

9.1 Appointment;
Authorization.

 

Each Lender hereby irrevocably
appoints, designates and authorizes Agent to take such action on its behalf under the provisions of this Agreement and each other
Loan Document and to exercise such powers and perform such duties as are expressly delegated to it by the terms of this Agreement
or any other Loan Document, together with such powers as are reasonably incidental thereto. Notwithstanding any provision to the
contrary contained elsewhere in this Agreement or in any other Loan Document, Agent shall not have any duty or responsibility except
those expressly set forth herein, nor shall Agent have or be deemed to have any fiduciary relationship with any Lender, and no
implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other
Loan Document or otherwise exist against Agent.

 

9.2 Delegation
of Duties.

 

Agent may execute any
of its duties under this Agreement or any other Loan Document by or through agents, employees or attorneys-in-fact and shall be
entitled to advice of counsel concerning all matters pertaining to such duties. Agent shall not be responsible for the negligence
or misconduct of any agent or attorney-in-fact that it selects with reasonable care.

 

9.3 Limited
Liability.

 

None of Agent or
any of its directors, officers, employees or agents shall (a) be liable for any action taken or omitted to be taken by any of
them under or in connection with this Agreement or any other Loan Document or the transactions contemplated hereby (except to
the extent resulting from its own gross negligence or willful misconduct as determined by a court of competent jurisdiction),
or (b) be responsible in any manner to any Lender for any recital, statement, representation or warranty made by any Loan
Party or Affiliate of any Loan Party, or any officer thereof, contained in this Agreement or in any other Loan Document, or
in any certificate, report, statement or other document referred to or provided for in, or received by Agent under or in
connection with, this Agreement or any other Loan Document, or the validity, effectiveness, genuineness, enforceability or
sufficiency of this Agreement or any other Loan Document (or the creation, perfection or priority of any Lien or security
interest therein), or for any failure of any Loan Party or any other party to any Loan Document to perform its Obligations
hereunder or thereunder. Agent shall not be under any obligation to any Lender to ascertain or to inquire as to the
observance or performance of any of the agreements contained in, or conditions of, this Agreement or any other Loan Document,
or to inspect the properties, books or records of any Loan Party or Affiliate of any Loan Party.

 

    [Solsys Medical] A&R Credit Agreement
 
- 57 -

     

    

 

9.4 Reliance.

 

Agent shall be entitled
to rely, and shall be fully protected in relying, upon any writing, resolution, notice, consent, certificate, affidavit, letter,
telegram, facsimile, telex or telephone message, statement or other document believed by it to be genuine and correct and to have
been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to
any Loan Party), independent accountants and other experts selected by Agent. Agent shall be fully justified in failing or refusing
to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of
Required Lenders (or all Lenders if expressly required hereunder) as it deems appropriate and, if it so requests, confirmation
from Lenders of their obligation to indemnify Agent against any and all liability and expense which may be incurred by it by reason
of taking or continuing to take any such action. Agent shall in all cases be fully protected in acting, or in refraining from acting,
under this Agreement or any other Loan Document in accordance with a request or consent of Required Lenders (or all Lenders if
expressly required hereunder) and such request and any action taken or failure to act pursuant thereto shall be binding upon each
Lender.

 

9.5 Notice
of Default.

 

Agent shall not be deemed
to have knowledge or notice of the occurrence of any Event of Default or Default except with respect to defaults in the payment
of principal, interest and fees required to be paid to Agent for the account of Lenders, unless Agent shall have received written
notice from a Lender or Borrower referring to this Agreement, describing such Event of Default or Default and stating that such
notice is a “notice of default”. Agent will notify Lenders of its receipt of any such notice or any such default in
the payment of principal, interest and fees required to be paid to Agent for the account of Lenders. Agent shall take such action
with respect to such Event of Default or Default as may be requested by Required Lenders in accordance with Section 8.2;
provided that unless and until Agent has received any such request, Agent may (but shall not be obligated to) take such
action, or refrain from taking such action, with respect to such Event of Default or Default as it shall deem advisable or in the
best interest of Lenders.

 

9.6 Credit
Decision.

 

Each Lender
acknowledges that Agent has not made any representation or warranty to it, and that no act by Agent hereafter taken,
including any review of the affairs of Borrower and the other Loan Parties, shall be deemed to constitute any representation
or warranty by Agent to any Lender. Each Lender represents to Agent that it has, independently and without reliance upon
Agent and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation
into the business, prospects, operations, property, financial and other condition and creditworthiness of Borrower, and made
its own decision to enter into this Agreement and to extend credit to Borrower hereunder. Each Lender also represents that it
will, independently and without reliance upon Agent and based on such documents and information as it shall deem appropriate
at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this
Agreement and the other Loan Documents, and to make such investigations as it deems necessary to inform itself as to the
business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties. Except for
notices, reports and other documents expressly herein required to be furnished to Lenders by Agent, Agent shall not have any
duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects,
operations, property, financial or other condition or creditworthiness of any Loan Party which may come into the possession
of Agent.

 

    [Solsys Medical] A&R Credit Agreement
 
- 58 -

     

    

 

9.7 Indemnification.

 

Whether or not the transactions
contemplated hereby are consummated, each Lender shall indemnify upon demand Agent and its directors, officers, employees and agents
(to the extent not reimbursed by or on behalf of Borrower and without limiting the obligation of Borrower to do so), based on such
Lender’s Pro Rata Term Loan Share, from and against any and all actions, causes of action, suits, losses, liabilities, damages
and expenses, including Legal Costs, except to the extent any thereof result from the applicable Person’s own gross negligence
or willful misconduct, as determined by a court of competent jurisdiction. Without limitation of the foregoing, each Lender shall
reimburse Agent upon demand for its ratable share of any costs or out-of-pocket expenses (including Legal Costs) incurred by Agent
in connection with the preparation, execution, delivery, administration, modification, amendment or enforcement (whether through
negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or responsibilities under, this Agreement,
any other Loan Document, or any document contemplated by or referred to herein, to the extent that Agent is not reimbursed for
such expenses by or on behalf of Borrower. The undertaking in this Section 9.7 shall survive repayment of the Loans, cancellation
of the Notes, any foreclosure under, or modification, release or discharge of, any or all of the Collateral Documents, termination
of this Agreement and the resignation or replacement of Agent.

 

9.8 Agent
Individually.

 

SWK and its Affiliates
may make loans to, issue letters of credit for the account of, accept deposits from, acquire equity interests in and generally
engage in any kind of banking, trust, financial advisory, underwriting or other business with any Loan Party and any Affiliate
of any Loan Party as though SWK were not Agent hereunder and without notice to or consent of any Lender. Each Lender acknowledges
that, pursuant to such activities, SWK or its Affiliates may receive information regarding Loan Parties or their Affiliates (including
information that may be subject to confidentiality obligations in favor of any such Loan Party or such Affiliate) and acknowledge
that Agent shall be under no obligation to provide such information to them. With respect to their Loans (if any), SWK and its
Affiliates shall have the same rights and powers under this Agreement as any other Lender and may exercise the same as though SWK
were not Agent, and the terms “Lender” and “Lenders” include SWK and its Affiliates, to the extent applicable,
in their individual capacities.

 

9.9 Successor
Agent.

 

Agent may resign
as Agent at any time upon 30 days’ prior notice to Lenders and Borrower (unless during the existence of an Event of
Default such notice is waived by Required Lenders). If Agent resigns under this Agreement, Required Lenders shall, with (so
long as no Event of Default exists) the consent of Borrower (which shall not be unreasonably withheld or delayed), appoint
from among Lenders a successor agent for Lenders. If no successor agent is appointed prior to the effective date of the
resignation of Agent, Agent may appoint, on behalf of, and after consulting with Lenders and (so long as no Event of Default
exists) Borrower, a successor agent from among Lenders. Upon the acceptance of its appointment as successor agent hereunder,
such successor agent shall succeed to all the rights, powers and duties of the retiring Agent and the term
“Agent” shall mean such successor agent, and the retiring Agent’s appointment, powers and duties as Agent
shall be terminated. After any retiring Agent’s resignation hereunder as Agent becomes effective, the provisions of
this Section 9 and Sections 10.4 and 10.5 shall continue to inure to its benefit as to any actions taken
or omitted to be taken by it while it was Agent under this Agreement. If no successor agent has accepted appointment as Agent
by the date which is thirty (30) days following a retiring Agent’s notice of resignation, the retiring Agent’s
resignation shall nevertheless thereupon become effective and Lenders shall perform all of the duties of Agent hereunder
until such time, if any, as Required Lenders appoint a successor agent as provided for above; provided that in the
case of any collateral security held by Agent on behalf of the Lenders under any of the Loan Documents, the retiring
Agent shall continue so to hold such collateral security until such time as a successor Agent is appointed and the provisions
of this Section 9 and Sections 10.4 and 10.5 shall continue to inure to its benefit so long as retiring
Agent shall continue to so hold such collateral security. Upon the acceptance of a successor’s appointment as Agent
hereunder, the retiring Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan
Documents in respect of the Collateral.

 

    [Solsys Medical] A&R Credit Agreement
 
- 59 -

     

    

 

9.10 Collateral and Guarantee Matters.

 

Lenders irrevocably authorize
Agent, at its option and in its discretion, (a) to release any Lien granted to or held by Agent under any Collateral Document (i)
when all Obligations have been Paid in Full; (ii) constituting property sold or to be sold or disposed of as part of or in connection
with any sale or other disposition permitted hereunder (including by consent, waiver or amendment and it being agreed and understood
that Agent may conclusively rely without further inquiry on a certificate of an officer of Borrower as to the sale or other disposition
of property being made in compliance with this Agreement); or (iii) subject to Section 10.1, if approved, authorized or
ratified in writing by Required Lenders; (b) notwithstanding Section 10.1(a)(ii) hereof to release any party from its guaranty
under the Guarantee and Collateral Agreement (i) when all Obligations have been Paid in Full or (ii) if such party was sold or
is to be sold or disposed of as part of or in connection with any disposition permitted hereunder (including by consent, waiver
or amendment and it being agreed and understood that Agent may conclusively rely without further inquiry on a certificate of an
officer of Borrower as to the sale or other disposition being made in compliance with this Agreement); or (c) to subordinate its
interest in any Collateral to any holder of a Lien on such Collateral which is permitted by Section 7.2(d) (it being understood
that Agent may conclusively rely on a certificate from Borrower in determining whether the Debt secured by any such Lien is permitted
by Section 7.1). Upon request by Agent at any time, Lenders will confirm in writing Agent’s authority to release,
or subordinate its interest in, particular types or items of Collateral pursuant to this Section 9.10.

 

Agent shall release any
Lien granted to or held by Agent under any Collateral Document (i) when all Obligations have been Paid in Full, (ii) in respect
of property sold or to be sold or disposed of as part of or in connection with any sale or other disposition permitted hereunder
(it being agreed and understood that Agent may conclusively rely without further inquiry on a certificate of an officer of Borrower
as to the sale or other disposition of property being made in compliance with this Agreement) or (iii) subject to Section 10.1,
if directed to do so in writing by Required Lenders.

 

In furtherance of the
foregoing, Agent agrees to execute and deliver to Borrower, at Borrower’s expense, such termination and release documentation
as Borrower may reasonably request to evidence a Lien release that occurs pursuant to terms of this Section 9.10. 

 

    [Solsys Medical] A&R Credit Agreement
 
- 60 -

     

    

 

9.11 Intercreditor
Agreements.

 

Each Lender hereby irrevocably
appoints, designates and authorizes Agent to enter into one or more intercreditor agreements in relation to any other Debt of Borrower
entered into in accordance with this Agreement or as otherwise approved by Required Lenders, on its behalf and to take such action
on its behalf under the provisions of any such agreement (subject to the last sentence of this Section 9.11). Each Lender
further agrees to be bound by the terms and conditions of any such intercreditor agreement. Each Lender hereby authorizes Agent
to issue blockages notices in connection with any such Debt of Borrower and such intercreditor agreement, or any replacement intercreditor
agreement, at the direction of Required Lenders.

 

9.12 Actions
in Concert.

 

For the sake of clarity,
each Lender hereby agrees with each other Lender that no Lender shall take any action to protect or enforce its rights arising
out of this Agreement, the Notes or any other Loan Document (including exercising any rights of setoff) without first obtaining
the prior written consent of Agent and Required Lenders, it being the intent of Lenders that any such action to protect or enforce
rights under this Agreement, the Notes and the other Loan Documents shall be taken in concert and at the direction or with the
consent of Agent or Required Lenders.

 

Section 10 Miscellaneous.

 

10.1 Waiver; Amendments.

 

(a) Except as otherwise expressly provided in
this Agreement, no amendment, modification or waiver of, or consent with respect to, any provision of this Agreement or any
of the other Loan Documents shall in any event be effective unless the same shall be in writing and signed by Borrower (with
respect to Loan Documents to which Borrower is a party), by Lenders having aggregate Pro Rata Term Loan Shares of not less
than the aggregate Pro Rata Term Loan Shares expressly designated herein with respect thereto or, in the absence of such
express designation herein, by Required Lenders, and then any such amendment, modification, waiver or consent shall be
effective only in the specific instance and for the specific purpose for which given; provided, however,
that:

 

(i) no
such amendment, modification, waiver or consent shall, unless in writing and signed by all of the Lenders directly affected thereby,
in addition to Required Lenders and Borrower, do any of the following: (A) increase any of the Commitments (provided that
only the Lenders participating in any such increase of the Commitments shall be considered directly affected by such increase),
(B) extend the date scheduled for payment of any principal of (except as otherwise expressly set forth below in clause (C))
or interest on the Loans or any fees or other amounts payable hereunder or under the other Loan Documents, or (C) reduce the principal
amount of any Loan, the amount or rate of interest thereon (provided that Required Lenders may rescind an imposition of
default interest pursuant to Section 2.6.1), or any fees or other amounts payable hereunder or under the other Loan Documents;
and

 

(ii) no
such amendment, modification, waiver or consent shall, unless in writing and signed by all of the Lenders in addition to Borrower
(with respect to Loan Documents to which Borrower is a party), and each such other Loan Party, do any of the following: (A) release
any material guaranty under the Guarantee and Collateral Agreement or release all or substantially all of the Collateral granted
under the Collateral Documents, except as otherwise specifically provided in this Agreement or the other Loan Documents, (B) change
the definition of Required Lenders, (C) change any provision of this Section 10.1, (D) amend the provisions of Section
2.10.2, or (E) reduce the aggregate Pro Rata Term Loan Shares required to effect any amendment, modification, waiver or consent
under the Loan Documents.

 

    [Solsys Medical] A&R Credit Agreement
 
- 61 -

     

    

 

(b) No
amendment, modification, waiver or consent shall, unless in writing and signed by Agent, in addition to Borrower and Required Lenders
(or all Lenders directly affected thereby or all of the Lenders, as the case may be, in accordance with the provisions above),
affect the rights, privileges, duties or obligations of Agent (including without limitation under the provisions of Section
9), under this Agreement or any other Loan Document.

 

(c) No
delay on the part of Agent or any Lender in the exercise of any right, power or remedy shall operate as a waiver thereof, nor shall
any single or partial exercise by any of them of any right, power or remedy preclude other or further exercise thereof, or the
exercise of any other right, power or remedy.

 

10.2 Notices.

 

All notices hereunder
shall be in writing (including via electronic mail) and shall be sent to the applicable party at its address shown on Annex
II or at such other address as such party may, by written notice received by the other parties, have designated as its address
for such purpose. Notices sent by electronic mail transmission shall be deemed to have been given when sent if sent during regular
business hours on a Business Day, otherwise, such deemed delivery will be effective as of the next Business Day; notices sent by
mail shall be deemed to have been given five (5) Business Days after the date when sent by registered or certified mail, first
class postage prepaid; and notices sent by hand delivery or overnight courier service shall be deemed to have been given when received.
Borrower, Agent and Lenders each hereby acknowledge that, from time to time, Agent, Lenders and Borrower may deliver information
and notices using electronic mail.

 

10.3 Computations.

 

Unless otherwise specifically
provided herein, any accounting term used in this Agreement (including in Section 7.13 or any related definition) shall
have the meaning customarily given such term in accordance with GAAP, and all financial computations (including pursuant to Section
7.13 and the related definitions, and with respect to the character or amount of any asset or liability or item of income or
expense, or any consolidation or other accounting computation) hereunder shall be computed in accordance with GAAP consistently
applied; provided that if Borrower notifies Agent that Borrower wishes to amend any covenant in Section 7.13 (or
any related definition) to eliminate or to take into account the effect of any change in GAAP on the operation of such covenant
(or if Agent notifies Borrower that Required Lenders wish to amend Section 7.13 (or any related definition) for such purpose),
then Borrower’s compliance with such covenant shall be determined on the basis of GAAP in effect immediately before the relevant
change in GAAP became effective, until either such notice is withdrawn or such covenant (or related definition) is amended in a
manner satisfactory to Borrower and Required Lenders. The explicit qualification of terms or computations by the phrase “in
accordance with GAAP” shall in no way be construed to limit the foregoing. Notwithstanding any other provision contained
herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios
referred to herein shall be made, without giving effect to any election under Statement of Financial Accounting Standards 159 (Codification
of Accounting Standards 825-10) to value any Debt or other liabilities of any Loan Party or any Subsidiary at “fair value”,
as defined therein.

  

    [Solsys Medical] A&R Credit Agreement
 
- 62 -

     

    

 

10.4 Costs;
Expenses.

 

Borrower agrees to pay
on demand the reasonable, out-of-pocket costs and expenses of (a) Agent (including Legal Costs) in connection with (i) the preparation,
execution, syndication and delivery (including perfection and protection of Collateral) of this Agreement, the other Loan Documents
and all other documents provided for herein or delivered or to be delivered hereunder or in connection herewith, (ii) the administration
of the Loans and the Loan Documents, and (iii) any proposed or actual amendment, supplement or waiver to any Loan Document, and
(b) Agent and Lenders (including Legal Costs) in connection with the collection of the Obligations and enforcement of this Agreement,
the other Loan Documents or any such other documents. In addition, Borrower agrees to pay and to save Agent and Lenders harmless
from all liability for, any fees of Borrower’s auditors in connection with any reasonable exercise by Agent and Lenders of
their rights pursuant to and to the extent provided in Section 6.2. All Obligations provided for in this Section 10.4
shall survive repayment of the Loans, cancellation of the Notes, and termination of this Agreement.

 

10.5 Indemnification by Borrower.

 

In consideration of
the execution and delivery of this Agreement by Agent and Lenders and the agreement to extend the Commitments provided hereunder,
Borrower hereby agrees to indemnify, exonerate and hold Agent, each Lender and each of the officers, directors, employees, Affiliates
and agents of Agent and each Lender (each a “Lender Party”) free and harmless from and against any and all
actions, causes of action, suits, losses, liabilities, damages and expenses, including Legal Costs but expressly excluding any
consequential, special or lost profits damages (collectively, the “Indemnified Liabilities”), incurred by Lender
Parties or any of them as a result of, or arising out of, or relating to any act or omission of any Loan Party or any of their
respective officers, directors or agents, including, without limitation, (a) any tender offer, merger, purchase of equity interests,
purchase of assets or other similar transaction financed or proposed to be financed in whole or in part, directly or indirectly,
with the proceeds of any of the Loans, (b) the use, handling, release, emission, discharge, transportation, storage, treatment
or disposal of any Hazardous Substance at any property owned or leased by Borrower or any other Loan Party, (c) any violation
of any Environmental Laws with respect to conditions at any property owned or leased by any Loan Party or the operations conducted
thereon, (d) the investigation, cleanup or remediation of offsite locations at which any Loan Party or their respective predecessors
are alleged to have directly or indirectly disposed of Hazardous Substances or (e) the execution, delivery, performance or enforcement
of this Agreement or any other Loan Document by any Lender Party, except to the extent any such Indemnified Liabilities result
solely from (i) the applicable Lender Party’s own gross negligence or willful misconduct as finally determined by a court
of competent jurisdiction in a non-appealable judgment or (ii) a claim brought by the Borrower or any other Loan Party against
a Lender Party for a material breach in bad faith of such Lender Party’s obligations hereunder or under any other Loan Document,
if the Borrower or such Loan Party has obtained a final and non-appealable judgment in its favor on such claim as determined by
a court of competent jurisdiction. If and to the extent that the foregoing undertaking may be unenforceable for any reason, Borrower
hereby agrees to make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is
permissible under applicable law. All Obligations provided for in this Section 10.5 shall survive repayment of the Loans,
cancellation of the Notes, any foreclosure under, or any modification, release or discharge of, any or all of the Collateral Documents
and termination of this Agreement.

 

    [Solsys Medical] A&R Credit Agreement
 
- 63 -

     

    

 

10.6 Marshaling; Payments Set Aside.

 

Neither Agent nor
any Lender shall be under any obligation to marshal any assets in favor of Borrower or any other Person or against or in
payment of any or all of the Obligations. To the extent that Borrower makes a payment or payments to Agent or any Lender, or
Agent or any Lender enforces its Liens or exercises its rights of set-off, and such payment or payments or the proceeds of
such enforcement or set-off or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set
aside or required (including pursuant to any settlement entered into by Agent or any Lender in its discretion) to be repaid
to a trustee, receiver or any other party in connection with any bankruptcy, insolvency or similar proceeding, or otherwise,
then (a) to the fullest extent permitted by applicable law, to the extent of such recovery, the obligation hereunder or part
thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had
not been made or such enforcement or setoff had not occurred and (b) each Lender severally agrees to pay to Agent upon demand
its ratable share of the total amount so recovered from or repaid by Agent to the extent paid to such Lender.

 

10.7 Nonliability of Lenders.

 

The relationship between
Borrower on the one hand and Lenders and Agent on the other hand shall be solely that of borrower and lender. Neither Agent nor
any Lender shall have any fiduciary responsibility to Borrower. Neither Agent nor any Lender undertakes any responsibility to Borrower
to review or inform Borrower of any matter in connection with any phase of Borrower’s business or operations. To the fullest
extent permitted under applicable law, execution of this Agreement by Borrower constitutes a full, complete and irrevocable release
of any and all claims which Borrower may have at law or in equity in respect of all prior discussions and understandings, oral
or written, relating to the subject matter of this Agreement and the other Loan Documents. Neither Agent nor any Lender shall have
any liability with respect to, and Borrower hereby, to the fullest extent permitted under applicable law, waives, releases and
agrees not to sue for, any special, indirect, punitive or consequential damages or liabilities.

 

10.8 Assignments.

 

10.8.1 Assignments.

 

(a) Any Lender may at any time assign to one
or more Persons (other than a Loan Party and their respective Affiliates) (any such Person, an “Assignee”)
all or any portion of such Lender’s Loans and Commitments, with the prior written consent of Agent, and, so long as no
Default or Event of Default has occurred and is continuing, Borrower (which consents shall not be unreasonably withheld or
delayed), provided, however, that no such consent(s) shall be required:

 

(i) from
Borrower for an assignment by a Lender to another Lender or an Affiliate of a Lender or an Approved Fund of a Lender, but
such Lender will give written notice to Borrower of any such assignment;

 

(ii) from
Agent for an assignment by a Lender to an Affiliate of a Lender or an Approved Fund of a Lender;

 

(iii) from
Borrower or Agent for an assignment by SWK Funding LLC, as a Lender, to any Person for which SWK Advisors LLC acts as an investment
advisor (or any similar type of representation or agency) pursuant to a written agreement, but SWK Funding LLC will give written
notice to Borrower of any such assignment;

 

(iv) from
Borrower or Agent for an assignment by a Lender of its Loans and its Note as collateral security to a Federal Reserve Bank
or, as applicable, to such Lender’s trustee for the benefit of its investors (but no such assignment shall release any Lender
from any of its obligations hereunder); or

 

    [Solsys Medical] A&R Credit Agreement
 
- 64 -

     

    

 

(v) from Borrower, Agent or any Lender
for (A) a collateral assignment by SWK of, and the grant by SWK of a security interest in, all of SWK’s right, title
and interest in, to and under each of the Loan Documents, including, without limitation, all of SWK’s rights and
interests in, to and under this Agreement, the Obligations and the Collateral (collectively, the “Assigned
Rights”), to a Permitted Assignee (as defined below), provided that no such collateral assignment shall
release SWK from any of its obligations under any of the Loan Documents or (B) in connection with any enforcement of or
foreclosure by a Permitted Assignee upon its security interests in any of the Assigned Rights, the assignment of SWK’s
Loans and Commitments to a Permitted Assignee. In connection with any enforcement of or foreclosure upon its security
interests in any of the Assigned Rights, a Permitted Assignee, upon notice to Borrower, SWK and the other Lenders, shall be
entitled to substitute itself, or its designee, for SWK as a Lender under this Agreement. For purposes hereof, the term “Permitted
Assignee” shall mean any lender to or funding source of SWK, together with its successors, assigns or designees
(including, without limitation, any purchaser or other assignee of the Assigned Rights from such Person). Effective
immediately upon the replacement of SWK as a Lender under this Agreement by a Permitted Assignee in accordance with this clause
(v), SWK shall automatically be deemed to have resigned as Agent pursuant to Section 9.9 of this Agreement
(without the need for Agent giving advance written notice of such resignation as required pursuant to such Section
9.9), and Required Lenders shall appoint a successor Agent in accordance with Section 9.9 of this Agreement.

 

(b) From
and after the date on which the conditions described above have been met, (i) such Assignee shall be deemed automatically to have
become a party hereto and, to the extent that rights and obligations hereunder have been assigned to such Assignee pursuant to
such Assignment Agreement, shall have the rights and obligations of a Lender hereunder and (ii) the assigning Lender, to the extent
that rights and obligations hereunder have been assigned by it pursuant to such Assignment Agreement, shall be released from its
rights (other than its indemnification rights) and obligations hereunder. Upon the request of the Assignee (and, as applicable,
the assigning Lender) pursuant to an effective Assignment Agreement, Borrower shall execute and deliver to Agent for delivery to
the Assignee (and, as applicable, the assigning Lender) a Note in the principal amount of the Assignee’s Pro Rata Term Loan
Share (and, as applicable, a Note in the principal amount of the Pro Rata Term Loan Share retained by the assigning Lender). Each
such Note shall be dated the effective date of such assignment. Upon receipt by the assigning Lender of such Note, the assigning
Lender shall return to Borrower any prior Note held by it.

 

(c) Agent,
acting solely for this purpose as an agent of Borrower, shall maintain at one of its offices in the United States a copy of each
Assignment Agreement delivered to it and a register for the recordation of the names and addresses of each Lender, and the Commitments
of, and principal amount of the Loans owing to, such Lender pursuant to the terms hereof. The entries in such register shall be,
in the absence of manifest error, conclusive, and Borrower, Agent and Lenders may treat each Person whose name is recorded therein
pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary.
Such register shall be available for inspection by Borrower and any Lender, at any reasonable time upon reasonable prior notice
to Agent.

 

(d)
Notwithstanding the foregoing provisions of this Section 10.8.1 or any other provision of this Agreement, any Lender
may at any time assign all or any portion of its Loans and its Note (i) as collateral security to a Federal Reserve Bank or,
as applicable, to such Lender’s trustee for the benefit of its investors (but no such assignment shall release any
Lender from any of its obligations hereunder) and (ii) to (w) an Affiliate of such Lender which is at least fifty
percent (50%) owned (directly or indirectly) by such Lender or by its direct or indirect parent company, (x) its
direct or indirect parent company, (y) to one or more other Lenders or (z) to an Approved Fund.

 

    [Solsys Medical] A&R Credit Agreement
 
- 65 -

     

    

 

10.9 Participations.

 

Any Lender may at any
time sell to one or more Persons participating interests in its Loans, Commitments or other interests hereunder (any such Person,
a “Participant”). In the event of a sale by a Lender of a participating interest to a Participant, (a) such
Lender’s obligations hereunder shall remain unchanged for all purposes, (b) Borrower and Agent shall continue to deal solely
and directly with such Lender in connection with such Lender’s rights and obligations hereunder and (c) all amounts payable
by Borrower shall be determined as if such Lender had not sold such participation and shall be paid directly to such Lender. No
Participant shall have any direct or indirect voting rights hereunder except with respect to any event described in Section
10.1 expressly requiring the unanimous vote of all Lenders or, as applicable, all affected Lenders. Each Lender agrees to incorporate
the requirements of the preceding sentence into each participation agreement which such Lender enters into with any Participant.
Borrower agrees, to the fullest extent permitted by applicable law, that if amounts outstanding under this Agreement are due and
payable (as a result of acceleration or otherwise), each Participant shall be deemed to have the right of set-off in respect of
its participating interest in amounts owing under this Agreement to the same extent as if the amount of its participating interest
were owing directly to it as a Lender under this Agreement; provided that such right of set-off shall be subject to the
obligation of each Participant to share with Lenders, and Lenders agree to share with each Participant, as provided in Section
2.10.4. Borrower also agrees that each Participant shall be entitled to the benefits of Section 3 as if it were a Lender
(provided that a Participant shall not be entitled to such benefits unless such Participant agrees, for the benefit of Borrower,
to comply with the documentation requirements of Section 3.1(c) as if it were a Lender and complies with such requirements,
and provided, further, that no Participant shall receive any greater compensation pursuant to Section 3 than
would have been paid to the participating Lender if no participation had been sold). Any such Lender transferring a participation
shall, as an agent for Borrower, maintain in the United States a register to record the names, address, and interest, principal
and other amounts owing to, each Participant. The entries in such register shall be, in the absence of manifest error, conclusive,
and Borrower, Agent and the Lenders may treat each Person whose name is recorded therein pursuant to the terms hereof as a Participant
hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. Such Participation register shall be available
for inspection by the Agent or Borrower, at any reasonable time upon reasonable prior written notice from Agent or Borrower.

 

10.10 Confidentiality.

 

Borrower, Agent and
each Lender agree to use commercially reasonable efforts (equivalent to the efforts Borrower, Agent or such Lender applies to
maintain the confidentiality of its own confidential information) to maintain as confidential all information (including, without
limitation, any information provided by Borrower pursuant to Sections 6.1, 6.2 and 6.9) provided to them
by any other party hereto and/or any other Loan Party, as applicable, except that Agent and each Lender may disclose such information
(a) to Persons employed or engaged by Agent or such Lender or any of their Affiliates (including collateral managers of Lenders)
in evaluating, approving, structuring or administering the Loans and the Commitments (provided that such Persons have been
informed of the covenant contained in this Section 10.10); (b) to any assignee or participant or potential assignee or
participant that has agreed to comply with the covenant contained in this Section 10.10 (and any such assignee or participant
or potential assignee or participant may disclose such information to Persons employed or engaged by them as described in clause
(a) above); (c) as required or requested by any federal or state regulatory authority or examiner, or any insurance industry
association, or as reasonably believed by Agent or such Lender to be compelled by any court decree, subpoena or legal or administrative
order or process; (d) as, on the advice of Agent’s or such Lender’s counsel, is required by law; (e) in connection
with the exercise of any right or remedy under the Loan Documents or in connection with any litigation to which Agent or such
Lender is a party; (f) to any nationally recognized rating agency or investor of a Lender that requires access to information
about a Lender’s investment portfolio in connection with ratings issued or investment decisions with respect to such Lender;
(g) that ceases to be confidential through no fault of Agent or any Lender; (h) to a Person that is an investor or prospective
investor in a Securitization that agrees that its access to information regarding Borrower and the Loans and Commitments is solely
for purposes of evaluating an investment in such Securitization and who agrees to treat such information as confidential; or (i)
to a Person that is a trustee, collateral manager, servicer, noteholder or secured party in a Securitization in connection with
the administration, servicing and reporting on the assets serving as collateral for such Securitization. For purposes of this
Section, “Securitization” means a public or private offering by a Lender or any of its Affiliates or their
respective successors and assigns, of securities which represent an interest in, or which are collateralized, in whole or in part,
by the Loans or the Commitments. In each case described in clauses (c), (d) and (e) (as such disclosure in
clause (e) pertains to litigation only), where the Agent or Lender, as applicable, is compelled to disclose a Loan Party’s
confidential information, promptly after such disclosure the Agent or such Lender, as applicable, shall notify Borrower of such
disclosure provided, however, that neither the Agent nor any Lender shall be required to notify Borrower of any
such disclosure (i) to any federal or state banking regulatory authority conducting an examination of the Agent or such Lender,
or (ii) to the extent that it is legally prohibited from so notifying Borrower. Notwithstanding the foregoing, Agent reserves
the right to provide to industry trade organizations information necessary and customary for inclusion in league table measurements.

 

    [Solsys Medical] A&R Credit Agreement
 
- 66 -

     

    

 

10.11 Captions.

 

Captions used in this
Agreement are for convenience only and shall not affect the construction of this Agreement.

 

10.12 Nature of Remedies.

 

All Obligations of Borrower
and rights of Agent and Lenders expressed herein or in any other Loan Document shall be in addition to and not in limitation of
those provided by applicable law. No failure to exercise and no delay in exercising, on the part of Agent or any Lender, any right,
remedy, power or privilege hereunder, shall operate as a waiver thereof; nor shall any single or partial exercise of any right,
remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy,
power or privilege.

 

10.13 Counterparts.

 

This Agreement may
be executed in any number of counterparts and by the different parties hereto on separate counterparts and each such
counterpart shall be deemed to be an original, but all such counterparts shall together constitute but one and the same
Agreement. Receipt by facsimile machine or in “.pdf” format through electronic mail of any executed signature
page to this Agreement or any other Loan Document shall constitute effective delivery of such signature page. This Agreement
and the other Loan Documents to the extent signed and delivered by means of a facsimile machine or other electronic
transmission (including “.pdf”), shall be treated in all manner and respects and for all purposes as an original
agreement or amendment and shall be considered to have the same binding legal effect as if it were the original signed
version thereof delivered in person. No party hereto or to any such other Loan Document shall raise the use of a facsimile
machine or other electronic transmission to deliver a signature or the fact that any signature or agreement or amendment was
transmitted or communicated through the use of a facsimile machine or other electronic transmission as a defense to the
formation or enforceability of a contract and each such party forever waives any such defense.

 

    [Solsys Medical] A&R Credit Agreement
 
- 67 -

     

    

 

10.14 Severability.

 

The illegality or unenforceability
of any provision of this Agreement or any instrument or agreement required hereunder shall not in any way affect or impair the
legality or enforceability of the remaining provisions of this Agreement or any instrument or agreement required hereunder.

 

10.15 Entire Agreement.

 

This Agreement, together
with the other Loan Documents, embodies the entire agreement and understanding among the parties hereto and supersedes all prior
or contemporaneous agreements and understandings of such Persons, verbal or written, relating to the subject matter hereof and
thereof.

 

10.16 Successors; Assigns.

 

This Agreement shall
be binding upon Borrower, Lenders and Agent and their respective successors and assigns, and shall inure to the benefit of Borrower,
Lenders and Agent and the successors and assigns of Lenders and Agent. No other Person shall be a direct or indirect legal beneficiary
of, or have any direct or indirect cause of action or claim in connection with, this Agreement or any of the other Loan Documents.
Borrower may not assign or transfer any of its rights or Obligations under this Agreement without the prior written consent of
Agent and each Lender.

 

10.17 Governing Law.

 

THIS AGREEMENT AND EACH
NOTE SHALL BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND
TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 AND SECTION
5-1402 OF THE NEW YORK GENERAL OBLIGATIONS CODE).

 

10.18 Forum Selection; Consent to Jurisdiction.

 

ANY LITIGATION
BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, SHALL BE BROUGHT AND
MAINTAINED EXCLUSIVELY IN THE COURTS OF THE STATE OF NEW YORK OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN
DISTRICT OF NEW YORK; PROVIDED THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE
BROUGHT, AT AGENT’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND.
EACH PARTY HEREBY EXPRESSLY AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK AND OF THE
UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK FOR THE PURPOSE OF ANY SUCH LITIGATION AS SET FORTH ABOVE.
EACH PARTY FURTHER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS BY REGISTERED MAIL, U.S. FIRST CLASS POSTAGE PREPAID, OR BY
PERSONAL SERVICE WITHIN OR WITHOUT THE STATE OF NEW YORK. EACH PARTY HEREBY EXPRESSLY AND IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED UNDER APPLICABLE LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH
LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN
INCONVENIENT FORUM.

 

    [Solsys Medical] A&R Credit Agreement
 
- 68 -

     

    

 

10.19 Waiver of Jury Trial.

 

EACH OF BORROWER, AGENT
AND EACH LENDER, TO THE FULLEST EXTENT PERMITTED UNDER APPLICABLE LAW, HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION
OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS AGREEMENT, ANY NOTE, ANY OTHER LOAN DOCUMENT AND ANY AMENDMENT, INSTRUMENT,
DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION HEREWITH OR THEREWITH OR ARISING FROM ANY
LENDING RELATIONSHIP EXISTING IN CONNECTION WITH ANY OF THE FOREGOING, AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED
BEFORE A COURT AND NOT BEFORE A JURY.

 

10.20 Patriot Act.

 

Each Lender that is
subject to the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Patriot Act”),
and Agent (for itself and not on behalf of any Lender), hereby notifies each Loan Party that, pursuant to the requirements of
the Patriot Act, such Lender and Agent are required to obtain, verify and record information that identifies each Loan Party,
which information includes the name and address of each Loan Party and other information that will allow such Lender or Agent,
as applicable, to identify each Loan Party in accordance with the Patriot Act.

 

10.21 Amendment and Restatement .

 

The parties hereto agree
that, on the Closing Date, the following transactions shall be deemed to occur automatically, without further action by any party
hereto: (a) the Original Credit Agreement shall be deemed to be amended and restated in its entirety pursuant to this Agreement;
(b) all Obligations under the Original Credit Agreement outstanding on the Closing Date shall in all respects be continuing and
shall be deemed to be Obligations outstanding hereunder; (c) Parent shall be joined to the Loan Documents as a Borrower in all
respects as if it were an original signatory hereto; (d) the guaranties made to the Lenders and Agent pursuant to the Original
Credit Agreement and the other Loan Documents, shall remain in full force and effect and are hereby reaffirmed; and (e) all references
in the other Loan Documents to the Original Credit Agreement shall be deemed to refer without further amendment to this Agreement.

 

[Remainder of page intentionally blank;
signature pages follow.]

  

    [Solsys Medical] A&R Credit Agreement
 
- 69 -

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed and delivered by their duly authorized officers as of the date first set
forth above.

 

	 	BORROWERS:
	 	 
	 	NEW MISONIX, INC., 
	 	a Delaware Corporation
	 	 	 
	 	By:	/s/ Joseph Dwyer
	 	Name: 	Joseph Dwyer
	 	Title: 	Chief Financial Officer
	 	 	 
	 	SOLSYS MEDICAL, LLC, 
	 	a Delaware limited liability company
	 	 	 
	 	By: NEW MISONIX, INC., 
	 	its sole member
	 	 	 
	 	By:	/s/ Joseph Dwyer
	 	Name: 	Joseph Dwyer
	 	Title: 	Chief Financial Officer

 

    [Solsys Medical] A&R Credit Agreement

     

    

  

	 	AGENT AND LENDERS:
	 	 
	 	SWK FUNDING LLC, 
	 	as Agent and a Lender
	 	 	 	 
	 	 	By: SWK Holdings Corporation, 
	 	 	its sole Manager
	 	 	 	 
	 	 	By:	/s/ Winston Black
	 	 	Name: 	Winston Black
	 	 	Title: 	Managing Director

 

    [Solsys Medical] A&R Credit Agreement

     

    

 

ANNEX I

 

Commitments and Pro Rata Term Loan Shares

 

	Lender	 	Commitment	 	 	Pro Rata Term Loan Share	 
	SWK Funding LLC 	 	$	25,095,761	 	 	 	100	%

 

    [Solsys Medical] A&R Credit Agreement

     

    

  

ANNEX II

 

Addresses

 

	Party	 	Notice Address
	Agent:	 	
        SWK Funding LLC

        14755 Preston Road, Suite 105

        Dallas, Texas 75254

        Email: notifications@swkhold.com

         

        with a copy to:

         

        Holland & Knight LLP

        200 Crescent Court, Suite 1600

        Dallas, Texas 75201

        Attn: Ryan Magee

        Email: ryan.magee@hklaw.com

	 	 	 
	Borrower:	 	
        New Misonix, Inc.

        1938 New Highway

        Farmingdale, New York 11735

        Attn: Joe Dwyer, Chief Financial Officer

        Email: jdwyer@misonix.com

         

        with a copy to:

         

        Jones Day

        3161 Michelson Drive, Suite 800

        Irvine, California 92612

        Attn: John R. Beeson

        Email: jbeeson@jonesday.com

 

    [Solsys Medical] A&R Credit Agreement

     

    

 

EXHIBIT A

 

Form of Assignment Agreement

 

This ASSIGNMENT AGREEMENT (the “Assignment
Agreement”) is entered into as of [              ],
20[    ], by and between the Assignor named on the signature page hereto (“Assignor”)
and the Assignee named on the signature page hereto (“Assignee”). Reference is made to the AMENDED AND RESTATED
Credit Agreement dated as of September 27, 2019 (as amended, restated, supplemented, or otherwise modified from time to time, the
“Credit Agreement”) among SOLSYS MEDICAL, LLC, a Delaware limited liability company, NEW MISONIX, INC., a Delaware
corporation (collectively, “Borrower”), the Lenders party thereto from time to time (“Lenders”),
and SWK FUNDING LLC, as administrative agent (in such capacity, together with its successors and assigns, the “Agent”)
on behalf of the Lenders. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the
Credit Agreement.

 

Assignor and Assignee agree as follows:

 

1. For an agreed consideration,
Assignor hereby irrevocably sells and assigns to Assignee, and the Assignee hereby irrevocably purchases and assumes from Assignor,
subject to and in accordance with the Credit Agreement, as of the Effective Date (as defined below) (a) all of Assignors’
rights and obligations in its capacities as Lender under the Credit Agreement and any other documents or instruments delivered
pursuant thereto to the extent related to the amount and percentage interest, as identified on the schedule attached hereto, of
all of such outstanding rights and obligations of Assignor under or in relation to the Credit Agreement, and (b) to the extent
permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of Assignor (in its capacity
as Lender) against any Person, whether known or unknown, arising under or in connection with the Credit Agreement, any other documents
or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of
the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other
claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (a) above (the rights
and obligations sold and assigned by Assignor to the Assignee pursuant to clauses (a) and (b) above being referred
to herein collectively as an “Assigned Interest”). Such sale and assignment is without recourse to Assignor
and, except as expressly provided in this Assignment Agreement, without representation or warranty by Assignor.

 

2. Assignor (a) represents that
as of the Effective Date, that it is the legal and beneficial owner of the Assigned Interests free and clear of any adverse claim;
(b) represents that, as of the date hereof, the balance of the Loan is $[              ];
(c) makes no other representation or warranty and assumes no responsibility with respect to any statement, warranties or representations
made in or in connection with the Credit Agreement or the execution, legality, validity, enforceability, genuineness, sufficiency
or value of the Credit Agreement, any other Loan Documents or any other instrument or document furnished pursuant thereto; and
(d) makes no representation or warranty and assumes no responsibility with respect to the financial condition of any Loan Party
or any other Person or the performance or observance by any Loan Party of its Obligations under the Credit Agreement or the other
Loan Documents or any other instrument or document furnished pursuant thereto.

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit A)
 
A-1

     

    

 

3. Assignee (a) represents and
warrants that it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Assumption
and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement; (b) confirms that it
has received a copy of the Credit Agreement and the other Loan Documents, together with copies of the most recent financial statements
delivered pursuant thereto and such other documents and information as it has deemed appropriate to make its own credit analysis
and decision to enter into this Assignment Agreement; (c) represents and warrants that it has, independently and without reliance
upon Agent or Assignor or any other Lender and based on such documents and information as it has deemed appropriate, made its own
credit analysis and decision to enter into this Assignment Agreement and to purchase such Assigned Interest; (d) agrees that it
will, independently and without reliance upon Agent, Assignor or any other Lender and based on such documents and information as
it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit
Agreement; (e) appoints and authorizes Agent to take such action as agent on its behalf and to exercise such powers under the Credit
Agreement as are delegated to Agent by the terms thereof, together with such powers as are reasonably incidental thereto; (f) hereby
represents and warrants that upon the effectiveness of this Assignment Agreement, Assignee will be a Lender under the Credit Agreement
and further agrees that it will perform in accordance with their terms all obligations which by the terms of the Credit Agreement
are required to be performed by it as a Lender; (g) represents that on the date of this Assignment Agreement it is not presently
aware of any facts that would cause it to make a claim under the Credit Agreement; (h) if organized under the laws of a jurisdiction
outside the United States, attaches the forms prescribed by the Internal Revenue Service of the United States, which have been
duly executed, certifying as to Assignee’s exemption from United States withholding taxes with respect to all payments to
be made to Assignee under the Credit Agreement or such other documents as are necessary to indicate that all such payments are
subject to such tax at a rate reduced by an applicable tax treaty; and (i) represents and warrants that it is sophisticated with
respect to decisions to acquire assets of the type represented by the Assigned Interest and either it, or the Person exercising
discretion in making its decision to acquire the Assigned Interest, is experienced in acquiring assets of such type.

 

4. The effective date for this
Assignment Agreement shall be as set forth on the schedule attached hereto (the “Effective Date”). Following
the execution of this Assignment Agreement, it will be delivered to Agent for acceptance and recording by Agent pursuant to the
Credit Agreement.

 

5. Upon such acceptance and recording,
from and after the Effective Date, (a) Assignee shall be a party to the Credit Agreement and, to the extent provided in this Assignment
Agreement, have the rights and obligations of a Lender thereunder and (b) Assignor shall, to the extent provided in this Assignment
Agreement, relinquish its rights (other than indemnification rights) and be released from its obligations under the Credit Agreement.

 

6. From and after the Effective
Date, Agent shall make all payments in respect of each Assigned Interest (including payments of principal, interest, fees and other
amounts) to Assignor for amounts which have accrued to but excluding the Effective Date and to Assignee for amounts which have
accrued from and after the Effective Date. Notwithstanding the foregoing, Agent shall make all payments of interest, fees or other
amounts paid or payable in kind from and after the Effective Date to Assignee.

 

7. THIS ASSIGNMENT AGREEMENT
SHALL BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE
PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES.

 

8. This Assignment Agreement
shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment
Agreement may be executed in any number of counterparts and by the different parties hereto on separate counterparts and each such
counterpart shall be deemed to be an original, but all such counterparts shall together constitute but one and the same Assignment
Agreement. Receipt by facsimile, portable document format (.pdf), or other electronic transmission of any executed signature page
to this Assignment Agreement shall constitute effective delivery of such signature page.

 

[Remainder of page intentionally blank;
signature page follows.]

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit A)
 
A-2

     

    

  

The parties hereto have caused this Assignment Agreement to
be executed and delivered as of the date first written above.

 

	 	ASSIGNOR:
	 	[___________________________]
	 	 
	 	By:	                               
	 	Name: 	                               
	 	Title:	                               
	 	 
	 	ASSIGNEE:
	 	[___________________________]
	 	 
	 	By:	                               
	 	Name: 	                               
	 	Title:	                               
	 	 
	 	Acknowledged and Agreed:
	 	 
	 	SWK FUNDING LLC, 
	 	as Agent
	 	 
	 	By: SWK Holdings Corporation, 
	 	its sole Manager
	 	 
	 	By:	                               
	 	Name:	                               
	 	Title:	                               

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit A)
 
A-3

     

    

  

Schedule to Assignment Agreement

 

	Assignor: 	_________________
	 	 
	Assignee:	_________________
	 	 
	Effective Date:	_________________
	 	 
	Credit Agreement:	Amended and Restated Credit Agreement, dated as of September 27, 2019, among SOLSYS MEDICAL, LLC, a Delaware limited liability company, and NEW MISONIX, INC., a Delaware corporation, each as Borrower, the other loan parties party thereto, the financial institutions party thereto from time to time as Lenders, and SWK FUNDING LLC, as Agent, as it may be amended, restated, supplemented or otherwise modified from time to time

 

Interests Assigned:

 

	 	 	Term Loan	 	 	Aggregate Pro Rata 
 Term Loan Share	 
	Assignor Amounts (pre-assignment)	 	$	25,095,761	 	 	 	100	%
	Assignor Amounts (post-assignment)	 	$	 	 	 	 	 	 
	Amounts Assigned	 	$	 	 	 	 	 	 
	Assignee Amounts (pre-assignment)	 	$	 	 	 	 		%
	Assignee Amounts (post-assignment)	 	$	 	 	 	 	 	 

 

Assignee Information:

 

	Address for Notices:	 	Address for Payments:
	 	 	 	 
	                   	 	 	 
	                   	 	Bank: 	                   
	Attention: 	                   	 	ABA #:	                   
	Telephone: 	 	 	Account #:	                   
	Telecopy:	 	 	Reference:	                   

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit A)
 
A-4

     

    

 

EXHIBIT B

 

Form of Compliance Certificate

 

COMPLIANCE CERTIFICATE

 

[____________], 20[__]

 

Please refer to the Amended and Restated
Credit Agreement, dated as of September 27, 2019 (as amended, restated or otherwise modified from time to time, the “Credit
Agreement”) among SOLSYS MEDICAL, LLC, a Delaware limited liability company, and NEW MISONIX, INC., a Delaware corporation,
(collectively, “Borrower”), the lenders party thereto from time to time as Lenders, and SWK FUNDING LLC, as
administrative agent (in such capacity, together with its successors and assigns, the “Agent”) on behalf of
the Lenders. This certificate (this “Certificate”), together with supporting calculations attached hereto, is
delivered to Agent pursuant to the terms of the Credit Agreement. Terms used but not otherwise defined herein are used herein as
defined in the Credit Agreement.

 

Enclosed herewith is a copy of the [annual
audited/quarterly] financial statements required under the Credit Agreement as at and for the period ending [__________________]
(the “Computation Date”), which financial statements fairly present in all material respects the financial
condition and results of operations of the Persons covered by such financial statements as of the Computation Date and for the
period then ended and have been prepared in accordance with GAAP consistently applied (subject to the absence of footnotes and
to normal year-end adjustments).

 

Borrower hereby certifies and warrants
that the computations set forth on the schedule attached hereto correspond to the computations required by Sections 7.13.1, 7.13.2,
and 7.13.3 of the Credit Agreement and such computations are true and correct as at the Computation Date.

 

Borrower further certifies that no Event
of Default or Default has occurred and is continuing [except as set forth on Annex I hereto, which Annex describes such Event
of Default or Default and the steps, if any, being taken to cure it].

 

Borrower has caused
this Certificate to be executed and delivered by its officers thereunto duly authorized on [          ],
20[      ].

 

	 	NEW MISONIX, INC., 

a Delaware corporation
	 	 
	 	By:	                               
	 	Name:	                               
	 	Title:	                               

  

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit B)
 
B-1

     

    

 

Schedule to Compliance Certificate

Dated as of ___________________1

 

		A.	Section 7.13.1
                                         – Consolidated Unencumbered Liquid Assets

 

		1A.	any Cash Equivalent Investment owned by Parent and
its Subsidiaries on a consolidated basis which are not the subject of any Lien or other arrangement with any creditor to have
its claim satisfied out of the asset (or proceeds thereof) prior to the general creditors of Borrower and such Subsidiaries other
than the Lien for the benefit of Agent and Lenders:

 

		(a)	any evidence of Debt, maturing not more than one year
after such time, issued or guaranteed by the United States Government or any agency thereof 	$________

 

		(b)	commercial paper, or corporate demand notes, in each case
(unless issued by a Lender or its holding company) rated at least A-l by Standard & Poor’s Ratings Group or P-l by Moody’s
Investors Service, Inc.	$________

 

		(c)	any certificate of deposit (or time deposit represented
by a certificate of deposit) or banker’s acceptance maturing not more than one year after such time, or any overnight Federal
Funds transaction that is issued or sold by any Lender (or by a commercial banking institution that is a member of the Federal
Reserve System or is a U.S. branch of a foreign banking institution and has a combined capital and surplus and undivided profits
of not less than $500,000,000)	$________

 

		(d)	any repurchase agreement entered into with any Lender (or
commercial banking institution of the nature referred to in Item (c) above) which (i) is secured by a fully perfected security
interest in any obligation of the type described in any of Items (a) through (c) above and (ii) has a market value
at the time such repurchase agreement is entered into of not less than 100% of the repurchase obligation of such Lender (or other
commercial banking institution) thereunder	$________

 

		(e)	money market accounts or mutual funds which invest  exclusively or substantially in assets
                                                                              satisfying the foregoing requirements	$________

 

 

		1	The descriptions of the calculations set forth in this
certificate are sometimes abbreviated for simplicity, but are qualified in their entirety by reference to the full text of the
calculations provided in the Credit Agreement.

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit B)
 
B-2

     

    

 

	 	(f)	cash	$________

 

	 	(g)	other short term liquid investments approved in writing by Agent	$________

 

	 	1B.	Total of Items (a) through (g) above	$________

 

	 	2.	Minimum Required	$________

 

	 	Is the amount in Item 1B greater than the amount in Item 2?	__ Yes
	 	 	 	 
	 	 	__ No

 

	B.	Section 7.13.2 – Minimum Aggregate Revenue

 

	 	1.	Net Sales for twelve consecutive month period ending on the Computation Date	$________
	 	 	 	 
	 	2.	Royalties for twelve consecutive month period ending on the Computation Date	$________
	 	 	 	 
	 	3.	Any other income or revenue recognized by Parent and/or its Subsidiaries, on a consolidated basis, in accordance with GAAP for twelve consecutive month period ending on the Computation Date	$________
	 	 	 	 
	 	4.	Sum of Items 1 through 3	$________
	 	 	 	 
	 	5.	Minimum Required for corresponding Fiscal Quarter	(See table in

 Section 7.13.2 of

 the Credit Agreement)

 

	 	Is the amount in Item 4 greater than the amount referenced in Item 5?	__ Yes
	 	 	 	 
	 	 	__ No

 

	C.	Section 7.13.3 – Minimum EBITDA

 

	 	1.	Consolidated net income (or loss) of Parent and its Subsidiaries as determined under GAAP for twelve consecutive month period ending on the Computation Date	$________
	 	 	 	 
	 	2.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, consolidated interest expense (including all imputed interest on Capital leases) of Parent and its Subsidiaries for twelve month period ending on the Computation Date	$________

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit B)
 
B-3

     

    

 

	 	3.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, income tax expense (including tax accruals) of Parent and its Subsidiaries for twelve month period ending on the Computation Date	$________
	 	 	 	 
	 	4.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, depreciation and amortization of Parent and its Subsidiaries for twelve month period ending on the Computation Date	$________
	 	 	 	 
	 	5.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, nonrecurring cash fees, costs and expenses incurred in connection with the Acquisitions of product licenses and product lines from a third party, and milestone and royalty payments to any third party, in relation to any Material Contract or any other Acquisition made by Parent and its Subsidiaries prior to the Closing Date	$________
	 	 	 	 
	 	6.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, non-cash expenses relating to equity-based compensation or purchase accounting of Parent and its Subsidiaries for twelve month period ending on the Computation Date	$________
	 	 	 	 
	 	7.	To the extent deducted in determining Item 1 and without duplication of the foregoing items, any other nonrecurring and/or non-cash expenses or charges approved by the Agent	$________
	 	 	 	 
	 	8.	Sum of Items 1 through 7	$________
	 	 	 	 
	 	9.	Minimum Required for corresponding Fiscal Quarter	(See table in 

Section 7.13.3 of 

the Credit Agreement)

 

	 	Is the amount in Item 8 greater than the amount referenced in	__ Yes
	 	 	 	 
	 	Item 9?	__ No

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit B)
 
B-4

     

    

 

EXHIBIT C

 

Form of Note

 

PROMISSORY NOTE

 

	$[___________]	[_____], 20[__]

 

FOR VALUE RECEIVED and pursuant to the
terms of this PROMISSORY NOTE (as amended, restated, supplemented, or otherwise modified from time to time, this “Note”),
each of the undersigned, SOLSYS MEDICAL, LLC, a Delaware limited liability company, and NEW MISONIX, INC., a Delaware corporation,
(collectively, “Borrower”), promises to pay to the order of [___________________] (together with all subsequent
holders of this Note being hereinafter referred to collectively, as “Holder”), at the offices of SWK FUNDING
LLC, a Delaware limited liability company, as agent (in such capacity, together with its successors and assigns, the “Agent”),
on behalf of Holder and the other Lenders (defined below), having an address at 14755 Preston Road, Suite 105, Dallas, Texas 75254,
or at such other place as Holder hereof may designate in writing, the principal sum of up to [___________] DOLLARS ($[___________]),
or such lesser amount as may be advanced by Holder pursuant to that certain Amended and Restated Credit Agreement, dated as of
September 27, 2019 (as amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”),
among Borrower, the lenders party thereto from time to time (each a “Lender” and collectively, the “Lenders”),
and Agent, together with interest on the unpaid amount from time to time outstanding under this Note at the rate or rates of interest
provided therefor in the Credit Agreement. This Note evidences the obligation of Borrower to repay, with interest thereon, the
Loans under the Credit Agreement made by Lenders to Borrower pursuant to the Credit Agreement.

 

DEFINITIONS

 

Capitalized terms not otherwise defined
herein shall have the meanings set forth in the Credit Agreement.

 

PRINCIPAL AND INTEREST

 

Principal. Borrower
shall make payments on the principal balance of this Note and accrued interest on the principal balance of this Note in accordance
with the provisions of the Credit Agreement. If not sooner paid, the entire unpaid principal balance of this Note and all interest
thereon shall be paid on the Term Loan Maturity Date.

 

Interest. Interest
on the unpaid balance of this Note will accrue from the date of this Note until final payment thereof in accordance with the applicable
provisions of the Credit Agreement.

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit C)
 
C-1

     

    

 

Prepayments.
Borrower may prepay the principal sum outstanding from time to time hereunder as provided in the
Credit Agreement, subject to any prepayment premium set forth in the Credit Agreement.

 

INCORPORATION OF CREDIT AGREEMENT

 

This Note has been issued pursuant to the
Credit Agreement, and all of the terms, covenants and conditions of the Credit Agreement (including all Exhibits and Schedules
thereto) and all other instruments evidencing or securing the indebtedness hereunder are hereby made a part of this Note and are
deemed incorporated herein in full.

 

EVENTS OF DEFAULT

 

Upon the occurrence and during the continuance
of an Event of Default, the Holder shall have the rights and remedies set forth in the Credit Agreement and the other Loan Documents,
in addition to any other remedies to which the Holder may be entitled.

 

LAWFUL LIMITS

 

All agreements between Borrower and Holder
are expressly limited so that in no contingency or event whatsoever, whether by reason of advancement of the proceeds hereof, acceleration
of maturity of the unpaid principal balance hereof, or otherwise, shall the amount paid or agreed to be paid to Holder for the
use, forbearance or detention of the money to be advanced hereunder exceed the highest lawful rate permissible under applicable
usury laws. If, from any circumstances whatsoever, fulfillment of any provision hereof, of the Credit Agreement or of any other
Loan Documents shall involve transcending the limit of validity prescribed by any law which a court of competent jurisdiction may
deem applicable hereto, then, ipso facto, the obligation to be fulfilled shall be reduced to the limit of such validity, and, if
from any circumstance Holder shall ever receive as interest an amount which would exceed the highest lawful rate, such amount which
would be excessive interest shall be applied to the reduction of the unpaid principal balance due hereunder and not to the payment
of interest. This provision shall control every other provision of all agreements between Borrower and Holder.

 

To the extent that either Chapter 303 or
306, or both, of the Texas Finance Code, as amended from time to time, apply in determining the Maximum Lawful Rate notwithstanding
that the parties have chosen that the laws of the State of New York (or applicable United States federal law to the extent that
it permits Holder to contract for, charge, take, receive or reserve a greater amount of interest than the laws of the State of
New York) to govern and control in the enforcement, interpretation and construction of the Loan Documents generally, Holder hereby
elects to determine the applicable rate ceiling by using the weekly ceiling from time to time in effect, subject to Holder’s
right from time to time to change such method in accordance with applicable law, as the same may be amended or modified from time
to time, to utilize any other method of establishing the Maximum Lawful Rate under the Texas Finance Code or under other applicable
law by giving notice, if required, to Borrower as provided by applicable law now or hereafter in effect. To the extent United States
federal law permits Holder to contract for, charge, take, receive or reserve a greater amount of interest than under Texas law,
Holder will rely on United States federal law instead of applicable state law for the purpose of determining the Maximum Lawful
Rate. As used herein, (x) the term “Maximum Lawful Rate” shall mean the maximum lawful rate of interest
which may be contracted for, charged, taken, received or reserved by Holder in accordance with the applicable law (or applicable
United States federal law to the extent that it permits Holder to contract for, charge, take, receive or reserve a greater amount
of interest than under applicable state law), taking into account all Charges made in connection with the transaction evidenced
by the Note and the other Loan Documents, and (y) the term “Charges” shall mean all fees, charges and/or
any other things of value, if any, contracted for, charged, received, taken or reserved by Holder in connection with the transactions
relating to the Loan Agreement, the Note and the other Loan Documents, which are treated as interest under applicable law.

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit C)
 
C-2

     

    

 

MISCELLANEOUS

 

WAIVERS.
PRESENTMENT FOR PAYMENT, NOTICE OF NONPAYMENT OR DISHONOR, PROTEST, NOTICE OF PROTEST, DEMAND,
NOTICE OF DEMAND, NOTICE OF ACCELERATION OR INTENT TO ACCELERATE AND ALL OTHER NOTICES IN CONNECTION WITH THE DELIVERY, ACCEPTANCE,
PERFORMANCE, DEFAULT OR ENFORCEMENT OF THIS NOTE ARE HEREBY IRREVOCABLY WAIVED BY BORROWER.

 

Exercise
of Remedies. No delay on the part of Agent
or Holder in the exercise of any right, power or remedy hereunder, under the Credit Agreement or under any other Loan Document
shall operate as a waiver thereof, nor shall any single or partial exercise by Agent or Holder of any right, power or remedy hereunder,
under the Credit Agreement or under any other Loan Document preclude other or further exercise thereof, or the exercise of any
other right, power or remedy. Upon the occurrence and continuance of an Event of Default, Agent and Holder shall at all times have
the right to proceed against any portion of the Collateral in such order and in such manner as Agent and Holder may deem fit, subject
to and in accordance with the Guarantee and Collateral Agreement and IP Security Agreement without waiving any rights with respect
to any other security.

 

Invalid
Provisions. The illegality or unenforceability
of any provision of this Note shall not in any way affect or impair the legality or enforceability of the remaining provisions
of this Note.

 

Governing
Law. THIS NOTE SHALL BE A CONTRACT MADE
UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN
SUCH STATE, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTION 5- 1401 AND SECTION 5-1402 OF THE NEW YORK GENERAL
OBLIGATIONS CODE).

 

Definition
of Note. All references to “Note”
or “Notes” in the Loan Documents shall also include this Note, to the extent not returned to Borrower for cancellation,
as the same may be amended, supplemented, modified, divided and/or restated and in effect from time to time.

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit C)
 
C-3

     

    

 

New Notes.
Upon Agent’s written request (on behalf of Holder) Borrower shall execute and deliver to Agent new Notes and/or split or
divide the Notes, or any of them, in exchange for the then existing Notes, in such smaller amounts or denominations as Agent shall
specify; provided, that the aggregate principal amount of such new, split or divided Notes shall not exceed the aggregate
principal amount of the Notes outstanding at the time such request is made; and provided, further, that such
Notes that are replaced shall then be deemed no longer outstanding under the Credit Agreement and replaced by such new Notes and
returned to Borrower within a reasonable period of time after Agent’s receipt of the replacement Notes.

 

Replacement Notes.
Upon receipt of evidence reasonably satisfactory to Borrower of the mutilation, destruction, loss or theft of any Notes and the
ownership thereof, Borrower shall, upon the written request of the holder of such Notes, execute and deliver in replacement thereof
new Notes in the same form, in the same original principal amount and dated the same date as the Notes so mutilated, destroyed,
lost or stolen; and such Notes so mutilated, destroyed, lost or stolen shall then be deemed no longer outstanding under the Credit
Agreement. If the Notes being replaced have been mutilated, they shall be surrendered to Borrower; and if such replaced Notes have
been destroyed, lost or stolen, such holder shall furnish Borrower with an indemnity in writing to indemnify, defend and save them
harmless in respect of such replaced Notes.

 

[Remainder of page intentionally blank;
signature page follows].

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit C)
 
C-4

     

    

 

IN WITNESS WHEREOF, the undersigned has
caused this Promissory Note to be executed as of the day and year first written above.

 

	 	BORROWER:
	 	 
	 	
        NEW MISONIX, INC.

        a Delaware Corporation

	 	 
	 	By:	                                        
	 	Name: 	 
	 	Title:	 
	 	 
	 	SOLSYS MEDICAL, LLC,
	 	a Delaware limited liability company
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

    [Mixonix-Solsys] Exhibits to A&R Credit Agreement (Exhibit C)
 
C-5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]